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Depression is a complex mental health disorder, predicted to be the highest global
burden of disease by 2030. Research has examined the antecedents of adolescent
depression in order to limit and prevent depression from occurring. However, de-
pression during this phase of development is multifactorial and variability in de-
pression is characterised by important features such as the age of onset, chronicity
and severity. Identifying these features, and how depressive mood changes across
time along with potential risk factors may aid in our understanding of the nature of
adolescent depression and help develop new interventions and treatments.
This thesis uses longitudinal methods to explore the nature of trajectories of
depressive symptoms and examine how genetic, and early environmental risk fac-
tors contribute to trajectories of depressive symptoms across adolescence and young
adulthood in a UK population based cohort, the Avon Longitudinal Study of Par-
ents and Children. Using group-based and multilevel frameworks, trajectories of
depressive symptoms are estimated across adolescence and then various risk factors
are explored to investigate how these trajectories change across time.
Genetic risk for depression, childhood bullying, female sex and childhood trauma
are all associated with less favourable trajectories of depressive symptoms. Impor-
tantly, several risk factors are associated with changes in depression across time,
and not just at certain stages of development. This implies they have lasting effects
and that it may be possible to identify when particular risk factors are having their
greatest effect on later depression.
This work provides further evidence that depressive symptoms across adolescence
to young adulthood are complex and associated with both genetic and environmental
contributions. Examining depressive symptoms across time within a longitudinal
framework provides a powerful opportunity to examine the nature of depression in
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1.1 Background and rationale
Depression is a major health concern, thought to affect approximately 300 million
people around the world [1], and predicted to become the highest global burden
of disease by 2030 [2]. Prevalence estimates vary, but lifetime risk of experiencing
depression is thought to be as high as 18%, meaning that almost one in five individ-
uals will go on to develop depression [3]. Depression is co-morbid with other mental
health disorders such as generalised anxiety disorder and substance misuse [4, 5],
and one of the leading risk factors for suicide [6]. Depression is also associated with
social and educational impairments and reduced physiological wellbeing [7]. It is
therefore important to examine the aetiology and nature of depression in order to
prevent and reduce the impact of this illness.
Given that most psychiatric disorders such as depression are complex, it is not
surprising that depression is often viewed as a dimensional phenotype [3]. For exam-
ple, there is evidence that depression should be viewed on a continuum rather than
just dichotomised [8, 9]. Studies have shown that increased depressive symptoms
are a strong risk factor for a diagnosis of depression [10–12]. As such, it is possible
to use a summarised score of depressive mood items as a proxy for investigating
higher or lower depression symptomology. This is not to say that such measures
are better than a clinical diagnosis of depression. Instead, these measures (which
are usually the summary score of several items) can be administered quickly and
are a cheap proxy for a face to face diagnosis which can be time consuming and
expensive. Examining depression as a dimensional outcome using depressive symp-
toms has been useful for determining the presence of depression across research [12,
13]. However, in order to improve treatments and interventions for depression, it
is important to identify and target rising symptoms at an early stage before they
become more severe. The identification of early symptoms could therefore prevent
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depression for occurring or reducing the likelihood of some of these negative social
and psychological detriments.
One of the key stages of development where depressive symptoms often first
arise is during adolescence [14, 15]. Thus, many researchers have targeted this stage
of maturation in order to prevent depressive symptoms from escalating. Adoles-
cence marks a period where depression will commonly onset, with almost 40% of
individuals having their first episode before the age of 20 [3, 16]. Furthermore, 50%
of individuals who experience depression before the age of 18 years old subsequently
relapse later in life [17]. Adolescent depression is also a significant predictive of
depression at later stage of life [18, 19], and a risk factor for other social and cogni-
tive dysfunctions downstream [20]. Worryingly, recent evidence suggests prevalence
of adolescent and young adulthood depression is increasing, with almost a fivefold
increase in the number of young people reporting a mental health condition [21].
Therefore, research has focused on identifying the aetiology of adolescent depression
to alleviate current and later depression.
1.2 Previous research, key limitations and poten-
tial solutions
Risk factors such as sex [22], maternal depression [23], childhood adversity [24],
childhood bullying [25] and childhood psychopathology [26] have all been identified
as potential risk factors for adolescent depression. Some of these are considered
biological risk factors (sex), whilst others are considered environmental risk factors
(adversity, bullying and psychopathology). Others still may be considered a mix-
ture of both (maternal depression and psychopathology). Additionally, there is now
the consensus that genetic factors also contribute to the onset and maintenance of
depression [16, 27]. Much of the research on genetic influences of depression has
been led by twin research [28]. However, there may be issues regarding generalis-
ability with twin study designs. On the other hand, many non-twin studies have
been unable to take genetic factors into account, likely because genetic data were
not available (or in the cases where they were available, they were restricted to
candidate genes which have been difficult to replicate). Recent advances in genomic
research has meant that many longitudinal cohorts can now include alternative forms
of genomic data such as measures of heritability and genetic liability scores (poly-
genic risk scores) to capture the genetic component of depression in an alternative
framework to traditional twins research [29]. However, in many studies, the true
longitudinal effect of these risk factors is not known as depression is only measured
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on one occasion (i.e., at age 18). Therefore, the ability to fully understand the rela-
tionship between a risk factor and later depression is limited in studies that do not
have multiple assessments of depression.
One way to explore the impact of risk factors on depression is to examine depres-
sion longitudinally using repeated measures that highlight the nature and changes of
depression over time [30]. In the context of adolescent depression, it is important to
examine when depression may be increasing or when it is at its highest as this could
help tailor and improve interventions that may benefit wellbeing at a later stage
of life. Likewise, if we can examine the course of depression and how and when it
reaches this maximum (i.e., what are the antecedents for greater depression over
time?), it may be possible to identify the key risk factors involved or preventative
mechanisms that could help reduce depression over time. How depression changes
over the course of development is therefore of great interest to researchers and clin-
icians alike. As figure 1.1 demonstrates, it is possible to use repeated assessments
to go over and above traditional cross-sectional research methods to probe more
information about the longitudinal nature of depression and its antecedents. Note
that in the cross-sectional method, person 1 has greater symptoms. But using the
repeated measures model, we can see that person 1 ends up with lower symptoms
over time. The repeated measures model therefore gives more information.
Figure 1.1: Comparisons between cross sectional method (A) and repeated measures
method (B). Note that in the cross-sectional method, person 1 has greater symptoms.
But using the repeated measures model, we can see that person 1 ends up with
lower symptoms over time. The repeated measures model therefore gives more
information.
One of the most widely used methods for examining change in depression over
time is growth curve modelling [30, 31]. Growth curve modelling can be achieved
by using repeated measures of depressive symptoms from the same person over
time (across multiple waves), which will highlight an individual’s overall trajectory.
This longitudinal approach has obvious advantages of some previous cross-sectional
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approaches, as it possible to examine depression at multiple stages of development,
rather than just one occasion.
Using this repeated measure approach, it is possible to highlight the course
of depression for an individual, group of individuals or a population [32]. Several
methods exist for deriving trajectories of depressive symptoms, which are discussed
in greater detail in chapter 2. In brief, one key approach is to estimate trajectories for
each individual and then capture the average trajectory across everyone – population
averaged trajectory. A second key approach is to stratify individual trajectories
into a limited number of groups of qualitatively distinct multiple-subpopulation
trajectories that highlight hidden population subgroups - the latent class approach
(referred to as the multiple trajectories approach from here onwards). Each approach
can be combined with earlier risk factors to show how they can be associated with
the varying trajectories.
Whilst growth curve modelling of depressive symptoms has been useful for
examining the nature of adolescent depression, there are several key limitations
of previous research, which I will state and aim to address in this thesis. These
limitations are highlighted in greater detail in chapter 2.
Firstly, it is important to state that many studies do not have truly longitudinal
data that captures the entirety of important periods of development. Depression will
commonly onset during adolescence and it therefore important to track preceding
and succeeding depression data to truly capture the nature of depression during this
stage of development (i.e., from childhood all the way through to young adulthood).
However, several studies only have data at certain key stages such as childhood to
adolescence or focus on adolescence alone. This makes it difficult to conceptualise
what the true pattern of longitudinal adolescent depression is and how a risk factor
might affect that pattern. Tracking depression throughout this period with enough
measures to capture any abrupt fluctuations in mood.
Secondly, previous research has often been limited to small or modest sample
sizes, which can result in issues regarding generalisability. Large sample studies
do exist [33, 34], but there are many studies that estimate complex growth curve
models on smaller sample sizes that are not adequate and result in biased estimates,
misinterpretations and contrasting conclusions [35, 36].
Thirdly, much of the previous work has been limited by the availability of
existing data and methods. As discussed earlier, genetic factors are likely to play a
key role in adolescent depression [16], yet the use of genetic methods in studies has
been largely limited to twin studies. Incorporating both genetic and environmental1
1When I refer to genetic and environmental risk factors, that does not necessarily mean that all
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risk factors into population studies is likely to further advance our understanding of
the nature of adolescent depression.
Finally, there are also issues with the interpretation and translation of complex
growth curve model findings into practice and policy. Using different methods to
estimate growth curves of depressive symptoms (population averaged trajectories
vs. multiple trajectories) can result in different interpretations of the same data.
Likewise, more complicated models can produce estimates that are not easy to
understand. For example, many trajectory estimates use higher order polynomials
to describe changes over time. These estimates are sometimes referred to as linear,
quadratic and cubic changes which highlight the nonlinearity of change over time
and can give varying estimates that cannot be interpreted in isolation (i.e., the
linear term goes up, the quadratic goes down and the cubic goes up). Translating
these findings into more interpretable results (in conjunction with other research
on predictions and diagnostic accuracy) could help pave the way for researchers,
clinicians and policy makers develop better interventions and prevention strategies
for depression.
1.3 Thesis aims and objectives
The aim of this thesis is to highlight how genetic and environmental factors con-
tribute to trajectories of depressive symptoms. Specifically, this thesis will use a
population cohort with multiple assessments of depression to achieve this main the-
sis aim and address many of the limitations of previous research which could help
clarify the nature and aetiology of adolescent depressive symptoms.
Objectives
To achieve this overarching thesis aim, four research objectives are presented:
1. What are the varying patterns of longitudinal depressive symptoms
across adolescence? To address this objective and build a platform for the rest of
the thesis, I use two different growth curve methods (population averaged trajectory
vs multiple trajectories approaches) to derive trajectories of depressive symptoms
between childhood and young adulthood. This allows me to explore the utility of
each approach and how different methods may produce varying or similar results
and interpretations. This objective will build upon previous research that has been
unable to examine a long enough duration of depression symptoms (i.e., transitions
these studies have both genetics and environmental data. I use the term genetic and environmental
risk factors as an umbrella term to capture multiple risk factors including parental behaviour,
bullying, genetic risk, childhood psychopathology, early life experiences and sex.
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between childhood to adolescence, and adolescence to young adulthood). By exam-
ining a wide temporal window where symptoms change, it may be possible to better
characterise the true nature of depressive symptoms across adolescence. Moreover,
previous research has often been subject to smaller sample sizes which limit the
generalisability of results to other populations and can be subject to bias. Creating
growth curves for larger populations will go some way to alleviating those biases.
Based upon previous research with limited and small data, I hypothesis that I will be
able to detect a variety of heterogeneous subpopulation trajectories in the multiple
trajectories approach (given the increase in power), and that population-averaged
trajectories will differ by specific populations (i.e., different trajectories of males and
females).
2. How are genetic and environmental risk factors differentially asso-
ciated with varying trajectories of depressive symptoms? Here I utilise
the two different growth curve methods to address this issue over several chapters.
Firstly, I use the results from the popular multiple-subpopulation trajectories ap-
proach to examine how genetic and early environmental risk factors are differentially
associated with varying longitudinal profiles of depressive symptoms in a multi-
variate fashion. Secondly, I run a series of analysis using the population-averaged
trajectory approach to examine how these varying genetic and environmental risk
factors are associated with overall depressive symptoms and changes in depressive
symptoms over time. This allows me to highlight how each approach could be
useful for examining the antecedents of trajectories of depressive symptoms. But
importantly, it allows me to examine genetic and environmental risk factors in both
a broad and specific manner (multivariate [multiple-subpopulation] and then uni-
variate [population-averaged] approaches). This objective is key to this thesis as
previous research has been limited by an inability to explore and compare both
genetic and environmental risk factors within the same study, especially in longi-
tudinal designs. Therefore, this objective expands upon previous work to include
these risk factors. I hypothesised that both genetic and environmental risk factors
will be associated with worse trajectories of depressive symptoms, and that certain
risk factors (i.e., female sex and bullying) may yield stronger associations compared
to other risk factors such as genetic risk for example.
3. Are there critical points in trajectories of depressive symptoms which
tell us more about how and when depressive symptoms change across
adolescence? I apply the results from the population-averaged trajectory approach
to explore whether it is possible to identify critical or important points in trajectories
of depressive symptoms such as when they are getting worse at the fastest rate or
when they are at their maximum. This allows me to determine if the growth curve
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modelling approach can be extended to help identify at risk individuals, before their
depressive symptoms are at their worst. Previous research has yet to explore this
notion of critical points, despite the fact that many growth curve studies suggest
that there are sensitive periods where depressive symptoms may be increasing. I
hypothesise that growth curve modelling can elucidate when depressive symptoms
are getting worse and when they are at their worst, and these critical points might
help infer more about the aetiology of adolescent depression.
4. Can the results from trajectory models be simplified to aid in the
interpretation and translation of findings? For this last objective, I maximise
the results from the three population averaged trajectory chapters to examine if
there are alternative ways of presenting trajectory results from complex models.
This allows me to explore if complex growth curve estimates can be better translated
into more accessible results that could be useful downstream for policy makers and
clinicians, and can help identify when a risk factor is likely to have its greatest effect
on depressive symptoms.
It is important to clarify here that multiple chapters were used to address
research objectives 2 and 4 (shown in table 1.1). This is done for several reasons.
For research aim 2, I use multiple chapters to address this research aim as different
growth curve methods have different utilities and could lend themselves to different
interpretations. However, finding consistent results that have similar implications
from both approaches would provide further evidence for addressing the research
question and boosting the generalisability of both approaches. Likewise, one chapter
(chapter 5) uses a multivariate analysis and in subsequent chapters (chapters 6, 7
and 8), I go into more detail to tease apart these associations. For research aim 4,
multiple studies are used to provide context for the results (i.e., when translating
complex estimates into a simpler interpretation, do the contexts of the results change
when examining genetic risk compared to childhood trauma?).
1.4 Thesis structure
Much of the work from this thesis has been published or submitted for publication
as five manuscripts in peer-reviewed journals (see below). Except for Chapter 2
(literature review), parts of chapter 3 (data and methods) and chapter 4 (the iden-
tification of varying trajectories), each of the thesis chapters presented form parts of
publications or submissions, yet all these research chapters fall under the overarch-
ing theme of examining genetic and environmental contributions to trajectories of
depressive symptoms. Here I produce a brief outline for what each chapter contains:
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Research Chapters
Research Objectives 4 5 6 7 8
1. What are the varying patterns of longitudinal
depressive symptoms across adolescence?
Y - - - -
2. How are genetic and environmental risk factors
differentially associated with varying trajectories
of depressive symptoms?
- Y Y Y Y
3. Are there critical points in trajectories of
depressive symptoms which tell us more about
how and when depression changes across
adolescence?
- - Y Y Y
4. Can the results from trajectory models be
simplified to aid in the interpretation and
translation of findings?
- - Y Y Y
Table 1.1: Thesis research objectives. Note that in research objectives 2, 3 and 4,
multiple research chapters can address each aim.
Chapter 2 presents a review of the current literature on trajectories of depres-
sive symptoms across adolescence. This review was undertaken to summarise the
previous literature, identify potential limitations in previous research and scope new
avenues for research. In this review, I highlight these limitations and summarise pre-
vious methods for examining trajectories of depressive symptoms. I also summarise
the findings from previous research on the nature and characteristics of trajectories
of depressive symptoms across adolescence and identify the most robust risk factors
that should be replicated in large samples with more assessments, and those risk
factors that warrant more investigation. Stemming from this overview I identify the
research gaps to form the basis of this thesis.
Chapter 3 introduces the data and describes the methods used in this the-
sis. The data come from the Avon Longitudinal Study of Parents and Children
(ALSPAC), a longitudinal birth cohort study which has followed over 14,000 chil-
dren and their families since the early 1990s. ALSPAC has an unparalleled richness
of genetic and environmental data, as well as a number of repeated assessments of
depression across development. In this chapter, I describe some of the issues with
the ALSPAC study such as varying methods for data collection and attrition and
introduce the key exposure and outcome variables used in this thesis. I then describe
the two main analytical methods used to estimate trajectories of depressive symp-
toms in this thesis: the population averaged trajectory and multiple trajectories
approaches.
In chapter 4, I apply these analytical methods to derive trajectories of depres-
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sive symptoms in ALSPAC. This chapter uses the two main growth-curve methods
identified in the literature review and chapter 3 to derive patterns of longitudinal de-
pressive symptoms: firstly, I derive both the multiple-subpopulation trajectory and
population-averaged trajectory approaches. I show here that each approach lends
to varying and similar interpretations from the same data, however both approaches
can be tailored to specific research questions where the utility of each approach is
maximised. These trajectories are then used as the foundation for all subsequent
chapters.
Chapter 5 uses the results from the multiple-subpopulation trajectories ap-
proach and limitations identified in the literature review to examine how both ge-
netic and environmental risk factors may be differentially associated with varying
trajectories. Using a multivariate approach to examine how multiple risk factors are
associated with varying trajectories, I show here that it is also possible to differen-
tiate trajectories that may be more reflective of either genetic or environmental risk
factors, and possibly combinations of both. The key finding in this chapter is that
being female, bullying and polygenic risk for depressive symptoms are all associ-
ated with higher trajectories, but can be differentiated to show specific associations.
This chapter forms the basis for the following chapters which explore the association
between these risk factors and trajectories of depressive symptoms in greater detail.
Chapter 6 then looks to replicate and extend one of the key findings from the
literature review and previous chapter: that females are more likely to be associated
with higher trajectories of depressive symptoms. Here I use the population-averaged
trajectories approach from chapter 4 to estimate trajectories separately for males
and females. I show that females are more likely to have higher trajectories of
depressive symptoms across adolescence and young adulthood and that it is possible
to identify critical points in these trajectories such as the age of peak velocity of
depressive symptoms (i.e., the age where depressive symptoms are increasing most
rapidly). I then show that females have an earlier age of peak velocity of depressive
symptoms compared to males, and that this period may be useful for prevention
and interventions.
Chapter 7 expands upon the previous chapters and findings from the literature
review to examine the extent to which a key environmental risk factor, early child-
hood trauma is associated with varying trajectories of depressive symptoms. Using
the population averaged trajectories approach established in chapter 4, I show that
trajectories of depressive symptoms are higher for those exposed to childhood trauma
compared to those who were not. I then show that this effect varies by the number
of types of childhood traumas (such as bullying or abuse), with those having more
types of childhood trauma being associated with the highest trajectory of depressive
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symptoms. I present these results in an alternative framework (which simplifies the
results from trajectory models) designed to aid in the interpretation and translation
of these findings.
Chapter 8 also expands on the previous chapters and addresses a major lim-
itation in the literature to explore how genetic risk for depressive symptoms (as
measured by a polygenic risk score) might be associated with higher trajectories of
depressive symptoms and how these results could be easily interpreted using an alter-
native results framework (established in the previous chapter). I show that greater
genetic risk is associated with greater overall symptoms throughout adolescence, but
also associated with a greater rate of change that begins to manifest in adolescence.
I show that by using the methods derived in previous chapters, it is possible demon-
strate that growth curve modelling has advantages over traditional cross-sectional
methods, and this former approach could be useful for genomic methods.
Finally, in Chapter 9, I give some conclusions which provide a summary of all
the research chapters and discuss how they address each of the thesis aims and their
context within the literature. I show that all the chapters fall under the overarching
theme within this thesis and demonstrate how having multiple chapters in support
of a single research aim may strengthen the validity of those results. I also then
highlight several limitations of the work conducted in this thesis and make several
suggestions for future research.
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Depressive Symptoms in the Avon Longitudinal Study of Parents and Children
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Chapter 5: Kwong, A. S. F., Lopéz-Lopéz, J., Hammerton, G., Manley, D.,
Timpson, N. J., Leckie, G., Pearson, R. M. (2019). Genetic and Environmental Risk
Factors Associated with Trajectories of Depressive Symptoms from Adolescence to
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Chapter 6: Kwong, A. S. F., Manley, D., Timpson, N. J., Pearson, R. M., Heron,
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hood Trauma and Trajectories of Depressive Symptoms.
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E., Tilling, K., (Submitted to Psychological Medicine). Association Between Genetic
Liability and Trajectories of Depressive Symptoms.
1.6 My contribution to this research
I conceived each chapter either jointly or in whole and led all the chapters in this the-
sis. I had sole access to the data used; cleaned, coded and prepared the data where
necessary; conducted all the statistical analyses; interpreted the data either jointly
or in whole; prepared first drafts of each chapter/manuscript; and had executive
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2.1 Introduction and chapter objectives
This chapter summarises the existing literature on trajectories of depressive symp-
toms across and beyond adolescence and identify any potential gaps in the literature
that could be addressed throughout this thesis. As highlighted in the introduction,
there are two popular methods for examining trajectories of depressive symptoms:
the multiple-subpopulation approach and the population-averaged approach. This
literature review synthesises and appraises both approaches before discussing the
longitudinal nature of trajectories of depressive symptoms. I then go on to highlight
several important risk factors for trajectories of depressive symptoms that have and
haven’t been explored in previous research. Finally, I give some considerations for
future research that this thesis will aim to address.
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2.2 Chapter abstract
Growth curve modelling has been used to derive trajectories of depressive symptoms
across adolescence and young adulthood and previous research has demonstrated
that these trajectories of depressive symptoms have a complex and multifactorial
basis. Many social, biological and psychological risk factors have been identified to
determine how and when they are having the greatest effects of adolescent depression
in order to develop and improve interventions and treatments.
However, elevated levels of depressive symptoms first begin to manifest in ado-
lescence, and this stage marks a period of substantial heterogeneity in depressive
symptoms that can be difficult to measure. One of the biggest issues in growth curve
modelling results from how this heterogeneity is modelled. One popular method is to
stratify individuals into multiple-subpopulation trajectories (or latent classes). An
alternative approach is to model the population-averaged trajectory. This choice of
modelling comes down to whether the researcher believes the heterogeneity should
be discrete or continuous.
In this chapter, I give an overview of these two popular methods for deriving
trajectories of depressive symptoms. I then synthesise previous research on trajec-
tories of depressive symptoms across the transition between childhood and young
adulthood to provide a comprehensive understanding of the nature, shape and char-
acteristics of these trajectories. I then highlight the key risk factors used in previous
studies, before giving some considerations for future research which could enhance
the understanding of the nature of trajectories of depressive symptoms and treat-
ment and prevention of depression.
2.3 Introduction
Growth curve modelling has been used to help explore the aetiology and nature
adolescent depression [37]. Taken from repeat measures of an individual, growth
curve modelling is an efficient method for examining the antecedents of depressive
symptoms, change in depressive symptoms over time and later downstream conse-
quences [32, 38, 39]. Growth curve modelling has advantages over cross-sectional
paradigms as it is possible to estimate how depressive symptoms change over time
and not just observe depressive symptoms at one occasion. Likewise, through the
use of repeated assessments, it is also possible to get a better representation of an
individual’s true depressive symptoms score as measurement error may be present
during cross-sectional methods, and this error may be reduced when considered lon-
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gitudinally. The most common application of growth curve modelling is to derive
trajectories, in this case trajectories of depressive symptoms. From here onwards,
the term trajectories will be used interchangeably with growth curve modelling,
unless otherwise specified.
2.3.1 Trajectories of depressive symptoms from childhood
to young Adulthood
The use of trajectories for examining depressive symptoms from childhood to young
adulthood has increased in recent years. This has likely coincided with advancements
in new methods such as growth mixture modelling [40, 41], and the availability of
new repeated data [32]. Using this trajectories approach, many social, biological
and psychological risk factors such as parental behaviour, social class, ethnicity and
early child psychopathology have been identified [35, 42, 43]. Additionally, this
methodology has become more important as trajectories can be useful tools for
identifying pathways to later psychopathology and other impairments [43]. This
importance is highlighted by a recent systematic review on trajectories of depressive
symptoms across the life course in 2016 [32] and two systematic reviews published
in 2017 on trajectories of depressive symptoms in young people [30, 31].
2.3.2 Existing limitations and considerations of trajectories
of depressive symptoms research
Although examining trajectories of depressive symptoms in young individuals has
enhanced our understanding of the mechanisms underlying risk factors for depres-
sive symptoms, there are still many limitations and considerations observed across
previous studies that are of note to this thesis. First, trajectories of depressive symp-
toms across adolescence are heterogeneous and these trajectories can be classified
into discrete or continuous heterogeneity, depending on the methodology. This has
a profound impact on the interpretation of the results as some studies group tra-
jectories into multiple-subpopulation trajectories (i.e., group-based trajectories or
latent classes – discrete heterogeneity), whilst others use population-averaged tra-
jectories (hierarchical linear models or multilevel growth-curve models – continuous
heterogeneity). This means it is sometimes difficult to compare trajectories across
multiple studies. Secondly, some studies only examine trajectories of depressive
symptoms at a certain period (e.g., adolescence), whilst others capture data across
the transition between several developmental periods (e.g., childhood to adolescence
or adolescence to adulthood). If only a snapshot of the data is captured, then it is
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not possible to infer more about the nature of trajectories of depressive symptoms
and inconsistent patterns can emerge. Finally, many studies have been limited by
the availability of existing data and have been unable to explore key risk factors
for trajectories of depressive symptoms such as genetic or familiar risk. This means
that there are many avenues for research which are left incomplete and are worth
addressing to help further explore the aetiology of adolescent depressive symptoms.
2.3.3 The current review
The purpose of this review is to highlight previous research and shed light on some
of the limitations and existing considerations in growth curve modelling research
across adolescence and young adulthood. For simplicity, I use the phrase ‘childhood
to young adulthood’ to describe these studies, even though many of these studies
will only cover certain ages or transitions. I also use the term “higher” trajectories to
describe trajectories that have more severe or less favourable patterns of depressive
symptoms – thus higher trajectories are perceived to be negative throughout this
chapter (note, I also use this term throughout the thesis). In this review, I first give
an overview of two popular methods for deriving trajectories of depressive symptoms
and then critically appraise each approach. Secondly, I then synthesise previous re-
search on trajectories of depressive symptoms across childhood and young adulthood
to provide a comprehensive understanding of the nature, shape and characteristics
of these trajectories. I then highlight the key risk factors identified in previous
studies and identify risk factors which require further research. Finally, I give some
considerations for future research which I will then address in the remainder of this
thesis.
2.4 Statistical methods for examining trajectories
of depressive symptoms
2.4.1 Methodological variation
There are several ways to model trajectories of depressive symptoms which may
impact on the interpretation of these trajectories. As shown in figure 2.1., one pri-
mary method is to stratify repeat measures of depressive symptoms into multiple-
subpopulation trajectories (the group-based method – discrete heterogeneity) which
all have qualitatively distinct trajectories that represent a group of individuals over
time for example, those with consistently low symptoms (stable low) or those with
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symptoms that rise throughout childhood (childhood rising) [41, 44–46]. An indi-
vidual then has a probability (and an associated degree of uncertainty) of belonging
to one of these subpopulation trajectories based upon their responses [40, 47]. A risk
factor (e.g., sex or ethnicity) may then be added into the model to increase/decrease
the odds of an individual belonging to a certain trajectory, that is conditional of the
model. The number of subpopulation trajectories identified tends to range between
3-5, but as many as 6 have been estimated in previous studies [30–32]. This method
is described as the multiple-subpopulation trajectories approach or multiple trajec-
tories approach from here onwards. An alternative approach is to estimate individ-
ual trajectories of each person that can then form an overall population trajectory
[48, 49]. These population trajectories are often referred to as population-averaged
growth-curve models or latent curve models and display the trajectories in a contin-
uous heterogeneity manner [49, 50]. These trajectories are composed of an intercept
and slope, which quantifies the rate of change (or uses these parameters to describe
the the growth-curve). A risk factor (e.g., sex or ethnicity) is then associated with
the trajectory to investigate its impact on the intercept and rate of change [30].
Figure 2.1: Comparison between multiple-subpopulation approaches such as Growth
Mixture Modelling (GMM) or Latent Class Growth Analysis (LCGA) where tra-
jectories could be ‘low’, ‘increasing’, ‘decreasing’ and ‘high’ (A.) and population-
averaged trajectory approaches such as Hierarchical Linear Models (HLM) or Mul-
tilevel Growth-Curve Models (MLM) where the trajectory could be the average
depressive symptoms score in the population (B.).
It is important to highlight that while both methods aim to quantify the nature
and change of trajectories of depressive symptoms, they both vary in their approach
to answering growth curve research due to how they each deal with the heterogeneity
of individual level trajectories. Consequently, the degree to which it is possible to
compare across studies using the two varying methodologies depends on the research
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questions involved. In the following section, I discuss the underlying approach for
each method and the potential advantages and disadvantages in relation to exploring
trajectories of depressive symptoms between childhood and young adulthood.
2.4.2 Multiple-subpopulation trajectories
Multiple-subpopulation trajectories have greatly enhanced our understanding about
the heterogeneity of depressive symptoms within populations [32]. There are various
forms of the multiple-subpopulation approach, however the overarching principle of
these multiple-subpopulation approaches is that they predict the posterior proba-
bility that an individual belongs to a certain subpopulation trajectory. Latent Class
Growth Analysis (LCGA) or Semi-parametric group-based models (SPGBM) clas-
sify individuals into qualitatively distinct subpopulation trajectories in which there
is often assumed to be no within-group variance (i.e., everyone within this trajec-
tory follows the same pattern) [40, 45, 46]. Multinomial logistic regression (or some
alternative e.g., basic logistic regression or analysis of variance [ANOVA]) is then
used to associate a risk-factor with a specific trajectory (against a comparison or
baseline trajectory – often a low or high trajectory) which can shed light on which
risk factors are associated with higher/lower trajectories [35, 37, 42]. However, as
depressive symptoms are heterogeneous and can fluctuate greatly over time [51],
it is unlikely that everyone within a subpopulation trajectory will follow the same
pattern and such models may be inadequate for measuring heterogeneous depressive
symptoms.
To circumvent this, Growth Mixture Models (GMM) and General Growth Mix-
ture Models (GGMM) have been used as an alternative approach to modelling
multiple-subpopulation trajectories [40, 41, 44]. GMM is a simple extension to
LCGA/SPGBM that allows variance to occur within-group subpopulation trajec-
tories (i.e., individual trajectories may all be classified into one subpopulation tra-
jectory but may have different patterns within that overarching trajectory). With
GMM, it is possible to explore the impact of a predictor on multiple trajectories
and then which trajectory may impact on a later outcome, all within a one-step
model [52]. A biased adjusted three step model that incorporates the uncertainty
regarding trajectory classification can also be used [53]. Like, LCGA/SPGBM, as-
sociations between a risk factor and a varying trajectory can be established with
through multinomial logistic regression or some alternative for GMM approaches.
GMM and GGMM have been increasingly popular for estimating trajectories of de-
pressive symptoms during the transition across childhood through young adulthood
with many studies using this approach and finding consistent evidence of multiple
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subpopulation trajectories of depressive symptoms across various populations [32].
Advantages. There are many advantages for the multiple-subpopulation approach.
For instance, a priori knowledge about the nature and shape of trajectories is not
required as the number of trajectories identified are formally tested using some
model fit criterion (usually through the smallest Bayesian information criterion
[BIC], highest entropy or likelihood ratio test [these are discussed in greater length
in the methods and data chapter]) [54]. This can also lead to a hypothesis free
approach that discovers potentially meaningful latent classes that might have been
overlooked in other forms of growth modelling [47]. Additionally, problems with
random variation are minimised in multiple-subpopulation models as variance is
stratified into subgroup populations [55]. This also means there are fewer problems
with over/underfitting of the model. Multiple-subpopulation models can also in-
clude covariates in the original model allowing for a degree of flexibility in model
fit [52]. Similarly, it is easy to explore associations between multiple risk factors
and trajectories in a multivariate approach, which means it is a popular approach
when considering multipe risk factors at one time. Finally, these studies are easy
to conduct in many software packages such as R, SAS or Mplus and can show clear
and easy to interpret associations between risk factors and specific trajectories [40].
Disadvantages. However, there are several disadvantages to the this approach
which are important to highlight. The first is that the identification of subpopu-
lation trajectories are based upon posterior probabilities and that every individual
trajectory belongs to every class, just some have a higher degree of certainty as to
which class they should belong to [56]. However, this can be minimised in a bias ad-
justed three step model which considers this uncertainty and reduces this potential
bias. A more pressing concern is the possibility that some subpopulation trajectories
identified from multiple-subpopulation models don’t exist [57]. This may be espe-
cially true with small sample sizes when trajectories are made from few individuals
or when the data are not normally distributed and non-linear. Likewise, it may not
be possible to form adequate trajectories when there are few measurements, and 4 or
5 measurements are often preferable to ensure the adequate identification of trajec-
tories [58]. The shape of trajectories can also change with the addition of covariates
– especially when trajectories are built in multiple stages (i.e., stage one identifies
the trajectories, stage two adds in covariates, stage 3 adds a distal outcome – and
each have missing data). If multiple studies are using the same data source, but ex-
amining including different covariates into the initial model, there is the possibility
that different trajectories will be estimated [53]. Additionally, when the data are
missing at random (MAR), there may be problems in recovering the correct number
of subpopulation trajectories and errors in the probability of belonging to a specific
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subpopulation if the individuals missing from the data are missing for a specific
reason [58]. For example, if an individual has two low scoring depressive symp-
toms measurements than misses the following two measurements due to depression
(missing not at random [MNAR]), the model would specify that the individual had
a low trajectory of depressive symptoms which is not the case. Finally, multiple-
subpopulation models may not adequately capture severe fluctuations in the data.
Depressive symptoms can rapidly change from each occasion and subpopulations
may not properly model these fluctuations.
2.4.3 Population-averaged trajectories
An alternative approach is to estimate trajectories of depressive symptoms through
the population-averaged approaches such hierarchical linear models (HLM) [48],
multilevel growth-curve models (MLM) [59] or latent curve models (LCM) [60].
Here, each individual trajectory is measured, and then a single population trajec-
tory can be identified that is the average of all these individual trajectories. This
trajectory is characterised by two factors: an intercept (starting point) and a slope
(rate of change [more advanced rates of change will be discussed in the data and
methods chapter]). Risk factors can then be included into the model to examine
associations between an intercept and/or slope. Like multiple-subpopulation tra-
jectories, there are variations in how trajectories of depressive symptoms can be
modelled. For example, HLM and MLM assume that repeat measures of depressive
symptoms are nested within individuals and growth curves can be derived to form
individual level and subsequent population-averaged trajectories [49]. There is a de-
gree of flexibility in how population trajectories are modelled as the slope (i.e., rate
of change) can be estimated using various functions of time (usually polynomials).
This is discussed in greater detail in chapters 3 and 4. A similar approach is to
estimate latent curve modes via a structural equation modelling framework (SEM)
[60]. Here, the trajectory is characterised by unobserved latent growth factors such
as the intercept and slope. The additional benefits of using the SEM approach is
that specific depression items, pathways and mediation models can be estimated in a
growth curve framework. The population-averaged approach can also be estimated
in many statistical packages such as Stata, SAS, R, Mplus and SPSS.
Advantages. There are several advantages of the population-averaged trajectory
approach. The first is that this approach gives a clear understanding about the
nature of a trajectory within a given population [49]. Model fit can be tested by BIC
or deviance to examine the best fit for the trajectory [61]), and derived trajectories
can be displayed next to descriptive data to visually examine model fit. The second
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advantage is that it is easy to explore rates of change within the population-averaged
approach. For example, it is possible to associate a risk factor with the rate of change
to investigate if depression is getting worse faster or slower. Consequently, it could
then be possible to examine if a risk group (e.g., males vs females) has a steeper
trajectory compared to another and if there is worse at a given time. Thirdly, many
HLM and MLM methods are more friendly to longitudinal studies as they allow
for a varying number of measurements per person, inconsistent spacing between
measurements and account for missing data [48], whereas methods like GMM may
have convergence issues with these factors.
Disadvantages. However, there are several disadvantages of the population-averaged
approach. The first is that population-averaged trajectories only describe the aver-
age course of depressive symptoms within a population. Critics of this approach ar-
gue that a single trajectory is not sufficient to model the heterogeneity of depressive
symptoms within the population and just estimating the means of the population
may not be enough to fully explain the nature of depressive symptoms [62]. The sec-
ond is that choosing how to model the slope (i.e., the polynomials) is more subjective
then the multiple-subpopulation approach as researchers do require some a priori
knowledge about the underlying nature before choosing a model that fits the data.
Whilst BIC and deviance can be used to assess model fit, there is more subjectivity
with the population-averaged approach. Thirdly, unlike the multiple-subpopulation
approach, it is much harder to conduct and interpret multivariate models, especially
when there are continuous and categorical risk factors. Finally, like the multiple-
subpopulation approach, there is also the issue of missing data. HLM and MLM
models tend to assume that data are MAR which can lead to biased estimates if the
data are MNAR.
2.4.4 Methods summary
In summary, there are merits and pitfalls to both approaches that must be con-
sidered during study design (see table 2.1 for an overview). Ultimately, whilst the
multiple-subpopulation and population-averaged approaches vary in how they clas-
sify the heterogeneity of depressive symptoms (discrete vs continuous heterogeneity),
it is possible that both methods could be used to draw inferences about the nature
of trajectories of depressive symptoms and their aetiology. The preferred approach
for examining trajectories of depressive symptoms will still depend on the overarch-
ing research question and in some scenarios, one approach may be more beneficial
than the other. However, the two methods could be used to complement one an-
other if results are potentially harmonisable. The greatest obstacle is comparing the
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overall shape between multiple-subpopulation trajectories to population-averaged
trajectories (as there often between 3-5 trajectories that take various shapes vs one
population-averaged trajectory). But if a pattern emerges whereby a risk factor
uniformly associates with “higher” subpopulation trajectories and is also associated
with a higher population-averaged trajectory, then it may be possible to utilise both
approaches rather than use any single approach alone. This thesis will use both
methods to further explore this possibility and examine if using information from
both approaches can lead to stronger inferences regarding the genetic and environ-
mental contributions to trajectories of depressive symptoms. This will be further
considered in the conclusions chapter.
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Multiple-subpopulation trajectories Population-averaged trajectories
Summary: Known as LCGA, SPGBM, GMM and GGMM Known as HLM, MLM, LGA
Multiple subpopulation trajectories One trajectory per population
Predicted odds of membership into each class Coefficients for intercept and slope
Odds of risk-factor being associated with each class Often conducted in Stata, SAS, R
Often conducted in Mplus or SAS
Advantages: No a priori knowledge about the classes Can examine rate of change of a population
Minimised random variation Flexible time function (i.e polynomials)
Fewer problems with model fit Varying measurements and inconsistent spacing
Model fit tested by BIC or entropy Easy to test model fit
Disadvantages: Membership into class based upon probabilities Population trajectory may not be sufficient
Risk of bias in one-step models More subjective modelling of trajectories
Potentially non-existent classes Polynomials may perform poorly at tails
Problems with few measurements Problems if data are not missing at random
Problems if data are not missing at random
Table 2.1: Summary of various trajectory methods. LCGA: Latent class growth analysis, SPGBM: Semi-parametric growth-based
modelling, GMM: Growth mixture modelling, GGMM: General growth mixture modelling, HLM: Hierarchical linear models, MLM:
Multilevel growth-curve models, LGA: Latent growth analysis, BIC: Bayesian information criterion.
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2.5 Previous findings on trajectories of depres-
sive symptoms between childhood and young
adulthood
2.5.1 Number of trajectories
The number of trajectories identified in previous studies will vary depending on the
methodology. Multiple-subpopulation approaches will typically identify multiple
trajectories (at least 3). However, population-averaged trajectories may only identify
one (depending on the number and nature of the risk-factors), especially if the
associated risk factor(s) is a continuous outcome such as a score. In the following
section, I refer to multiple-subpopulation modelling approaches when discussing
the number of trajectories that have previously been identified in the trajectories
of depressive symptoms between childhood and young adulthood literature (unless
otherwise stated). This is because this approach is more popular and always results
in multiple trajectories, whereas the population-averaged approach will only tend
to identify the population trajectory.
Most studies report between 3 or 4 distinct subpopulation trajectories, although
up to 6 have been found in some studies [63–65]. Additionally, some studies also
fit separate models for sex, so that males and females can have a different number
of trajectories [56, 66, 67]. The number of trajectories identified will also depend
on varying sample sizes over different age ranges and duration of follow up/number
of measurements. Conceptually, larger sample sizes may have greater power which
results in more trajectories identified. However, this is not always the case. Heath
and Camarena used data on 268 American children assessed between the ages of
11-14 years, over 3 years (6 waves) and derived 6 subpopulation trajectories of
depressive symptoms [65]. However, similar studies with roughly comparable sizes,
ages and follow ups have observed 3 or 4 trajectories [62, 68]. Likewise, other studies
with larger follow ups and waves [38, 69, 70], have identified fewer trajectories than
studies with smaller follow ups and less waves of data [62, 71, 72]. Of note, when
the sample size surpasses 3000 individuals, there appears to be less variation in the
number of classes identified with most studies identifying at least 4 trajectories of
depressive symptoms [34, 37, 63, 73–79]. This is likely a result of more date resulting
in increased power to detected any meaningful differences between the subpopulation
trajectories. The inconsistency surrounding the number of trajectories identified in
previous studies is therefore likely be partially dependent on sample size, duration
of follow up and the number of measurements and sample size.
40
2.5.2 Characteristics of trajectories
The description of these trajectories tends to vary, but in most studies, there are
common trajectories that emerge regardless of sample size, cohort or measure. As
shown in figure 2.1., the most commonly identified trajectories are often labelled
‘low’, ‘stable-low’ or ‘absence of symptoms’ for individuals with low or no depressive
symptoms [34–37, 62, 63, 68, 73, 75, 80], and ‘high’ or ‘persistent high’ for indi-
viduals with constantly high depressive symptoms [43, 71, 72, 81–84]. In between
these, there are intermediary trajectories that have been identified as: ‘increasing’,
‘decreasing’, ‘moderate’, ‘transient’ and ‘adolescent-onset’, all of which appear in
various forms across studies [34, 37, 62, 69, 71, 73, 75, 85, 86]. These intermediary
trajectories vary more than the “low” or “high” trajectories and are likely depen-
dent on when depressive symptoms were assessed, follow-up duration and sample
size. Nevertheless, these intermediary trajectories are more challenging groups to
quantify given the heterogeneity of depressive symptoms. However, not all studies
will simply have these “low”, “high” and intermediary trajectories. Some studies
have identified trajectories based upon their onset such as ‘low’, ‘moderate early’,
‘severe early’ and ‘late’ [35], or ‘adolescent onset’ and ‘high childhood’ [34, 87], whilst
others have found that both high and low trajectories change over time: ‘increasing’
and ‘decreasing’ [38], and ‘low and declining’, ‘moderate and stable’ and ‘high in-
creasing’ [69]. These trajectories are potentially more interesting as these describe
the nature of a trajectory, but also qualitatively describe when it is beginning to
occur (i.e., an onset during adolescence or limited to childhood). Such trajectories
may be more informative within developmental research as they provide more in-
formation on an individual’s trajectory than a simple “increasing” or “decreasing”
label.
The number of individuals belonging to these varying trajectories also tends
to differ. In a systematic review of 20 studies, Shore and colleagues found that
about 67% (range: 24-93%) of individuals across these studies belonged to some
low trajectory group [31]. Individuals belonging to a ‘high’ trajectory contributed
3% (range: 0-25%), whilst 17% (range: 0-76%), 4% (range: 0-22%) and 8% (range:
0-23%) belonged to a ‘moderate’, ‘increasing’ or ‘decreasing’ trajectory respectively.
In a separate systematic review on 47 studies, Schubert and colleagues suggested
that between 60-80% of individuals fall into a lower trajectory, whilst between 5-12%
of individuals belong to higher trajectories. Schubert and colleagues also suggested
that intermediary trajectories that vary by shape and numbers may be dependent
on specific population characteristics and sample size [30].
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2.5.3 Shapes of trajectories
The shapes of the trajectories also differ for both multiple-subpopulation and population-
averaged approaches. In many multiple-subpopulation studies, intermediary tra-
jectories take linear and non-linear patterns where they increase/decrease across
time and then level out, continue increasing/decreasing or eventually plateau. In
multiple-subpopulation approaches, there may be several trajectories that follow a
cross-diagonal shape like the pattern shown in figure 2.1 (A) [35, 36, 75, 77, 86].
Some studies also have multiple opposing non-linear trajectories that cross one an-
other. For instance, Repetto and colleagues observed high and low trajectories that
surrounded two increasing and decreasing trajectories in adolescence [83]. Costello
and colleagues observed two trajectories that were stable (no depressed mood and
low) and two cross-diagonal trajectories with one starting high and decreasing (early
high) and one rising through adolescence and into young adulthood (late escalating)
[37]. Studies that show non-linear trajectories imply that depressive symptoms are
affected by severity (low, moderate or high), chronicity (childhood limited or high
persistent) and stability (stable, increasing or decreasing) [32].
Population-averaged trajectories also show severity, chronicity and stability and
highlight how trajectories of depressive symptoms within the population are hetero-
geneous and not stable. Studies have shown linear [88–92], and nonlinear trajectories
[18, 33, 93–96]. Nonlinear trajectories of depressive symptoms research are typi-
cally explored with quadratic growth. Edwards et al. (2014) showed that depressive
symptoms between male and female populations followed different shapes, with male
trajectories having a more rising inverse quadratic shape (a convex shape), whilst
females had a more traditional quadratic shape that declined towards adulthood (a
concave shape). Quadratic trajectories of depressive symptoms have been used to
model growth curves in multiple studies [97–100]. For more complex trajectories,
cubic growth has also been explored when quadratic growth cannot adequately cap-
ture the depressive symptoms [101, 102]. The fact that both multiple-subpopulation
trajectory and population-averaged trajectory approaches show varying degrees of
severity, chronicity and stability provides evidence that the two methods can be used
to complement one another. In the data and methods section and the first research
chapter, I will discuss this notion of linearity and non-linearity in greater detail.
2.5.4 Nature of Trajectories
Given that several trajectories are often identified in multiple-subpopulation ap-
proaches and this obviously contrasts the number identified by population-averaged
42
approaches, the observable nature of depressive symptoms from childhood to young
adulthood is not entirely clear. Research has suggested that trajectories of depres-
sive symptoms tend to increase from late childhood but peak during or towards the
end of adolescence, around the ages of 15-17 [18, 30, 97–99, 101, 103]. Other studies
suggest this peak occurs earlier or later, but may not have data that precedes or
succeeds adolescence, making it harder to investigate whether these effects are uni-
versal and can lead to contrasting patterns and varying inferences [42, 62, 81, 93, 96,
100].The nature of trajectories of depressive symptoms from late childhood to young
adulthood will be better understood from studies that use data from a wide enough
time period as these studies can highlight the dynamic patterns, shapes and char-
acteristics of trajectories which could be translated into treatment and prevention
for depression.
The nature of these trajectories of depressive symptoms from childhood to
young adulthood is typified by the number of trajectories identified, their character-
istics and their shapes. These are then based upon stability, chronicity and severity.
Evidence suggests that both multiple-subpopulation and population-averaged tra-
jectories are not only heterogeneous (and vary between approaches) but are also
dynamic across this stage of development and can be difficult to assess.
2.5.5 Risk factors for trajectories of depressive symptoms
between childhood and young adulthood
This next section provides an overview of the risk factors associated with trajecto-
ries of depressive symptoms across childhood to young adulthood. It is important
to state here that when I discuss risk factors, I am referring to predictors of these
trajectories and not causal mechanisms. That is to say that when exploring associ-
ations between risk factors and trajectories, the association is correlational and not
presumed to be causal. Many of these risk factors could be causal or on the causal
pathway, yet the current study designs do not allow for causal estimations to be
made.
Sex differences. The most consistent finding in the literature is that females are at
greater risk of higher trajectories of depressive symptoms from childhood to young
adulthood 1. This is consistent with a wealth of cross sectional and longitudinal re-
search showing that females have a greater preponderance to depressive symptoms
compared to males [3, 16, 22]. In multiple-subpopulation methods, females are more
likely to belong to be associated with the more severe and chronic trajectories of
1Whilst this a biological risk factor, there is so much research on it that it warrants its own
section.
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depressive symptoms. For instance, females were more likely to be associated with
the ‘high and persistent’ trajectories compared to males [42, 64, 71, 103]. In other
studies, being female often shows a stronger association with “higher” and interme-
diary trajectories [34, 43, 56, 79, 83]. However, there are some instances where sex is
not associated with “higher” trajectories [104]. Instead, Olino and colleagues found
that being female was associated with greater odds of belonging to the ‘late onset’,
‘increasing’ and ‘initially high’ trajectories, but not the ‘persistent high trajectory’.
Similar results were observed by Costello and colleagues who showed stronger as-
sociations for females belonging to the ‘early high’, rather than ‘late escalating’
trajectories [37]. Such findings imply that being female may not automatically be
associated with “higher: trajectories. Instead, more nuanced sex mechanisms may
exert themselves at different times which may have downstream effects of depressive
symptoms (i.e., around puberty or transition into adolescence) [105]. An example of
this is highlighted by Lee and colleagues who showed that females were more likely
to belong to a higher trajectory in adolescence but not in young adulthood [106].
Similar results are also observed for population-averaged trajectories where fe-
males are often associated with a higher intercept and steeper slope [18, 93, 97,
99]. Additional research has also shown that the rate of change between sexes also
varies. Chen and colleagues observed that females had initially greater depressive
symptoms, but these symptoms declined faster than their male counterparts [89].
Similar effects have also been observed in other studies [99]. However, other re-
search has found no evidence of sex differences regarding rates of change [102, 107]
or opposite effects with increased depressive symptoms across time for males in com-
parison to females [108]. The extent to which sex is associated with rates of change
warrants more research to clarify this issue as mixed findings could be a result of
the time period assessed (i.e., adolescence or young adulthood). Additionally, there
is some evidence of sex interactions with other risk factors such as social-economic
status/stressful life events [97], dating status [99], parental behaviour [34] and self-
esteem [102], which in turn can have more negative effects on female trajectories of
depressive symptoms.
Ethnicity. Another strong risk factor for less favourable trajectories of depressive
symptoms from childhood to young adulthood is ethnicity. There is evidence that
ethnic minorities are at risk of higher trajectories of depressive symptoms and this
is observed across multiple methods and populations [30]. In one study, being of
African, Latino or Asian descent was associated with the ‘early high’ trajectory [37].
However, these ethnicities were not associated with the ‘late escalating’ trajectory,
implying that association between ethnicity and greater depressive symptoms is
stronger in early adolescence, rather than later on in development. Adkins and col-
44
leagues observed higher trajectories of depressive symptoms for African, Asian and
Hispanic descendants, but only Asian descendants showed a faster decrease across
time – implying there are differential effects between ethnicities [97]. Similar results
have also shown an association between Asian descendants and higher trajectories of
depressive symptoms, but that symptoms begin to decrease and match White indi-
viduals after 15 years of age [89]. Finally, higher ethnic discrimination is associated
with higher trajectories of depressive symptoms [100], indicating additional social
influences other than being an ethnic minority may contribute to worse depressive
symptoms.
Socioeconomic status and poverty. The association between socioeconomic
status (SES) / poverty and trajectories of depressive symptoms is less clear than
other risk factors. Several studies have demonstrated that low SES is associated
with higher trajectories of depressive symptoms from childhood to young adulthood
[97]. Adkins and colleagues observed strong sex interactions where females in low
SES were associated with greater depressive symptoms. Other studies have also
shown that lower SES is associated with a greater likelihood of being in “higher”
trajectories of depressive symptoms [37, 103] and similar findings have shown that
lower poverty is associated the lowest depressive symptoms trajectory [77]. However,
in other research, this association is not replicated. For instance, several studies have
found no association between lower SES and less favourable trajectories [34, 35]. It
is unclear why SES is associated with trajectories of depressive symptoms in some
studies, but not others. One reason may be SES is a proxy for other measures of
the “physical” environment (i.e., residency, mobility or earnings), and studies may
require more nuanced analyses to further explore this association.
Psychological risk factors. Many psychological risk factors have been associated
with trajectories of depressive symptoms. Hankin showed that negative cognitive
styles mediated the relationship between females and higher trajectories of depressive
symptoms [109]. Additionally, Hankin also found that rumination and interactions
between rumination and stress was also strongly associated with higher trajectories
of depressive symptoms. In a similar study, negative affectivity, negative cognitive
styles and rumination were all associated with membership into “higher” trajectories
of depressive symptoms [38]. Likewise, negative cognitive styles was associated with
both the ‘high-declining’ and ‘high-persistent’ trajectories of depressive symptoms
[110]. Other psychological risk factors such as lower human agency (belief in one’s
self) have also been associated with higher trajectories of depressive symptoms and
may mediate the relationship between poorer communities and greater depressive
symptoms [111]. Similarly, inter-personal dependency and loneliness were associated
with membership into several “higher” trajectories of depressive symptoms, whilst
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a higher coping score was associated with a stable-low trajectory [43]. Lower self-
concept has also been associated with a higher trajectory across adolescence [103].
Other psychological risk factors such as poorer temperament [35] and greater
pessimism and avoidance [70] have also been associated with higher trajectories of
depressive symptoms. Likewise, Weeks and collagues found that greater conduct
and hyperactivity scores in childhood were associated with the the ‘adolescent on-
set’, ‘high childhood’, ‘high stable’ and ‘moderate stable’ trajectories, whilst difficult
temperament was associated with all but the ‘adolescent onset’ trajectory [34]. Ex-
ternalizing, and avoidant behaviour in early development have also been associated
with membership into “higher” trajectories of depressive symptoms [112]. Addi-
tionally, risk factors like childhood anxiety, peer rejection, social competency and
attentional problems are all associated with increased “higher” trajectories of de-
pressive symptoms throughout adolescence [80]. Anxiety was also associated with
greater depressive symptoms during childhood to late adolescence in another study,
although depressive symptoms decreased across time [92]. Low self-control has also
been associated with both ‘moderate’ and ‘high’ trajectories of depressive symptoms
[82]. In a separate study, lower self-esteem was associated with steeper trajectories
of depressive symptoms, although this effect was only prominent in females [102].
Similar effects of low self-esteem being associated with higher trajectories of de-
pressive symptoms have also been shown [83]. However, what is not clear in many
of these studies is how reciprocal these effects are (i.e., how low self-esteem may
reinforce greater depressive symptoms and vice versa).
Parental depression has been strongly associated with some of the higher sub-
population trajectories of depressive symptoms [34, 36, 43, 74, 104, 106]. However,
what is less clear is how the timing of parental depression (i.e., prenatal vs postnatal)
and the effect of each parents plays a role in trajectories of depressive symptoms as
these studies did not discriminate between these timings. In other studies, parental
depression has not been associated with any of the “higher” trajectories [80, 112]
suggesting this intergenerational pathway may be complex and require more sensi-
tive analysis to tease apart.
Social risk factors. Many of the strongest risk factors for higher trajectories of
depressive symptoms from childhood to young adulthood have social underpinnings.
For example, witnessing partner violence as a child was associated with higher tra-
jectories of depressive symptoms across adolescence and later in life [113]. These
effects were worse for females and for children without social support. Similarly,
abuse suffered before the age of 18 was strongly associated with the ‘persistent’,
‘increasing’ and ‘initially high’ trajectories, but not the ‘later onset’ trajectory of
depressive symptoms [104], suggesting that the timing of abuse may be important
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and have more immediate consequences rather than long term. Stressful life events
(or negative life events) such as emotional or physical neglect have also been as-
sociated with “higher” trajectories of depressive symptoms across multiple studies
[36, 43, 88, 98]. There is also evidence that stressful life events increase female
trajectories of depressive symptoms, but not males [97, 107], however, the opposite
effect has also been observed in another study [74]. Research has shown that the
number of stressful life events may play an important role as more than two stressful
life events in early life were strongly associated with membership into the “higher”
trajectories of depressive symptoms [34]. The timing of stressful life events may also
play a role as stressful life during adolescence have also been shown to be associated
with a “higher” subpopulation trajectory [112]. However, there has also been no as-
sociation observed between stressful life events and trajectory membership in several
studies [80, 86], indicating that the timing and context of these stressful life events
is likely to play an important role in this association – it may not be enough to
simply classify different stressful experiences together. Instead it may be beneficial
to explore the number of stressful life events over a period of time – to examine time
specific outcomes, or specific types of events such as emotional neglect or physical
abuse.
Other social factors such as lower parental educational attainment and a dis-
ruptive family structure have also been associated with “higher” trajectories [34,
37, 77, 114]. For example, children not part of a 2-parent family structure were
more likely to be associated with a higher subpopulation trajectory of depressive
symptoms [37]. Likewise, family adversity was associated with membership into the
‘consistently high’ trajectory of depressive symptoms [62], whilst family dysfunction
has been associated with ‘high childhood’, ‘high stable’ and ‘moderate stable’ tra-
jectories [34]. Ge and colleagues also observed that children from divorced families
had higher trajectories of depressive symptoms, and that this effect was worse for
females [98]. As yet, no studies have examined the association between the timing
of parental separation and trajectories of depressive symptoms, as this could play an
important role. Worse relationships with parents have been shown to a risk factor
for higher trajectories of depressive symptoms [34, 62, 85, 86, 107]. For example,
Weeks and colleagues found hostile and punitive parenting were both associated with
the ‘high childhood’ trajectory. Parental substance abuse such as excessive smoking
and drinking have also been associated with higher trajectories of depressive symp-
toms, independently of childhood/adolescent substance misuse [34, 43]. However,
this association is likely to be complex and hard to disentangle as parental drinking
at ages 4 and 12 has not been associated with trajectories of depressive symptoms
in a separate study [115].
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Substance use has been shown to be a strong risk factor for higher trajectories
of depressive symptoms. Marmorstein found reciprocal associations for higher de-
pressive symptoms and alcohol problems, but that greater alcohol consumption was
associated with much higher trajectories of depressive symptoms [5]. These effects
varied by sex with females showing stronger associations and a slower decrease in
depressive symptoms compared to males. In other studies, similar effects of alcohol
consumption have been observed [79, 108, 116, 117]. Smoking has also been as-
sociated with higher trajectories of depressive symptoms [118], and Wickrama and
Wickrama showed that excessive smoking was associated with the higher trajecto-
ries [78]. Similar effects were shown also shown by Rodriguez and colleagues who
demonstrated that baseline smoking was associated with increased depressive symp-
toms over time [84]. Overall, general substance abuse has been associated with the
‘high stable’ trajectory compared to the ‘low-decreasing’ trajectory [43], suggesting
there may be long term effects of substance use that may not recover over time.
Substance use was also associated with the ‘early high’ trajectory [37], implying
that such effects may also have immediate consequences. These findings are not
surprising given that mood and substance abuse disorders are highly co-morbid [5],
and may imply that mood and substance use disorders share a common pathway.
Other social risk factors such as negative dating experiences have also been
identified as risk factors for higher trajectories of depressive symptoms [99, 106],
although evidence suggests that this effect may only be present in young adult-
hood [106]. Similarly, poorer quality relationships with friends and peers have been
associated with much higher trajectories of depressive symptoms [62, 70, 81]. Mar-
shal and colleagues found that sexual minority youths were at a much greater risk
of higher trajectories of depressive symptoms, with this association strongest for
females [95]. Similar findings were also observed by Needham who showed that con-
sistent gay/lesbian/bi-sexual attraction was associated with higher trajectories of
depressive symptoms across adolescence [119].
Biological risk factors. Several biological risk factors have also been associated
with higher trajectories of depressive symptoms. Ferro and colleagues showed that
individuals with chronic illness were associated with higher trajectories of depressive
symptoms, which decreased at a slower rate across adolescence and young adulthood
[101]. Similar effects were also observed by Weeks and colleagues who showed that
chronic illness was associated with the ‘high childhood’ trajectory, but when inter-
acted with sex, females were more likely to belong to the ‘adolescent onset’ trajectory
– implying there may be differential effects for sexes with regards to chronic illness
[34].
One important risk factor for higher trajectories of depressive symptoms is
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pubertal status. Previous research has shown that early maturation is associated
with a higher trajectory of depressive symptoms [93]. In the same study, this effect
was amplified for females. Additionally, females with recent stressful life events were
more vulnerable to higher trajectories of depressive symptoms. Other findings have
demonstrated that early pubertal timing was also associated with the ‘early high’
trajectory, although this effect did not differ by sex [38]. In another study, both early
and late puberty was associated with higher trajectories of depressive symptoms, yet
the effect diminished over time [99]. Interestingly, Natsuaki and colleagues observed
that females with early/late maturation who also experienced negative effects of
dating were at a greater risk of higher trajectories of depressive symptoms.
Other studies have suggested mothers who experience stressful life events dur-
ing pregnancy may have offspring with higher trajectories of depressive symptoms
via in utero expsoure. Kingsbury and colleagues found that the number of stress-
ful life events in pregnancy was associated with the ‘consistently high’ trajectory
[75], implying that stressful events may impact on development in utero, which
has downstream consequences. The role of genetics has also been explored in sev-
eral studies. Lubke and colleagues assessed the twin heritability of trajectories of
depressive symptoms and found that heritability was higher for trajectories in com-
parison to cross sectional measurements of depressive symptoms – implying that
1) trajectories may better methods for assessing genetic effects compared to cross
sectional methods and 2) that change in depressive symptoms over time may have
a genetic component [120]. Genetic variation has also been identified as a potential
risk factor for varying trajectories of depressive symptoms. In one study, two can-
didate dopamine receptor variants (D2D2 and DRD4) were associated with higher
trajectories of depressive symptoms [94]. In another study, carriers of the dopamine
receptor D4 5-repeat allele were associated with trajectories of depressive symptoms
that started higher, yet decreased more rapidly until early adulthood where they
began to rise again [33]. In the same study, carriers of the monoamine oxidase A
3.5R allele also had a higher trajectory of depressive symptoms compared to carriers
of other monoamine oxidase A alleles. However, these findings are from candidate
gene studies which are notorious for false positives and consistently lack replication
across studies [121]. There is now the consensus that there is no one “gene” for
depression or depressive symptoms, instead the genetic epidemiology of depression
is likely to be complex and comprised of multiple genetic variants, each contributing
small effects [9, 122, 123]. These multiple genetic variants can be tallied to create a
polygenic risk score that measures an individual’s genetic liability to depression [29].
To date, only one study has examined polygenic risk score in relation to trajectories
of depressive symptoms and found that a greater risk score (i.e., greater genetic
liability to depression) was associated with an “adolescent-onset” trajectory – im-
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plying that genetic liability to greater depressive symptoms may begin to manifest
in adolescence [87].
Risk factors summary. The studies described here demonstrate that multiple
social, biological and psychological risk factors are all associated with higher tra-
jectories of depressive symptoms. Many of these risk factors occur early in life,
implying that they have long term effects on depressive symptoms but provide a
potential opportunity to intervene at an early stage of development. Alternatively,
it may be useful for services and policy makers to be aware who are at the greatest
risk of higher trajectories of depressive symptoms that may need to more routinely
followed. There is evidence that sex may play a role in mediating or moderating
these trajectories and future research should control for sex or use sex interactions
to explore these mechanisms further. Likewise, there may be multiple environment
interactions that facilitate higher trajectories of depressive symptoms such as SES.
There are several risk factors such as genetic liability which have shown promise
in early studies but require more research. Crucially, the findings from many of
these studies show comparable results between multiple-subpopulation trajectory
and population-averaged trajectory approaches. This suggests that whilst both
methods handle heterogeneous trajectories differently, the findings can be some-
what compared with regards to identifying risk factors for higher trajectories of
depressive symptoms.
2.6 Limitations in previous studies and consider-
ations for future research
2.6.1 Small duration of follow-up and lack of waves of data
collection
There has been a plethora of research on adolescent trajectories of depressive symp-
toms, yet there are still many limitations in previous research that this thesis will
look to address. The first is that a major limitation in previous studies regards
the duration of follow-up and the number of waves of data collection. In several
studies, depressive symptoms are measured over two-year [81, 86, 113] or three-year
periods [62, 65, 71], often around adolescence. Depressive symptoms are likely to be
greatest during adolescence between the ages of 15-17 [30], yet consistent evidence
for this, and the identification of the exact ages has not been fully established. This
makes it difficult to determine when depressive symptoms are at their worst, which
would be important to identify regarding treatment and support. This paucity in
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research arises from a lack of studies that measure depressive symptoms across a
wide enough period. Studies that measure depressive symptoms over a small dura-
tion of follow-up are unable to infer more about the preceding and succeeding nature
of trajectories of depressive symptoms, only that trajectories may be higher/lower
during that age range. Depressive symptoms are dynamic and can change rapidly
across a short period of time [51]. Therefore, it is necessary to have studies with
frequent repeated assessments of depressive symptoms over multiple stages of devel-
opment to fully capture any nuanced changes and achieve a more holistic approach
to examining the nature of trajectories of depressive symptoms.
2.6.2 Size matters
Many of the studies exploring trajectories of depressive symptoms from childhood
to young adulthood have used small sample sizes which may not be applicable to
the general population or result in bias. In several studies, sample sizes are fewer
than 150 individuals [86, 100, 113], so the extent to which we can generalise these
findings to the wider population may be limited. Other studies have used larger
sample sizes ranging between 200 and 400 individuals with varying methods, risk
factors and cohorts [18, 35, 36, 81, 91]. As mentioned earlier, studies using multiple-
subpopulation trajectories may be less applicable for smaller studies as they cate-
gorise people into qualitatively distinct subpopulation trajectories with potentially
small classes that are not representative of the population or are statistical artefacts
that result from this model. These concerns have previously been raised as smaller
studies using multiple-subpopulation methods may have a higher risk of bias then
population-averaged trajectories [58]. However, the counter to this is that depression
prevalence rates within the population are generally similar to some of these higher
subpopulation trajectories, and so low numbers of individuals are expected. Sim-
ilarly, studies using larger sample sizes have also demonstrated comparable group
sizes to smaller studies. Nevertheless, we must be cautious about the claims made in
studies using small sample sizes and larger longitudinal cohorts would be preferred
to minimise some of the biases in previous research.
2.6.3 Future research
Multiple-subpopulation trajectories and population-averaged trajectories have demon-
strated that multiple risk factors are associated with trajectories of depressive symp-
toms from childhood to young adulthood. However, there are avenues for future
research which could improve our understanding of the nature of these trajecto-
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ries and translation into prevention and treatment for depression. This review has
highlighted many limitations in previous research such as difficulties in harmonising
varying growth curve approaches (and so the overall nature of trajectories across
development is not clear) and a lack of investigation in some risk factors (i.e., ge-
netic and some environmental risk factors, and combinations of the two). However,
there are several additional limitations that thesis also aims to address.
One research gap is that whilst previous research has explored the nature of
trajectories and risk factors for these trajectories, very little is known about critical
points for trajectories (i.e., when are depressive symptoms at their highest?; When
are they getting worse or better?; When is a risk factor having the greatest effect
on these trajectories?). Identifying critical points along trajectories could help re-
searchers, services and policy makers determine what ages or stages are the best
time to intervene to reduce or potentially prevent greater symptoms from occurring.
Likewise, it may be important to identify when depressive symptoms are increasing
the fastest as there is the potential to intervene at these ages to stop depressive
symptoms persisting or getting more severe. Previous research has already called
for more research to explore critical periods outside of the trajectories literature
[124] and research in other fields has begun to derive critical periods for other forms
of childhood growth such as height [125]. However, such research has yet to be ex-
tended for trajectories of depressive symptoms, and this is a limitation of previous
research that this thesis will explore. In particular, identifying when a risk factor
is having its greatest effect on trajectories of depressive symptoms, and comparing
this to other ages could be of great use to clinicians and policy makers as it provides
an age that could be targetable for a host of interventions and treatments.
A second gap in the literature, but a more general limitation of previous re-
search is how these results can be used to guide policy and clinical treatment. There
is evidence that trajectories derived from repeated measures models may be bet-
ter than cross-sectional research [120], but there may be issues in how the results
from growth curve studies are interpreted. One concern is that it hard to compare
between multiple-subpopulation and population-averaged trajectories (as discussed
earlier). A second is that population-averaged trajectories are likely to be non-linear
across adolescence and require advanced modelling to appropriately capture these
trajectories. This can result in complex estimates are that are hard to interpret
and communicate to non-statistical audiences, all of which prevents the translation
from research to clinical practise. Presenting complex results in a more interpretable
manner will not only address these concerns but help guide future research.
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2.7 Conclusions
This chapter has highlighted that trajectories of depressive symptoms from child-
hood to young adulthood are multifactorial and associated with a number of risk fac-
tors, with several risk factors warranting more investigation. Trajectories of depres-
sive symptoms are estimated using varying growth-curve methodologies but can be
affected by variation in cohorts, duration of follow up and the timing of assessments.
It may be possible to use both multiple-subpopulation and population-averaged ap-
proaches to complement one another as they often highlight similar findings and
combining these two approaches could pave the way for better treatment and in-
terventions for depression. The nature of these trajectories is complex and still not
fully understood given the variability found in many previous studies. This thesis
will look to address these concerns by primarily examining how genetic and environ-
mental contributions are associated with trajectories of depressive symptoms. To
do this, I will further probe the nature of depressive symptoms across this period by
utilising both growth-curve approaches. I will look to replicate and expand upon the
risk factors identified earlier in this review and further the existing literature by ex-
amining the notion of critical periods and providing more interpretable results from
complex estimates in my models. This thesis will also make use of a large sample
size and use depressive symptoms data with a long duration of follow that will help
quantify the nature of depressive symptoms from childhood to young adulthood and
build upon the existing literature.
2.8 Chapter summary
This chapter has summarised the previous literature on trajectories of depressive
symptoms and highlighted several key points and limitations that can be used to
build the platform for this thesis. The first is that multiple growth curve methods can
be used to explore trajectories of depressive symptoms and that using both methods
may be more beneficial than one single approach alone. The second is that there are
several genetic and environmental risk factors for trajectories of depressive symptoms
that have been robustly identified in previous research, but there are several that
require more investigation such as genetic liability and childhood adversity. Third
is that previous research can be expanded to identify the notion of critical points
such as when symptoms are getting worse and when a risk factor is having its
greatest effect. Finally, the results from varying growth-curve models can be complex
and could be more easily translated into simpler estimates that are more readily
interpretable. This thesis will aim to address these limitations through the four
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research objectives stated in the introduction. First, I will derive trajectories of
depressive symptoms using the two approaches described here - this will build a
platform for the rest of the thesis to explore genetic and environmental contributions.
Immediately after, I will use the more common approach of establishing multiple-
subpopulation trajectories in order to explore the association between genetic and
environmental risk factors and trajectories of depressive symptoms in a multivariate
approach. The following 3 chapters (6, 7 and 8) will then expand upon these findings
to disentangle some of the complex genetic and environmental associations using the
population-averaged approach. In the conclusions chapter, I will sum up how these
various approaches have helped answer the overarching research question and how
these findings relate to the existing literature described within this chapter. More
immediately, in the next chapter I will go on to introduce the data and methods





This chapter provides the reader with an introduction to the data and methods
used throughout the thesis. Firstly, I outline the source of the data and how it
was collected. Next, I introduce the depressive symptoms data which are the focal
point of this thesis. Here I discuss how depressive symptoms are measured and the
descriptive statistics and longitudinal patterns of the data. I then highlight some
considerations for the depressive symptoms data such as attrition and bias. Finally,
I give a brief introduction to the statistical methods used in this thesis: population
averaged trajectories (created using multilevel growth-curve models) and multiple
trajectories (growth mixture models).
Part of this chapter was published as a Data Note in Wellcome Open Research
as below. This chapter therefore has elements of that publication.
Kwong, A. S. F. (2019). Examining the Longitudinal Nature of Depressive Symp-
toms in the Avon Longitudinal Study of Parents and Children (ALSPAC). Wellcome
Open Res. 4: 126. doi.org/10.12688/wellcomeopenres.15395.1
3.2 Data source
The data used in this thesis is from the Avon Longitudinal Study of Parents and Chil-
dren (ALSPAC), an ongoing population-based study in the South-West of England
designed to examine the effects of a number of factors on health and development
surrounding pregnancy (see figure 3.1). Full details regarding the study are described
in the cohort profiles [126, 127] . ALSPAC initially recruited pregnant mothers with
an estimated delivery date between April 1991 and December 1992. The initial co-
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hort consisted of 14,541 pregnancies, which resulted in 14,092 live births with 13,988
children still alive one year later. When the children were approximately seven years
old, ALSPAC attempted to recruit eligible children who were not recruited between
April 1991 and December 1992. This resulted in an increased sample of 15,247 preg-
nancies with 14,775 live births, of which 14,701 children still alive one year later
[128].
Figure 3.1: ALSPAC recruitment areas [126]. DHA: District Health Area. Figure
reprinted with permission.
As ALSPAC is a multiple generational study currently spanning currently just
under 30 years, the data come from multiple respondents in a variety of methods.
For example, data has been collected through questionnaires, clinic assessments and
data linkages to medical, obstetric and educational records. For questionnaires,
these have been completed by the mother, her partner, children and their teachers
in both self-report format and parent/teacher reported format. At clinic assess-
ments, biological samples (hair, urine, biomarkers and blood) and physical and
psychological assessments have been measured giving anthropometric data (height,
weight and lung function) as well as genetic and epigenetic data. This thesis mainly
focuses on the self-reported data from the children/young-people but maximises
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the use of the biological samples (for genetics) and parent reported data (for ex-
ploring risk factors). I will discuss this in more detail in subsequent chapters.
Further information about the data in ALSPAC is available on the study web-
site (www.bris.ac.uk/alspac), which also contains a fully searchable data dictionary
(www.bris.ac.uk/alspac/researchers/data-access/data-dictionary). ALSPAC has its
own Law and Ethics Committee that reviews and manages all projects that use
ALSPAC data. Furthermore, projects that collect new data are approved by the
Local Research Ethics Committees. This thesis had approval from the Law and
Ethics Committee.
ALSPAC is largely representative of the UK population, yet it has been noted
that children included within the study were more educated at age 16 compared to
the national average, more likely to come from homeowner backgrounds and more
likely to be of Caucasian descent [126]. Additionally, analysis by Boyd and colleagues
found that children who had participated in a questionnaire and a clinic assessment
around age 17 had greater educational attainment compared to those who had not
participated at these assessments or those who were lost to attrition. Therefore, it is
possible to argue that individuals enrolled in ALSPAC may differ from the national
average and this may not lead to generalisable results. This is discussed in greater
detail in the overall limitations section in the final chapter and in several research
chapters.
3.2.1 Depressive symptoms
ALSPAC is one of the few longitudinal cohorts that has repeated assessments of
self-reported depressive symptoms. Furthermore, ALSPAC has measured depressive
symptoms more frequently across adolescent development than many other studies,
making it an invaluable tool for exploring the nature of depressive symptoms. The
literature review highlighted that many studies do not have repeated measures data
will enough duration of follow up, or enough measures to capture any nuanced
changes throughout adolescence. In ALSPAC, depressive symptoms are measured
using the short mood and feelings questionnaire (SMFQ). In this part of the thesis,
I describe the SMFQ and the nature of depressive symptoms in ALSPAC.
The short mood and feelings questionnaire (SMFQ)
The SMFQ is a 13-item questionnaire that measures the presence of depressive
symptoms in the last two weeks [129]. The SMFQ has been used in clinical and
general populations for examining depressive symptoms [14, 15]. Table 3.1 shows the
list of questions used in the SMFQ, that were also used in ALSPAC. For each of the
13-item questions, the response can be “not true” (scored 0), “sometimes” (scored
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1) and “true” (scored 2). Each question is scored between 0-2 and the resulting
summary score of all the items can range between 0-26, with higher scores being more
indicative of greater depressive symptoms. Previous research has shown that the
SMFQ is predictive of adolescent clinical depression in ALSPAC [13], and research
has used the SMFQ for exploring the potential risk factors for higher depressive
symptoms [75, 87], and the later consequences of greater depressive symptoms [108,
130].
Question number List of questions used
1 I felt miserable or unhappy
2 I didn’t enjoy anything at all
3 I felt so tired I just sat around and did nothing
4 I was very restless
5 I felt I was no good anymore
6 I cried a lot
7 I found it hard to think properly or concentrate
8 I hated myself
9 I was a bad person
10 I felt lonely
11 I thought nobody really loved me
12 I thought I could never be as good as others
13 I did everything wrong
Table 3.1: List of short mood and feelings questions (SMFQ). For each question,
the responses are: not true (scored 0), sometimes (scored 1) and true (scored 2).
The total scores are then added up to give a score ranging between 0 and 26 where
higher scores indicate higher depressive symptoms.
SMFQ within ALSPAC
The SMFQ was measured on nine occasions between the ages of 10 and 24
in ALSPAC. At each of these occasions, the SMFQ was self-completed by the
child/young person. The SMFQ was administered in ALSPAC via postal/email
questionnaire or at research clinics depending on the wave. Table 3.2 shows how
each occasion was collected. The SMFQ in ALSPAC was not collected at regular
age intervals and table 3.2 shows the mean age of participants at each assessment.
There is no obvious pattern for time between assessments but the longest period
between assessments was between the ages of 18.6 and 21.95. The shortest period
was between the ages of 17.84 and 18.65.
Characteristics of the SMFQ in ALSPAC
As shown in table 3.2, the sample size of the SMFQ sample varies in ALSPAC,
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Figure 3.2: The mean depressive symptoms scores of each occasion, as measured by
the short mood and feelings (SMFQ) questionnaire in ALSPAC.
with a maximum of 7,364 individuals at the first occasion (age 10.65), compared to
the minimum sample of 3,305 at the seventh occasion (age 21.95). Thus, ALSPAC
and the SMFQ in particular is subject to attrition, which I will discuss later in
this chapter and again in the overall limitations section in the conclusions chapter.
The profile of attrition can be seen in table 3.2. Additionally, one of the thesis
research aims was to identify the nature of depressive symptoms across adolescence
and beyond. Here I give a brief description of the depressive symptoms data in
ALSPAC but will use more advanced statistical methods to quantify the nature of
depressive symptoms in the next chapter. Table 3.2 and figure 3.2 both highlight
how the SMFQ changes over time with all the data available. In chapter 6, I discuss
sex differences in depressive symptoms but for the overall sample, individuals had
initially low levels of depressive symptoms in late childhood. Scores then tended
to increase until the age of 18. From here, depressive symptoms began to decline
until the age of 22, where symptoms then began to rise again to greater levels
than previously observed at age 18. There was more heterogeneity around the data
towards the later stages of data collection with higher standard deviations observed,
implying there was more variability towards the later stages of adolescence and early
adulthood. Figure 3.3 shows histograms for the nine occasions of the SMFQ.
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Occasion Mean Age Sample Size SMFQ Mean SMFQ SD SMFQ Median SMFQ IQR α SMFQ Source
1 10.65 7,364 4.04 3.51 3 5 0.797 Clinic
2 12.81 6,716 3.97 3.86 3 4 0.842 Clinic
3 13.84 6,019 4.92 4.49 4 5 0.865 Clinic
4 16.68 4,997 5.91 5.64 4 6 0.908 Questionnaire
5 17.84 4,497 6.59 5.25 5 7 0.897 Clinic
6 18.65 3,335 6.83 5.93 5 8 0.906 Questionnaire
7 21.95 3,305 5.7 5.58 4 6 0.915 Questionnaire
8 22.88 3,856 6.21 5.55 5 7 0.906 Questionnaire
9 23.8 3,915 7.03 6.06 5 8 0.913 Questionnaire
Table 3.2: Descriptive statistics and reliability of the SMFQ within ALSPAC. α was measured using Cronbach’s alpha.
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Figure 3.3: Histograms for the short mood and feelings questionnaires (SMFQ) at each of the nine occasions in ALSPAC.
61
Validity and utility of the SMFQ
Within ALSPAC, the SMFQ has good internal reliability as assessed by Chron-
bach’s alpha 1. Table 3.2 shows that the reliability was lowest on the first occasion
(0.797) and highest on the seventh occasion (0.915), which suggests that earlier as-
sessments may not have been as well understood as the later assessments. There
were strong correlations observed between each of the assessments (Ps < .0001). As
table 3.3 shows, there was a pattern where occasions measured more closely together
had higher correlations (i.e., ages 10.65 and 12.81, compared to the correlations be-
tween ages 22.88 and 23.8), and these were particularly strong towards the last
three assessments (r > .569), which could imply that depressive symptoms are more
similar at later stages of development and vary at different stages (i.e., depressive
symptoms mean different things to at different ages – yet at the later stages they
mean the same thing). The strong correlation between all the assessments indicated
that the SMFQ is a valid tool for examining depressive symptoms over time within
ALSPAC.
1Even though there was good reliability at each occasion, that does not mean that the SMFQ
is measuring the same construct at each occasion. In the conclusions chapter, I give a discussion
about what this might mean for the thesis and how it may limit some of the results.
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Age 10.65 Age 12.81 Age 13.84 Age 16.68 Age 17.84 Age 18.65 Age 21.95 Age 22.88 Age 23.8
Age 10.65 -
Age 12.81 0.361* -
Age 13.84 0.271* 0.528* -
Age 16.68 0.233* 0.349* 0.397* -
Age 17.84 0.202* 0.297* 0.365* 0.502* -
Age 18.65 0.180* 0.290* 0.328* 0.490* 0.544* -
Age 21.95 0.178* 0.268* 0.283* 0.406* 0.424* 0.454* -
Age 22.88 0.187* 0.260* 0.301* 0.424* 0.396* 0.466* 0.618* -
Age 23.8 0.171* 0.264* 0.320* 0.409* 0.402* 0.462* 0.569* 0.664* -
Table 3.3: Correlations between the SMFQ across the nine occasions. SMFQ: Short mood and feelings questionnaire. * denotes that
correlations were p < .0001.
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3.3 Data considerations
There are several considerations to be made with regards to the ALSPAC data and
depressive symptoms that are important with regards to this thesis. As shown in
table 3.2, ALSPAC is subject to attrition as the sample size for individuals with the
SMFQ data decreased throughout the study from 7,354 at age 10 to 3,915 at age
24. An exploration with complete case analysis showed that the overall pattern of
the SMFQ across the nine occasions was attenuated compared to the overall pattern
shown in figure 3.2. As shown in figure 3.3, the shape of the SMFQ in ALSPAC
was similar to the overall pattern, but for this complete case analysis, there were
lower estimates. This supports the idea that individuals with greater depressive
symptoms are more likely to drop out of the study. A further discussion on how I
dealt with this issue is described later on in chapter 4. A more thorough discussion
about how this may impact on the thesis is discussed in the conclusions chapter.
Figure 3.4: The mean depressive symptoms scores at each occasion as measured
by the short mood and feelings (SMFQ) for individuals who answered every SMFQ
assessment (i.e., complete case analysis).
Additionally, as shown in table 3.4 with the column percentages, there were de-
mographic differences between individuals who completed the SMFQ at both ages
10 and 24, compared to those who only completed the SMFQ at age 10, with this
latter group more likely to be male, have mothers with poorer educational attain-
ment and lower occupational status, and have younger mothers. Given that some of
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demographics are risk factors for depression, it may mean that depressive symptoms
estimates presented in this thesis are lower than what they should be if there are
missing data, that are not missing at random. Therefore these estimates may be
more conservative due to more depressed individuals missing from the study.
This thesis focuses on trajectories of depressive symptoms and it is possible
to estimate trajectories using at least one measure of depressive symptoms, as it is
possible to estimate a trajectory using this information and thus maximise statistical
power (I will discuss this method in the next chapter and how potential biases may
be addressed). Thus, it is important to examine how individuals who have any
SMFQ data in ALSPAC may differ from those who have not responded to any
SMFQ assessments. A brief exploration of these data shows that the demographic
information of individuals who have completed at least one assessment of the SMFQ
varies from those who have not completed any assessments. Table 3.5 highlights
these differences, but it is important to note that individuals without any SMFQ
measures were also more likely to be male, have mothers with poorer educational
attainment and lower occupational status at birth, be the third + born child and
have a younger mother. I return to the issue of missing/non-random data in the
next chapter.
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SMFQ at 10 and 24 SMFQ at 10 but not 24 x2, p
Sex (n=7,359)
Males n (%) 1,118 (35.6) 2,508 (59.4) 407.54, <.001
Females n (%) 2,020 (64.4) 1,713 (40.6)
Maternal Education (n=6,723)
A Level or Higher n (%) 1,442 (49.2) 1,418 (37.4) 137.18, <.001
O Level n (%) 1,016 (34.7) 1,368 (36.1)
<O Level n (%) 472 (16.1) 1,007 (26.5)
Maternal occupational Status (n=5,811)
Non-manual n (%) 1,165 (45.1) 1,264 (39.2) 20.64, <.001
Manual or lower n (%) 1,419 (54.9) 1,963 (60.8)
Parity (n=6,749)
First Born n (%) 1,410 (48.4) 1,701 (44.4) 11.48, =.003
Second Born n (%) 1,024 (35.1) 1,421 (37.0)
Third Born + n (%) 481 (16.5) 712 (18.6)
Maternal Age at Pregnancy (n=6,983)
<25 Years n (%) 372 (12.4) 675 (16.9) 47.39, <.001
25-29 n (%) 1,161 (38.8) 1,644 (41.2)
30-34 n (%) 1,041 (34.8) 1,253 (31.4)
35+ n (%) 416 (13.9) 421 (10.5)
Table 3.4: Participant demographics for individuals with SMFQ at both 10 and 24 years compared to SMFQ at only 10 years. Pearson’s
chi-squared tests (x2) used to highlight differences between participant demographics and individuals having both data.
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Included in Analysis Excluded in Analysis x2, p
Sex (n=14,854)
Males n (%) 4,495 (47.9) 3,140 (57.5) 128.98, <.001
Females n (%) 4,899 (52.1) 2,320 (42.5)
Maternal Education (n=12,493)
A Level or Higher n (%) 3,453 (40.9) 957 (23.7) 566.51, <.001
O Level n (%) 2,380 (35.3) 1,347 (33.3)
<O Level n (%) 2,016 (23.8) 1,740 (43.0)
Maternal occupational Status (n=10,118)
Non-manual n (%) 2,940 (40.8) 841 (28.8) 126.95, <.001
Manual or lower n (%) 4,263 (59.2) 2,074 (71.2)
Parity (n=13,124)
First Born n (%) 3,918 (45.9) 1,955 (42.5) 54.16, <.001
Second Born n (%) 3,041 (35.7) 1,547 (33.7)
Third Born + n (%) 1,569 (18.4) 1,094 (23.8)
Maternal Age at Pregnancy (n=14,076)
<25 Years n (%) 1,531 (17.3) 1,830 (35.2) 652.28, <.001
25-29 n (%) 3,513 (39.6) 1,927 (37.0)
30-34 n (%) 2,809 (31.7) 1,069 (20.5)
35+ n (%) 1,019 (11.4) 378 (7.3)
Table 3.5: Pearson’s chi-squared tests (x2) used to highlight differences between participant demographics and individuals having at least
one measure of the SMFQ.
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3.4 Statistical methods
To explore trajectories of depressive symptoms, this thesis uses quantitative methods
such as multilevel growth-curve modelling (to create population averaged trajecto-
ries) and growth mixture modelling (to compose multiple subpopulation trajecto-
ries). As discussed in chapter 2, these methods are useful for examining trajectories
of depressive symptoms as they quantify how depressive symptoms change over time,
but can be stratified to explore continuous and discrete heterogeneity between indi-
vidual person trajectories, which can help answer substantively interesting questions
regarding the aetiology of varying trajectories of depressive symptoms.
3.4.1 Multilevel growth-curve models
Multilevel growth-curve modelling [59, 131], is particularly effective for exploring
trajectories of depressive symptoms as multilevel analysis is an appropriate method
for handling longitudinal data. Traditional regression analysis assumes that re-
sponses from individuals (having adjusted for any covariates) are uncorrelated and
independent of one another. However, with longitudinal data, the responses are
not independent. Instead they are correlated as measures from the same individual
will be more alike compared to measures from different people. This is graphically
depicted in figure 3.4. Multiple measurements of depressive symptoms for person 1
(P1) are expected to be more alike compared to measurements from person 2 (P2).
Examining longitudinal data with traditional regression analysis will naively assume
multiple measures on the same individual are independent, and therefore result in
biased standard errors (typically standard errors which are too small potentially
leading to Type I errors of inference).
Figure 3.5: Multiple measurements from the same individual are more alike than
multiple assessments from different individuals. P = Person; DS = Depressive symp-
toms.
Throughout this thesis, I use equations to define multilevel growth-curves for
estimating trajectories of depressive symptoms. Let’s first consider a very basic
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multilevel growth-curve to estimate a random intercept and random linear slope
trajectory of depressive symptoms:
yij = β0 + β1tij + u0j + u1jtij + eij (3.1)
where yij is the depressive symptom score and tij is the age for individual j
at occasion i. Age can be set in days, months or years and can be centred to a
specific age i.e., 0 – the timing of the first assessment. I will discuss this more in
the next chapter with an example. Here, β0, β1 denote the associated regression
coefficients for the intercept and slope terms, and u0j, u1j are the random intercept
and linear effects of age that allow each individual to have their own trajectory. The
occasion-specific residual eij allows the depressive symptom scores to deviate from
the individual-specific trajectories, so this captures the degree of within-individual
variability.
The random effects are assumed bivariate normal distributed with zero mean


















The elements of the covariance matrix summarise the degree to which individual-
specific trajectories vary around the population-averaged trajectories – so showing
how each person deviates from the population average with regards to their inter-
cept, slope and intercept-slope covariance.







However, as noted earlier in this chapter, the change in depressive symptoms is
rarely linear. In fact, figure 3.2 demonstrates that the overall pattern of depressive
symptoms is distinctly non-linear. To better capture this non-linearity, it is possible
to enter time as a higher order polynomial (e.g., quadratic, cubic, or quartic). In
the next chapter, I will expand upon the multilevel growth-curve model in order to
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take this non-linearity into account.
Throughout this thesis I use these multilevel growth-curves to estimate trajec-
tories. In each chapter that uses this method to examine the association with a risk
factor, I incorporate a risk factor that is interacted with the trajectories to examine
how that risk factor (i.e., genetic risk or childhood trauma) affects change over time.
I provide further information on how this is done in each of these chapters.
3.4.2 Growth mixture modelling
An alternative approach for estimating trajectories of depressive symptoms is to
use growth mixture modelling (GMM) to create a number (e.g., 2-5) of subpopula-
tion trajectories (or latent classes) within a population corresponding to unobserved
groups [41, 55]. As highlighted in chapter 2, the GMM approach extends the growth
curve model to create multiple trajectories that follow distinct developmental trajec-
tories and this approach is popular for examining trajectories of depressive symptoms
as it is useful for creating discrete patterns of mood. As highlighted in the literature
review, these may be useful for qualitatively describing groups of individuals such as
those with consistently low symptoms (stable low), or those with consistently high
symptoms (high-persistent). In this thesis, I use the GMM approach to stratify in-
dividual’s into multiple subpopulation trajectories using posterior probabilities [40],
which essentially means that each person has a probability of belonging to every
trajectory or class, but the trajectory with the highest probability determines the
classification for that individual. As stated in the literature review, GMM is an
extension of latent class growth analysis (LCGA) as it allows for within-trajectory
variability which means that each individual can have their own trajectory within
each group. Depressive symptoms are heterogeneous, especially around adolescence
and so this thesis will not use the LCGA approach. The simplest form of the GMM
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where yij is the depressive symptom score and tij is the linear age term for
individual j at occasion i. Let Cj denote the latent class for which individual j










1j are the random intercept and slope effects that allow each




ij is the occasion specific residual which is allowed to vary within trajectories. As
with the multilevel growth-curve model, these models can be expanded to allow for
non-linearity, which I will expend on in the next chapter.
After determining the optimal number of trajectories, covariates (risk factors)
were added into the model to examine risk factors for varying trajectory membership.
Odds ratios (ORs) and their corresponding 95% confidence intervals (95% CI) were
derived from multinomial logistic regressions, where the trajectory with the largest
sample size was used as the reference.
In the following chapter I go on to use this method and provide more information
about how the variances can be constrained and relaxed, depending on the data
available. Additionally, I also use the multilevel growth-curve model to show how
both trajectories can be created in ALSPAC and how they compare and contrast
one another. In later chapters, I also show how risk factors can be included into
these models, which will identify which genetic and environmental risk factors are
associated with these trajectories of depressive symptoms.
3.5 Chapter summary
This chapter has introduced the data and methods used throughout this thesis.
I have demonstrated that ALSPAC is one resource that can be used to examine
the longitudinal nature of depressive symptoms and can be used for examining the
main aim of this thesis: exploring associations between genetic and environmental
risk factors and trajectories of depressive symptoms. However, I have also high-
lighted several key issues (i.e., missing data and bias) that should be considered
throughout this thesis. I will return to the issue of missing data in the next chapter
and discuss the implications in the conclusions chapter. The following chapters are
now based upon empirical studies that utilise this data for examining the associa-
tion between genetic and environmental risk factors and trajectories of depressive
symptoms. In particular, the next chapter will derive and model these trajecto-
ries in ALSPAC (which can then be used in subsequent studies), whilst chapter
5 will use the multiple-subpopulation approach and chapters 6, 7 and 8 will use
the population-averaged approach. Chapters 5, 6, 7 and 8 will all examine vary-










Before it is possible to examine genetic and environmental contributions to trajec-
tories of depressive symptoms (chapters 5, 6, 7 and 8), it is first important to model
and identify the trajectories themselves within the ALSPAC data. The literature
review in chapter 2 highlighted two issues that are worth noting here: 1) whilst there
are common patterns of trajectories between studies and cohorts, it is important to
adequately model the trajectory according to the data available; 2) there are two
popular methods that can be used to derive trajectories: one that creates population
averaged trajectories (using multilevel growth-curve modelling) another that creates
multiple-subpopulation trajectories (using growth mixture modelling). In this chap-
ter, I aim to derive trajectories of depressive symptoms within ALSPAC using both
approaches to explore two different types of trajectories of depressive symptoms.
This will be achieved in order to answer the first research objective: “what are the
varying patterns of longitudinal depressive symptoms across adolescence?”. These
results can then be used to explore the association between genetic and environmen-
tal risk factors and trajectories of depressive symptoms in the subsequent chapters
- thus this chapter is the foundation for the rest of the thesis.
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4.2 Introduction
Examining the longitudinal nature of depressive symptoms can be complex, espe-
cially during adolescence as this developmental period marks a stage where depres-
sion will commonly onset [16], and is characterised by abrupt changes in depressive
mood [103]. As discussed in the literature review, growth curve modelling is one
approach that can be used to adequately capture the nature and extent of changes
in depressive symptoms over time.
The literature review identified many studies that use a growth curve mod-
elling approach to identify trajectories of depressive symptoms. As discussed in the
data and methods chapter (chapter 3), ALSPAC is one of the few cohorts that has
repeated assessments of depressive symptoms (the short mood and feelings question-
naire [SMFQ]) across important stages of development (childhood to adolescence,
adolescence to young adulthood). Additionally, few studies have as many assess-
ments of depressive symptoms (currently nine occasions), which can help capture
some of these abrupt nuanced changes in depressive symptoms and give inference
on the patterns, onset and severity of depression.
Using ALSPAC data, trajectories of depressive symptoms have been derived
in several ways. For example, within the population-averaged approach for trajec-
tories, one study derived trajectories separately for males and females in order to
predict later alcohol use. They fitted a quadratic polynomial model yet were only
able to use data up to the ages of 18 [108]. Regardless of the sex differences observed,
Edwards and colleagues found that depressive symptoms were distinctly non-linear,
and showed patterns of increasing and decreasing depressive symptoms across the
time course that were sex specific (i.e., males tended to have symptoms that in-
creased, whilst females had symptoms that increased until the age of approximately
17, where symptoms then began to decrease). Additionally, using similar data and
methods with data up to the age of approximately 18, several studies have shown
that depressive symptoms can increase and change the rate at which they increase
with regards to the age of menarche in females [132, 133]. These studies imply that
when examining changes within population-averaged trajectories, it is important
to consider the non-linearity for how depressive symptoms may change over devel-
opment. As shown in the data and methods chapter, the depressive symptoms in
ALSPAC begin to decrease after the age of 18 to the ages of 22, before increasing
again until the age of 24. As no studies have examined the change in depressive
symptoms in ALSPAC post age 18, it is important to identify why this patter is
occurring and if risk factors for adolescent depressive symptoms are the same or
are maintained throughout young adulthood and beyond. Identifying the longitudi-
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nal nature of depressive symptoms is important for understanding for epidemiology
of depressive symptoms, but examining if (different) risk factors have long lasting
consequences that occur in both adolescence and young adulthood (or certain risk
factors that are specific to one period) is important for developing treatments and
interventions.
It is also important to highlight that several other studies have used the multiple-
subpopulation trajectories approach (i.e., grouping the population into qualitatively
distinct trajectories) to derive trajectories of depressive symptoms in ALSPAC. For
example, one study found that between the ages of 10 and 18, it was possible to
identify 4 qualitatively distinct trajectories of depressive symptoms that were de-
scribed as “stable low”, “stable moderate”, “moderate increasing” and “consistently
high” [75]. More recently, using the binary measures of the SMFQ (where the cut-off
point of more than or equal to 11 is used; see chapter 3 for details), one study has
identified three distinct trajectories with similar data that were described as “persis-
tently low”, “later-adolescent onset” and “early-adolescence onset” [87]. The nature
of these trajectories also suggests that the change in depressive symptoms is non-
linear and may be characterised by the onset, chronicity and severity of symptoms
across development. Thus, the multiple-subpopulation approach gives a similar but
also alternative view of how trajectories of depressive symptoms can be modelled,
compared to the population-averaged approach. Similar in that the change in de-
pressive symptoms are unlikely to be linear over time, but different in that the
heterogeneity of these trajectories is classified by discrete groups, rather than con-
tinuous heterogeneity and it is possible to identify groups of individuals (i.e., those
with increasing symptoms at later or early adolescence or those with chronically
severe symptoms) that may not be visible in the population averaged approach.
It is important to highlight that whilst only a handful of studies have utilised
ALSPAC to derive trajectories of depressive symptoms for examining substantively
interesting questions regarding the longitudinal nature of depressive symptoms, this
is likely a result of available data rather than a lack of interest (as the three latter
waves were recently released post late-2016). Nevertheless, the release of this new
data provides an exciting opportunity to explore how depressive symptoms change
over the later stages of adolescence and into young adulthood (and downstream al-
lows researchers to explore if certain risk factors are differentially associated with
greater levels of depressive symptoms at different developmental periods (i.e., ado-
lescence or young adulthood or both). With regards to this thesis, to efficiently
explore the genetic and environmental contributions to trajectories of depressive
symptoms, these trajectories must be suitably modelled and identified in ALSPAC,
before risk factors can be included into the analysis. Thus, this chapter forms the
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foundations for this thesis as the remaining chapters will all utilise the trajectories
estimated here. Therefore, the remainder of this chapter describes the methods used




As described in the data and methods chapter (chapter 3), the data used in this
study came from the Avon Longitudinal Study of Parents and Children (ALSPAC).
The response is depressive symptoms measured on nine occasions using the short
mood and feelings questionnaire (SMFQ).
Multilevel growth-curve models
As described in the data and methods chapter, multilevel growth-curve modelling
[59, 131] can be used to derive population-averaged trajectories of depressive symp-
toms. In the previous chapter I described this method for a very simple random
intercept and random slope trajectory model (equation 3.1), but as discussed there
and in the literature review (chapter 2), the change in depressive symptoms is un-
likely to be linear and will therefore require a more advanced modelling of the rela-
tionship between the response and age to capture this non-linearity. To do this, age
can be entered as a quadratic, cubic, quartic or higher-order polynomial [102, 108].
However, as shown in figures 3.2 and 3.4 (in the previous chapter), there appear to
be three inflection points in depressive symptoms within ALSPAC (i.e., ages where
depressive sympotms tend to go up or down). For instance, depressive symptoms
at age 10 decrease until age 12, then they begin to increase until about the age of
18. From here, depressive symptoms decrease until the age of about 22, where they
begin to increase again post the age of 24. This latter increase between the ages of
22 and 24 suggest that a quartic age polynomial is required. To demonstrate this, I
estimated a multilevel growth-curve model using a quartic polynomial model which
takes the following form:























ij are the linear,
quadratic, cubic and quartic age terms for individual j at occasion i. Additionally,
β0, β1, β2, β3, and β4 denote the associated regression coefficients for the intercept
and age terms. The u0j, u1j, u2j, u3j and u4j are the random intercept, linear,
quadratic, cubic and quartic individual-specific effects that allow each individual
to have their own trajectory, and eij is the occasion-specific residual. Prior to con-
structing the quartic polynomial, age was grand mean centred around age 16.53 (the
mean age of assessments) in order to improve interpretation and aid in convergence.
Specifically, the interpretation of the intercept and intercept variance will describe
the population average depression and between-subject variance evaluated at age
16.53.
The random effects are assumed multivariate normal distributed with zero mean
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The elements of the covariance matrix summarise the degree to which individual-
specific trajectories vary around the population-averaged trajectory. The residuals
are still assumed normally distributed with zero mean and constant variance:
eij ∼ N(0, σ2e) (4.3)
All models were fit by maximum likelihood estimation and were conducted using
Stata 15 (StataCorp, College Station, TX, USA) using the user-written runmlwin
command [134], which calls the standalone multilevel modelling package MLwiN
v3.01 (www.cmm.bristol.ac.uk/MLwiN/index.shtml).
Multilevel comparisons
To demonstrate that the quartic polynomial growth-curve model was the preferred
model to use throughout this thesis, I also estimated linear, quadratic and cubic
polynomial trajectory models and compared them to one another using likelihood-
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ratio tests and information criteria (deviance, Akaike information criterion [AIC] and
Bayesian information criterion [BIC]), as recommended by Singer and Willett [50].
As a further check, I also explored comparisons between other non-linear models
such as fractional polynomials, that have been used in other forms of childhood
growth [61, 135]. Results from these further checks can be found in appendix 4.
4.3.1 Growth mixture modelling
The alternative approach to growth curve modelling considered here is to derive
multiple-subpopulation trajectories using growth mixture modelling (GMM). Ifit
these models by maximum likelihood estimation as implemented in Mplus v7 [41].
I introduced this method in the previous chapter, by focusing on a very simple
model that estimated K trajectories or classes such as “stable low” or “increasing,
with linear change (shown in equation 3.4). Let us now consider a more advanced
approach that allows for trajectories (or classes) to be non-linear (as highlighted
in the literature review), so that it is possible to derive some of these potentially
interesting characteristics such as age of onset or severity. To do this, I estimated
trajectories with intercept, slope and quadratic growth factors for each class. This




















where yij is the depressive symptom score and tij, t
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ij, are the linear and
quadratic age terms for individual j at occasion i. Let Cj denote the latent class for







2 denote the associated regression coefficients for the intercept,






2j are the class
specific random intercept, linear and quadratic individual specific effects that allow
each individual to have their own trajectory. Thus, we have K sets of individual




















Like the multilevel growth curve model, e
[k]
ij is the class specific occasion residual:
e
[k]
ij ∼ N(0, σe[k]
2) (4.6)
In order to reduce convergence issues, the individual-level random effects variance-
covariance matrix was constrained to be equal across the latent classes, which is
common in this methodology [41], the residual variance was constrained equal across
classes as with previous research [130].
As is typical in GMM, I built a stepwise model starting with a single trajectory
and continued to add trajectories into the model until the optimal number of trajec-
tories was reached [40]. To assess this optimum, I used a range of criteria including:
lowest sample-size-adjusted Bayesian Information Criterion (ssaBIC; which based
on the log-likelihood penalised for model complexity as captured by the number of
parameters [136]), and hypothesis testing to help model choice by comparing model
fit for k versus k-1 trajectories, using the adjusted likelihood ratio test (LRT) and
bootstrap likelihood ratio test (BLRT) proposed by Lo-Mendell-Rubin [137]. I chose
to use a variety of model fit statistics as there is no universal appraised approach and
that support for the “preferred” number of trajectories is often achieved through
agreement of numerous fit statistics.
4.3.2 Missing data
Missing data in the multilevel growth-curve models and GMM were handled using
full information maximum likelihood estimation (FIML), which assumes that the
data are missing at random [138, 139]. This means that once we account for the
series of depressive symptoms scores on each individual that we do observe, the
probability that they are missing any subsequent measurement in the data does
not depend on their unknown level of depressive symptoms at that occasion. This
method is common in growth-curve research provides similar estimates to imputation
approaches [138], providing the assumption of missing at random is still held. To
maximise the data, I included individuals into these analysis if they had at least one
measurement of depression symptoms [130] as this boosts the effectiveness of the




There were 9,399 individuals who had at least one measurement of depressive symp-
toms, that were used to create trajectories in the population-averaged and multiple
trajectories approach. I describe the results for each approach in the following sec-
tion.
4.4.2 Multilevel growth-curve models
When estimating the multilevel growth curves, the quartic polynomial model best
fitted the data compared to the linear, quadratic and cubic polynomial models as
assessed by likelihood ratio tests and information criterion. Building a stepwise
model, the quadratic model was preferred to the linear model (x2 = 1383.27, p
<.001), the cubic model was preferred to the quadratic model (x2 = 394.1, p <.001),
and the quartic model preferred to the cubic model (x2 = 858.25, p <.001). As
shown in table 4.1. the model fit (as assessed by deviance, AIC and BIC) were all
lower for the quartic model. The quartic model also observably fitted the data best,
capturing the changes in depressive symptoms across development, including three
turning points, as shown in figure 4.1. Comparisons between the quartic polynomial
model and the fractional polynomials revealed the quartic polynomial model had
better model fit (see table 4.2. and appendix 4 for further details).
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Linear Model Quadratic Model Cubic Model Quartic Model
Parameter Estimate SE p Estimate SE p Estimate SE p Estimate SE p
β0 Intercept 5.473 0.038 <.001 5.848 0.05 <.001 5.858 0.051 <.001 6.279 0.057 <.001
β1 Age (linear) 0.219 0.006 <.001 0.238 0.006 <.001 0.325 0.014 <.001 0.366 0.014 <.001
β2 Age2 (quadratic) - - - -0.02 0.001 <.001 -0.016 0.001 <.001 -0.099 0.004 <.001
β3 Age3 (cubic) - - - - - - -0.002 0.0003 <.001 -0.005 0.0004 <.001
β4 Age4 (quartic) - - - - - - - - - 0.002 0.0001 <.001
Intercept var 9.255 0.199 - 14.172 0.33 - 13.985 0.329 - 16.907 0.412 -
Intercept/slope cov 0.72 0.022 - 0.813 0.03 - 1.045 0.062 - 1.271 0.072 -
Slope var 0.105 0.004 - 0.11 0.005 - 0.352 0.024 - 0.408 0.024 -
Intercept/quadratic cov - - - -0.158 0.007 - -0.145 0.007 - -0.493 0.025 -
Slope/quadratic cov - - - -0.002 0.001 - -0.006 0.002 - -0.03 0.005 -
Quadratic var - - - 0.003 0.0002 - 0.003 0.0002 - 0.028 0.002 -
Intercept/cubic cov - - - - - - -0.007 0.001 - -0.018 0.002 -
Slope/cubic cov - - - - - - -0.005 0.001 - -0.007 0.001 -
Quadratic/cubic cov - - - - - - 0.0002 0.00004 - 0.001 0.0001 -
Cubic var - - - - - - 0.0001 0.00001 - 0.0001 0.00002 -
Intercept/quartic cov - - - - - - - - - 0.007 0.0005 -
Slope/quartic cov - - - - - - - - - 0.0005 0.0001 -
Quadratic/quartic cov - - - - - - - - - -0.0004 0.00004 -
Cubic/quartic cov - - - - - - - - - -0.00001 0.000003 -
Quartic var - - - - - - - - - 0.00001 0.000001 -
Residual variance 13.898 0.115 - 12.69 0.116 - 12.364 0.126 - 11.594 0.128 -
ICC 0.54 0.55 0.53 0.59
Deviance 254892.83 252509.56 253115 252257.21
AIC 254904.8 253529.6 253145.5 252299.2
BIC 254957 253616.5 253275.8 252481.7
Table 4.1: Model estimates between trajectories. Note: SE: Standard error; p: p-value; Var: Variance; Cov: Covariance; ICC: Intraclass
correlation; AIC: Akaike information criterion; BIC: Bayesian information criterion. Age was centered to 16.53 years, the mean age of all
the assessments
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The estimates for the quartic polynomial model are also given in table 4.1 and
indicate that population averaged depressive symptom scores at age 16.53 were 6.28.
These results combined with inspecting the plot of the population average trajectory
in figure 4.1 suggest that from initially low levels of depressive symptoms around age
10, depressive symptoms began to increase towards the age of 18, before decreasing
until the age of 22. From here, depressive symptoms then began to rise again.
Figure 4.2 shows the predicted population averaged trajectory for this quartic
model now supplemented with 100 random individual trajectories surrounding the
population averaged trajectory. The trajectories in the latter ages appeared to be
“fanning out”, which suggests that the trajectories were getting more heterogeneous
at these later ages.
Model Deviance AIC BIC
Linear Model 254892.8 254904.8 254957
Quadratic Polynomial 252509.6 253529.6 253616.5
Cubic Polynomial 253115 253145.5 253275.8
Quartic Polynomial 252257.2 252299.2 252481.7
Fractional Cubic Polynomial 252728.6 252758.6 252889.8
Fractional Quartic Polynomial 252279.7 252319.7 252493.5
Table 4.2: Comparison between polynomial models(n=9,399). Note: AIC: Akaike
information criterion; BIC: Bayesian information criterion.
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Figure 4.1: Comparisons between linear (A), quadratic (B), cubic (C) and quartic (D) polynomial models.
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Figure 4.2: Quartic population averaged trajectory with a random 100 individual specific trajectories.
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4.4.3 Growth mixture models
Whilst using the k + 1 approach, there was evidence that five qualitatively distinct
subpopulation trajectories of depressive symptoms best fitted the data in ALSPAC.
As shown in table 4.3., the five trajectories model was preferred to both the four and
six classes trajectories solutions. Adding classes generally resulted in better model fit
(as shown by smaller ssaBIC). This suggested that multiple classes were preferred to
a single unconditional model. However, adding classes also resulted in lower entropy,
which is a marker for accuracy in the assignment of posterior class distributions
(i.e., the certainty to which an individual belongs to a specific class). The LRT
showed that adding a sixth class did not improve the model fit over and above the
five-class solution. Taken all of this into consideration, I decided to settle on the
five-class solution as class certainty and model fit are often regarded as the best
indices of model selection in growth mixture models [139]. As shown in figure 4.3,
the 5 trajectories can be described as the following: those who had consistently low
levels of depression symptoms - stable low (black line: 70.5%/n=6627), individuals
who started with low depression symptoms but rose throughout adolescence and
young adulthood – early-adult onset (turquoise line: 11.6%/n=1087), individuals
who experienced elevated levels of depression symptoms only during adolescence –
adolescent limited (pink line: 9.4%/n=881), individuals who started with elevated
levels of depression symptoms in childhood which decreased over time – childhood
limited (yellow line: 5.1%/n=480) and individuals with moderate levels of depression
symptoms that continued to rise and stay high across adolescence and into young
adulthood – childhood persistent (purple line: 3.5%/n=324). Figure 4.3 shows all
the estimated trajectories whilst, figure 4.4 and figure 4.5 show the estimated average
trajectories with 100 individual specific observed and predicted trajectories for each
latent class, respectively.
k NP ssaBIC Entropy LRT(p) BLRT(p)
1 10 253634.62 - - -
2 11 252306.66 0.793 <.0001 <.001
3 15 251346.88 0.743 <.0001 <.001
4 19 250909.03 0.752 .1040 <.001
5 23 250484.48 0.736 .0014 <.001
6 27 250230.41 0.735 .0966 <.001
Table 4.3: Comparison between trajectory groups in the growth mixture model.
Note: k: number of classes; NP: number of parameters; ssaBIC: sample size ad-
justed Bayesian Information Criterion; LRT: Lo-Mendell-Rubin likelihood ratio test;
BLRT: bootstrap likelihood ratio test.
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Figure 4.3: 5 trajectories from the growth mixture modelling in ALSPAC
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(a) Stable Low (b) Adolescent Onset (c) Childhood Limited
(d) Childhood Persistent (e) Early Adult Onset
Figure 4.4: Observed trajectories from the GMM. A random subset of 100 observed individual trajectories assigned to the various trajectory
groups.
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(a) Stable Low (b) Adolescent Onset (c) Childhood Limited
(d) Childhood Persistent (e) Early Adult Onset




The analysis in this chapter has allowed me to identify trajectories of depres-
sive symptoms using two different methodologies: the population averaged ap-
proach (within the multilevel growth-curve modelling framework) and the multiple-
subpopulation trajectories approach (within the growth mixture modelling frame-
work). For the population averaged approach, the analysis revealed that a quartic
polynomial model best fitted the data, in preference to simpler polynomial models
such as the linear, quadratic and cubic polynomial models. For the multiple tra-
jectories approach, the analysis in this chapter revealed that a five-class quadratic
trajectories solution bets fitted the data, in preference to a two, three, four or six
class solution. For both approaches, the results were compared using a variety of
model fit criterion and statistics.
4.5.1 Comparisons with previous research
Previous research examining depressive symptoms using the population averaged
approach has normally utilised a quadratic or cubic polynomial model [101, 102].
With ALSPAC data, previous analysis has only tended to use a quadratic polynomial
approach for estimating non-linear trajectories of depressive symptoms [108], as
many studies have only had depressive symptoms data to the age of approximately
18. With the release of new data in ALSPAC, it was necessary to expand upon these
previous models to capture this pattern of depressive symptoms from childhood to
young adulthood.
4.5.2 Population-averaged trajectories in ALSPAC
The analysis in this chapter has shown that a quartic polynomial model is preferred
to the simpler models and this was verified by both likelihood ratio tests and a series
of information criterion. Also, it was possible to observably see that the quartic
polynomial fitted the data better than the other models (as shown in Figure 4.1). It
is important to state that no previous studies have gone beyond a cubic polynomial
model whilst deriving trajectories of depressive symptoms. However, this is likely
because very few studies have such frequent measures of depressive symptoms within
such a short period. Other longitudinal studies such as the Add Health study [140],
which has rich measures of depressive symptoms (as assessed by the CES-D) only
has four assessments of data spanning a 20-year period. Other longitudinal studies
such as the NLSCY [141], have similar waves of data (8 assessments over 14 years)
and have used higher order polynomials (cubic polynomials) to capture trajectories
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in their studies – suggesting that more assessments of depressive mood within a
shorter period of time may require more advanced and complicated models to fully
capture the changes across different periods of development (i.e., from childhood to
adolescence, changes in adolescence and then from adolescence to young adulthood).
4.5.3 Multiple-subpopulations in ALSPAC
The analysis in this chapter also revealed that a five trajectories solution was pre-
ferred in ALSPAC. Previous studies have identified multiple trajectories for this
developmental period, with several also identifying five trajectory solutions, similar
to what we observed [34, 72, 73]. Within ALSPAC, previous research using the
multiple trajectories approach has identified four [75] and three [87] trajectories re-
spectively. The trajectories estimated here are broadly consistent with these studies
in that the majority of the population fall into some stable low trajectory. However,
there are differences in the number of individuals that fall into some of these in-
termediary trajectories which results from the number of trajectories identified and
then classification of individuals into these trajectories. In both the previous studies,
data were only available up to the age of approximately 18. In the latter case, the
binary version of the SMFQ was used, rather than the continuous summary score. It
is likely that the additional assessments of depressive symptoms that were recently
released by ALSPAC allowed me to identify additional trajectories, that were not
present in previous studies. Still, it is important to determine whether these trajec-
tories are clinically meaningful or just a product of discrete groups of data. Previous
research examining different types of depression within the population has identified
four groups of individuals that are somewhat consistent with the trajectories that
I and other researchers have identified using the multiple-subpopulation approach
[142]. Here Jaffee and colleagues observed that the majority of individuals within
the population did not have a diagnosis of depression up until the age of 26 (65% of
individuals), whilst 31% of individuals had a diagnosis between the ages of 18 and
26. Likewise, 2% had a diagnosis between the ages of 11 and 15 but not after and
3% had a diagnosis of depression across adolescence and young adulthood. Whilst
the prevalence estimates vary for the results presented here and for other studies
using ALSPAC data, they give weight to the idea that depression is heterogeneous
within the population and characterised by varying timings of onset, severity and
chronicity. We were able to identify these profiles with these trajectories analysis
and the variation in estimates could be a result of the timing between the studies as
adolescent depression is though to be increasing in recent times [21], and that study
was conducted in 2002.
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4.5.4 Similarities and opposites
The distinction and similarities between these two approaches for deriving trajec-
tories of depressive symptoms is interesting and worth discussing. Both approaches
model individual level trajectories, yet the multiple-subpopulation trajectories ap-
proach categorises these individuals into multiple discrete distinct groups, whilst the
population-averaged approach just takes the average of all the individuals. An in-
teresting question is whether the discrete or continuous trajectories have an overall
impact on the interpretation of the results, especially with regards to earlier risk
factors. This question is not possible to answer without the inclusion of risk fac-
tors into the model. In the conclusions chapter I give an answer this question with
regards to several risk factors. However, what is clear that both approaches deal
with heterogeneous trajectories differently and that both approaches can be used for
examining trajectories of depressive symptoms. Both approaches also suggest that
change in depressive symptoms is non-linear and requires advanced modelling to
capture these changes across development. We see that in all the trajectories apart
from the stable low, there are changes in depressive symptoms that may be char-
acteristic of the nature of depressive symptoms such as the age of onset, chronicity
and severity. For example, in the multiple-trajectories approach, the late adolescent
onset trajectory may characterise a group of individuals who have an onset of de-
pression during adolescence, which is commonly reported [16]. Something similar is
also observed with the population-averaged approach, where depressive symptoms
increase at a much higher rate during adolescence.
It may be possible to harmonise both approaches for examining the nature of
depressive symptoms. That is to say that both approaches may yield the same an-
swer when it comes to examining what risk factors may be associated with higher
trajectories for example. Likewise, they may yield very different answers and in-
terpretations that indicate that both approaches cannot be harmonised. However,
it is important to highlight here that the thesis is not concerned with whether one
approach is better than the other. Instead this thesis seeks to use both approaches
for inferring more about how genetic and environmental contributions to trajectories
of depressive symptoms. In the following chapters, I will explore this possibility as
I look to see how varying genetic and environmental risk factors may be differen-
tially associated with these trajectories of depressive symptoms. As mentioned in
the literature review, one advantage of the multiple-subpopulation approach is that
it can handle multivariate analysis better than the population-averaged approach.
Therefore, the multiple-subpopulation approach provides the ideal platform for ex-
amining the association between both genetic and environmental risk factors and
trajectories of depressive symptoms.
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4.6 Chapter summary
The aim of this chapter was to derive trajectories of depressive symptoms in ALSPAC
using two different methodologies: the population averaged approach (within the
multilevel growth-curve modelling framework) and the multiple-subpopulation tra-
jectories approach (within the growth mixture modelling framework). As such, this
chapter has addressed the first research objective and I have shown that it was neces-
sary to build upon previous work examining growth curve models within ALSPAC,
as the models used in previous studies would not sufficiently model the newly avail-
able data in ALSPAC. These trajectories can now be used to address the subsequent
research objectives throughout the remainder of this thesis. In the next chapter I
take the multiple trajectories derived from the growth mixture modelling approach
to examine how genetic and environmental risk factors may be differentially asso-
ciated with these five differing trajectories in a multivariate approach. In chapters
6,7 and 8 I then expand upon those results (from chapter 5) and use the popula-
tion averaged approach to examine specific associations between risk factors and
trajectories of depressive symptoms.
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Chapter 5
Genetic and Environmental Risk
Factors Associated with
Trajectories of Depressive
Symptoms from Adolescence to
Young Adulthood
5.1 Chapter outline
This chapter uses the five multiple-subpopulation trajectories identified in the pre-
vious chapter to examine the association between genetic and environmental risk
factors and trajectories of depressive symptoms across adolescence and young adult-
hood. As stated in the literature review, this is the more common approach for ex-
amining the association between trajectories of depressive symptoms and earlier risk
factors - partially due to the ability to include multiple risk factors in a multivariate
analysis. Therefore, this chapter explores whether there are differential effects of
multiple genetic and environmental risk factors on trajectories. These results could
shed light on the aetiology of trajectories of depressive symptoms and guide the
timing and focus of prevention strategies. However, the results from this chapter
can also be expanded upon and investigated further and in more detail with the
population-averaged approach (as done in chapters 6, 7 and 8).
This chapter addresses the second research objective: “how are genetic and envi-
ronmental risk factors differentially associated with varying trajectories of depressive
symptoms?” and provides a platform for subsequent chapters which expand upon
this work and address subsequent research objectives. This chapter also contributes
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to the existing literature on risk factors associated with trajectories of depressive
symptoms and part of this chapter was published as a manuscript in JAMA Network
Open as below (additional supplementary materials are provided in appendix 5).
Kwong, A. S. F., Lopéz-Lopéz, J., Hammerton, G., Manley, D., Timpson, N. J.,
Leckie, G., Pearson, R. M. (2019). Genetic and Environmental Risk Factors Associ-
ated with Trajectories of Depressive Symptoms from Adolescence to Young Adult-
hood. JAMA Network Open. 2, doi:10.1001/jamanetworkopen.2019.6587
5.2 Chapter abstract
Less favourable trajectories of depressive mood across adolescence into early adult-
hood are associated with current and later psychopathology, impaired educational
attainment and social dysfunction, yet the genetic and environmental risk factors
associated with these trajectories are not fully established. Examining what risk
factors are associated with different trajectories of depressive mood could help iden-
tify the nature of depressive symptoms and improve preventative interventions for
those at most risk.
To examine how genetic and environmental risk factors differentially associate
with trajectories of depressive symptoms between ages 10 to 24 years.
In a longitudinal cohort study established in 1990 and currently ongoing (Avon
Longitudinal Study of Parents and Children), I used growth mixture modelling to
identify trajectories of depressive symptoms in 9,394 individuals. I then examined
associations between different risk factors and membership in these trajectories.
Analysis was conducted between August 2018 and January 2019.
Trajectories were composed from depressive symptoms measured using the short
mood and feelings questionnaire (SMFQ) across nine occasions between the ages
10 and 24 years. Risk factors included sex, a polygenic risk score (PRS) taken
from a recent genome wide association study of depressive symptoms, maternal
postnatal depression, partner cruelty to the offspring’s mother between ages 2-4
years, childhood anxiety at age 8, being bullied at age 10.
Data on all risk factors, confounders and the outcome were available for 3,525
individuals, including 1,771 (50.2%) females. Trajectories were assessed between
10.65 years and 23.8 years. I identified 5 distinct trajectories of depressive symp-
toms: ‘stable low’ (71.1%), ‘adolescent limited’ (9.2%), ‘childhood limited’ (5.8%),
‘early-adult onset’ (11.1%) and ‘childhood persistent’ (2.8%). Of all the associations
between risk factors and trajectories, female sex (OR, 6.45; 95% CI, 2.89-14.38), the
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PRS for depressive symptoms (OR, 1.47; 95% CI, 1.1-1.96) and childhood anxi-
ety (OR, 1.3; 95% CI, 1.16-1.45) showed strongest associations with the childhood
persistent trajectory, compared to the stable low trajectory. Maternal postnatal
depression (OR, 2.39; 95% CI, 1.41-4.07) had the strongest association with the
early-adult onset trajectory, whilst partner cruelty to mother (OR, 2.3; 95% CI,
1.36-3.9) had the strongest association with the adolescent limited trajectory. Bul-
lying (OR, 8.08; 95% CI, 4.92-13.26) showed the strongest association with the
childhood limited trajectory.
The least favourable trajectories of depressive symptoms (childhood persistent
and early-adult onset) were associated with both genetic and environmental risk
factors. However, the two trajectories of limited duration that had resolved by early
adulthood (childhood limited and adolescent limited) were not associated with the
PRS or maternal postnatal depression (two more ‘genetic’ risk factors). Instead,
bullying (a more ‘environmental’ exposure) was strongly associated with both the
childhood onset and childhood limited trajectories, suggesting that this risk factor
may have a time-specific impact. These findings suggest that examining genetic
and multiple time-specific environmental antecedents could help identify trajectories
of varying onset and chronicity. Understanding whether there are different risk
profiles (including timing/nature of exposure and prior vulnerabilities) may offer
more opportunities to target interventions at certain stages of development.
5.3 Introduction
As stated in the introduction, Depression is a leading cause of disability worldwide
[2], expected to be the highest global burden of disease by 2030 [3]. Despite efforts
to improve interventions, prevalence is still increasing, especially in adolescence [21].
Evidence suggests that depression during adolescence is associated with many con-
current and later psychological and social impairments [16, 20]. However, what is
driving this rise in adolescent depression is still not clear. A greater understanding
of the nature of adolescent depression and how to minimise it is crucial if we are to
reduce this global burden.
There is evidence that depression should be viewed on a continuum [8, 9], as
individuals with subthreshold depression [143, 144] and elevated levels of depressive
symptoms [10] are also at risk of concurrent and later psychopathology. Impor-
tantly, a similar pattern is also observed for those displaying consistently higher
levels of depressive symptoms over time [32, 43, 64, 67, 130]. Detailed longitudinal
analysis provides an opportunity to further understand how depression may mani-
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fest differentially over time, and its aetiology. Towards this goal, researchers have
identified trajectories of depressive symptoms across adolescence and potential risk
factors [30, 31]. Previous research suggests that adolescence, is characterised by
a clear rise in symptoms of depressed mood, however trajectories vary within the
population and differ by age of onset, duration and severity of symptoms [30–32,
103] . Evidence has shown that several less favourable trajectories of depressive
symptoms exist (i.e., those with depressive symptoms that start high and continue
[childhood persistent], those that start low but rise over time [early-adult onset] or
those that that start high in early childhood but decline over adolescence and young
adulthood [childhood limited]), which are present across multiple populations and
all often associated with poorer outcomes compared to the majority of adolescents
with low symptoms over time (stable low) [32, 34, 37, 43]. It may be possible to
start targeting specific interventions and treatments for certain individuals by disen-
tangling different risk factors (or different combinations of risk factors) for different
trajectories.
Identifying how different risk factors are associated with varying patterns of
depressive mood could be important for understanding the aetiology of depression
and improving treatment. Risk factors such as being female [37, 64], childhood
psychopathology [34, 43], parental mood [36, 37] and early life socioeconomic posi-
tion [43, 145] are important predictors of less favourable trajectories of depressive
symptoms. Stronger associations are typically observed for chronically high or rising
trajectories (Costello et al., 2008; Ferro et al., 2015; Stoolmiller et al., 2005; Weeks
et al., 2014; Yaroslavsky et al., 2013) [34, 36, 37, 43, 103], yet the evidence for this
is not clear cut. A recent study also found that polygenic risk for depression was
associated with a late adolescent onset trajectory [87], implying genetic liability may
be a key component for higher trajectories at specific periods of development [146].
The evidence is less clear on what predicts more adolescent or childhood limited
trajectories, although research suggests they could be reactive to more immediate
stressors and events [43]. For example, bullying is arguably one of the strongest pre-
dictors of adolescent and adulthood depression [25, 147, 148], and is most frequent
and salient during certain periods of childhood and adolescent development. There-
fore, bullying in childhood is likely to have immediate consequences. However, the
direction of this association is unknown and there is evidence that as bullying is also
associated with depression across the life-course suggesting it could also be reflective
of pre-existing vulnerability [149]. Therefore, it is unclear whether the relationship
between bullying and depression is time-specific and/or dependent on other prior
vulnerabilities [150]. Investigating how bullying affects differential trajectories of
depressive symptoms across adolescent development could give insight into how and
when the impact of this key risk factor occurs. Bullying in childhood has also yet
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to be linked to different trajectories of depressive symptoms.
Trajectories of depressive symptoms are likely to have a highly complex ae-
tiology comprised of both genetic and environmental influences. This is because
behavioural phenotypes such as depression are unlikely to have purely direct genetic
or environmental pathways [27]. Instead, it is more likely that an interplay of gene-
environment correlations exists and that complex traits (such as depression) may
have a greater contribution of genetic or environmental contributions [9, 87, 148,
151, 152]. For example, stressful life events may cause higher depressive symptoms,
but it is possible that genetically liable individuals may be more prone to stressful
life events, thus making it hard to determine the direction of effects. Therefore,
whilst we cannot yet separate whether a risk factors operates through genetic or
environmental mechanisms, examining both genetic and environmental risk factors
could build better prediction models and provide new understanding which could
be translated into improved prevention and interventions.
Currently, no studies have examined the longitudinal nature of trajectories of
depressive symptoms across adolescence and associations with both genetic and en-
vironmental risk factors between early childhood and adolescence. Understanding
whether different risk profiles are associated with specific manifestations of trajecto-
ries of depressive symptoms may offer more precise opportunities to target interven-
tions during certain periods. I hypothesized that the most vulnerable trajectories
(i.e., childhood persistent) would be associated with a combination of both genetic
and environmental risk factors (possibly reflecting a complex gene-environmental
interplay, and/or greater genetic contribution where genetic liability is reinforced by
environmental events). However, given the ambiguity surrounding the antecedents
of adolescent or childhood limited trajectories, there may be some specificity in these
trajectories that could be more reflective of emotional reactions to recent negative
environmental events, such as bullying.
5.4 Methods
5.4.1 Sample




Self-reported depressive symptoms were measured on nine occasions between ages 10
and 24 using the short mood and feelings questionnaire (SMFQ) [129], as described in
chapter 3. Further descriptive information for this chapter can be found in appendix
5.
5.4.3 Risk factors
Biological Sex was identified from birth notifications taken around the time of de-
livery and was coded as male or female. Data for four individuals were missing.
As mentioned in the literature review, it is possible to estimate an individuals genetic
liability to a trait (such as depression) through the use of polygenic risk scores (PRS)
[29]. Polygenic risk scores are created from summary statistics taken from large scale
genome-wide association studies (GWAS). GWAS look to identify specific genetic
variants (or single nucleotide polymorphisms [snps]) that are robustly associated
with a trait [9]. PRS are usually weighted by their effect size (taken from the intial
GWAS) and the number of risk alleles that an individual possesses [153], and at
their most basic can be thought of as summary score of an individuals liability
to a disease or trait. In the context of depressive symptoms and this thesis, a
PRS can be used to explore the association between genetic liability for depressive
symptoms and measured depressive symptoms in later life. PRS are not subject
to usual confounding as these snps are fixed at birth and cannot change. However,
just because these snps are fixed, does not necessarily mean they cause depression
or other traits. They essentially assess an individuals liability to depression and as
discussed earlier, depression is likely to be based upon a complex gene-environment
correlation. Finally, these PRS can be used for exploring associations but liberal
PRS (that have multiple risk variants) should not be used as instruments for methods
like Mendelian randomization due to violations in assumptions like pleitropy (one
gene affecting multiple traits) [154].
The PRS used here was a PRS for depressive symptoms was created in PRSice
[155], using summary statistics from a recent GWAS of depressive symptoms on
161,460 individuals [156]. I included SNPs that had a MAF of > 1% and info score
> 80%) and excluded SNPs with an R2 of >0.1, which were within 250Kb of each
other. I excluded SNPs located in the extended MHC region (chromosome 6 (26-
33Mb)). Participant genotyping information is available in appendix 5. The PRS
was created by weighting the effect sizes of 120,422 single nucleotide polymorphisms
(SNPs) associated with depressive symptoms from the initial GWAS at eight p-value
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thresholds (between 5x10-8 and 0.5; see appendix 5 for further details) and I used
the most liberal threshold (0.5) for prediction based upon recent evidence that more
liberal polygenic scores may be better predictors if the scores are only concerned
with maximising prediction [9, 122]. The PRS was standardised to have a mean of
0 and a standard deviation of 1, thus a higher PRS represents higher liability to
depressive symptoms but this should be normally distributed across the population
(see Figure 5.1. for a distribution of the PRS). Population stratification can be a
problem in genomic analysis, so to account for this I adjusted this analysis for the
first five principal components of ancestry, as per previous studies [157].
Figure 5.1: Histogram of the depressive symptoms polygenic risk score
Postnatal Depression was assessed at 8 weeks postpartum by the mother completing
the Edinburgh Postnatal Depression Scale (EPDS) [158]. A cut-off score of 13 or
more indicating probable depression was used [159, 160]. Postnatal depression was
chosen given the high correlation between pre and post-natal depression [161].
Cruelty to the Mother was assessed by the Family Adversity Index (FAI) which
asked the mother whether her partner was abusive towards her between the child’s
ages of 2-4 years (yes vs no) [145].
Childhood Anxiety was measured at approximately age 8 by asking the child’s main
caregiver about the child’s general anxieties taken from the Development and Well-
Being Assessment (DAWBA) [162]. A weighted summary score between 0-12 was
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created from 6 questions on childhood anxiety, with 12 indicating maximum child-
hood anxiety. These scores were derived from the following questions where the
response could be not at all; yes, but not on most days or yes, more days than not:
1. Does worrying lead to her/him being restless, feeling keyed up, tense or on
edge, or being unable to relax?
2. Does worrying lead to her/him feeling tired or “worn out” more easily?
3. Does worrying lead to difficulties in concentrating or her/him mind going
blank?
4. Does worrying lead to irritability?
5. Does worrying lead to her/him looking physically tense (tense muscles)?
6. Does worrying interfere with her/him sleep (e.g. difficulty in falling or staying
asleep, or restless sleep, or doesn’t have a good night’s sleep)?
Childhood Bullying was measured at approximately age 10 when the child attended
a research clinic, using the modified Bullying and Friendship Interview Schedule
[163]. A child was classed as being bullied, if he/she was on the receiving end of
any of the following five components of overt bullying frequently (several times a
month) or very frequently (several times a week):
1. Had personal belongings taken
2. Been threatened/blackmailed
3. Been hit/beaten up
4. Been tricked in a nasty way
5. Been called bad/nasty names
I used a binary variable to assess bullying of the child in the last 6 months (yes
vs no).
5.4.4 Confounders
The following confounders were included based upon previous literature linking them
to the risk factors and the depressive trajectories but not under current investigation
as hypothesised primary risk factors [75, 115, 160]: maternal age at birth (in years),
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maternal occupational status at birth (manual vs non-manual), maternal educational
attainment at birth and parity (1st born vs 2nd born vs 3rd born or more) and the
first 5 principle components of ancestry to control for population stratification in
the genetic analysis. These were included to examine the impact of confounders on
the relationship between depressive symptoms and the risk factors, as well as being
markers of missing data and participant demographics.
5.4.5 Statistical analysis - growth mixture modelling
I conducted growth mixture modelling (GMM) in Mplus version 8 [139] to identify
latent trajectories of depressive symptoms as described in the previous chapter.
Briefly, GMM stratifies individuals from a population into multiple heterogeneous
trajectories (or latent classes) [40]. Odds ratios (ORs) and their corresponding 95%
confidence intervals (95% CI) were derived from multinomial logistic regressions,
where the trajectory with the largest sample size was used as the reference. Further
details about model fit and how I assessed the validity of these trajectories can be
found in chapter 4 and appendix 5.
5.4.6 Missing data
Missing data in the GMM were handled using full information maximum likelihood
estimation (FIML) [139]. I included individuals into this analysis if they had at least
one measurement of depressive symptoms [87]. Previous research on this data has
demonstrated little difference on the shape of trajectories, distribution of trajectory
membership and associations between trajectories and outcomes when comparing
individuals with at least one measurement of depressive symptoms to participants
with at least 3, or all 9 measurements [130].
5.5 Results
Data were available for 9,394 individuals with at least 1 measurement of depressive
symptoms. Demographics for these individuals can be found in appendix 5, but
briefly, individuals included in the analysis were more likely to be female and have
mothers with better education and occupational status at birth. The sample size for
individuals with all risk factors and confounders was 3,525, including 1,771 (50.2%)
females. The mean age at the first occasion of depressive symptoms was 10.65 years
and 23.8 years at the last assessed occasion. Results from the GMM indicated a 5-
class trajectory solution best suited the data (as described in chapter 4). The shapes
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of these trajectories and class distributions did not differ substantially between the
sample consisting of 9,394 and the sample of 3,525 (see appendix 5). The following
analysis uses this sample of 3,525.
5.5.1 Trajectories of depressive symptoms
5 heterogeneous trajectories of depressive symptoms were derived: individuals who
had consistently low levels of depressive symptoms - stable low (71.1%), individuals
who started with low depressive symptoms but rose throughout adolescence and
young adulthood – early-adult onset (11.1%), individuals who experienced elevated
levels of depressive symptoms only during adolescence – adolescent limited (9.2%),
individuals who started with elevated levels of depressive symptoms in childhood
which decreased over time – childhood limited (5.8%) and individuals with moderate
levels of depressive symptoms that continued to rise and stay high across adolescence
and into young adulthood – childhood persistent (2.8%), see figure 5.2 (reproduced
from chapter 4 for ease of readership).
5.5.2 Association between risk factors and trajectories of
depressive symptoms
Unadjusted and adjusted results from the multivariate analysis between risk factors
and varying trajectories are presented in tables 5.1 and 5.2. The risk factors for
varying trajectories of depressive symptoms are shown in figure 5.3. For all the
following analysis, the odds ratio (OR) is for each trajectory compared to the stable
low. Correlations between risk factors and univariate or unadjusted multivariate
analyses are given in appendix 5.
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Figure 5.2: 5 trajectories from the growth mixture modelling in ALSPAC used in this chapter. Note this graph is recycled from the
previous chapter.
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Female 6.09 [2.91, 12.74] 2.22 [1.55, 3.19] 5.9 [3.6, 9.66] 1.88 [1.23, 2.89] <.001
Genetics
Polygenic Risk Score 1.54 [1.16, 2.02] 1.28 [1.08, 1.52] 1.12 [0.93, 1.35] 1.05 [0.86, 1.29] 0.002
Early Life
Postnatal Depression 2.56 [1.3, 5.02] 1.98 [1.2, 3.28] 1.18 [0.64, 2.2] 1.69 [0.9, 3.18] 0.009
Cruelty to Mother 2-4 Years 1.82 [0.82, 4.05] 2.17 [1.36, 3.46] 2.13 [1.33, 3.42] 1.07 [0.54, 2.12] 0.001
Childhood
Anxiety at 7.6 Years 1.26 [1.12, 1.4] 1.12 [1.02, 1.23] 1.1 [1.0, 1.21] 1.27 [1.14, 1.41] <.001
Bullied at 10 Years 4.23 [2.27, 7.89] 1.71 [1.12, 2.6] 1.37 [0.84, 2.25] 7.55 [4.86, 11.71] <.001
Table 5.1: Unadjusted multivariate associations between genetic and environmental risk factors and trajectories of depressive symptoms.
Note: Analysis was adjusted for all risk factors.
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Female 6.45 [2.89, 14.38] 1.96 [1.33, 2.88] 6.04 [3.35, 10.87] 1.81 [1.13, 2.9] <.001
Genetics
Polygenic Risk Score 1.47 [1.1, 1.96] 1.29 [1.06, 1.57] 1.04 [0.85, 1.27] 1.01 [0.81, 1.25] 0.012
Early Life
Postnatal Depression 2.37 [1.16, 4.85] 2.39 [1.41, 4.07] 1.12 [0.54, 2.31] 1.7 [0.8, 3.62] 0.005
Cruelty to Mother 2-4 Years 1.61 [0.66, 3.95] 1.78 [1.05, 3.04] 2.3 [1.36, 3.9] 1.06 [0.48, 2.37] 0.008
Childhood
Anxiety at 7.6 Years 1.3 [1.16, 1.45] 1.12 [1.01, 1.24] 1.09 [0.98, 1.21] 1.23 [1.08, 1.41] <.001
Bullied at 10 Years 4.91 [2.52, 9.58] 1.73 [1.1, 2.7] 1.56 [1.0, 2.44] 8.08 [4.92, 13.26] <.001
Table 5.2: Adjusted associations between genetic and environmental risk factors and trajectories of depressive symptoms. Note: Analysis
was adjusted for all risk factors and the following confounders: maternal age at birth, maternal occupational status at birth, maternal
educational attainment at birth and parity.
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Figure 5.3: Association between (A) being female, (B) polygenic risk, (C) maternal postnatal depression, (D) partner cruelty to mother,
(E) childhood anxiety and (F) bullying and trajectories of depressive symptoms.
106
5.6 Discussion
I used the five distinct trajectories of depressive symptoms established in chapter 4.
These trajectories were associated with both genetic and environmental risk factors.
These findings suggest that examining both genetic and environmental antecedents
could help identify groups with severe and chronic depressive symptoms (childhood
persistent), who should be prioritised for early intervention. Certain risk profiles
also show specific associations with longitudinal patterns of depressive symptoms.
Polygenic risk for depressive symptoms (i.e., greater genetic liability to depres-
sion) was associated with the childhood persistent and early-adult onset trajectories,
which supports the notion that genetic liability may play an important role in the
onset of depression in adolescence [87, 142]. Polygenic risk has previously been asso-
ciated with both depression and higher trajectories of depressive symptoms in later
adult populations [164, 165]. However, these results suggest that genetic liability
to greater depressive symptoms may begin to manifest in both childhood and ado-
lescence, highlighted in previous research [87]. As such, genetic liability could be
a mechanism for chronic and/or higher depressive symptoms across the life-course,
that operates through specific neurological or hormonal systems at certain stages of
development [146]. Similar results have been observed for trajectories of attention-
deficit/hyperactivity disorder (ADHD) [166], suggesting that genetic liability can
impact on the development of a trait. However, it is unlikely that genetic liability
alone is responsible for higher trajectories. Instead, a more plausible explanation is
that a complex interplay between genetics and the environment exists [27, 142, 151].
However, this is not yet understood and it is also not clear how genetic liability of
depression might impact on later environmental risk factors [167]. Future research
should look to explore this in order to discover potential pathways and mechanisms
involved in the maintenance of depression.
Previous research has shown that bullying is highly predictive of the onset of
depression in adolescence and adulthood [25, 147], however these findings highlight
that being bullied in childhood is strongly associated with both short and long-term
consequences. Whether exposure to bullying has a lasting impact may depend on
genetic vulnerabilities in both depression and vulnerability to bullying [148–150].
Bullying was assessed at age 10 (shortly before the first assessment of depressive
symptoms) and was most strongly associated with the childhood-limited trajectory
that showed high symptoms in early childhood that diminished over time. This could
reflect an immediate reaction to bullying which then resolves, thus making bully-
ing time-specific as bullying had weaker associations with the early-adult onset and
adolescent limited trajectories. However, bullying was strongly associated with the
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childhood persistent trajectory, suggesting there could be long term consequences
for individuals who were bullied in childhood (but still have consistently high symp-
toms over 10 years later). The difference between these two resulting trajectories
could be that the childhood persistent group also have genetic and additional en-
vironmental vulnerabilities that make it harder to recover. This supports previous
research highlighting genetic liability to schizophrenia and subsequent bullying is
associated with worse trajectories of poorer mental health [168]. This suggests that
victims of bullying that also have family and accumulating risks should be prioritised
for intervention. A similar interpretation could exist for childhood anxiety, which
showed associations with the childhood persistent, early-adult onset and childhood-
limited trajectories. Interventions to build resilience early on for those with genetic
liability may yield the most effective method for prevention of long-term or severe
depression.
Sex differences have consistently been associated with less favourable trajecto-
ries of depressive symptoms [99] and we observe strong associations between females
and the childhood persistent rising and adolescent limited trajectories, supporting
previous research [37]. The childhood persistent and adolescent limited trajectories
are distinct, yet the reason why we observed these differences may also be due to
childhood persistent rising females having a genetic liability to depression in addi-
tion to other factors such as early pubertal timing [99, 133] and stress reactivity
[105]. In contrast, the adolescent limited females who may not have the genetic
liability to depressive symptoms are maybe reacting only to early pubertal timing
or stressful events. However, it is likely that other biological and environmental risk
factors underlie less favourable trajectories for females, and more research is needed
to disentangle this relationship.
Maternal postnatal depression was associated with the childhood persistent
and early-adult onset trajectories, likely reflecting the transmission of maternal de-
pression to offspring depression [23, 159, 169, 170]. This association likely reflects
genetic influences (as these two trajectories were associated with the PRS) as well as
possibly impacting parental depression on offspring brain development in utero [23,
171]. Alternatively, it could reflect childhood vulnerabilities established in infancy
and early development that results in later depression [169]. As postnatal depres-
sion was not associated with the adolescent limited or childhood-limited trajectories
(i.e., trajectories not associated with genetic liability), it may suggest that maternal
depression has more long-lasting associations possibly through a genetic and envi-
ronmental interplay. Interestingly, this pattern was not observed for partner cruelty
to the mother, which was associated with the early-adult onset and adolescent lim-
ited trajectories, but not the childhood persistent or childhood limited trajectories
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(the trajectories associated with bullying). It could be that partner cruelty operates
through a different pathway and does not share the same time-specific impact com-
pared to bullying. Instead, membership into the adolescent limited trajectory could
be reflective of depressive symptoms that reduce post adolescence once they are less
influenced by family life. However, partner cruelty to the mother is a rare exposure
and it is possible that the associations between the early-adult onset and adolescent
limited trajectories may reflect a lack of power, rather than a true association.
5.6.1 Strengths and limitations
Previous research has validated the five-class trajectory model by observing that
different trajectories correspond with a diagnosis of depression that is applicable to
each time (i.e., childhood limited had a stronger association with a diagnosis early
on; early-adult onset had a stronger association with depression at a later diag-
nosis) [130]. Five-class trajectories have also been observed in other longitudinal
cohorts using similar methods, thus increasing the generalisability of these trajec-
tories [72, 73]. However, it is worth noting that previous research using the same
data (albeit only to age 18) only identified three trajectories of depressive symp-
toms, compared to the five in the present analysis [87]. This is likely a result of
the additional three measurement occasions and that I used a continuous scale of
depressive symptoms, compared to the binary diagnosis used by Rice and colleagues.
Despite these methodological differences, these results were broadly the same as ge-
netic liability to depressive was associated with a later onset trajectory, and weakly
associated with an early onset trajectory. Additionally, I used both genetic and
environmental risk factors with greater longitudinal data on depressive symptoms
to explore the long-term impact of these risk factors. However, one of the problems
with longitudinal cohort studies relates to attrition and although the model utilised
full information maximum likelihood to account for missing data, the data could
be missing not at random potentially leading to biased results. Furthermore, the
interplay between genetics and the environment is highly complex as genetic and
environmental risk factors are not independent (highlighted by previous research
and correlations between genetic and environmental risk factors in appendix 5). It
is therefore hard to disentangle genetic liability from later environmental risk fac-
tors that could be on the causal pathway. The analysis using genetic data was also
restricted to non-related individuals and individuals of European descent. Previous
research has shown ethnic differences in trajectories of depressive symptoms, with
Black, Asian and Hispanic populations all showing less favourable trajectories of
depression [88, 97]. I was unable to explore trajectories in these populations due to
the availability of DNA samples from the depressive symptoms GWAS and exclu-
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sion criteria, thus these results lack generalisability to these populations. However,
GWAS are being applied to other non-European populations and so future work
will be able to untangle ethnic differences in depression research using genetic and
environmental determinants [121]. It is also important to note that I made multiple
comparisons and confidence intervals in many cases overlapped and therefore the
specificity of the associations deserves replication. Future research that also untan-
gles genetic-environment correlations will be pivotal for identifying pathways and
mechanisms underlying various forms of depression. This will eventually lead to the
improvement and treatment of depression.
5.7 Conclusions
I used five trajectories of depressive symptoms between late childhood and young
adulthood. The childhood persistent and early-adult onset trajectories were as-
sociated with genetic and environmental risk factors. These findings suggest that
looking at the combination of both genetic and environmental antecedents could
help identify groups with chronic and severe depressive symptoms, who should be
prioritised for intervention. Yet the severity and course of these symptoms could
depend on the timing of specific risk factors and other prior vulnerabilities. For
example, bullying was strongly associated with both the childhood onset and child-
hood limited trajectories, suggesting it may be time-specific and that severity and
duration could depend on other vulnerabilities (i.e., genetic liability). Overall, these
findings imply that the aetiology for different trajectories of depressive symptoms is
multifactorial, with a complex interplay of genetic and environmental contributions.
It may be possible to differentiate between different risk profiles that show varying
trajectories of depressive symptoms. This could be transformed into the develop-
ment of interventions and treatments for those at most risk of greater depressive
symptoms, which could in turn prevent or reduce depression and other detriments
in later life.
5.8 Chapter summary
This chapter has shown that certain genetic and environmental risk factors may
be differentially associated with varying trajectories of depressive symptoms and in
doing so has addressed the second research objective “how are genetic and environ-
mental risk factors differentially associated with varying trajectories of depressive
symptoms?”. The findings presented here are the first to combine both polygenic
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risk and environmental risk factors within the same model and have contributed to
the existing literature. However, this is only one approach to examining trajecto-
ries of depressive symptoms and as stated in the literature review (chapter 2), an
alternative approach can be used to derive population-averaged approaches for ex-
amining associations between risk factors and trajectories of depressive symptoms.
In chapters 6, 7 and 8, I build upon this chapter to examine in more detail how
several of the genetic and environmental risk factors identified here are associated
with population averaged trajectories. Using both approaches will provide a dual
prospective on how genetic and environmental risk factors might play a role in the




Sex Differences and Trajectories of
Depressive Symptoms from
Childhood to Young Adulthood
6.1 Chapter outline
This chapter follows on from the conclusions of the last chapter (chapter 5) and
from existing research highlighted in the literature review (chapter 2): that fe-
male sex is a strong risk factor for higher trajectories of depressive symptoms. In
the previous chapter using a multivariate analysis, I showed that female sex was
strongly associated with the four “higher” trajectories, compared to the stable-low
trajectory. However, these results can be expanded to explore when female sex is
having the greatest effect on these trajectories. Therefore, the aim of this chapter
was to explore this association in more detail using the population-averaged ap-
proach for estimating trajectories of depressive symptoms. In chapter 4, I derived
the population-averaged trajectories using multilevel growth curve models and in
this chapter I use this model to compare trajectories of depressive symptoms be-
tween females and males in a more holistic approach that characterises the nature
of depressive mood for each sex across multiple stages of development1. With this
chapter I also wanted to build upon previous growth curve model research by esti-
mating critical points in these trajectories such as the age of peak velocity (i.e., the
age at which depressive symptoms are increasing at the fastest rate) or age at max-
imum depressive symptoms, which could be useful a tool for examining important
points at which it may be beneficial to intervene to reduce current or later depressive
1Note: this chapter was conducted before the release of the ninth SMFQ data wave, and so this
chapter focuses on only the first 8 waves of the SMFQ and was modelled with a cubic polynomial
model - see appendix 6.
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symptoms.
This chapter addresses the second research objective: “how are genetic and
environmental risk factors differentially associated with varying trajectories of de-
pressive symptoms?” but also the third research objective: “are there critical points
in trajectories of depressive symptoms which tell us more about how and when de-
pression changes across adolescence?” and the fourth research objective: “can the
results from trajectory models be simplified to aid in the interpretation and trans-
lation of findings?”. As such, this chapter advances the findings from the previous
chapter by highlighting different ages at which depressive symptoms could be get-
ting worse or when they are at their worst and how this varies by sex. Part of this
chapter was published as a manuscript in the Journal of Youth and Adolescence as
below (with supplementary materials provided in appendix 6).
Kwong, A. S. F., Manley, D., Timpson, N. J., Pearson, R. M., Heron, J., Sallis,
H., Stergiakouli, E., Davis, O., Leckie, G. (2019). Identifying Critical Points of
Trajectories of Depressive Symptoms from Childhood to Young Adulthood. Journal
of Youth and Adolescence. 48, 815-827. doi.org/10.1007/s10964-018-0976-5
6.2 Chapter abstract
Research has focused on late childhood and adolescent depression in an attempt
to prevent or reduce later psychopathology and/or social impairments. It is impor-
tant to establish and study population-averaged trajectories of depressive symptoms
across adolescence as this could characterise specific changes in populations and help
identify critical points to intervene with treatment. Multilevel growth-curve models
were used to explore adolescent trajectories of depressive symptoms in 9,301individ-
uals (57% female) from the Avon Longitudinal Study of Parents and Children, a UK
based pregnancy cohort. Trajectories of depressive symptoms were constructed for
males and females using the short mood and feelings questionnaire over 8 occasions,
between 10 and 22 years old. Critical points in development such as age of peak
velocity for depressive symptoms (the age at which depressive symptoms increase
most rapidly) and the age of maximum depressive symptoms were also derived. The
results suggested that from similar initial levels of depressive symptoms at age 11,
females on average experienced steeper increases in depressive symptoms than males
over their teenage and adolescent years until around the age of 20 when levels of
depressive symptoms plateaued and started to decrease for both sexes. Females on
average also had an earlier age of peak velocity of depressive symptoms that oc-
curred at 13.5 years, compared to males who on average had an age of peak velocity
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at 16 years old. Evidence was less clear for a difference between the ages of maxi-
mum depressive symptoms which were on average 19.6 years for females and 20.4 for
males. Identifying critical periods for different population subgroups may provide
useful knowledge for treating and preventing depression and could be tailored to
be time specific for certain groups. Possible explanations and recommendations are
discussed.
6.3 Introduction
Research has focused on childhood and adolescent depressive symptoms as a po-
tentially modifiable risk factor for more severe depression during adulthood [10, 32]
and previous research has shown that elevated levels of depressive symptoms within
a population (and even those that never rise above the threshold for depression) are
associated with a greater risk for depression in later life [35, 43]. Evidence concludes
that the period between late childhood and adolescence may be important for sub-
sequent mental health and social functioning, thus identifying and treating elevated
depressive symptoms during this time could limit or prevent depression in later life
through support and services [16, 144].
Research has yet to fully understand the nature of trajectories of depressive
symptoms across adolescence and into young adulthood and identifying the key
characteristics and time course of depressive symptoms across this period will ul-
timately aid in improving treatments and interventions. The chapter attempts to
build upon previous research by estimating trajectories of depressive symptoms be-
tween late childhood and young adulthood, and identifying critical points along
those trajectories that could shed light on the nature of how these trajectories of
depressive symptoms develop and change over time.
Previous studies have examined trajectories of depressive symptoms between
childhood and young adulthood in an attempt to explore the nature and risk factors
underlying greater depressive symptoms (see chapter 2), for reviews see Musliner
et al. [32], Shore, Toumbourou, Lewis, and Kremer [31] and Schubert, Clark, Van,
Collinson, and Baune [30]. Indeed, research suggests that trajectories of depressive
symptoms tend to increase from childhood through adolescence, before decreasing in
young adulthood [98, 99]. Evidence also suggests that these trajectories may peak
in mid-to-late adolescence, towards the ages of 15-17 years old [37, 103].
Other research has suggested that depressive symptoms may increase post ado-
lescence. For instance, Ge and colleagues demonstrated that trajectories of depres-
sive symptoms were highest around the ages of 17 to 18 years old, but were unable
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to explore depressive symptoms further than this age due to a cease in data collec-
tion [93]. Other research has suggested that trajectories of depressive symptoms are
highest in young adulthood (towards age of 20) but then decline until older age [172].
In this instance, Sutin and colleagues did not have data preceding young adulthood
so they were unable to explore if trajectories were higher around adolescence. It
may be that trajectories of depressive symptoms could peak outside adolescence,
yet do not have preceding and succeeding data around this period to substantiate
these claims [62, 96]. Likewise, many studies also use small sample sizes, which can
make it difficult to infer about population level changes of depressive symptoms.
Observing the longitudinal nature of trajectories of depressive symptoms en-
ables researchers to identify critical points at which to intervene to limit or prevent
more severe depression. The notion of identifying critical points is not new [173],
but this application to trajectories of depressive symptoms has yet to be fully ex-
plored. Using depressive symptoms data from childhood to young adulthood (12 to
25 years), Ferro and colleagues identified the age of maximum depressive symptoms
to occur between the ages of 15 to 17 years old [103], whilst Rawana and Morgan
found that depressive symptoms were highest at approximately 17 years old [102].
Similar results have also been observed by Natsuaki and colleagues who plotted tra-
jectories that indicated the age of maximum depressive symptoms was 16 years old
[99]. Other research has also found evidence of sex differences in regards to an age
of maximum depressive symptoms with females reaching this maximum earlier than
males [97, 108].
While identifying the age of maximum depressive symptoms is important for
characterising the nature of depressive symptoms, calculation of the age of peak
velocity may also be important (i.e., the age at which depressive symptoms are
increasing most rapidly). Research has suggested that identifying depressive symp-
toms early or before depression already manifested may be a key step towards pre-
venting greater depressive symptoms or severe depression from occurring [17, 174].
By identifying the age of peak velocity of depressive symptoms, it may be possible to
highlight a critical point where interventions and treatments could be implemented
to reduce or limit greater depressive symptoms from escalating. However, no studies
have calculated the age of peak velocity of depressive symptoms and studies that
have previously identified the age of maximum depressive symptoms have done so
using heuristics, graphs or figures rather than empirically calculating these ages.
Trajectories of depressive symptoms are not homogeneous within the population
[32], and a number of risk factors can influence trajectories of depressive symptoms
[43, 175]. Consistent evidence has shown that females tend to have higher trajecto-
ries of depressive symptoms compared to males [43, 64]. Although in several studies
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where heterogeneous trajectories are identified, there is some evidence that females
are associated with more intermediary trajectories such as “increasing”, “late on-
set” or “early high” [37, 104]. These studies suggest there may be mechanisms that
underpin membership into varying trajectories, but the extent to which this can
be explained has yet to be fully understood. Females also appear to have a higher
peak along these trajectories of depressive symptoms [93, 97, 99], and may reach
this peak earlier than males [108], yet it is also not clear why this is the case.
6.3.1 The current study
Previous research has shown that trajectories of depressive symptoms tend to in-
crease throughout adolescence and into young adulthood [37, 101], and that females
are more likely to have higher trajectories of depressive symptoms [98, 99]. However,
the longitudinal nature of depressive symptoms has yet to be fully understood as
previous research has used small sample sizes, not had depressive symptoms data
that spans a wide enough temporal window, and/or has been unable to measure
depressive symptoms over important periods and transitions of development (e.g.,
from late childhood to adolescence and/or from adolescence into young adulthood).
Likewise, no studies have identified critical periods of trajectories of depressive symp-
toms that could potentially highlight modifiable stages at which to best intervene.
Identifying critical points such as the age of peak velocity of depressive symptoms
(i.e., the age at which depressive symptoms are increasing most rapidly) could help
researchers and clinicians target a stage of development where depressive symptoms
might be increasing at the fastest rate, which may in turn prevent or reduce higher
symptoms or the onset of depression.
The current study aims to address the previous limitations firstly by using mul-
tilevel growth-curve modelling to create trajectories of depressive symptoms in a
large UK based population cohort. Multilevel growth-curve modelling has previ-
ously been a useful method for examining trajectories of depressive symptoms [102,
103]. Trajectories are created for both male and female populations between 10 and
22 years using 8 waves of depressive symptoms follow up. It was hypothesised that
females would have higher trajectories of depressive symptoms throughout adoles-
cence and young adulthood compared to males. Secondly, the ages of peak velocity
and maximum depressive symptoms, as well as the depressive symptoms scores at
both these ages for males and females are then calculated and compared. It was
also hypothesised that the ages of peak velocity and maximum depressive symptoms
would be earlier for females given their tendency to have elevated trajectories at the





As described in chapter 3, the data used in this chapter were taken from the Avon
Longitudinal Study of parents and Children (ALSPAC).
6.4.2 Measures
Depressive symptoms: Depressive symptoms were measured on eight occasions
between ages 10 and 23 using the short mood and feelings questionnaire (SMFQ)
[129], as described in chapter 3. Further descriptive information for this chapter can
be found in appendix 6.
Biological sex: Biological sex was identified from birth notifications around the
time of delivery and coded as a dummy variable for being female (male = 0; female















1 3,605 3,730 4.17 3.45 3.92 3.91
2 3,271 3,421 3.57 3.47 4.35 4.16
3 2,922 3,074 4.09 3.8 5.71 4.93
4 2,010 2,967 4.31 4.58 7.0 6.02
5 1,898 2,588 5.63 4.77 7.29 5.47
6 1,172 2,151 5.34 5.02 7.64 6.21
7 1,161 2,132 4.87 4.82 6.15 5.90
8 1,323 2,517 5.35 4.95 6.67 5.79
Table 6.1: Descriptive statistics for the Short Mood and Feelings Questionnaire (SMFQ) by sex
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6.4.3 Statistical methods
Trajectories of depressive symptoms were estimated using multilevel growth-curve
modelling [48, 49]. Descriptive statistics indicated the change in depressive symp-
toms followed a non-linear pattern (table 3.2). Thus the model needed to appropri-
ately capture the non-linearity of these trajectories. A multilevel cubic growth-curve
polynomial model was chosen for two reasons. First, entering age as a cubic poly-
nomial fitted the data better and produced more plausible results than entering age
as a quadratic or quartic polynomial (see appendix 6)2. Second, compared to more
complex cubic splines and fractional polynomials which have also been used to model
non-linear growth in other contexts [125, 135], entering age as a cubic polynomial
led to a more parsimonious model. Multilevel cubic growth-curve polynomials have
been used in previous studies examining trajectories of depressive symptoms [102,
103]. As in chapter 4, model fit was assessed using likelihood ratio tests and infor-
mation criteria, consistent with other studies using multilevel growth-curve models
[50, 102]. The preferred model specifies separate population-averaged trajectories
for males and females by interacting the fixed-effects age polynomial terms with the
female dummy variable. The age polynomial terms were allowed to vary randomly
across individuals to capture each individual’s unique trajectory. Very similar to
the equations presented in chapter 4, the model can be written as:












where yij is the depressive symptom score and tij is the age for individual j at
occasion i, x1j is a dummy variable for being female, and u0j, u1j, u2j, and u3j are
the random intercept, linear, quadratic and cubic effects of age, respectively. The
occasion-specific residual eij allows the depressive symptom scores to deviate from
the individual-specific cubic trajectories.
The random effects are assumed multivariate normal distributed with zero mean
2note: as stated earlier there were only eight occasions available at the time of this study and
so a cubic polynomial model best fitted this data (even though later data resulted in a quartic
model). This variation in model selection is unlikely to have any overall bearing on the results for
this study (regarding critical points)
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The elements of the covariance matrix summarise the degree to which individual-
specific trajectories vary around the sex-specific population-averaged trajectories.







which can be expanded to:
σ2ej = α0 (1− x1j) + α1x1j (6.4)
All analyses were conducted using Stata 14 (StataCorp, College Station, TX,
USA) using the user-written runmlwin command [134], which calls the standalone
multilevel modelling package MLwiN v2.35 (www.cmm.bristol.ac.uk/MLwiN/index.shtml).
The population male and female trajectories are therefore given by:
Male : E (yij|tij, x1j = 0) = β0 + β1tij + β2t2ij + β3t3ij (6.5)
Female : E (yij|tij, x1j = 1) = (β0 + β4) + (β1 + β5) tij+
(β2 + β6) t
2




Critical points: Several critical features were calculated from these sex-specific
mean trajectories including: the ages of peak velocity of depressive symptoms (i.e.,
ages at which male and female depressive symptoms are increasing most rapidly),
and the ages of maximum depressive symptoms (i.e., the ages at which male and
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female depressive symptoms were the highest). The depressive symptoms scores
were also calculated at each of these critical ages. The delta method in Stata was
used to compare differences in the intercept, linear, quadratic and cubic terms, as
well as at the critical points between the male and female trajectories. This was
done to ease interpretation of the results. The delta method, which incorporates
the estimate, standard errors and confidence intervals from post estimation results
allows for wald test comparisons for non-linear models. This allowed me to explore
differences of critical points with precision and uncertainty. See appendix 6 for
further details.
6.5 Results
There were 9,301 individuals with data on sex and at least one measurement of
the SMFQ, resulting in 39,942 measurements (17,362 male [43.47%]/22,580 female
[56.53%]).
6.5.1 Trajectories of depressive symptoms
Females and males followed different trajectories (figure 6.1). The intraclass cor-
relation evaluated at age 16 was 0.56 (SE = 0.01) indicating that over half of
the variation in individuals’ depressive symptoms at this age is captured by their
individual-specific cubic trajectories. The correlation between the intercept (i.e.,
first measurement of depressive symptoms) and the slope (i.e., change in depressive
symptoms with every year increase) was 0.52 (SE = 0.03). Table 6.2 presents the
regression coefficients from the cubic polynomial model. The marginal sex-specific
trajectories did not differ substantively with the addition of covariates (see Supple-
mentary materials), so only the unadjusted trajectories and main features of the
trajectories are described.
The differences in trajectories of depressive symptoms between males and fe-
males are shown in table 6.3 and figure 6.1. Briefly, females had higher trajectories
compared to males, except between 10 and 11 years old where males were predicted
to have higher depressive symptoms. Females were associated with higher depressive
symptoms at 16 years of age (β = 6.7, SE = 0.07 [95% CI: 6.57, 6.83]) compared
to males (β = 4.57, SE = 0.07 [95% CI: 4.43, 4.7]; pDIFF < 0.001). Females had a
higher linear slope (β = .049, SE = 0.02 [95% CI: 0.45, 0.53]) compared to males
(β = 0.36, SE = 0.02 [95% CI: 0.31, 0.4]; pDIFF < 0.001) which showed that de-
pressive symptoms increased more rapidly for females until the age of 20. However,
females had a greater negative quadratic slope (β = -0.04, SE = 0.002 [95% CI:
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Parameter Estimate Std. Error p value
Intercept 4.57 [4.43, 4.7] 0.07 <0.001
Age (slope) 0.37 [0.31, 0.4] 0.027 <0.001
Age2 (acceleration) 0.01 [0.008, 0.02] 0.002 <0.001
Age3 (cubic change) -0.007 [-0.009, -0.006] 0.001 <0.001
Female 2.13 [1.95, 2.32] 0.1 <0.001
Female x Age 0.14 [0.06, 0.19] 0.03 <0.001
Female x Age2 -0.05 [-0.06, -0.05] 0.003 <0.001
Female x Age3 0.002 [0.0001, 0.003] 0.001 0.04
ICC 0.56
Deviance 227890.58
Table 6.2: Regression coefficients for the cubic polynomial model (n=9,301). 95%
confidence intervals given in [parenthesis]
-0.05, -0.03]), suggesting from around age 20 their depressive symptoms started to
decrease, in contrast to males (β = 0.01, SE = 0.002 [95% CI: 0.008, 0.2]; pDIFF <
0.001). Finally, a negative cubic slope was observed for both females (β = -0.01, SE
= 0.001 [95% CI: -0.001, -0.004]) and males (β = -0.007, SE = 0.001 [95% CI: -0.01,
-0.006]; pDIFF = 0.04), indicating that depressive symptoms were decreasing from
age 20 onwards, however the current analysis suggested that both sexes decreased
at similar rates into young adulthood (tables 6.2 and 6.3).
Males Females Difference p value
Intercept term
for SMFQ
4.57 (0.07) 6.7 (0.07) 2.13 (0.1)
<0.001
[4.43, 4.7] [6.57, 6.83] [1.95, 2.32]
Linear term
for SMFQ
0.36 (0.02) 0.49 (0.02) 0.14 (0.03)
<0.001
[0.31, 0.4] [0.45, 0.53] [0.08, 0.19]
Quadratic term
for SMFQ
0.01 (0.002) -0.04 (0.002) 0.05 (0.003)
<0.001
[0.008, 0.2] [-0.05, -0.03] [0.05, 0.06]
Cubic term
for SMFQ
-0.007 (0.001) -0.01 (.001) 0.002 (0.001)
0.04
[-0.01, -0.006] [-0.001, -0.004] [0.0001, 0.003]
Table 6.3: The intercept was centered to age 16 for interpretability. The differences
between each term were calculated as follows: the intercept term for males (β0)
minus the intercept term for females (β0 + β4), the linear term for males (β1) minus
the linear term for females (β1 + β5), the quadratic term for males (β2) minus the
quadratic term for females (β2 + β6), the cubic term for males (β3) minus the cubic
term for females (β3+β7). Standard errors are given in (parenthesis), 95% confidence
intervals are given in [parenthesis]
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(a) Individual and averaged population trajectories for a random set of 100 partici-
pants - by sex
(b) Averaged population trajectories for males and females. • Male age of peak
velocity of depressive symptoms. N Male age of maximum depressive symptoms. 
Female age of peak velocity of depressive symptoms.  Female age of maximum
depressive symptoms
Figure 6.1: Cubic polynomial trajectories by sex. SMFQ: Short Mood and Feelings
Questionnaire
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6.5.2 Age of Peak Velocity and Age at Maximum Depressive
Symptoms
The age of peak velocity in the model was earlier for females (13.51 years old, SE
= 0.32 [95% CI: 12.88, 14.14]) compared to males (16.36 years old, SE = 0.1 [95%
CI: 16.18, 16.55]; pDIFF < .001). However there was little evidence of a difference
between the age at the maximum point of depressive symptoms for females (19.61
years old, SE = 0.5 [95% CI: 18.63, 20.6]) compared to males (20.42 years old, SE
= 0.14 [95% CI: 20.14, 20.69]; pDIFF = .13). See table 6.4 for full statistics.
6.5.3 Depressive Symptoms Score at Age of Peak Velocity
and at Age of Maximum Point of Depressive Symp-
toms
The predicted depressive symptoms scores at the estimated age of peak velocity were
higher for females (5.42 points, SE = 0.06 [95% CI: 5.3, 5.55]) than they were for
males (4.76 points, SE = 0.07 [95% CI: 4.62, 4.91]; pDIFF < .001). The depressive
symptoms scores at the maximum point of depressive symptoms were also higher for
females (7.7 points, SE = 0.09 [95% CI: 7.52, 7.88]) compared to males (5.75 points,
SE = 0.1 [95% CI: 5.55, 5.95]; pDIFF < .001). See table 6.4 for full statistics.
Males Females Difference p value
Age of Peak
Velocity in SMFQ
16.36 (0.1) 13.51 (0.32) 2.86 (0.34)
<0.001
[16.18, 16.55] [12.88, 14.14] [2.2, 3.51]
Age of Maximum
SMFQ
20.42 (0.14) 19.61 (0.5) 0.80 (0.55)
0.14
[20.14, 20.69] [18.63, 20.6] [-0.27, 1.88]
SMFQ at
Peak Velocity
4.76 (0.07) 5.42 (0.06) 0.66 (0.1)
<0.001
[4.62, 4.91] [5.3, 5.55] [0.47, 0.85]
SMFQ at
Maximum Point
5.75 (0.1) 7.7 (0.09) 1.95 (0.14)
<0.001
[5.55, 5.95] [7.52, 7.88] [1.69, 2.22]
Table 6.4: Calculated features from the trajectories of the cubic polynomial model.
Standard errors are given in (parenthesis), 95% confidence intervals are given in
[parenthesis]
6.5.4 Missing Data and Sensitivity Analysis
Missing data were handled using full information maximum likelihood (FIML),
which assumes that data are missing at random. The initial analysis included indi-
viduals with at least one measurement from the SMFQ. Although individuals with
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only one measurement do contribute to the analysis (e.g. via association between
average depressive symptoms and sex), it is not meaningful to predict and examine
trajectories for these individuals. To overcome this, a sensitivity analysis was run
on a subset of individuals who had four or more depressive symptom scores. The
sample size reduced from 9,301 to 5,409. However, removing these individuals had
no substantive impact on the interpretation and conclusions from these trajectories
(see appendix 6), thus only the full analysis is reported here. Results were also
robust to the inclusion of covariates that are associated with missing data and attri-
tion. Further analysis on individuals with depressive symptoms data at ages 10 and
22 revealed varying distributions of the depressive symptoms data and underlying
demographics compared with individuals who only had depressive symptoms data
at age 10 (i.e., had depressive symptoms data missing at 22), see appendix 6.
6.6 Discussion
The nature of trajectories of depressive symptoms between adolescence and young
adulthood is not fully established, and research has yet to identify critical periods
of trajectories of depressive symptoms that could potentially be used to target a
stage of development where depressive symptoms might be increasing at the fastest
rate. A greater understanding of the nature of depressive symptoms would aid
researchers and clinicians in developing and improving treatments and interventions.
The purpose of this analysis was to explore trajectories of depressive symptoms
from childhood to young adulthood between males and females and to identify and
compare critical points along these trajectories for both populations.
This analysis showed that females and males have different population-averaged
trajectories of depressive symptoms, with varying ages of peak velocity of depres-
sive symptoms. Using multilevel growth-curve modelling on 8 waves of data between
ages 11 to 22, results suggest that females were on average associated with higher
trajectories of depressive symptoms compared to males, with the exception of be-
tween 10 and 11 years old where on average males had higher depressive symptoms.
Both male and female population-averaged trajectories increased during adolescence
before declining in young adulthood, yet females on average had a higher rate of
deceleration (depressive symptoms slowing down) from age 20 and both sexes had
trajectories that first plateaued and then started to decline in young adulthood.
Evidence suggested that that on average, females had an earlier age of peak velocity
of depressive symptoms (i.e., age at which depressive symptoms is increasing most
rapidly), but little evidence to indicate that females had an earlier age of maximum
depressive symptoms (i.e., age at which depressive symptoms is highest on the tra-
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jectory). Finally, depressive symptoms scores at the age of peak velocity and age of
maximum depressive symptoms were both higher for females on average compared
to males.
These findings support earlier hypothesis and previous research that trajectories
of depressive symptoms increase from late childhood, through adolescence and begin
to decrease in young adulthood [97, 99, 103]. One possible explanation for increased
depressive symptoms during adolescence is that young people face a number of social,
psychological and biological changes during this stage of development [16, 97]. These
changes include transitioning between schools, making new friends, taking exams
and experiencing puberty. As many studies highlight that trajectories of depressive
symptoms increase during this period, efforts should be made to monitor individuals
who show heightened depressive symptoms as they may be individuals at a greatest
risk of depression or higher levels of depressive symptoms.
This chapter was also able to expand on previous work by estimating points on
population-averaged trajectories marking the average age of peak velocity, of max-
imum depressive symptoms and the depressive symptoms scores at both of these
ages. These results show the age of peak velocity of depressive symptoms was al-
most 3 years earlier for females. The results suggest that depressive symptoms are
increasing most rapidly for females at approximately 13.7 years old and for males
at 16.4 years old, and that treatment and interventions could be implemented at
different ages for males and females. These findings have implications for clinical
services, schools and parents, who should be made aware that females are more likely
to be younger when depressive symptoms are increasing most rapidly, with males
following at a later stage. Likewise, as females appear to have higher trajectories
for a longer of period of time, more awareness could be targeted towards services,
schools and parents over this period of heightened and increasing depressive symp-
toms. Identifying features such as the age of peak velocity may help determine at
what age depressive symptoms are getting worse most rapidly, but also highlight a
key characteristic of trajectories of depressive symptoms that is potentially modifi-
able. Future research should primarily examine if the age of peak velocity identified
here is universal to other cultures and countries and should also look to examine
other predictors of these ages to see if they are potentially modifiable. Given that
individuals with higher starting points (intercepts), had steeper trajectories (slopes),
it is important to identify depressive symptoms early and when they are increasing
as the current results suggest that those who start with higher depressive symptoms
are at a greater risk of continuing to have higher trajectories of depressive symptoms.
This chapters’s findings suggested that the age of maximum depressive symp-
toms was approximately a year apart between males (20.7 years old) and females
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(19.7 years old), although evidence for a difference was weak. Several studies have
suggested that this age should occur around mid-to-late adolescence, approximately
between 15-17 years old [99, 102, 103]. However, other evidence has indicated that
this age of maximum depressive symptoms occurs later in development [93, 172],
which coincides with the current results. There are several potential explanations
as to why the current results observed a much later age of maximum depressive
symptoms compared to some previous research. In several studies, the number of
depressive symptoms measurements from follow-up are low and are therefore unable
to pick up more nuanced changes in depressive symptoms over time. Depressive
symptoms are dynamic and can change rapidly over a short period, thus researchers
need frequent measurements to track subtle changes [51]. In the present analysis,
the measurements were assessed on average never more than 3.5 years apart, which
is more regular than many of the previous studies. It could be that frequently
assessing depressive symptoms allowed detected changes and characteristics of the
trajectories that were not observed in previous studies.
Another explanation is that variation in the age of maximum depressive symp-
toms is the result of contextual differences between the cohorts used. For example,
similar ages of maximum depressive symptoms were observed using data from the
National Longitudinal Study of Adolescents Health [37, 99], and the Canadian-based
National Longitudinal Survey of Children and Youth [102, 103]. However, other re-
search using different North American cohorts have observed later ages of maximum
depressive symptoms [93, 172]. ALSPAC is one of the few longitudinal studies in
the UK that currently has repeat depressive symptoms data across this period of
development so it hard to conclude whether similar effects would be observed in
other UK studies at this point. Other studies that examine depressive symptoms
in longitudinal settings around the world use alternative methods to derive latent
classes of trajectories of depressive symptoms [37, 43], and as such it is harder to
compare critical points from these studies as there are often 4 or 5 trajectories from
each study (each with their own age of maximum depressive symptoms). However,
an important point to consider is that this analysis is the first to empirically estimate
this age and present it with measures of uncertainty rather than simply describing it
from figures. It is unlikely that this will explain the observed differences with other
studies, but in the interest of interpretability and to help characterise the nature of
trajectories of depressive symptoms, future research should estimate and report this
age as this will help clarify whether there cross cultural differences for critical ages
in the development of depression. Similarly, this is the first analysis to calculate and
then compare critical points from two population trajectories (males vs. females).
Interestingly, the current results supported previous research that suggested no sex
differences between the ages of maximum depressive symptoms [93, 99], but con-
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tradicted other research suggesting that females have an earlier age of maximum
depressive symptoms compared to males [108]. However, the authors here did not
use the same number of measurements, used a quadratic polynomial model and only
had data that went up to approximately 18 years old. Future research should ex-
amine depressive symptoms regularly around these ages to see if the critical periods
identified are similar across contexts. Such research will inform services, schools and
parents about the nature of depression and how to prevent and treat it around these
ages.
Still, it is not clear why females on average have higher trajectories of depres-
sive symptoms and why females and males differ in their ages of peak velocity of
depressive symptoms. One explanation is that women tend to experience puberty
earlier than men and evidence has suggested that early pubertal timing may be
a mechanism responsible for depression and higher depressive symptoms [16, 176].
Research has also shown that an earlier age of menarche is positively associated with
higher depressive symptoms [132, 176] and a causal mechanism for greater depressive
symptoms [177]. Transitioning through puberty is associated with other psychologi-
cal and social changes, and individuals who transition early may not have developed
the cognitive and emotional skills to combat these changes, and therefore experience
lasting effects of depressive symptoms. Likewise, early pubertal changes could re-
sult in increased responsiveness to stressors in females, resulting in higher depressive
symptoms [16]. These findings suggest that individuals with higher starting points,
had higher trajectories. Therefore an earlier age of higher depressive symptoms may
set an individual up for a higher trajectory which takes longer to recover from. This
could explain why females have higher trajectories compared to males, although
more research using the timing and changes in pubertal status for both males and
females would be needed to substantiate this claim.
Additionally, Angold and colleagues found that depression was higher for fe-
males between the ages of 9 and 16, and this seemed to coincide with both pubertal
status and timing of puberty [178]. Of note, the number of girls with depression
in their study was highest at around age 14, which coincides with the age of peak
velocity of depressive symptoms in the present analysis. This suggests there may
be some common mechanism at this age that is underpinning depressive symptoms,
and how this manifests. The age of peak velocity from the current analysis tends
to match the ages at which both males and females experience puberty and so one
possible reason why the current analysis observed varying ages of peak velocity of
depressive symptoms between males and females may be through the role of puberty.
Despite a number of strengths, this analysis has several limitations that should
be highlighted. One limitation that arises with the data used here, and more gen-
129
erally with longitudinal data, is attrition and the role this plays in biasing results
towards individuals who respond. The sample size in this analysis decreased from
7,335 at the first wave of data collection to 3,840 by the eighth occasion opening
the possibility to potential attrition bias. Analysis on individuals with depressive
symptoms data at both the first and last occasion, compared to those with depres-
sive symptoms data at the first occasion but not the last, revealed differences in the
overall symptoms scores and underlying demographics. However, this is consistent
with previous research [108], and suggests that studies with attrition could be un-
derestimating the effect of sex differences in trajectories of depressive symptoms as
females were more likely to have not responded at the last occasion. Previous stud-
ies have also imputed missing data utilising a missing at random approach (MAR)
but found that bias due to systematic missingness in ALSPAC is not substantial
[26, 179]. The multilevel growth-curves models used in the present analysis also use
FIML to account for missing data and sensitivity analyses revealed that the main
effects of this analysis (i.e., the trajectories and the critical points) were not sub-
stantively affected by the inclusion of covariates associated with missing data and
attrition bias. Nevertheless, future studies should highlight missing data patterns
and attempt to account for data that could potentially be missing not at random.
A more thorough discussion regarding missing data and potential biases is given in
the conclusions chapter.
Another limitation in this analysis stems from the choice of model used and
the assumptions made with multilevel growth-curve models. Modelling trajectories
of depressive symptoms appropriately is challenging. A cubic polynomial model
was chosen given it is a more parsimonious approach in comparison to splines and
fractional polynomials and that it has been used in previous studies that show
nonlinearity [101, 102]. However, alternative approaches such as a restricted cubic
spline model may fit the data better at the expense of parsimony. Similarly, a
quartic polynomial model may be a better model if the depressive symptoms data
continues to rise. Cubic terms (and other polynomials) may also perform poorly at
the start and end of the trajectories, as well as potentially producing artificial turns
in the data that do not exist [61]. Checks were made to ensure that no artificial
turns occurred in the data by comparing against other models and the underlying
data and descriptive statistics for plausibility. Additionally, the age of peak velocity
of depressive symptoms and age of maximum depressive symptoms were calculated
well within the range of the trajectories so any bias from potentially mismodelling
the start and end of the trajectories is minimised.
A similar limitation in this analysis is in regard to highlighting variability with
the multilevel growth-curve model. A problem with population growth curves like
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the ones used in the present analysis is that it is harder to convey how much vari-
ability exists across the population, compared to other methods such as latent class
growth analysis or growth mixture modelling, which typically stratify population
trajectories into multiple subpopulation trajectories. Future research could derive
critical periods from latent class analysis to examine if certain groups of trajectories
have earlier ages of peak velocity or later times of maximum depressive symptoms.
Such research could further highlight variability in critical points across multiple
trajectories.
6.7 Conclusion
The nature of trajectories of depressive symptoms between adolescence and young
adulthood is not yet clear, but research has suggested that increased levels of de-
pressive symptoms throughout this period are associated with a greater risk of psy-
chopathology and adverse social outcomes in later life [20, 43]. It is important to
examine the nature of depressive symptoms and identify critical periods that could
potentially be used to target a stage of development where depressive symptoms are
increasing at the fastest rate. A greater understanding of these two facets would aid
in developing and improving treatments and interventions. This chapter examined
trajectories of depressive symptoms between males and females in a large UK based
population cohort over multiple stages of development. Using multilevel growth-
curve models, the findings suggested that females on average were associated with
steeper trajectories of depressive symptoms compared to males, indicating they were
more likely to experience higher depressive symptoms for longer. Importantly, the
age at which depressive symptoms were increasing most rapidly were much earlier
for females on average compared to males. Whilst the mechanisms underpinning
this sex difference are not entirely understood, pubertal status and the timing of
pubertal status could play a role in explaining why females on average have higher
trajectories and commence on these trajectories earlier than males. Calculating the
age of peak velocity of depressive symptoms is a potentially useful tool for exploring
how depressive symptoms are changing and at what age they are increasing most
rapidly, which may have consequences downstream. If this can be used for clinical
purposes, it may be possible to treat individuals at this age, which may help reduce
depressive symptoms or depression at a later stage.
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6.8 Chapter summary
This chapter has shown that female sex is a strong risk factor for higher population-
averaged trajectories of depressive symptoms and supports the work highlighted in
the previous chapter (that female sex is associated with the four “higher” trajecto-
ries), and research identified in the literature review. This chapter has addressed the
second research objective by showing the association between sex and trajectories
of depressive symptoms, the third research objective by identifying critical points in
trajectories and the fourth research objective by simplifying some of the estimates
taken from the cubic polynomial growth curve model. This chapter has also shown
that the estimation of critical points in trajectories (such as the age of peak velocity)
could be used for preventing depressive symptoms from increasing or highlighting a
potentially important period when depressive symptoms could be targeted. These
results expand upon the findings of chapters 4 and 5, and previous research through
this notion of identifying critical points, but is limited by only focusing on one risk
factor (sex). In the next chapter, I build upon this work and the findings from chap-
ter 5 by using a different risk factor (childhood trauma) and then translating the







This chapter expands upon the findings from chapters 4, 5 and 6 by using the
population-averaged trajectories approach to probe the association between child-
hood trauma and later trajectories of depressive symptoms. Chapter 4 identified the
trajectories across adolescence and young adulthood. Chapter 5 then used a mul-
tivariate approach to exploring risk factors for trajectories of depressive symptoms,
and found that exposure to childhood bullying was strongly associated with higher
trajectories - indicating that environmental risk factors such as bullying could be
important for heightened depressive symptoms across adolescence and young adult-
hood. Likewise, chapter 6 demonstrated how a risk factor could be explored in
greater detail using the population-averaged approach. In this chapter, I explore
how childhood trauma (which can be thought of as an extension of bullying) and
the number of childhood traumas (which can be thought of as an accumulation of
negative environmental events) are association with later trajectories of depressive
symptoms in an attempt to expand upon the previous chapters. Here I use the
population-averaged approach and extend the findings from the previous chapter to
show how estimates from complex trajectory models can be translated into simpler
findings through an “alternative model parametrisation”. I show how this alterna-
tive framework could be useful for determining when a risk factor is likely to have its
greatest effect on depressive symptoms (and how this may differ for different popu-
lations) and how it extends the traditional growth curve approach, which could be
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useful for clinicians policy makers downstream.
This chapter mainly addresses the second research objective: “how are genetic
and environmental risk factors differentially associated with varying trajectories of
depressive symptoms?”, and the fourth research objective: “can the results from
trajectory models be simplified to aid in the interpretation and translation of find-
ings?” but it also touches upon third research objective: “are there critical points
of trajectories of depressive symptoms which tell us more about how and when de-
pression changes across adolescence?” This chapter is the culmination of chapters
4, 5 and 6 and was written with a narrative that aimed to help the reader better
interpret complex trajectory estimates - thus the structure of this chapter varies
from chapters 5, 6 and 8. Part of this chapter was adapted to be manuscript which
is currently under review at Social Science and Medicine: Population Health. All
supplementary materials for this chapter are provided in appendix 7.
Kwong, A. S. F., Maddalena, J. M., Croft, J., Heron, J., Leckie, G. (Under Review
at Social Science and Medicine: Population Health). Early Childhood Trauma and
Trajectories of Depressive Symptoms.
7.2 Chapter abstract
Growth curve modelling such as trajectory analysis is useful for examining the lon-
gitudinal nature of depressive symptoms, their antecedents and later consequences.
However, issues in interpretation associated with this methodology could hinder the
translation from results to policy changes and interventions. The aim of this article
is to provide a “model interpretation framework” for highlighting growth curve re-
sults in a more interpretable manner. Here I demonstrate the association between
childhood trauma and trajectories of depressive symptoms. Childhood trauma has
been shown to a be strong predictor for later depression, but less is known how
childhood trauma has an effect throughout adolescence and young adulthood. Iden-
tifying when childhood trauma (and its severity) is likely to have its greatest impact
on depression is important for determining the timing of interventions for depression.
I used data on over 6,500 individuals from the Avon Longitudinal study of
Parents and Children (ALSPAC) to estimate trajectories of depressive symptoms
between the ages of 11 and 24. Depressive symptoms were measured using the short
mood and feelings questionnaire (SMFQ) across 9 occasions. Childhood trauma was
assessed between the ages of 5 and 10 years old, and I estimated population averaged
multilevel growth curves of depressive symptoms for exposure to trauma (yes vs no)
and then in a separate model, the number of trauma types reported such as inter-
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personal violence, abuse or neglect (coded as 0, 1, 2, 3+). I then calculated what
the depressive symptoms scores would be ages 12, 14, 16, 18, 20, 22, 24, between
these varying trajectories.
Reported exposure to childhood trauma was associated with less favourable
trajectories of depressive symptoms across adolescence, mainly characterised by
exposed individuals having worse depressive symptoms at age 16. There was an
exposure-response relationship between the number of childhood traumas and tra-
jectories of depressive symptoms. Individuals exposed to 3 or more types of trauma
had substantially steeper and less favourable trajectories of depressive symptoms:
becoming worse at a more rapid rate until the age of 18. By age 18, individuals that
reported the greatest exposure to trauma (3+ types of trauma) had 14% greater
depressive symptoms compared to non-exposed participants.
Childhood trauma is strongly associated with less favourable trajectories of
depressive symptoms across adolescence. Individuals exposed to multiple types of
inter-personal violence, abuse or neglect are at the greatest risk of worsening depres-
sive symptoms throughout adolescence and young adulthood. Individuals exposed
to traumatic experiences in childhood should be identified as at high risk of depres-
sion and other adverse outcomes as early trauma may disrupt social development
and have lasting consequences on mental health outcomes. The model interpreta-
tion framework presented here may be more interpretable for researchers, clinicians
and policy makers as it allows comparisons of depression across multiple stages of
development to highlight when the effects of depression are greatest.
7.3 Introduction
Growth curve modelling is useful for examining the longitudinal nature of depression
across development [32, 172]. Growth curve models allow researchers to estimate
trajectories that describe patterns of change in depressive mood over time. These
are potentially more useful than analysis of data from any single occasion, as it is
possible to estimate the longitudinal nature of depression across periods of devel-
opment and transitions. Furthermore, it is possible to examine the antecedents of
varying trajectories of depressive symptoms [80, 98], their later consequences [43,
67], their relationship with other co-occurring traits [5, 76, 180] and the identifica-
tion of critical points that could be translated into preventions and interventions (as
shown in the previous chapter). Consequently, growth curve or trajectory analysis
is not only a useful tool for research, but also potentially for clinical inference and
identifying at risk groups for treatment [30].
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Methodology exploring trajectories of depressive symptoms has been increas-
ingly used in recent years [30–32]. However, much of this research has yet to impact
on policy and clinical inference, which could be a result of difficulties in translating
findings to inference. Estimating trajectories of depressive symptoms can be done in
several ways: one approach is to plot the mean scores by age and depressive symp-
toms and compare differences at each age (i.e., with a t-test/ANOVA). However,
one problem with this approach is that there may be different samples at the vari-
ous ages, and this can lead to biased estimates with missing data. A more popular
approach is to stratify population trajectories into multiple sub-group trajectories
(e.g., latent classes growth analysis or growth mixture models, see [41]). An al-
ternative approach is to estimate population-averaged trajectories, with individuals
being allowed to vary around this population average (e.g., multilevel growth-curves
and structural equation models, see [59]). These latter approaches quantify the de-
gree of change, making them useful methods for estimating how depression changes
over a certain period of time, and what might predict this change. These two ap-
proaches are somewhat similar but can produce different results and interpretations,
thus harmonising results from both analyses is challenging and could impact on how
clinicians and policy makers interpret and implement these findings.
As highlighted in the literature review and throughout this these, one issue
with the longitudinal analyses of depressive mood is that depressive symptoms fluc-
tuate and are characterised by periods of rapid growth, severity and varying ages
of onset [103], especially during heightened risk periods such as adolescence [16].
In many studies, modelling trajectories of depressive symptoms and the subsequent
interpretation is complex and not easily understood. For example, changes in de-
pression are rarely linear. Studies may typically use higher order polynomials to
model non-linear trajectories (e.g., quadratic and cubic functions of age), which can
result in complicated model estimates (positive quadratic terms but negative cubic
terms etc). This can be seen in chapter 6 for example). In turn, this can be difficult
for researchers and clinicians to interpret and inform policy and practise. To combat
this, researchers often use illustrations of trajectories to highlight complex results,
however in many cases [97, 102, 103], these illustrations: 1) do not come with de-
grees of certainty (i.e., confident intervals) 2) can be difficult to compare when there
are multiple trajectories that cross and overlap (even with certainty levels) and 3)
do not precisely define key characteristics of the trajectory such as estimating when
the trajectory is at it’s highest or lowest (the terminology used will often be vague
using words like “approximately” or “around”). Therefore, whilst graphical repre-
sentations of trajectories are useful to an extent, it is important to find alternative
ways to highlight and further supplement results from trajectory methods. An ex-
ample of this has been demonstrated in longitudinal assessments of autistic traits
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[181]. Here, Mandy and colleagues estimated differences in the predicted autistic
traits scores between male and female trajectories at multiple ages and were able to
quantify the exact age where autistic traits began to change.
This approach could be beneficial when applied to the longitudinal study of
depressive symptoms. It is often important to not only highlight the course of de-
pression over time, but also when differences may be occurring and how two or more
trajectories (i.e., exposed vs not exposed) differ at a certain stages of development
(i.e., is one higher at a particular time). The results in many studies highlighting dif-
ferences between trajectories are not straight forward, as the presented estimates are
typically the estimated coefficients of polynomials and the coefficient of each term in
the polynomial is hard to interpret in isolation. More clarity in this area could assist
clinicians and policy makers to understand the implications of results from analyses
of trajectories of health outcomes, but could also shed light on interesting results
from the models (such as empirically testing when a trajectory is “higher” than an-
other and how this changes across time). Therefore, the first aim of this analysis is
to highlight how the results from these analyses can be made more interpretable to
researchers, clinicians and policy makers by presenting an alternative model inter-
pretation framework to highlight results that show the depressive symptoms scores
of different trajectories at different ages. This framework essentially calculates what
the depressive symptoms scores would be for an exposed trajectory at a given age
(i.e., 12, 14 or 16. . . ) and compares it to the age of an unexposed group at the same
age. This gives a depressive symptoms score that can be quantified and compared
at numerous stages of development to help translate complex estimates and help
determine when depressive symptoms may be changing or at their greatest/lowest.
One of the most useful applications for growth curve modelling is to exam-
ine how early antecedents or risk factors may predict the trajectory of depressive
symptoms over time. In chapter 5, I showed that childhood bullying was strongly
associated with the ”higher” trajectories of depressive symptoms, providing further
evidence that traumatic events in childhood can have persistent effects on depressive
symptoms. Bullying is one traumatic event that children may be exposed to, how-
ever less is known about more general forms of childhood trauma. Therefore, this
chapter looked to expand upon previous chapters by examining the association be-
tween childhood trauma and trajectories of depressive symptoms across adolescence
and young adulthood. Childhood traumas is a key predictor for adolescent and
young adulthood depression [182–184], yet its effect on depressive mood throughout
the course of adolescence and young adulthood is still not clear.
Latent class analysis has found that exposure to abuse before the age of 18
years old is associated with less favourable trajectories of depressive symptoms [104].
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Here, Olino and colleagues found that individuals who scored higher on a scale of
childhood adversity and abuse has increased odds of belonging to the ‘persistent’,
‘increasing’ and ‘initially high’ trajectories, but interestingly not the ‘later onset’
trajectory of depressive symptoms. Maltreatment in childhood has also been asso-
ciated with steeper trajectories of depressive symptoms, and those who experienced
sexual abuse younger were more likely to have trajectories that started off higher,
but then reduced over time [185, 186]. These results suggest that the effects of
childhood trauma may have more damaging effects during the formative years of
adolescence, as opposed to an increased risk of depression at a later age. There is
also evidence to suggest that more stressful negative events in childhood are asso-
ciated with higher trajectories of depressive symptoms in other longitudinal studies
[34, 36, 74, 106]. However, in many of these studies, depressive symptoms are not
measured across the entire period of adolescence and therefore the true longitudinal
nature of childhood trauma on trajectories of depressive symptoms is not known.
For population averaged trajectories, the relationship between childhood trauma
and trajectories of depressive symptoms is less clear. Recent studies have suggested
that adverse childhood experiences including abuse and neglect were associated with
less favourable trajectories of depressive symptoms [187] and that increased stressful
negative events were associated with a steeper slope for trajectories of depressive
symptoms across adolescence, that began to decrease in young adulthood [18, 97].
Identifying when childhood trauma is likely to have its greatest impact on depres-
sion throughout adolescence and young adulthood is important for indicating when
interventions and support may be most beneficial. Currently, there is a paucity
of knowledge on when childhood trauma is likely to have the greatest impact on
trajectories of depressive symptoms. There is also some evidence to suggest that
childhood trauma and stressful life events are not associated with worsening tra-
jectories [80, 86]. However, I note that in one of these studies, negative life events
were assessed by parental report [80], which could lead to an underreporting of the
exposure.
Research has also yet to focus on how the number of types of traumatic expe-
riences may predict the longitudinal nature of depression. Multiple traumas (or
polyvictimisation) represent an accumulation of different types of traumas (i.e.,
abuse, neglect and violence) and evidence suggests traumatic expereicnes are of-
ten not isolated incidents (they often co-occur) [188]. Therefore, it is important to
consider multiple traumatic experiences and not just bullying for example. There
is some evidence to suggest that the number of negative events in childhood may
partially explain the extent to which the risk of depression is increased by exposure
to trauma, as more than two negative life events early in childhood have been asso-
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ciated with higher trajectories of depressive symptoms [34]. However, little is known
about the number of types of traumatic experiences in childhood and later trajec-
tories of depressive symptoms. Life-course models suggest that an accumulation of
negative events may be more harmful than traumatic exposure on a single occasion
[124]. It is therefore important to examine if the number of types of childhood
traumatic experiences might differentially predict varying trajectories of depressive
symptoms across adolescence.
Thus, the second aim of the current analysis is to build upon previous research
by examining the association between childhood trauma and trajectories of depres-
sive symptoms across adolescence and young adulthood. I was also interested in
extending previous research by investigating how this association might change de-
pending on the number of types of childhood traumatic experiences.
7.4 Methods
7.4.1 Sample
As described in chapter 3, the data were taken from the Avon Longitudinal Study
of Parents and Children (ALSPAC).
7.4.2 Measures
Depressive symptoms
Self-reported depressive symptoms were measured on nine occasions between
ages 10 and 24 using the short mood and feelings questionnaire (SMFQ) [129].
Further information can be found in chapter 3.
Childhood trauma
Two measures of trauma were used for this analysis derived from previous
analysis [189, 190]: (1) A binary measure of inter-personal violence, abuse and
neglect during mid-childhood (age 5-10.9 years; [no=0; yes=1]) and (2) the number
of trauma types reported during mid-childhood (0, 1, 2 or 3 or more [3+]). Briefly,
these variables were derived from 121 self-report and parent report questions about
traumatic experiences and cover six domains of trauma: physical abuse, emotional
abuse, bullying, sexual abuse, domestic violence and emotional neglect. The data
used to create these variables were taken from multiple trauma questions collected
from both parents and children regarding exposure to these traumas.
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Confounders
The following confounders were included based upon previous literature exam-
ining early social risk factors and trajectories of depressive symptoms [75, 115]: sex
(coded as a dummy variable for being female [male = 0; female =1]), maternal
postnatal depression (no vs yes), maternal occupational status at birth (manual vs
non-manual), maternal educational attainment at birth (A-level or higher vs O-level
vs < O-level) and parity (1st born vs 2nd born vs 3rd born or more).
Statistical methods
As stated in in chapter 4, trajectories of depressive symptoms were estimated
using multilevel growth-curve modelling [59, 131]. Briefly, I was able to use nine
occasions for this analysis and so I chose to use a multilevel quartic age polynomial
growth-curve model (i.e., the preferred model fit from chapter 4). Age was first
grand-mean centred around 16.53 years (the mean age of all assessments) in order
to improve interpretation [101, 102], since model intercept and intercept variance
then correspond to the middle of adolescence.
I ran separate models to examine the association between each trauma vari-
able and these trajectories of depressive symptoms. The first model examined
population-averaged trajectories for the exposure to trauma (no vs yes) by interact-
ing the fixed-effects quartic age polynomial terms with the “any trauma” dummy
variable. This produced two trajectories of depressive symptoms corresponding to
the sub-populations with and without trauma. The second model repeated this
approach by entering dummy variables representing the number of traumatic expe-
riences (1, 2 and 3+). In all the analyses, the quartic polynomial age terms varied
randomly across individuals to capture each individual’s unique trajectory. Model
equations are given in appendix 7.
I then predicted depressive symptoms scores at each of the following ages: 12,
14, 16 18, 20, 22 and 24, separately for each population averaged trajectory. I used
the delta method to compare these predicted scores across the different trajecto-
ries at each of these ages. All analyses were conducted using Stata 15, yet for the
analysis using the delta method, non-linear comparisons were estimated using the
‘nlcom’ command in Stata. The delta method used here relies on nonlinear trans-
formations of the estimated parameters from a model to calculate the variance,
standard error and Wald test statistic. This essentially means that when comparing
depressive symptoms scores at various ages, we can use the beta, standard error
and confidence intervals to calculate and compare differences. Model equations and
additional information are provided in appendix 7.
Missing data
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Missing data in the repeated measures data were again handled using full in-




Participant demographics are described in table 7.1. Additional descriptive statistics
and reliability measures for the SMFQ are described in chapter 3 and appendix
7. There were 6,711 individuals with data on the number of traumas, at least one
measurement of depressive symptoms and all confounders. The interpretation of the
results did not vary substantially with the inclusion of confounders, thus only the
adjusted analysis are reported here. Unadjusted analyses are reported in appendix
7.
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No Trauma 1 Trauma 2 Traumas 3+ Traumas x2, p
Sex
Males n (%) 2,607 (45.70) 1,166 (54.13) 355 (49.44) 141 (47.64)
45.04, p <.001
Females n (%) 3,907 (54.30) 988 (45.87) 363 (50.56) 155 (52.36)
Maternal Education
A Level or Higher n (%) 2,197 (40.60) 838 (40.60) 293 (42.80) 125 (43.20)
3.17, p = 0.79O Level n (%) 1,904 (35.20) 737 (35.70) 242 (35.40) 97 (33.60)
<O Level n (%) 1,311 (24.2) 489 (23.70) 149 (21.80) 67 (23.20)
Maternal Occupational Status
Non-manual n (%) 1,890 (40.80) 704 (40.30) 251 (42.80) 95 (40.20)
1.14, p = 0.77
Manual or lower n (%) 2,743 (59.20) 1,043 (59.70) 336 (57.20) 141 (59.80)
Parity
First Born n (%) 2,485 (45.20) 996 (48.20) 320 (46.90) 117 (41.30)
9.09, p = .169Second Born n (%) 1,998 (36.40) 704 (34.10) 233 (34.10) 106 (37.50)
Third Born + n (%) 1,012 (18.40) 367 (17.70) 130 (19.00) 60 (21.20)
Maternal Postnatal Depression
No n (%) 4,849 (92.60) 1,790 (89.10) 587 (87.30) 288 (81.10)
68.67, p <.001
Yes n (%) 388 (7.40) 219 (10.90) 85 (12.70) 53 (18.90)
Table 7.1: Participant demographics for the number of traumas. Parenthesis represent column percentages
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7.5.2 Direct model output vs alternative model parameter-
isation
Estimates from each trauma model can be parameterised in two ways. As the trauma
variables were coded as dummy variables for both any trauma variable (coded as 0/1)
and number of traumas (coded as 0/1/2/3+), the 0 coded dummy variable can be
thought of as the baseline trajectory. Therefore, the effect of trauma (being coded
as 1) or the number of traumas (coded as 1/2/3+) are ‘added’ onto the baseline
trajectory to represent the effect of having any trauma/number of traumas. As
shown in tables 7.2 and 7.3, the direct model output shows the intercept and age term
coefficients in the dummy variable regression format. However, it is also possible
to calculate an alternative parameterisation of the model in a more interpretable
manner by showing the complete trajectory estimates for an individual with no
trauma compared to an individual with trauma or the number of traumas. This is
achieved by adding the coefficient of the trauma variable onto the coefficient of the
reference variable which then calculates the intercept or age terms for each distinct
population trajectory.
7.5.3 Association between any trauma and trajectories of
depressive symptoms
As shown in figure 7.2.a, individuals exposed to trauma (between ages 5-10) had
worse trajectories of depressive symptoms compared to those who had not experi-
enced trauma. Both trajectories increased throughout adolescence until the age of
18, where symptoms decreased. However, symptoms then began to rise again from
the age of 22. The main differences between the two trajectories were characterised
by individuals exposed to trauma having a higher intercept1 at age 16 (β = 6.4,
SE= 0.13 [95% CI: 6.15, 6.65]) compared to non-trauma exposed individuals ((β =
5.17, SE= 0.11 [95% CI: 4.96, 5.38]; pDIFF < .001). There was a weak association
between individuals exposed to trauma and the linear age term (β = 0.38, SE= 0.03
[95% CI: 0.33, 0.43]), compared to non-trauma exposed individuals (β = 0.32, SE=
0.02 [95% CI: 0.28, 0.36]; pDIFF = .09), which showed that individuals with trauma
may have higher linear growth. However, there was no association between the re-
maining age terms (e.g., quadratic, cubic and quartic age terms) and the non-trauma
and trauma exposed individuals (psDIFF = .11), suggesting that overall growth was
not substantially different between the two trajectories. Full estimates are shown in
table 7.2.
1Intercepts were centered to 16.53 years, the grand mean age. Centering the intercepts is
common practice and allows for easier interpretation
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Direct Model Output Alternative Parametrisation
Parameter Estimate Std. Error p value Estimate Std. Error p value
No Trauma Intercept 5.17 [4.96, 5.38] 0.11 <.001 5.17 [4.96, 5.38] 0.11 <.001
No Trauma x Age 0.32 [0.28, 0.36] 0.02 <.001 0.32 [0.28, 0.36] 0.02 <.001
No Trauma x Age2 -0.10 [-0.11, -0.08] 0.01 <.001 -0.10 [-0.11, -0.08] 0.01 <.001
No Trauma x Age3 -0.004 [0.01, -0.003] 0.001 <.001 -0.004 [0.01, -0.003] 0.001 <.001
No Trauma x Age4 0.002 [0.001, 0.002] 0.0001 <.001 0.002 [0.001, 0.002] 0.0001 <.001
Yes Trauma Intercept 1.23 [0.97, 1.49] 0.13 <.001 6.40 [6.15, 6.65] 0.13 <.001
Yes Trauma x Age 0.06 [-0.01, 0.12] 0.03 0.09 0.38 [0.33, 0.43] 0.03 0.09
Yes Trauma x Age2 -0.001 [-0.02, 0.02] 0.01 0.95 -0.10 [-0.11, 0.08] 0.01 0.95
Yes Trauma x Age3 -0.001 [-0.003, 0.003] 0.001 0.11 -0.006 [-0.007, 0.005] 0.001 0.11
Yes Trauma x Age4 0.0001 [-0.0003, 0.0005] 0.0002 0.69 0.002 [0.001, 0.002] 0.0002 0.69
Deviance 189554.21
Table 7.2: Childhood trauma estimates. The no trauma variable should be viewed as the reference category as trauma was coded as
a dummy variable (0/1). Thus, the intercept coefficient (and the coefficients for subsequent age terms) for an individual with trauma
are the trauma intercept + yes trauma intercept (i.e., β0 + β5). The same applies for all age terms. The Alternative Parametrisation
results can therefore be thought of as the calculated scores and therefore the βx refer to the direct model output only. The standard error
and p-value correspond to the differences between the trauma estimates and the no trauma differences. The adjusted analysis included
confounders (all entered as main effects) child sex, maternal postnatal depression, maternal education and social economic status at birth
and parity. Intercepts are centred to age 16, the mean age of all assessments
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(a) Unadjusted adjusted association between any trauma (between 5-10 Years) and
SMFQ trajectories. Differences between the trajectories are given in the adjusted
results (figure 7.2)
(b) Unadjusted association between number of trauma types (between 5-10 Years)
and SMFQ Trajectories
Figure 7.1: Unadjusted association between childhood traumas and trajectories of
depressive symptoms. SMFQ: Short Mood and Feelings Questionnaire
145
(a) Adjusted association between any trauma (between 5-10 Years) and SMFQ tra-
jectories. Mean SMFQ differences at ages 12, 14, 16, 18, 20, 22 and 24 are calculated
between trajectories.  indicates age comparison for no trauma. N indicates age
comparison for yes trauma. * indicates p < .001.
(b) Adjusted association between number of trauma types (between 5-10 Years) and
SMFQ Trajectories
Figure 7.2: Adjusted association between childhood traumas and trajectories of
depressive symptoms. SMFQ: Short Mood and Feelings Questionnaire
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7.5.4 Association between the number of types of trauma
and trajectories of depressive symptoms
As shown in figure 7.2.b, there was an exposure-response relationship between the
number of types of traumas (between ages 5-10) and later trajectories of depres-
sive symptoms, with a tendency for more traumatic experiences in childhood to be
associated with steeper trajectories of depressive symptoms. All four trajectories
increased throughout adolescence and began to decrease from about the age of 18
and all trajectories again began to rise from the age of about 22. These differences
between trajectories were mainly characterised by individuals who experienced no
trauma having a lower intercept score at age 16 (β = 5.18, SE= 0.11 [95% CI: 4.97,
5.39]) compared to individuals with one trauma (β = 5.9, SE= 0.15 [95% CI: 5.61,
6.18]; pDIFF < .001), two traumas (β = 6.87, SE= 0.23 [95% CI: 6.43, 7.32]; pDIFF
< .001) and three or more types of traumas (β = 8.81, SE= 0.35 [95% CI: 8.12,
9.49]; pDIFF < .001). There was a weak association between individuals exposed
to two traumas and the linear age term (β = 0.43, SE= 0.06 [95% CI: 0.33, 0.54]),
compared to non-trauma exposed individuals (β = 0.32, SE= 0.02 [95% CI: 0.28,
0.36]; pDIFF = .05), which suggested that individuals exposed to two traumatic
experiences may have higher linear growth. There were no associations between the
remaining age terms and the non-trauma, one trauma and two traumas exposed
individuals (psDIFF = .13), suggesting that overall growth of the trajectories did
not differ substantially between no trauma and the one/two traumas trajectories.
There were also associations between individuals exposed to three or more types
of traumatic experiences and the linear (β = 0.51, SE= 0.09 [95% CI: 0.34, 0.67]),
quadratic (β = -0.2, SE= 0.03 [95% CI: -0.26, -0.15]), cubic (β = -0.009, SE= 0.002
[95% CI: -0.01, -0.005]) and quartic age terms (β = 0.004, SE= 0.001 [95% CI: 0.003,
0.005]), compared to the linear (β = 0.32, SE= 0.02 [95% CI: 0.32, 0.36]; pDIFF =
.03), quadratic (β = -0.1, SE= 0.01 [95% CI: -0.11, -0.08]; pDIFF = <.001), cubic (β
= -0.004, SE= 0.001 [95% CI: -0.01, -0.003]; pDIFF = .05) and quartic age terms (β
= 0.002, SE= 0.0001 [95% CI: 0.001, 0.002]; pDIFF = <.001) for those individuals
who were not exposed to any trauma respectively. This suggested that individuals
exposed to three or more types of traumas had less favourable trajectories that had
a higher rate of change compared to the non-trauma exposed group. Full estimates
are shown in table 7.3.
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Direct Model Output Alternative Parametrisation
Parameter Estimate (95% CIs) Std. Error p value Estimate (95% CIs) Std. Error p value
No Traumas Intercept 5.18 [4.97, 5.39] 0.11 <.001 5.18 [4.97, 5.39] 0.11 <.001
No Traumas x Age 0.32 [0.28, 0.36] 0.02 <.001 0.32 [0.28, 0.36] 0.02 <.001
No Traumas x Age2 -0.10 [-0.11, -0.08] 0.01 <.001 -0.10 [-0.11, -0.08] 0.01 <.001
No Traumas x Age3 -0.004 [-0.01, -0.003] 0.001 <.001 -0.004 [-0.01, -0.003] 0.001 <.001
No Traumas x Age4 0.002 [0.001, 0.002] 0.0001 <.001 0.002 [0.001, 0.002] 0.0001 <.001
1 Trauma Intercept 0.72 [0.43, 1.02] 0.15 <.001 5.90 [5.61, 6.18] 0.15 <.001
1 Trauma x Age 0.02 [-0.06, 0.09] 0.04 0.64 0.34 [0.28, 0.4] 0.04 0.64
1 Trauma x Age2 0.02 [-0.01, 0.04] 0.01 0.13 -0.08 [-0.1, -0.06] 0.01 0.13
1 Trauma x Age3 -0.001 [-0.003, 0.001] 0.001 0.5 -0.005 [-0.007, -0.004] 0.001 0.5
1 Trauma x Age4 -0.0003 [-0.001, 0.0002] 0.0002 0.22 0.001 [0.001, 0.002] 0.0002 0.22
2 Traumas Intercept 1.70 [1.24, 2.15] 0.23 <.001 6.87 [6.43, 7.32] 0.23 <.001
2 Traumas x Age 0.11 [-0.0001, 0.23] 0.06 0.05 0.43 [0.33, 0.54] 0.06 0.05
2 Traumas x Age2 -0.01 [-0.04, 0.03] 0.02 0.6 -0.10 [-0.14, -0.07] 0.02 0.6
2 Traumas x Age3 -0.002 [-0.01, 0.001] 0.002 0.13 -0.007 [-0.01, -0.004] 0.002 0.13
2 Traumas x Age4 0.0004 [-0.0003, 0.001] 0.0004 0.28 0.002 [0.001, 0.003] 0.0004 0.28
3+ Traumas Intercept 3.63 [2.94, 4.32] 0.35 <.001 8.81 [8.12, 9.49] 0.35 <.001
3+ Traumas x Age 0.19 [0.02, 0.36] 0.09 0.03 0.51 [0.34, 0.67] 0.09 0.03
3+ Traumas x Age2 -0.11 [-0.16, -0.06] 0.03 <.001 -0.20 [-0.26, -0.15] 0.03 <.001
3+ Traumas x Age3 -0.005 [-0.01, -0.0001] 0.002 0.05 -0.009 [-0.01, -0.005] 0.002 0.05
3+ Traumas x Age4 0.002 [0.001, 0.003] 0.001 <.001 0.004 [0.003, 0.005] 0.001 <.001
Deviance 189944.36
Table 7.3: Adjusted associations between number of traumas (5-10 Years) and SMFQ trajectories (n=6,711). The no traumas variable
should be viewed as the reference category as the number of traumas were coded as dummy variable (0/1/2/3). The intercept coefficient
(and the coefficients for the subsequent age terms) for an individual with 3+ traumas is the no trauma intercept + 3+ traumas intercept.
The Alternative Parametrisation results can therefore be thought of as the completed results. The adjusted analysis included child sex,
maternal postnatal depression, maternal education and social economic status at birth and parity.
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7.5.5 Comparing depressive symptom scores at different ages
To aid the interpretation of this analysis I compared predicted depressive symptoms
scores at various ages throughout adolescence and young adulthood. I then examined
whether these symptoms scores differed by the varying trajectories. To correct for
multiple hypothesis testing, I used a Bonferroni adjustment of 0.0012 to estimate
corrected main effects between these differences. As shown in table 7.4, the predicted
depressive symptoms scores at all ages were higher for individuals exposed to any
trauma, compared to those who experienced no trauma (psDIFF = <.001). The
largest difference between these two trajectories occurred at age 20 (β = 1.37, SE=
0.16, pDIFF = <.001), which corresponded to a 5.27%3 difference in depressive
symptoms.
Results were comparable for the analysis on the number of traumas with in-
dividuals with more types of traumas having greater depressive symptoms score
differences compared to those who had experienced no trauma as shown in table
7.5. However, there was no difference in predicted depressive symptoms at age 24
between the no trauma trajectory and those with 1 trauma (β = 0.7, SE= 0.23,
pDIFF = .003 [Bonferroni adjusted]). Likewise, there were no differences between
symptom scores for individuals in the one trauma trajectory, and those in the two
traumas trajectory at ages 12, 14 and 22 (psDIFF > 0.002 [Bonferroni adjusted]),
and the one trauma trajectory and the three or more trauma trajectory at ages
12 and 22 (psDIFF > 0.002 [Bonferroni adjusted]). There were no differences in
symptoms scores between the two traumas trajectory and the three of more trauma
trajectory at ages 12, 20, 22 and 24 (psDIFF > 0.016 [Bonferroni adjusted]). The
largest difference between the trajectories occurred between the no trauma trajec-
tory and three or more traumas trajectory at age 18 (β = 3.67, SE= 0.38, pDIFF =
<.001), which corresponded to a 14% difference in depressive symptoms.
2The Bonferroni adjustment was calculated by assuming an alpha level of 0.05. I ran 49 sta-
tistical comparisons. Thus, the adjusted Bonferroni corrected level was calculated by 0.05/49 =
0.001. Thus I only declared comparisons with p-values less than 0.001 as significant at the 5%
level.
3The % difference in depressive symptoms was calculated by taking the predicted difference score
(e.g., 1.37) and dividing it by the total maximum depressive symptoms score of 26 (1.37/26=5.27).
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No Trauma VS Any Traumas Age 12 Age 14 Age 16 Age 18 Age 20 Age 22 Age 24
Predicted No Trauma
DS Score
2.90 (0.09) 3.89 (0.09) 5.17 (0.11) 5.43 (0.11) 5.20 (0.12) 4.88 (0.13) 5.73 (0.14)
Predicted Any Traumas
DS Score
4.03 (0.10) 5.00 (0.11) 6.40 (0.13) 6.73 (0.13) 6.57 (0.14) 6.24 (0.15) 7.03 (0.17)
Difference, p value 1.12 (0.10), <.001 1.11 (0.10), <.001 1.23 (0.13), <.001 1.30 (0.14), <.001 1.37 (0.16), <.001 1.36 (0.17), <.001 1.30 (0.20), <.001





3.86 (0.11) 4.69 (0.12) 5.90 (0.13) 6.22 (0.15) 6.13 (0.17) 5.88 (0.18) 6.43 (0.21)
Difference, p value 0.95 (0.11), <.001 0.79 (0.12), <.001 0.72 (0.15), <.001 0.78 (0.16), <.001 0.93 (0.18), <.001 0.99 (0.20), <.001 0.70 (0.23), =.003*
SMFQ % Difference 3.65 3.04 2.77 3 3.58 3.81 2.69
Predicted 2 Traumas
DS Score
4.27 (0.17) 5.30 (0.18) 6.87 (0.23) 7.27 (0.24) 7.14 (0.26) 6.89 (0.33) 7.99 (0.21)
Difference, p value 1.37 (0.17), <.001 1.40 (0.18), <.001 1.70 (0.23), <.001 1.84 (0.25), <.001 1.94 (0.27), <.001 2.00 (0.29), <.001 2.25 (0.35), <.001
SMFQ % Difference 5.27 5.38 6.54 7.08 7.46 7.69 8.65
Predicted 3+Traumas
DS Score
4.67 (0.26) 6.50 (0.28) 8.81 (0.35) 9.10 (0.37) 8.26 (0.40) 7.24 (0.42) 8.71 (0.49)
Difference, p value 1.77 (0.26), <.001 2.61 (0.28), <.001 3.63 (0.35), <.001 3.67 (0.38), <.001 3.06 (0.27), <.001 2.36 (0.43), <.001 2.97 (0.50), <.001
SMFQ % Difference 6.81 10.04 13.96 14.12 11.77 9.08 11.42
Table 7.4: Comparisons between no trauma trajectories and 1) any trauma trajectories 2) number of types of traumas trajectories at
various ages. DS: Depressive symptoms. SMFQ: Short mood and feelings questionnaire. Predicted mean depressive symptom scores
calculated at various ages for each trajectory (standard errors are given in parenthesis). All analysis was Bonferroni corrected (an alpha
level of 0.05 divided by the number of statistical comparisons (49) is therefore 0.05/49= 0.001) to allow for multiple hypothesis testing.




Age 12 Age 14 Age 16 Age 18 Age 20 Age 22 Age 24
Predicted 1 Trauma
DS Score
3.86 (0.11) 4.69 (0.12) 5.90 (0.13) 6.22 (0.15) 6.13 (0.17) 5.88 (0.18) 6.43 (0.21)
Predicted 2 Traumas
DS Score
4.27 (0.17) 5.30 (0.18) 6.87 (0.23) 7.27 (0.24) 7.14 (0.26) 6.89 (0.33) 7.99 (0.21)
Difference, p value 0.41 (0.18), =.025* 0.61 (0.2), =.002* 0.97 (0.25), <.001 1.05 (0.27), <.001 1.01 (0.29), =.001 1.01 (0.32), =.002* 1.56 (0.38), <.001
SMFQ % Difference 1.58 2.35 3.73 4.04 3.88 3.88 6
Predicted 3+Traumas
DS Score
4.67 (0.26) 6.50 (0.28) 8.81 (0.35) 9.10 (0.37) 8.26 (0.4) 7.24 (0.42) 8.71 (0.49)
Difference, p value 0.82 (0.27), =.002* 1.82 (0.29), <.001 2.91 (0.37), <.001 2.89 (0.39), <.001 2.13 (0.42), <.001 1.36 (0.45), =.002* 2.28 (0.53), <.001





4.27 (0.17) 5.30 (0.18) 6.87 (0.23) 7.27 (0.24) 7.14 (0.26) 6.89 (0.33) 7.99 (0.21)
Predicted 3+ Traumas
DS Score
4.67 (0.26) 6.50 (0.28) 8.81 (0.35) 9.10 (0.37) 8.26 (0.4) 7.24 (0.42) 8.71 (0.49)
Difference, p value 0.40 (0.3), =.176* 1.21 (0.32), <.001 1.94 (0.41), <.001 1.83 (0.43), <.001 1.12 (0.47), =.016* 0.35 (0.5), =.478* 0.72 (0.59), =.221*
SMFQ % Difference 1.54 4.65 7.46 7.04 4.31 1.35 2.77
Table 7.5: Comparisons between number of types of traumas trajectories at various ages. DS: Depressive symptoms. SMFQ: Short mood
and feelings questionnaire. Predicted mean depressive symptom scores calculated at various ages for each trajectory (standard errors are
given in parenthesis). All analysis was Bonferroni corrected (an alpha level of 0.05 divided by the number of statistical comparisons (49)





I examined the association between childhood trauma and trajectories of depressive
symptoms between the ages of 11 and 24 years. I also examined how the number
of types of trauma exposure reported during mid-childhood may be associated with
higher trajectories of depressive symptoms. One of the main goals was to convey
these results in a more interpretable manner that might be beneficial for researchers,
clinicians and policy makers. Previous research tends to just display the coefficients
from a model, thus making it difficult to interpret results that are non-linear over
time. I have provided a framework which easily transforms direct model output
into more interpretable coefficients that can be compared across multiple stages of
development. Figure 7.2.a demonstrates the utility of this approach. The use of this
framework quantifies how different population averaged trajectories vary between
each other at varying times (i.e., how no trauma individuals differ from exposed
to trauma individuals at age 12 or age 18 etc). I hope that future research will
utilise this approach for other trajectory comparisons in the hope of developing and
improving treatments and interventions.
Exposure to childhood trauma was strongly associated with a steeper trajectory
of depressive symptoms. As well as having higher predicted depressive symptoms
scores at age 16, predicted symptoms scores were also higher between the ages
of 12 and 24. However, the growth or rate of change did not change substantively
depending on exposure to trauma. Importantly, the analysis on the number of types
of traumas revealed an exposure-relationship response which demonstrated that a
greater number of the types of traumatic experiences in childhood was associated
with less favourable trajectories. Whilst the overall rate of change did not differ
substantially between those not exposed to trauma and those who reported either
one or two types of trauma exposure, individuals exposed to three or more trauma
types (i.e., those who are polyvictimised) had a substantively higher rate of change
compared to non-exposed individuals. Specifically, polyvictimised individuals had
an increased rate of depressive symptoms throughout adolescence, which suggests
that depressive symptoms were getting worse more rapidly compared to individuals
who did not report exposure to trauma. Importantly, I also observed that depressive
symptoms scores were higher at almost every two-year interval for the non-exposed
individuals compared to those with exposure to one, two or three or more types of
trauma. The greatest difference occurred between the no trauma trajectory and the
three or more traumas trajectory at age 18 (corresponding to nearly a 4 point or
14% difference in depressive symptoms).
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These findings advance the results from chapter 5, and support previous re-
search examining the effects of trauma and negative life experiences on later trajec-
tories of depressive symptoms [104, 185–187], and the number of traumatic events on
higher trajectories [34]. These findings are consistent with additional research that
suggests that childhood trauma has lasting and persistent impact on later depressive
symptoms [182, 183] and efforts should be made to prevent traumatic experiences oc-
curring in childhood and support those individuals who are exposed to trauma [184].
This research highlights that those most at risk (i.e., polyvictimised in childhood)
have substantially less favourable trajectories of depressive symptoms and efforts
should be made to support this at-risk group, potentially through community and
individual-level interventions to mitigate or prevent the risk of adverse mental health
outcomes post-trauma and throughout adolescence. These results also suggest that
polyvictimised individuals have depressive symptoms that get worse at much faster
rate and have higher symptoms for longer. This suggests there are continuing ef-
fects of early childhood trauma on depressive symptoms that manifest at a faster rate
(meaning they could be easily missed in screening) and are maintained/heightened
throughout adolescence (meaning they may be hard to continually treat).
There are several mechanisms, both psychological and biological, that have been
considered to contribute to the pathway from exposure to traumatic experiences to
the development of depression. Findings of the association between exposure to
trauma and the trajectory of depressive symptoms may inform theoretical frame-
works of these mechanisms. Trauma in early life may have lasting effects on the risk
of depression due to its impact during development, and as such reduces the ability
to build resilience in adolescence which results in an increased risk of greater depres-
sive symptoms later in life [24, 182, 191]. Chronic exposure to childhood trauma
is associated with repeated victimisation and psychological distress in adolescence
[188], and a range of negative functional outcomes in adulthood [182]. Previous
research has also found that extreme stress during childhood and adolescence may
have stronger or longer lasting effects on the HPA axis compared to trauma expo-
sure in adulthood [192], and is considered a key mediator in the relationship between
trauma and negative mental health outcomes [193, 194]. Findings for increased risk
of depressive symptoms from exposure to trauma over the course of adolescence is
consistent with evidence of sustained dopamine dysregulation from trauma exposure
during early life [192].
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7.6.2 Considerations
I have transformed the direct model output into two potentially more helpful frame-
works which better highlight results and I consider this one of the key contributions
of this work. The first is to transform the original model coefficients into a calcu-
lated set of alternative model framework: the “Alternative Parametrisation”. This
simply adds the baseline intercept and age terms onto the additional groups giving
a clearer idea of what depressive symptoms scores are at the intercept age and how
they change over a one-year period. However, as the trajectories are non-linear and
have multiple age terms, even this can be challenging to interpret, so the second ap-
proach is to create predicted depressive symptoms scores at various ages for different
population averaged trajectories and to compare them with degrees of uncertainty.
This takes into account the non-linearity of the age terms and represents an easy
way to interpret the coefficients from the model. Both these methods could improve
interpretation from the direct model output and are important to highlight as it is
important to know the coefficients for change over time, not just what the scores
are at the intercept. Such analysis could be useful for individuals without statis-
tical backgrounds, and it is much easier to interpret a predicted mean difference
in symptoms at a particular age, rather than interpreting complex non-linear and
contrasting coefficients (e.g., interpreting a positive linear age term but negative
quadratic and positive cubic terms). Interpreting these coefficients in isolation is
often not practical, but the framework presented in tables 7.2, 7.3, 7.4, 7.5 and fig-
ure 7.2.a could aid in the interpretation of complex results into clinical practise and
treatment. These results should be used to help interpretation with illustrations
and qualitative descriptions of the trajectories.
However, there are certain considerations that must be made. Firstly, in this
analysis, I chose to use multilevel growth-curve models. Alternative analysis could
have used a growth mixture modelling or latent class approach to derive multiple
sub-population trajectories and then compared depressive symptom scores at various
ages between differing sub-population trajectories (i.e., differences in depression at
age 12 between a stable low, increasing and decreasing trajectory). I chose to use
a population-averaged approach with quartic polynomials in order to quantify the
population averaged rate of change of depressive symptoms associated with exposure
to varying degrees of trauma. However, higher order polynomials may constrict the
data to take a quartic shape, thus giving estimates that are extrapolated beyond the
data. This problem would also be present in the growth mixture and latent class
approach. It could be possible to use other functions of time in place of higher order
polynomials such as splines and fractional polynomials [61]. However, extrapolation
beyond the data is still an issue with these models. Thus, a safer option to account
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for extrapolation would be to refrain from computing estimates close to the tails of
the trajectory. This would avoid calculating nonsensical estimates that are beyond
the range of the data.
A second consideration regards the number of tests that could be run in the
framework presented here. As shown in tables 7.4 and 7.5, I ran multiple compar-
isons between the no trauma and yes trauma trajectories, and with the no trauma
and number of trauma trajectories, resulting in 49 statistical comparisons. Whilst it
is important to compare these multiple ages, one concern is that by running multiple
sets of analysis, the chances of obtaining a type one error increase (i.e., reporting
a sample mean difference to be significant when there is not mean difference in the
population: a chance result). Alternatively, such methods may also facilitate re-
search that searches for “statistically significant” differences. This is not the point
of such analysis and I advocate the use of Bonferroni adjusted comparisons, or false
discovery rates (FDR) to minimise the impact of both scenarios.
7.6.3 Limitations and future research
Attrition plays a part in any longitudinal study. Missing data could be biasing these
results. Previous analysis using similar methods has shown that when using multiple
methods for dealing with missing data, the estimates do not change substantively
[130]. To account for this missing data, I used full information maximum likeli-
hood (FIML) which makes a missing at random (MAR) assumption. However, even
though I used this approach to account for missing data, I cannot fully rule out the
effect of missing data on these results. One alternative approach would be to use
multiple imputation where auxiliary variables can be introduced into the imputation
model to make the MAR assumption more credible
Additionally, I only examined childhood trauma between the ages of 5 and 10
years old. There may be varying effects for traumas at earlier or later ages that
could be investigated further. However, this was beyond the scope of this analysis
and would likely require advanced modelling techniques, in order to approximately
capture the time-varying element of childhood trauma. For instance, childhood
trauma may cause depression, but there may also be reverse-causal effects from
depressive symptoms on the risk of childhood trauma. Future models should take
such modelling into account when examining the longitudinal relationship between
childhood trauma and depression. Future research should also consider the timing
and accumulation of exposures as these are important for later depression [124,
195]. For example, those who have exposure to multiple instances of trauma over
consecutive periods of development may be at the greatest risk, but research has yet
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to explore this.
Also, many of the childhood trauma items were parent-reported, which may
be subject to report bias. However, sensitivity analyses using this data has found
little difference in parent-child reports for trauma [189]. The measure of exposure
frequency used in the analysis is based on the number of different types of trauma
reported, which is only an approximate measure of how chronic trauma exposure is
during the age period. There may be variation in the frequency of a single type of
trauma exposure and its severity that this analysis is unable to account for. This
analysis also assumes that there is an equal effect of each trauma type on the risk of
depression, which may not be the case. These analyses were not the primary focus of
this analysis, however, future research should look to explore the impact of different
types of trauma and their associations with later depression as this may help identify
at risk individuals, who could be targeted for interventions and treatment.
Previous research has also shown that sex differences in child trauma and de-
pression may exist , and evidence suggests that stressful life events increase female
trajectories of depressive symptoms, but not males [97, 107]. However, the opposite
effect has also been observed in another study [74]. Sex differences were beyond the
scope of this analysis as I was initially interested in presenting a model interpreta-
tion framework for trajectories analysis with a binary and then categorical variable.
However, this methodology could be extended to run a three-way interaction be-
tween sex, exposure to trauma and varying trajectories of depressive symptoms.
7.7 Conclusions
In conclusion, exposure to childhood trauma was associated with less favourable tra-
jectories of depressive symptoms. Further to this, there was an exposure-response
relationship with the number of reported types of trauma, with individuals exposed
to 3 or more childhood traumas having substantially higher trajectories of depressive
symptoms. These results suggest that polyvictimised children should be considered
at higher risk of depression during adolescence, which could inform intervention ap-
proaches. I have also provided an alternative model interpretation framework for
examining and comparing trajectories of depressive symptoms, which shows depres-
sive symptoms scores at different ages for different trajectories. This framework
could be more interpretable for researchers, clinicians and policy workers, which




This chapter has shown that childhood trauma and in particular, the number of
childhood traumas are strong risk factors for higher population averaged trajecto-
ries of depressive symptoms. This chapter extends the findings from chapters 4, 5
and 6 and primarily addresses the second research objective by showing the asso-
ciation between childhood trauma and trajectories of depressive symptoms. This
chapter also addresses the fourth research objective by translating the estimates
from the complex trajectories model into simpler results that can be easily inter-
preted using an “alternative model parametrisation”. In doing so, this chapter has
also addressed the third research objective by highlighting several critical points
of trajectories where childhood trauma could be having its greatest effect on later
adolescent depressive symptoms. These points highlight when childhood trauma is
likely to have its greatest effect which could be used to guide support and inter-
ventions. Importantly, I have advanced the findings from chapter 5 that looked at
bullying and have shown that the number of types of traumatic experiences (i.e.,
an accumulation of traumatic events) are an important risk factor for trajectories
of depressive symptoms.In the next chapter, I build upon this work, and the find-
ings from chapters 4,5 and 6 to show how genetic risk for depressive symptoms is
associated with trajectories of depressive symptoms and if the population-averaged
trajectories approach can used to determine when genetic risk begins to manifest





Risk and Trajectories of
Depressive Symptoms
8.1 Chapter outline
This final research chapter is the culmination of chapters 4, 5, 6 and 7, and aims to
demonstrate how genetic risk for depressive symptoms is associated with trajectories
of depressive symptoms. Chapter 5 showed that genetic risk for depressive symptoms
was associated with the two more severe trajectories: the childhood persistent and
early adult-onset trajectories, suggesting that more severe and pervasive trajectories
of depressive mood may have a genetic basis. In this chapter, I use the population-
averaged trajectories derived in chapter 4, and the alternative model parametrisation
used in chapter 7 to explore the association between genetic risk and trajectories of
depressive symptoms in greater detail. Using the methods highlighted in chapters 6
and 7, this chapter determines when genetic risk begins to manifest and when it is
having its greatest effect on depressive symptoms.
This chapter primarily addresses the second research objective: “how are ge-
netic and environmental risk factors differentially associated with varying trajecto-
ries of depressive symptoms?”. But much like chapter 7, this chapter also addresses
the third research objective: “are there critical points of trajectories of depressive
symptoms which tell us more about how and when depression changes across adoles-
cence?” and the fourth research objective: “can the results from trajectory models
be simplified to aid in the interpretation and translation of findings?”. Part of this
chapter was submitted as a manuscript to Psychological Medicine. All supplemen-
tary materials are provided in appendix 8.
159
Kwong, A. S. F., Morris, T. T., Pearson, R. M., Rice, F., Stergiakouli, E., Tilling,
K. (Submitted to Psychological Medicine). Association Between Genetic Liability
and Trajectories of Depressive Symptoms.
8.2 Chapter abstract
Adolescence marks a period where depression will commonly onset and previous
research using twin studies has suggested that genetic influences play a role in how
depression manifests and changes across adolescence. Recent genome-wide associ-
ation studies have also shown that common genetic variants – often summed into
polygenic risk scores (PRS) are also implicated in depression. However, the role of
PRS in adolescent depression and changes in adolescent depression is not yet fully
understood. The aim of this chapter was to examine the association between a PRS
for depressive symptoms and depressive symptoms across adolescence and young
adulthood, and how polygenic risk may influence changes in depressive symptoms
using two methods: cross-sectional analysis and growth curve modelling.
I used data from over 7000 participants of the Avon Longitudinal Study of Par-
ents and Children (ALSPAC) to examine associations between a depressive symp-
toms (PRS), and depressive symptoms measured on nine occasions between the
ages of 10 and 24 years using the short mood and feelings questionnaire. I examined
cross-sectional associations at each age and trajectories of depressive symptoms in
a repeated measures framework using growth curve analysis.
The PRS was associated with depressive symptoms throughout adolescence and
young adulthood in both cross-sectional and longitudinal analyses, though associa-
tions were stronger in the longitudinal analyses. Additionally, longitudinal analyses
provided additional insights, demonstrating that individuals with a higher PRS for
depressive symptoms were associated with higher trajectories of depressive symp-
toms that were characterised by greater depressive symptoms scores at age 16 and
a steeper increase in depressive symptoms over time.
These results provide further support for the role of common variants in the
onset and severity of adolescent depressive symptoms and how they change over
time – most notably that a PRS for depressive symptoms is associated with how
depressive symptoms change across development. Repeated measures models may
provide additional insights that could be used to help identify potential pathways
in the onset and maintenance of depression.
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8.3 Introduction
Adolescence marks a period where depression will often onset [3, 16, 17], with de-
pression during this stage of development associated with a number of psychiatric
and social impairments in later life [19, 20, 196]. Understanding the nature of adoles-
cent depression is important for developing treatments and interventions that could
help reduce these impairments.
Depression has a complex and multifactorial aetiology [197], comprised of both
environmental and genetic contributions [151]. With regards to genetic influences,
twin studies have estimated that the heritability of depression is between 31% - 42%
[198], suggesting there is a sizable genetic component. Twin studies on childhood
and adolescent depression have also suggested that depression is partly heritable
with estimates similar to that of adult depression around 40% [199]. However, this
estimate varies between studies and can range between 11% - 72% [200]. Twin stud-
ies have also shown that genetic influences may play a role in how depressive mood
changes across adolescence [28], and in particular that genetic influences may in-
crease throughout development [146, 201]. A recent study of American twins found
that additive genetic effects explained a greater amount of variance in depression
around mid-to late-adolescence than early childhood [202]. However, a separate
study found that twin estimated heritability of depression decreased across child-
hood, and was relatively stable throughout adolescence [203]. Evidence from molec-
ular studies has also shown inconsistent heritability throughout adolescence using
single nucleotide polymorphisms (SNPs), with heritability ranging between 2% and
17% [180]. Interestingly, Sallis and colleagues identified a peak in heritability at age
13, which declined thereafter. Using longitudinal data to measure genetic influences
of depression could be useful for examining pathways towards depression and exam-
ining when genetic effects are likely to have the greatest effects on depression across
periods of development.
Recent advances in large scale molecular studies (i.e., genome-wide association
studies [GWAS]) have provided evidence that common genetic variation is also likely
to play an important role in depression, with SNP based heritability though to
explain about 9% of the variation in depression [9, 122, 123]. GWAS have also
demonstrated that depression is polygenic, with many genetic variants or SNPs each
having a small effect [121]. Polygenic risk scores (PRS), which sum the number
of “risk” variants that an individual possesses for a trait [204], can be used as
an indicator of an individual’s genetic liability to depression. PRS for depression
explains up to about 3.2% of the variation in depression in adult populations [122],
yet this approach has yet to be fully explored in younger populations, particularly
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with regards to adolescent depression and changes in adolescent depression.
Recent research on children and adolescents has found that a PRS taken from
a large GWAS of major depressive disorder (MDD) in adults was associated with
both child and adolescent depression in clinical and population cohorts [205]. Hall-
dorsdottir and colleagues found that the PRS predicted up to 5% of variation in case
control status, and up to 0.4% of the variance in a population cohort. Likewise, two
recent studies have shown that PRS taken from GWAS of depression and depressive
symptoms in adult populations are associated with developmental trajectories that
are characteristic of the onset of adolescent depression [87], as well as a trajectory
that reflects chronic depressive symptoms throughout adolescence and young adult-
hood, as shown in chapter 5. Together, these studies highlight that polygenic risk is
likely to play a role in the development and maintenance of adolescent depression.
However, as some studies have only assessed depression across parts of development
(i.e., ages 12-17) or at single occasions in cross-sectional designs, it is not clear when
polygenic risk is having the greatest contribution to depression in adolescence, or if
polygenic risk plays a role in how depression changes across development. Examin-
ing if greater polygenic risk manifests differentially over time, and if it is associated
with change over time could enhance our understanding of the nature of adolescent
depression and help identify potential pathways in the onset of depression.
There is evidence that PRS are associated with changes across childhood and
adolescence for other traits such as height [206] and BMI [207, 208]. These studies
have all used a repeated measures framework (i.e., to estimate trajectories or growth
curve models) to examine genetic influences for changes in a trait. Evidence suggests
that using a repeated measures framework such as growth curve modelling may help
improve the statistical power of genetic analysis [120]. For example, measurement
error and low power are problems in genomic analysis as genetic effects tend to be
small in magnitude and require large sample sizes with precision to detect true effects
[209]. Likewise, variation in the reported genetic component for depression (i.e.,
heritability) may be partially a result of measurement error in longitudinal studies
that have multiple assessments [199]. However, a longitudinal approach which uses
repeated measures may reduce measurement error and minimise noise by increasing
statistical power as there are multiple occasions included in the analysis, rather
than just one occasion [157]. Multiple measurements also maximise the number
of participant responses and may obtain a more precise estimate of an individual’s
“true” latent trait score as the assessment is repeated over time, and not just at one
occasion. It is also possible to reduce the burden for multiple testing in a growth
curve setting as the number of multiple comparisons are reduced [210]. Repeated
measures analysis, in particular growth curve modelling, may provide an advantage
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to traditional cross-sectional analysis and also quantify how a trait changes over
time, which in this context could help further explain the role of genetics in changes
to adolescent depression over time.
The aim of this chapter was to examine how a PRS for depressive symptoms was
associated with depressive symptoms, and changes in depressive symptoms across
adolescence. Evidence suggests that depression should be viewed on a continuum
[8, 9], as depressive symptoms are strongly associated with depression [10, 12], and
elevated depressive symptoms are associated with a host of adverse outcomes similar
to depression [143, 144]. I conducted several analyses: 1) I used a PRS taken from
a recent GWAS of depressive symptoms [156], and examined associations at nine
separate occasions in a UK based population cohort between the ages of 10 and
24 years old (cross-sectional analysis). 2) I then used growth curve modelling to
construct trajectories of depressive symptoms in the same cohort and examined
how the PRS for depressive symptoms was associated with change in depressive
symptoms throughout adolescent development. 3) finally, I then examined if a




Data were taken from the Avon Longitudinal Study of Parents and Children (ALSPAC),
as described in chapter 3.
8.4.2 Depressive Symptoms
Depressive symptoms were measured on nine occasions between ages 10 and 24 using
the short mood and feelings questionnaire (SMFQ) [129]. See chapter 3 for specific
details and table 8.1.
8.4.3 Polygenic risk score for depressive symptoms
The PRS for depressive symptoms was created in PRSice [155], using summary
statistics from a recent genome wide association study (GWAS) of depressive symp-
toms on 161,460 individuals [156],as descibed in chapter 5. The PRS was created by
weighting the effect sizes of 120,422 single nucleotide polymorphisms (SNPs) asso-
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ciated with depression symptoms from the initial GWAS at eight p value thresholds
(as 5x10−08, 5x10−07, 5x10−06, 5x10−05, 5x10−04, 5x10−03, 5x10−02 and 5x10−01).
The PRS was standardised to have a mean of 0 and a standard deviation of 1, thus
a higher PRS represents higher liability to depression symptoms. Further genotyping
information is available in chapter 5 and appendix 8.
8.4.4 Statistical analysis
For the cross-sectional analysis, linear regression analysis was used to examine the
association between depressive symptoms and the PRS at each of the nine occasions.
P values were corrected for false discovery rate (FDR) due to the number of statis-
tical tests (eight PRS thresholds x nine depressive symptoms occasions [72 tests]).
Bootstrapping, with 1000 repetitions was used to calculate confidence intervals for
R2 (the amount of variance explained by the PRS).
For the repeated measures analysis, trajectories of depressive symptoms were
estimated using multilevel growth-curve modelling [59, 131], as described in chapter
4. Briefly, I again used a multilevel quartic growth-curve polynomial model which
contained five key parameters: the intercept, the linear age term, the quadratic
age term, the cubic age term and the quartic age term. To examine how the PRS
was associated with changes in the growth curve model, I included a main effect
of the standardised PRS and an interaction of the PRS with the intercept and
each of the fixed-effects age polynomial terms (i.e., the linear, quadratic, cubic and
quartic age terms). Age was grand-mean centred to 16.53 years (the mean age of all
assessments) in order to improve interpretation, since model intercept and intercept
variance then correspond to the middle of adolescence [102]. The intercept and four
polynomial age terms were allowed to vary randomly across individuals to capture
each individual’s unique trajectory (i.e., each person had their own intercept and
slope). Further information regarding model fit and the model equations can be
found in appendix 8.
In order to highlight differences between greater or lower PRS on changes in
depressive symptoms, I also created trajectories that were +/- 1 standard deviation
(SD), thus resulting in two trajectories (greater risk [+1 SD] vs. lower risk [-1 SD]).
I then calculated the predicted depressive symptoms scores at each of the following
ages: 10.64, 12.81, 13.83, 16.68, 17.82, 18.64, 21.95, 22.88 and 23.86 (to coincide with
the ages at which the SMFQ was assessed at each of the nine occasions), for both
the greater and lower PRS trajectories. I then compared the predicted depressive
symptoms scores at each of these ages between greater and lower PRS trajectories.
Further information on how these were calculated for the trajectories is presented in
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the previous chapter and in appendix 7, but briefly the depressive symptoms scores
are calculated at each age for the two trajectories (i.e., depressive symptom scores
at age 12 for the low PRS and high PRS trajectory). Then using the delta method
(which incorporates the estimate, standard errors and confidence intervals), these
two scores are then compared to reveal an estimated difference that has measures
of certainty and precision.
Finally, I ran negative control analysis between the height PRS and trajecto-
ries of depressive symptoms and between the depressive symptoms PRS and height
trajectories (see appendix 8 for more details).
All analyses were conducted using Stata 15 (StataCorp, College Station, TX,
USA), with trajectories analysis using the user-written runmlwin command [134],
which calls the standalone multilevel modelling package MLwiN v3.01. All analyses
were adjusted for sex, age (only in the cross-sectional analyses, as the longitudinal
analyses adjust for age by default) and the first ten principal components of ancestry.
8.4.5 Missing data
Missing data in the trajectories analysis were handled using full information maxi-
mum likelihood estimation (FIML) [211]. Briefly, this assumes that the probability
of an individual missing a measure of depressive symptoms does not depend on their
underlying depressive symptoms score at that occasion, given their observed depres-
sive symptoms trajectory at other occasions. I included individuals into analysis if
they had at least one measurement of depression symptoms in order to maximise
power [130]. Previous research on these data has shown that trajectory shapes and
characteristics do not vary when comparing individuals with at least one or at least
4 measurements of depressive symptoms as shown in chapter 6.
8.5 Results
8.5.1 Sample characteristics
Of the original 14,901 participants, 9,399 individuals had at least one measurement
of depressive symptoms and 7,877 had genotype data that passed quality control,
removal of non-Europeans and related samples. For the cross-sectional analysis, data
were available for 5,324 individuals with a measurement of depressive symptoms at
age 10 and genotype data. However, sample size decreased to 2,737 individuals with
both a depression symptoms measurement at age 24 and genotype data. Descriptive
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information can be found in table 8.1. For the repeated measures analysis, data were














1 (N = 7,364) 2,040 5,324 10.67 (0.29) 10.64 (0.25) 4.15 (3.55) 4.00 (3.49)
2 (N = 6,716) 1,785 4,931 12.83 (0.24) 12.81 (0.23) 4.05 (3.90) 3.94 (3.84)
3 (N = 6,019) 1,521 4,498 13.85 (0.22) 13.83 (0.21) 4.91 (4.49) 4.92 (4.49)
4 (N = 4,997) 1,470 3,527 16.68 (0.24) 16.68 (0.24) 6.04 (5.66) 5.85 (5.63)
5 (N = 4,497) 1,284 3,213 17.89 (0.45) 17.82 (0.37) 6.79 (5.33) 6.50 (5.21)
6 (N = 3,335) 946 2,389 18.67 (0.49) 18.64 (0.49) 7.05 (6.12) 6.73 (5.85)
7 (N = 3,305) 925 2,380 21.97 (0.53) 21.95 (0.52) 6.05 (5.84) 5.56 (5.46)
8 (N = 3,856) 1,149 2,707 22.92 (0.53) 22.88 (0.51) 6.54 (5.87) 6.07 (5.40)
9 (N = 3,915) 1,178 2,737 23.89 (0.52) 23.86 (0.51) 7.48 (6.38) 6.84 (5.91)
Table 8.1: Descriptives of the SMFQ between those with and without genetic data. PRS: Polygenic Risk Score. Standard deviations are
given in (parenthesis).
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8.5.2 Association between depressive symptoms polygenic
risk score and depressive symptoms using cross-sectional
analysis
The depressive symptoms PRS showed weak and inconsistent associations with de-
pressive symptoms using the more stringent thresholds for the PRS such as 5x10−08,
5x10−07, 5x10−06, 5x10−05 and 5x10−04, similar to previous analyses [205]. This is
likely a result of low power as these thresholds include a small number of variants
and explain a small amount of variation. More liberal thresholds have been used
when examining the predictive capabilities of PRS [9]. Therefore, the remaining
analysis focuses on the more liberal PRS thresholds of 0.005, 0.05 and 0.5. Full
estimates are given for all analyses can be found in appendix 8.
The PRS with the strongest association varied according to the occasion (i.e.,
at what age depressive symptoms were measured). The PRS with a threshold of
0.5 showed the strongest associations between a one standard deviation increase of
the PRS and depressive symptoms at age 10.60 (β = 0.129, 95 CIs = 0.034, 0.223,
pFDR = 0.026), age 12.80 (β = 0.210, 95 CIs = 0.102, 0.317, pFDR = 0.001), age
13.80 (β = 0.170, 95 CIs = 0.041, 0.299, pFDR = 0.028), age 17.80 (β = 0.413,
95 CIs = 0.236, 0.591, pFDR = 9.00x10−05), and age 22.90 (β = 0.456, 95 CIs =
0.253, 0.658, pFDR = 0.001). However, the PRS with a threshold of 0.005 showed
the strongest associations between a one standard deviation increase of the PRS and
depressive symptoms at age 16.70 (β = 0.349, 95 CIs = 0.170, 0.528, pFDR = 0.001),
age 18.70 (β = 0.453, 95 CIs = 0.225, 0.681, pFDR = 0.001), age 21.90 (β = 0.371,
95 CIs = 0.153, 0.590, pFDR = 0.005) and age 23.90 (β = 0.608, 95 CIs = 0.389,
0.828, pFDR = 2.12x10−06). Despite the differences in the PRS threshold, effect
sizes increased throughout adolescence and into young adulthood (full estimates
are given in appendix 8). An example of the association between the PRS and
depressive symptoms using the 0.005 threshold can be seen in table 8.2 and figure
8.1.a, along with predicted values for individuals with 1+ SD above for the PRS at

























































(0.389, 0.828) (0.76%, 1.37%) (5.45, 6.36) (6.00, 7.02)
Table 8.2: Table 2. Association between the depressive symptoms PRS and depressive symptoms at various across adolescence. PRS:
Polygenic Risk Score; FDR: False Discovery Rate. Upper and lower 95% confidence intervals for the beta are given in (parenthesis).
Incremental R2 (4R2) or the percentage of variance explained by the polygenic risk score was calculated by first regressing depressive
symptoms on age, sex and first ten principal components of ancestry, then including the PRS and comparing the variance explained in
the two models. The confidence intervals for 4R2 were derived using bootstrapping with 1000 repetitions. The average beta and 4R2
were calculated by taking the average across all occasions.
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8.5.3 Association between depressive symptoms polygenic
risk score and trajectories of depressive symptoms
I selected the PRS with threshold of 0.005 for the trajectory analysis because this
PRS threshold showed stronger average effect sizes in the cross-sectional analyses
(see Figure 1 and Table 1). Therefore, the subsequent trajectory analysis used this
threshold score of 0.005, but I conducted sensitivity analysis at other thresholds,
which showed almost identical results (see appendix 8).
A one standard deviation increase in the depressive symptoms PRS was asso-
ciated with higher depressive symptoms at the intercept age of 16.53 (β = 0.363,
95 CIs = 0.230, 0.496, p = 8.56x−08). The depressive symptoms PRS also showed
evidence for change over time, with a one standard deviation increase in the PRS
strongly associated with a linear change in depressive symptoms (β = 0.048, 95 CIs
= 0.016, 0.080, p = 0.003). However, a one standard deviation increase in the PRS
was not associated with the quadratic, cubic or quartic age terms (see figure 8.2 and
appendix 8 for full estimates).
8.5.4 Comparisons between higher and lower genetic risk at
various ages
The comparisons between those with higher risk (+1 SD in the PRS) and those
with lower risk (-1 SD in the PRS) found evidence that depressive symptoms were
higher for those with greater PRS risk across all ages of adolescence and young
adulthood (psFDR < 0.036), as shown in table 8.3. The largest difference between
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(5.46, 6.03) (6.42, 7.0) (0.59, 1.33)
Table 8.3: Comparisons across ages between trajectories that were +/- 1 SD Above for the PRS (N=6,305). PRS: Polygenic Risk
Score. DS: Depressive Symptoms. FDR: False Discovery Rate. Upper and lower 95% confidence intervals for the estimates are given
in (parenthesis). The low PRS was for trajectories which were 1 SD below. The high PRS was for trajectories which were 1 SD above.
Differences were calculated using the delta method. Analysis were adjusted for sex and the first ten principal components of ancestry.
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(a) Cross-sectional analysis between the depressive symptoms PRS and depressive
symptoms across adolescence. Analysis were adjusted for sex, age and the first
ten principal components of ancestry.
(b) Association between depressive symptoms PRS and trajectories of depressive
symptoms. Averaged population trajectories of depressive symptoms for greater
and less genetic liability (+/- 1 SD PRS). Analysis were adjusted for sex and the
first ten principal components of ancestry.
Figure 8.1: Association between depressive symptoms and depressive symptoms
across adolescence. PRS: Polygenic Risk Score (with a threshold of 0.005). SMFQ:
Short Mood and Feelings Questionnaire (depressive symptoms).
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8.6 Discussion
In this analysis, I focused on a cross-sectional analysis and a growth curve modelling
approach that utilised a repeated measures framework. In the cross-sectional anal-
ysis, I found that greater genetic liability to depression (as measured by a polygenic
risk score for depressive symptoms) was associated with higher levels of depres-
sive symptoms throughout adolescence and early adulthood. There were stronger
associations between the PRS and depressive symptoms at older ages, with some
evidence this varied by the threshold of the PRS at each occasion. The PRS with
a threshold of 0.005 generally had the strongest associations across occasions. In
the growth curve analysis, I found that a higher PRS for depressive symptoms was
associated with higher trajectories of depressive symptoms (i.e., a higher depressive
symptoms across development), and that a higher PRS was associated with changes
in depressive symptoms over time, as characterised by the linear age term.
These results suggest that a higher PRS is associated with greater child and
adolescent depressive symptoms and may influence how depressive symptoms change
across an important stage of development. Importantly, we see that those with a
higher PRS for depressive symptoms begin to have higher symptoms scores between
the ages of 12 and 14. These results suggest that genetic liability may play a role in
the onset of adolescent depression. Such results place further emphasis on the idea
that depression is not only heritable, but genetic liability may result in non-stable
patterns of depressive mood.
These results support previous research on genetic influences for depression as
studied in twins [28, 200], and are broadly consistent with previous work examin-
ing the association between PRS’ and depression in children and adolescents who
identified 0.4% explained by the PRS [205]. These results show similar associations
with regards to the amount of variance explained by the PRS (between 0.04% to
1.08% depending on age), but I also demonstrated greater variance explained at
later ages of development that are consistent with some adult GWAS studies of de-
pression, 1% [9, 156]. This is not surprising as these later ages would be closer to
the populations in the original GWAS, but important to highlight as the amount of
variance explained by the PRS during adolescence (up to age 18), was never more
than 0.63%. Future GWAS that focus on periods such as adolescence will provide
the most effective avenue for examining the genetic risk in younger populations.
The repeated measures analysis further supplemented the initial cross-sectional
research by highlighting that the PRS had stronger associations as age increased and
that differences in trajectories that could be the result of varying genetic liability
across development. This supports previous twin research showing larger genetic
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effects in later adolescence and young adulthood rather than in early childhood
[146, 201]. There are several possible explanations as to why genetic liability may
influence change over time. Firstly, genetic liability to depression may act upon bio-
logical and hormonal pathways, especially during adolescence [212]. This may result
in changes to brain development and hormonal responses that put an individual at
greater risk of depression [213]. Secondly, a related explanation for the association
between genetic liability and adolescent depression may also be underpinned by a
complex genetic and environmental interplay, where genetic liability may manifest
differentially over time through gene-environment correlations [151]. Genetic lia-
bility to depression may produce evocative effects for some social and behavioural
traits, which are then associated with greater depression (i.e., genetic liability may
result in individual being more susceptible to stressful life events, which therefore
results in greater depression). Thirdly, there is also evidence of interaction effects
with later life events, where older individuals with greater genetic risk for depres-
sion have higher trajectories of depressive symptoms following the death of a spouse
[164]. Fourthly, differences in genetic liability could be the result of measurement er-
ror and noise at the varying occasions [120] and it may also be possible for sampling
differences to affect the precision of these results.
Previous research has shown that genetic liability (in the form of a PRS) can
be included into longitudinal models that examine change in a trait over time [206–
208]. Research has suggested that it is also possible to examine genetic influences
on age related changes in depression [120]. I was able to expand upon this previous
work to examine genetic contributions to varying trajectories of depressive symp-
toms. I demonstrated that genetic influences may be age specific (i.e., may begin to
onset at different times). These results show the benefits of using a repeat measures
framework (such as a growth curve model) to quantify the extent to which genet-
ics may influence traits over time. By using the correlation between the repeated
measurements, it may be possible to reduce measurement error and boost statistical
power, which is why the repeated measures model was able to detect stronger esti-
mates throughout development, compared to the cross-sectional analysis. To ensure
that any potential gains from the repeated measures framework were not random,
I conducted a negative control analysis examining the association between a PRS
of height and trajectories of depressive symptoms, and then a depressive symptoms
PRS for trajectories of height. Both showed no evidence of an association sug-
gesting this method could be useful for examining genetic influences for change in
psychiatric traits (see appendix 8).
The analysis in this chapter had several strengths. Firstly, I was able to use a
large longitudinal population cohort with rich phenotype and genotype data. Few
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studies have as many repeated assessments of depressive symptoms, especially across
adolescence. I was able to utilise these assessments to accurately characterise trajec-
tories of depressive symptoms. Secondly, I was then able to expand upon previous
research by using a repeat measures model that is more powerful than cross-sectional
analysis. Some of the benefits of this approach include a boost in power and reduc-
tion of measurement error, but I was also able to use the same sample across this
analysis as the repeated measures model used full information maximum likelihood
(FIML) to account for missing data, which is an advantage over the cross-sectional
analysis. Thirdly, I was also able to estimate quantify how depressive symptoms
changed over time, which is an extension over the cross-sectional methodology. Us-
ing trajectories to estimate change over time in genetics analysis could also be ex-
panded for causal analysis such as time varying mendelian randomization [154],
where it may be possible to examine if genetic effects at a particular time are causal
for other traits.
However, this analysis also had several limitations. Firstly, this analysis did
suffer from attrition as sample sizes varied across ages in the cross-sectional analy-
sis, which may bias the results if missingness is not random. However, one of the
advantages of using the repeat measures model is that we can instead use FIML to
account for missing data. This approach also minimises the bias that may be present
if each occasion (age wave) represents a different sample. However, even this ap-
proach may be biased if the data are missing not at random, for example, genetic
risk for depression may predict missing assessments [157]. Secondly, depression is a
heterogeneous condition and there may be a genetic difference between sum scores,
and specific symptoms of depression [214]. Depression symptoms may also differ at
different ages [215]. That is to say that the symptoms of depression may differ at
younger ages, compared to later ages . I used the same summary score of depres-
sive symptoms throughout this analysis, which therefore only captures the sum of
depressive symptoms and does not highlight if certain symptoms of depression (i.e.,
anhedonia, lack of appetite or depressive thoughts) are more related to genetic liabil-
ity. Future research should look to examine if different profiles of depression change
across time and if these profiles are more related to genetic or environmental factors.
Finally, these results lack generalisability to all populations as the original GWAS
was conducted on individuals of European ancestry. However, future research is
beginning to capture GWAS of non-European populations [216], and future studies




In conclusion, I found evidence that a depressive symptoms PRS is associated with
depressive symptoms across adolescence and young adulthood. This PRS was also
associated with how depressive symptoms change over time, providing evidence that
higher genetic liability to depression is associated with higher trajectories of de-
pressive symptoms (higher intercept and slope). Growth curve models that use a
repeated measures framework may be a useful tool in genetic analysis, providing
greater statistical power/measurement precision and the opportunity to examine
changes and variation in depression over time. These results add to the body of
evidence that genetics may be one pathway involved in the onset and maintenance
of adolescent depression.
8.8 Chapter summary
This chapter has shown that greater genetic risk for depressive symptoms (as mea-
sured by a polygenic risk score) is associated with higher trajectories of depressive
symptoms and has advanced the findings from chapter 5 (that greater polygenic risk
is associated with the two more severe trajectories). In doing so, this chapter has
primarily addressed the second research objective by showing that polygenic risk
plays a role in higher trajectories of depressive symptoms. However, this chapter
has also addressed the third research objective by showing that adolescence may be
a critical period where genetic risk may begin to manifest, and that young adulthood
is where these genetic differences in depressive symptoms are greatest. This chapter
has also addressed the fourth research objective by translating the complex quartic
polynomial estimates into simpler results that can be easily interpreted and used to
highlight genetic differences in depressive symptoms at various ages. This chapter
has been the culmination of chapters 4, 5, 6 and 7. In the conclusions chapter,
I discuss some overarching themes among these chapters that include comparisons





Depression is global mental health disorder that will commonly onset during adoles-
cence, and is associated with cognitive, social and behavioural impairments (Thapar
et al., 2012). Depressive mood throughout adolescence can be measured by creating
trajectories of depressive symptoms, which can further shed light on the nature and
characteristics of depressive mood across stages of development. Previous research
has also looked to identify the predictors of less favourable trajectories of depressive
symptoms to reduce depressive symptoms and later impairments. However, whilst
there is a large body of research that has examined trajectories of depressive symp-
toms across adolescence, and their antecedents, there are several flaws in much of
the previous research. These flaws relate to 1) how long depressive symptoms were
assessed for and whether they spanned a long enough duration across developmen-
tal periods (i.e., childhood to adolescence, across adolescence and post adolescence),
2) smaller sample sizes in longitudinal studies which can make it difficult to make
population inferences and result in biased models (e.g., the creation of small trajec-
tory groups), 3) the (un)availability and use of key risk factors in previous (such as
genetic predictors) and 4) interpretation of complex estimates from the trajectory
models. This thesis has aimed to address these limitations by answering the four
key research objectives:
RQ1. What are the varying patterns of longitudinal depressive symptoms across
adolescence?
RQ2. How are genetic and environmental risk factors differentially associated with
varying trajectories of depressive symptoms?
RQ3. Are there critical points in trajectories of depressive symptoms which tell us
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more about how and when depression changes across adolescence?
RQ4. Can the results from trajectory models be simplified to aid in the interpre-
tation and translation of findings?
In this conclusions chapter, I briefly summarise the research chapters under-
taken in this thesis, how they addressed the research objectives and their contribu-
tion to the literature. I then consider how these chapters are linked through a series
of “local” considerations. Then I examine how this thesis fits within the context of
the existing literature by making several “global” considerations. Finally, I highlight
some limitations of this thesis and give some thoughts about future work.
9.2 Contributions to the literature
9.2.1 Identifying trajectories of depressive symptoms across
adolescence
The aim of chapter 4 was to address the first research objective: “what are the
varying longitudinal patterns of depressive symptoms across adolescence?”. To an-
swer this, I ran a series of analyses that estimated trajectories of depressive symp-
toms using two methodologies: 1) the multilevel growth curve approach to estimate
population-averaged trajectories and 2) the growth mixture modelling approach to
estimate multiple trajectories within the population. This chapter identified several
key findings, but also acted as a platform for the rest of the thesis:
1) A quartic polynomial growth curve model best fitted the ALSPAC data when
considering a population-averaged approach. Within this analysis, I revealed that
population averaged trajectories of depressive symptoms tend to rise until the age
of 18, where they then begin to decrease. However, from the age of 22, depressive
symptoms then begin to increase again through the age of 24. These trajectories were
then used to explore the association between various risk factors and trajectories of
depressive symptoms in chapters 6, 7 and 8.
2) Growth mixture modelling analysis suggested that a five-class trajectory solution
best fitted the data in ALSPAC when using a multiple-trajectories approach. This
resulted in five qualitatively distinct trajectories: those who had consistently low
levels of depressive symptoms - stable low, individuals with initially low depressive
symptoms but rose throughout adolescence and young adulthood – early-adult on-
set, individuals who only experienced elevated levels of depressive symptoms during
adolescence – adolescent limited, individuals with initially elevated levels of de-
pressive symptoms in childhood which decreased over time – childhood-limited and
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individuals with moderate levels of depressive symptoms that continued to rise and
stay high– childhood persistent. The trajectories identified here were then used to
explore the association between risk factors and trajectories of depressive symptoms
in chapter 5.
9.2.2 Genetic and environmental risk factors associated with
trajectories of depressive symptoms from adolescence
to young adulthood
The main aim of chapter 5 was to address the second research objective: “how are
genetic and environmental risk factors differentially associated with varying trajecto-
ries of depressive symptoms?”. To answer this, I used the five trajectories identified
in chapter 4 (via the multiple trajectories approach), and then explored associations
between these trajectories with several previously identified and novel risk factors
(such as polygenic risk, maternal depression, sex and childhood bullying). As stated
in the literature review, this approach is common for exploring the impact of risk
factors on trajectories of depressive symptoms due to the ease of running multivari-
ate analysis. Therefore, this chapter was undertaken to provide a holistic analysis
for the overarching theme of this thesis (genetic and environmental risk factors for
trajectories of depressive symptoms). This chapter drew many comparisons with
previous research, but extended the literature with these key findings:
1) Genetic liability to depressive symptoms (as measured via a polygenic risk score)
and maternal depression were both associated with the childhood persistent and
early adult onset trajectories – the two most severe trajectories.
2) Specific “environmental” risk factors, namely bullying were also associated with
these two severe trajectories, but also strongly associated with the childhood limited
trajectory (with this trajectory not showing any evidence of an association with
genetic liability).
3) Different risk factors have differential effects on the nature of the trajectories
of depressive symptoms. However, the fact that risk factors (like bullying) were
associated with multiple-subpopulation trajectories is consistent with the notion
that more severe trajectories may depend on other prior susceptibilities such as
genetic or familial risk.
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9.2.3 Sex differences and trajectories of depressive symp-
toms from childhood to young adulthood: the role of
critical points
The aim of chapter 6 was to also address the second research objective and focus
on a the role of sex as a risk factor in greater detail. This chapter expanded upon
chapter 5 (which showed strong associations between sex and higher trajectories of
depressive symptoms) and the existing literature by also addressing the third and
fourth research objectives: ”are there critical periods in depressive symptoms?” and
“can trajectory results be simplified to aid in interpretation and translation?” re-
spectively. To answer these objectives, I used the population averaged trajectories
identified in chapter 4 to explore sex differences in trajectories of depressive symp-
toms and built upon previous research by expanding upon the notion of critical
points along these trajectories. This chapter advanced the previous two chapters
with the following key findings:
1) Females were more likely to have higher trajectories of depressive symptoms
compared to males, and this began to manifest around the age of 12 and continued
throughout adolescence and young adulthood.
2) Females also had an earlier age of peak velocity of depressive symptoms (the age
where depressive symptoms are getting worse at the fastest rate), with the female
age of peak velocity being around 13.5 years old, whilst for males it was much later
at around 16 years of age. This seems to coincide with the timing of puberty in
both females and males and may identify a period which could be targeted with
interventions and preventions.
3) The age at which depressive symptoms were highest was slightly earlier for females
(19 years old), although there was little evidence for a difference between females
and males (20 years old).
9.2.4 Early childhood trauma and trajectories of depressive
symptoms
The aim of chapter 7 was to again address the second research objective, but within
the context of childhood trauma as an environmental risk factor. Chapter 5 iden-
tified that bullying was a risk factor for higher trajectories, so in this chapter I
looked at an extension of bullying: childhood trauma and the number of types of
childhood traumas (which can be thought of as an accumulation of different types
of traumas - including bullying). This chapter also addressed the third and fourth
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research objectives. To address these research objectives, I explored the association
between childhood trauma and later population-averaged trajectories of depressive
symptoms. I also wanted to examine if the number of childhood traumas might be
differentially associated with higher trajectories, and to explore if the results from
these models could be translated into an alternative set of parameters that were
easier to interpret. This chapter added the following key findings to the literature:
1) Exposure to childhood trauma was associated with higher trajectories of depres-
sive symptoms across adolescence and young adulthood, with the greatest difference
in depressive symptoms occurring around the age of 20.
2) Exposure to three or more types of childhood trauma were strongly associated
with higher trajectories of depressive symptoms compared to those with none, one
or two childhood traumas. Those exposed to three or more types of traumas had
trajectories that did not only have a higher starting point at age 10, but also got
worse at a much faster rate. The greatest difference in depressive symptoms for
those with three or more traumas was observed around the age of 18.
3) Complex model estimates may be more easily interpreted by calculating the
predicted difference in depressive symptoms scores at various ages rather than by
interpreting the estimated parameters of the depressive symptoms polynomial tra-
jectories directly. This may aid in the interpretation of results and help translate
findings from research into practise and policy as specific ages are given to determine
when a risk factor may be having the greatest effect.
9.2.5 Association between polygenic risk and trajectories of
depressive symptoms
The aim of this final research chapter was to again address the second, third and
fourth research objectives, but this time within the context of examining genetic
risk for the population averaged trajectories of depressive symptoms. Chapter 5
showed that polyegnic risk may play a role in the onset and maintenance of greater
adolescent depressive symptoms and so this chapter looked to expand upon those
results using a different approach: the the population-averaged approach. This
chapter was therefore the culmination of the previous chapters and sought to expand
upon these chapters with the following key contributions to the literature:
1) Genetic risk for depressive symptoms (as assessed by a polygenic risk score) was
associated with higher trajectories of depressive symptoms, that seemed to manifest
in early adolescence. Greater genetic risk was associated with a higher starting point
and a greater rate of change across adolescence.
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2) Both cross-sectional and growth-curve models revealed that genetic risk for de-
pressive symptoms had a stronger effect in young adulthood, compared to adoles-
cence and late childhood. However, results were more precise in the growth curve
framework suggesting repeated measures analysis may be a useful tool in genetic
analyses compared to traditional cross-sectional methods.
3) Results from the growth curve model may be more easily interpreted when com-
paring depressive symptoms scores at varying ages (i.e., comparing depressive symp-
toms scores for high vs low risk at age 12, 14 or 16 etc. . . ), and this framework could
be useful for examining characteristics of depressive symptoms such as the age of
onset or age of greatest difference.
9.3 Local considerations
In the following two sections I give some “local” considerations that are specific
to this thesis (and how the research chapters are linked) and then highlight some
“global” considerations that are applicable to this thesis, but also to the growth
curve research literature in general.
This thesis has used a large population study to examine the genetic and en-
vironmental contributions to trajectories of depressive symptoms. I first looked
to identify trajectories of depressive symptoms using two varying methods (the
population-averaged and multiple-subpopulation approach). I then took these tra-
jectories and explored if different genetic and environmental risk factors would pro-
vide differential associations. Finally, I then explored if the results from these studies
could be expanded (via the notion of critical points) and simplified to help aid in
interpretation and translation into practise and policy. As a result, this thesis has
addressed several limitations identified from previous research and answered four re-
search objectives that have contributed to the literature of trajectories of depressive
symptoms. Still, there are several “local” issues that are common across research
chapters in this this thesis.
9.3.1 Comparing methodological approaches
The first issue worth discussing is whether it is appropriate to compare results be-
tween population-averaged trajectories (multilevel growth-curve models) and mul-
tiple trajectories (growth mixture modelling). The literature review in chapter 2
highlighted that each approach has strengths and weaknesses, and that each ap-
proach could be tailored to address specific research questions and a variety of data.
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For example, if the research question was to examine what risk factors are associated
with trajectories that are characteristic of early adult onset depressive symptoms,
then the multiple trajectories approach may be more appropriate. If the research
question was to explore the average population trajectory between two groups (i.e.,
females vs males), then the population averaged approach may be more appropri-
ate. Previous research has suggested that the choice in method depends on whether
the researcher believes trajectories should be classified by discrete or continuous
heterogeneity, so ultimately the two approaches have a different focus on emphasis
so it not as simple to state that one approach is better than the other. The re-
sults from this thesis suggest that both methods can complement, not just oppose
one another. As mentioned in the literature review, it is challenging to compare
one population averaged trajectory compared to five multiple distinct trajectories
(like in chapter 4), but if certain risk factors are being similarly associated between
the two methods, then this suggests that both approaches can be used for similar
research questions and that it may be advisable to utilise both approaches within
the same study to untangle the complex aetiology of depressive symptoms. For ex-
ample, female sex was associated with all the “higher” trajectories in the multiple
trajectories approach but was also associated with a much higher/steeper trajectory
of depressive symptoms in the population averaged approach. Likewise, genetic risk
was associated with the childhood persistent and early-adult onset trajectories in
the multiple trajectories approach and associated with a higher trajectory in the
population averaged approach. With the latter approach, the greatest difference
between higher and lower risk was observed in young adulthood, also where both
the childhood persistent and early-adult onset trajectories end up. Such analysis
indicates that both approaches can give similar interpretations and inferences in
some instances. However, it is important to state that distinguishing between dis-
crete or continuous heterogeneity could also lead to contrasting estimates (and then
inferences), and this is likely why no research has used both approaches within the
same study. However, as stated above, the choice in method used will vary much
depend on the overarching research question and so in many studies it may not be
suitable to use both approaches.
9.3.2 Varying effect sizes
A second consideration relates to the effect sizes of the varying genetic and environ-
mental risk factors. When comparing across the chapters, a common theme emerges
in that some risk factors are more strongly associated with trajectories of depressive
symptoms than others. This can be demonstrated by highlighting the results from
the population averaged trajectories approach as female sex had a difference of 2.13
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short mood and feelings questionnaire (SMFQ) points at age 16, whilst genetic risk
to depressive symptoms had a difference of only 0.73 SMFQ points. Previous re-
search has shown that sex differences in depression are large [22], and that directly
measured genetic liability to depression (i.e., via a polygenic risk score) is likely to
be small/modest [9], so these results are not surprising. Still, these comparisons
are interesting to note as they help shed light on what are the most prominent risk
factors for greater depressive symptoms across adolescence and when they could
be having their greatest effects, which could in turn help develop preventions and
interventions that could be risk factor or timing specific.
9.3.3 Benefited interpretation and translation
Thirdly, one of the key limitations in previous research has been the inability to
translate complex model estimates (e.g., sex specific estimates of flexible polynomial
trajectories) into more interpretable findings. The results from chapter 5 regarding
the association between various genetic and environmental risk factors and the mul-
tiple trajectories (e.g., stable low) was easy to interpret and could be translated into
policy and practise if needed. However, the results from the population-averaged
trajectories are more complex, especially when considering the underlying growth
parameters (linear, quadratic, cubic and quartic age functions) in isolation as re-
searchers often attempt to do. The overall graphical representation of the population
averaged trajectory is easy to understand yet comparing lines on a graph is should
not be the only method that guides policy and practise. Growth curve models offer
much more than graphical representations and can be used to quantify the nature
and changes of depressive symptoms in great detail that go beyond examining fig-
ures. The estimates from these growth-curve models can be used to inform exactly
when symptoms are beginning to rise or the score at a particular age and how the
score for one trajectory contrasts with other trajectories. However, as stated in
chapter 7, it is hard to interpret a set of estimates which are in opposing directions
(i.e., positive linear and quadratic effects, but negative cubic and quartic effects,
for example). This thesis has attempted to address this limitation by providing an
“alternative parameterisation” framework which aims to make the model estimates
simpler to interpret and calculates the difference in depressive symptoms scores at
various ages. This approach is likely to be useful when growth curves move beyond
simple quadratic models and require more advanced modelling. These simplified
results may help aid in the interpretation of complex results (as they are categorised
into groups) and may join the multiple trajectories approach in being easier to un-
derstand by individuals without statistical backgrounds. Likewise, by identifying
multiple time points where there could be differences in population-averaged tra-
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jectories (i.e., between females and males, low vs high genetic risk, or number of
traumas), it is possible identify when risk factors are likely to exert the greatest
effects – or in other words, when is a risk factor having the worst effect on de-
pressive symptoms? This “alternative parameterisation” framework builds upon
previous research as it now possible to visually see the differences (via figures), as
well as quantify the estimates underlying the figures and statistically compare them
at different stages of development (i.e., at age 12 compared to age 24).
9.4 Global considerations
9.4.1 Viable data?
There are also several global considerations that should be made regarding how this
thesis fits in with the existing literature on genetic and environmental contribu-
tions to trajectories of depressive symptoms. Firstly, as highlighted in the literature
review, many studies do not have truly longitudinal data that covers multiple de-
velopmental periods (i.e., childhood to adolescence, across adolescence and post
adolescence). As depression will commonly onset during adolescence [3, 16], it is
important to have data that examines mood prior, during and after this period in
order to fully maximise our ability to adequately track changes in depressive symp-
toms. This thesis has maximised the use of a well detailed longitudinal cohort, with
nine repeated assessments of depressive symptoms across these stages of develop-
ment. In addition, ALSPAC is considered to be a largely representative cohort, and
so the nature of these trajectories is likely to extend across other populations. Other
longitudinal studies have shown similar characteristics of depressive symptoms tra-
jectories with similar waves of data [99, 101, 102]. Furthermore, other research
has found similar results when examining the association between risk factors and
trajectories of depressive symptoms [34, 43].
9.4.2 Repeated measures benefits
A second consideration is whether there are additional benefits of using a repeated
measures framework compared to a simpler model that only uses one occasion like in
several studies [205, 217]. As stated in the introduction, there are obvious advantages
to using the repeated measures model such as the ability to examine depressive
symptoms across a period of development (i.e., before, during and after adolescence),
which therefore provides more information about the nature of depressive symptoms.
However, this thesis has also provided further evidence that a repeated measures
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framework that derives trajectories of depressive symptoms can: 1) help identify
critical periods in depressive symptoms, that might be targetable for prevention
and intervention; 2) determine when risk factors might be having their greatest
effect and comparing this across multiple stages of development and; 3) potentially
boost statistical power and reduce measurement error that can make for a more
precise associations compared to simpler cross sectional methods.
9.4.3 Public health and policy implications for growth-curve
research
A third and final consideration is whether the findings from growth-curve models
of depressive symptoms have any public health or policy implications, alongside re-
search into the aetiology of adolescent depressive symptoms. Estimating a trajectory
of depressive symptoms is useful for examining when symptoms are getting worse,
when they are highest and when they are potentially getting better. As demon-
strated in this thesis, it is also possible to examine what risk factors play a role
in how depressive symptoms develop and change over time (e.g., sex differences or
childhood trauma). From a public health or policy standpoint, understanding the
nature of these trajectories (i.e., when they onset, the severity and chronicity) could
be useful for identifying when a treatment or intervention could be implemented
(if it could be implemented at all) or to help services or schools be aware of the
patterns so that worsening mood may be identified quicker. Likewise, identifying
critical points could be of great use (especially in chapter 6 with the notion of the
age of peak velocity) as this could potentially be utilised to prevent depressive symp-
toms from rising in the first instance (which has beneficial downstream consequences
such as increased social functioning or educational attainment). Additionally, as
shown in chapters 7 and 8, critical points can also inform when a risk factor is
having the greatest effect on depressive symptoms, which could aid in the timing of
treatments. The identification of critical points could be achieved through simpler
cross-sectional models, yet these repeated measures models are more powerful and
precise than cross-sectional methods (which have conceptual and statistical flaws,
e.g., only one time point; increased measurement error at one occasion). Both the
population-averaged and multiple-subpopulations approach build upon the cross-
sectional approach and there appears to be the potential for growth curve research
to be used to help inform public health and policy makers, if the information is
correctly presented and translated.
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9.5 Limitations
As with most research, there are several limitations that should be addressed within
this thesis. Whilst, I have discussed specific limitations of the research in each chap-
ter, there are several ‘broader’ limitations that are common among these chapters.
I now provide an overview of these broader limitations and how they could impact
on the thesis.
The first limitation is that this thesis exclusively used data from ALSPAC and
in particular, ALSPAC data on the children/young people and so the results pre-
sented here may not be generalisable to other cohorts and populations. ALPSAC
is considered to be representative of the population but may suffer from bias (as
discussed later). Reassuringly, the pattern of depressive symptoms observed in this
thesis matched other studies, as identified in the literature review - suggesting these
results (in particular the association between risk factors and trajectories of depres-
sive symptoms) may be applicable to other populations. The results identified here
could be replicated in other cohorts such as the Add Health or E-Risk cohorts, if the
data were permitted. However, the fact that I was unable to compare these specific
analyses in other cohorts is a limitation of this thesis.
Cohort attrition is a limitation in any longitudinal study, and ALSPAC is no
different. As shown in the data and methods chapter, the sample size for completion
of the SMFQ tended to decrease throughout the study – from a sample size of over
7000 individuals around age 10 to just over 3000 in age 24. One way to address
missing data in longitudinal growth curve studies is to use full information maxi-
mum likelihood (FIML) to take account of the missing data [138, 139]. This means
that once we account for the depressive symptoms scores which we do observe, the
probability a score is missing at any occasion does not depend on its unknown level
of depressive symptoms at that occasion. The FIML approach assumes that the
data are missing at random, however some evidence suggests that depressive symp-
toms data in ALSPAC should be considered missing not at random. Recent research
using genetic risk for psychiatric traits has shown that higher genetic liability of de-
pressive symptoms is associated with less participation in the ALSPAC study [157].
The authors suggested that participation within ALSPAC may not be dependent
on other factors, and a lack of participation may not be random, implying that
attrition and selected participation may bias cohort studies like ALSPAC. Attrition
and selected participation for the depressive symptoms measures may bias results
in this thesis but it is not currently possible to examine if the data are or are not
missing at random. Likewise, if individuals with greater depressive symptoms are
more likely to have missing data, than the estimates presented in this thesis are
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more likely to be underestimating the true depressive symptoms scores, rather than
overestimating them.
Another limitation of this thesis could result from the choice of modelling used
to estimate multilevel growth curves throughout this thesis. Previous research has
shown that using higher order polynomials (such as quadratic and cubic growth
terms) can be used to model trajectories of depressive symptoms across adolescence
[101, 102]. However, this is the first study to use quartic polynomials to capture the
complex changes in depressive symptoms. I chose to use a quartic polynomial model
as there were four distinct changes in the SMFQ descriptive statistics that resembled
a quartic model (see data and methods section). Likewise, when assessing model fit,
a quartic polynomial model best fitted the data as assessed by a series of model fit
statistics (AIC, BIC, deviance and likelihood ratio tests). The quartic model was also
preferred to other polynomial models such as higher order fractional polynomials.
However, this does not necessarily mean that the quartic model is the optimal
model for estimating complex trajectories of depressive symptoms and as discussed
in previous chapters, one limitation of this model is the resulting complex estimates
that are derived from model. Other research on childhood height and weight has
used linear splines or piecewise models to estimate trajectories of childhood growth
[61, 135]. This approach, which essentially estimates a linear trajectory between
certain ages (i.e., linear growth between 10 to 12, 12 to 18, 18 to 22, 22 to 24) could
also be applied to trajectories of depressive symptoms, especially if future waves
of depressive symptoms fluctuate and become harder to model using polynomial
models. There is currently no evidence of splines being used to measures trajectories
of depressive symptoms, and this may be because critics of the spline approach claim
that a series of linear changes do not capture the complexity of childhood growth and
unrealistic of the nature of depressive symptoms. That said, other research utilising
a structural equation approach has estimated trajectories of depressive symptoms
across adolescence, and then separately in young adulthood using a similar model
to splines [106]. It may be that estimating specific periods of growth (i.e., childhood
to adolescence, across adolescence, adolescence to young adulthood) may be one
approach for future research, both in ALSPAC and other longitudinal studies.
A further limitation in this thesis is the issue of time-varying covariates (or
risk factors). In several of the research chapters, the risk factors have been time-
invariant – they do not change over time (e.g., sex or genetic risk). However, other
risk factors such as maternal depression, bullying and childhood trauma are not
stationary traits and may change over time [148, 218]. This thesis did not consider
time-varying covariates as the focal point of this thesis was to examine genetic
and environmental contributions to trajectories of depressive symptoms in the first
188
instance. Modelling time-varying risk factors such as maternal depression or bullying
would require an additional trajectory (or crossed-lagged approach) of those risk
factors, thus providing further complexity and distraction to this thesis. However,
whilst I did not examine the impact of time-varying risk factors, I acknowledge
that this thesis suffers from the possibility that time-varying risk factors are likely
to play an important and reciprocal role in the nature of trajectories of depressive
symptoms. For example, previous research has shown that depressive symptoms and
alcohol use across adolescence have a bi-directional relationship that may influence
current and later behaviours [5]. It is likely that bi-directional relationships may
also occur between depressive symptoms and the risk factors mentioned within this
thesis, and future work should look to build upon the research in this thesis by taking
into account time-varying risk factors that either use additional trajectories through
a bivariate response model or cross-lagged approaches that utilise the development
of multiple traits.
On a related note, this thesis may also be subject to residual confounding
which may have biased some of these results even after adjusting for relevant con-
founders. Whilst every attempt was made to to include confounding variables into
these chapter (for example in researh chapters 2 and 4, which contain a high de-
gree of environmental data), there is still the possibility that additional important
confounding factors were not included. This can be due to the availability of the
data within ALSPAC, but also as a result of the models chosen. For example, the
multivariate analysis in research chapter 2 included a variety of biological, genetic
and environmental data and thus it is possible that some confounding varibales that
were included in the model may also be mediators or indeed on the causal path-
way. The literature regarding residual confounding when considering both genetic
and environmental variables has yet to be fully established, and so this opens up a
potential limitation for this thesis.
A final limitation of this thesis relates to the assessment of depressive symptoms
within ALSPAC: the SMFQ. The SMFQ has been used in many epidemiological
studies around the world [14, 15, 129] and extensively in ALSPAC [13, 75, 87, 108,
219], but there are potential limitations of its use in this thesis. The first is that the
SMFQ was only assessed from the ages of 10. Prior to this, alternative measures
of mood were used, that cannot be translated between measures. This lack of data
before the age of 10 limits the ability to examine the direct effects of early life
measures such as maternal depression or childhood anxiety. However, to have data
from late childhood and all the way through to young adulthood is a major strength
of ALSPAC and this thesis. One potential caveat of this is that research using
the SMFQ in adults, and in particular examining the transition to adulthood are
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scarce as the SMFQ was originally designed for use in younger individuals [14, 129].
Therefore it is unclear how these results may replicate in older populations or the
transitions in other populations. Alternative studies in older popualtions tend to
use the Centre for Epidemiological Studies Depression Scale (CES-D), which may
be more effective for detecting clinical thresholds of depression [164]. The second
limitation is whether it is appropriate to use the SMFQ for growth curve analysis,
when the SMFQ only assesses depressive symptoms within the last two weeks and
was measured at least a year apart (or in some cases, three years apart). Given
how depression is particularly volatile during adolescence, an argument could be
made that the SMFQ does not appropriately capture the full nature of depressive
symptoms when it is assessed within this framework. An alternative approach could
look to maximise linked health records data, although a diagnosis would more likely
be used rather than depressive symptoms. Alternatively, more frequent assessments
of mood scores could be assessed in schools (e.g., every two weeks) giving a possible
wealth of data that could be linked – although this approach would be expensive and
time consuming. Given the costs of collecting data and managing a multifactorial
study, there is unlikely to be perfect method for assessing depressive symptoms and
the current methodology is probably more than adequate for this thesis.
9.6 Future research
This thesis has addressed several limitations of previous work and contributed to
the ongoing literature on trajectories of depressive symptoms. However, there are
still many unanswered questions and more research that follows directly on from the
work presented in this thesis.
Firstly, whilst the use of depressive symptoms summary scores has been use-
ful for determining the overall nature of depressive symptoms across development,
there is a growing consensus that summary scores of depressive symptoms may not
be adequate to fully capture the heterogeneity of depressive mood [220]. Depres-
sion is a complex disorder that is characterised by several specific symptoms such
as anhedonia, changes in appetite, thoughts of suicide and fatigue [3]. Individuals
with depression may experience some, or all these symptoms, but identifying which
symptoms to treat is vital for intervention [87]. Summary scores of depressive symp-
toms do not discriminate between these symptoms, and so it is difficult to determine
what symptoms may need to be treated and if some symptoms are more prevalent
at different stages of development. Previous research has shown that symptoms do
differ between adolescence and adulthood [87], but importantly, previous research
has also shown that some risk factors may differentially predict specific symptoms of
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depression [221]. Given how heterogeneous depressive symptoms are, future research
should consider approaches that examine trajectories of specific symptoms (in this
case items of the SMFQ) and risk factors for these trajectories as this could help
target specific forms of treatment and interventions and identify if certain symptoms
(or items) are more prevalent at specific times.
Secondly, whilst this thesis has examined the genetic and environmental con-
tributions to trajectories of depressive symptoms, the next logical step would be to
consider the impact of these trajectories on later distal outcomes. Previous research
has shown that the multiple trajectories approach can derive depressive symptoms
that are good predictors of later distal outcomes such as social and cognitive func-
tioning, educational attainment and psychopathology [32, 43]. However, in these
studies the sample sizes remain small to modest and these trajectories do not have
a long duration of follow up. The trajectories identified within this thesis could
further examine the relationship between depressive symptoms across adolescence
and later outcomes. In fact, one very recent study has used the multiple trajectories
approach within ALSPAC and found that the two more severe trajectories (the child-
hood persistent and early-adult onset trajectories) were strongly associated with a
not in education, employment or training (NEET) status [130]. Further work using
these trajectories should also explore other outcomes such as psychopathology in
adulthood and other forms of social and cognitive functioning. Trajectories could
also be associated with later outcomes using the population averaged approach as
in previous research [108]. This work could also be expanded to have models that
jointly consider risk factors and later outcomes within the same model with trajecto-
ries as potential mediators. Such work could be vital for exploring how a risk factor
manifests itself in later life and future research could examine the impact of this
manifestation, when trajectories are lower or higher. This may provide clinicians
and policy makers with a tool that demonstrates that if depressive symptoms can
be lowered across adolescence (the mediator), then the impact between a risk factor
and a later outcome may also be lowered. Future research should explore these kinds
of models with the aim of showing that trajectories of depressive symptoms could
be modified and reduced.
9.7 Concluding remarks
Trajectories of depressive symptoms have a complex and multifactorial aetiology,
that is comprised of both genetic and environmental contributions. This thesis
looked to examine these contributions through a series of research objectives. Specif-
ically, this thesis identified two forms of trajectories: population averaged trajecto-
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ries and multiple trajectories. There appeared to be some specificity in that certain
risk factors were more strongly associated with trajectories of depressive symptoms
such as female sex, genetic risk for depressive symptoms, bullying and childhood
trauma. These results appeared to be common across the varying methodologies,
giving weight to the idea that different modelling approaches can support one an-
other. This thesis also looked to expand upon previous work by estimating critical
points in trajectories of depressive symptoms and providing an alternative way of
displaying estimates from complex models that could be more easily interpreted.
This thesis has contributed several key findings to the existing literature and helped
further knowledge regarding the nature of trajectories of depressive symptoms. How-
ever, this thesis is not without its limitations that should be fully considered and
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[130] J. A. Lopéz-Lopez et al. “Trajectories of depressive symptoms through ado-
lescence and associations with education and employment: a growth mixture
modelling approach”. In: (2019).
[131] S. W. Raudenbush and A. S. Bryk. Hierarchical Linear Models: Applica-
tions and Data Analysis Methods. Second Edition. Thousand Oaks, Califor-
nia: Sage Publications, Inc, 2002.
[132] C. Joinson et al. “Timing of menarche and depressive symptoms in adolescent
girls from a UK cohort”. In: Br J Psychiatry 198.1 (2011), pp. 17–23, 17–23.
issn: 1472-1465 (Electronic) 0007-1250 (Linking). doi: 10.1192/bjp.bp.
110.080861. url: https://www.ncbi.nlm.nih.gov/pubmed/21200072.
[133] C. Joinson et al. “Early menarche and depressive symptoms from adolescence
to young adulthood in a UK cohort”. In: J Am Acad Child Adolesc Psychiatry
52.6 (2013), 591–8 e2. issn: 1527-5418 (Electronic) 0890-8567 (Linking). doi:
10.1016/j.jaac.2013.03.018. url: https://www.ncbi.nlm.nih.gov/
pubmed/23702448.
[134] G. Leckie and C. Charlton. “runmlwin: A Program to Run the MLwiN Multi-
lvel Modeling Software from within Stata”. In: Journal of Statistical Software
52.11 (2013).
[135] L. D. Howe et al. “Linear spline multilevel models for summarising childhood
growth trajectories: A guide to their application using examples from five
birth cohorts”. In: Stat Methods Med Res 25.5 (2016), pp. 1854–1874. issn:
1477-0334 (Electronic) 0962-2802 (Linking). doi: 10.1177/0962280213503925.
url: https://www.ncbi.nlm.nih.gov/pubmed/24108269.
[136] G. Schwarz. “Estimating the dimension of a model”. In: The Annals of Statis-
tics 6.2 (1978), pp. 461–4.
208
[137] Y. Lo, N. Mendell, and D. Rubin. “Testing the number of components in a
normal mixture”. In: Biometrika 88 (2001), pp. 767–778.
[138] R. J. A. Little and D. B. Rubin. Statistical analysis with missing data. 3rd
Edition. Hoboken, NJ: John Wiley and Sons, 2019.
[139] L. K. Muthén and B. O. Muthén. Mplus User’s Guide. Eighth Edition. Los
Angeles, CA: Muthén and Muthén, 1998-2017.
[140] K.M. Harris et al. “The National Longitudinal Study of Adolescent to Adult
Health”. In: (2009). doi: http://www.cpc.unc.edu/projects/addhealth/
design.
[141] Statistics-Canada. “Statistics Canada and Human Resources and Skills De-
velopment Canada. National Longitudinal Survey of Children and Youth:
Survey Overview for the 2008/2009 Data Collection, Cycle 8.” In: Ottawa,
CN (2009).
[142] S. R. Jaffee et al. “Differences in Early Childhood Risk Factors for Juvenile-
Onset and Adult-Onset Depression”. In: Arch Gen Psychiatry 59.3 (2002),
pp. 215–222. doi: doi:10.1001/archpsyc.59.3.215.
[143] J. Balazs et al. “Adolescent subthreshold-depression and anxiety: psychopathol-
ogy, functional impairment and increased suicide risk”. In: J Child Psychol
Psychiatry 54.6 (2013), pp. 670–7. issn: 1469-7610 (Electronic) 0021-9630
(Linking). doi: 10.1111/jcpp.12016. url: https://www.ncbi.nlm.nih.
gov/pubmed/23330982.
[144] D. M. Fergusson et al. “Subthreshold Depression in Adolescence and Men-
tal Health Outcomes in Adulthood”. In: Arch Gen Psychiatry 62.1 (2005),
pp. 66–72.
[145] E. Bowen et al. “Domestic violence risk during and after pregnancy: findings
from a British longitudinal study”. In: BJOG 112.8 (2005), pp. 1083–9. issn:
1470-0328 (Print) 1470-0328 (Linking). doi: 10.1111/j.1471-0528.2005.
00653.x. url: https://www.ncbi.nlm.nih.gov/pubmed/16045522.
[146] F. Rice, G. T. Harold, and A. Thapar. “Assessing the effects of age, sex and
shared environment on the genetic aetiology of depression in childhood and
adolescence”. In: J Child Psychol Psychiatry 43.8 (2002), pp. 1039–1051. doi:
doi/epdf/10.1111/1469-7610.00231.
[147] W. E. Copeland et al. “Adult psychiatric outcomes of bullying and being
bullied by peers in childhood and adolescence”. In: JAMA Psychiatry 70.4




[148] T. Singham et al. “Concurrent and Longitudinal Contribution of Exposure
to Bullying in Childhood to Mental Health: The Role of Vulnerability and
Resilience”. In: JAMA Psychiatry 74.11 (2017), pp. 1112–1119. issn: 2168-
6238 (Electronic) 2168-622X (Linking). doi: 10.1001/jamapsychiatry.
2017.2678. url: https://www.ncbi.nlm.nih.gov/pubmed/28979965.
[149] L. Arseneault. “The long-term impact of bullying victimization on mental
health”. In: World Psychiatry 16.1 (2017), pp. 27–28. issn: 1723-8617 (Print)
1723-8617 (Linking). doi: 10.1002/wps.20393. url: https://www.ncbi.
nlm.nih.gov/pubmed/28127905.
[150] L. Bowes et al. “Chronic bullying victimization across school transitions:
the role of genetic and environmental influences”. In: Dev Psychopathol 25.2
(2013), pp. 333–46. issn: 1469-2198 (Electronic) 0954-5794 (Linking). doi:
10.1017/S0954579412001095. url: https://www.ncbi.nlm.nih.gov/
pubmed/23627948.
[151] S. R. Jaffee and T. S. Price. “The implications of genotype-environment
correlation for establishing causal processes in psychopathology”. In: Dev
Psychopathol 24.4 (2012), pp. 1253–64. issn: 1469-2198 (Electronic) 0954-
5794 (Linking). doi: 10.1017/S0954579412000685. url: https://www.
ncbi.nlm.nih.gov/pubmed/23062295.
[152] J. B. Pingault et al. “Using genetic data to strengthen causal inference in
observational research”. In: Nat Rev Genet (2018). issn: 1471-0064 (Elec-
tronic) 1471-0056 (Linking). doi: 10 . 1038 / s41576 - 018 - 0020 - 3. url:
https://www.ncbi.nlm.nih.gov/pubmed/29872216.
[153] F. Dudbridge. “Polygenic Epidemiology”. In: Genet Epidemiol 40.4 (2016),
pp. 268–72. issn: 1098-2272 (Electronic) 0741-0395 (Linking). doi: 10.1002/
gepi.21966. url: https://www.ncbi.nlm.nih.gov/pubmed/27061411.
[154] N. M. Davies, M. V. Holmes, and G. Davey Smith. “Reading Mendelian
randomisation studies: a guide, glossary, and checklist for clinicians”. In:
BMJ 362 (2018), k601. issn: 1756-1833 (Electronic) 0959-8138 (Linking).
doi: 10.1136/bmj.k601. url: https://www.ncbi.nlm.nih.gov/pubmed/
30002074.
[155] J. Euesden, C. M. Lewis, and P. F. O’Reilly. “PRSice: Polygenic Risk Score
software”. In: Bioinformatics 31.9 (2015), pp. 1466–8. issn: 1367-4811 (Elec-
tronic) 1367-4803 (Linking). doi: 10.1093/bioinformatics/btu848. url:
https://www.ncbi.nlm.nih.gov/pubmed/25550326.
210
[156] A. Okbay et al. “Genetic variants associated with subjective well-being, de-
pressive symptoms, and neuroticism identified through genome-wide analy-
ses”. In: Nat Genet 48.6 (2016), pp. 624–33. issn: 1546-1718 (Electronic)
1061-4036 (Linking). doi: 10.1038/ng.3552. url: https://www.ncbi.nlm.
nih.gov/pubmed/27089181.
[157] A. E. Taylor et al. “Exploring the association of genetic factors with par-
ticipation in the Avon Longitudinal Study of Parents and Children”. In: Int
J Epidemiol (2018). issn: 1464-3685 (Electronic) 0300-5771 (Linking). doi:
10.1093/ije/dyy060. url: https://www.ncbi.nlm.nih.gov/pubmed/
29800128.
[158] J.L. Cox, J.M. Holden, and R. Sagovsky. “Detection of Postnatal Depres-
sion: Development of the 10-item Edinburgh Postnatal Depression Scale”.
In: British Journal of Psychiatry 150 (1987), pp. 782–786.
[159] R. M. Pearson et al. “Prevalence of Prenatal Depression Symptoms Among
2 Generations of Pregnant Mothers”. In: JAMA Network Open 1.3 (2018).
issn: 2574-3805. doi: 10.1001/jamanetworkopen.2018.0725.
[160] D. Rai et al. “Association of Autistic Traits With Depression From Childhood
to Age 18 Years”. In: JAMA Psychiatry (2018). issn: 2168-6238 (Electronic)
2168-622X (Linking). doi: 10 . 1001 / jamapsychiatry . 2018 . 1323. url:
https://www.ncbi.nlm.nih.gov/pubmed/29898212.
[161] R. M. Pearson et al. “Maternal depression during pregnancy and the postna-
tal period: risks and possible mechanisms for offspring depression at age 18
years”. In: JAMA Psychiatry 70.12 (2013), pp. 1312–9. issn: 2168-6238 (Elec-
tronic) 2168-622X (Linking). doi: 10.1001/jamapsychiatry.2013.2163.
url: https://www.ncbi.nlm.nih.gov/pubmed/24108418.
[162] R. Goodman et al. “The Development and Well-Being Assessment: Descrip-
tion and Initial Validation of an Integrated Assessment of Child and Adoles-
cent Psychopathology”. In: J Child Psychol Psychiatry 41.5 (2000), pp. 645–
655.
[163] D. Wolke et al. “Bullying and victimisation of primary school children in
South England and South Germany: Prevalence and school factors.” In:
British Journal of Psychology 92 (2001), pp. 673–696.
[164] B. W. Domingue et al. “Genetic Heterogeneity in Depressive Symptoms Fol-
lowing the Death of a Spouse: Polygenic Score Analysis of the U.S. Health
and Retirement Study”. In: Am J Psychiatry 174.10 (2017), pp. 963–970.
issn: 1535-7228 (Electronic) 0002-953X (Linking). doi: 10.1176/appi.ajp.
2017.16111209. url: https://www.ncbi.nlm.nih.gov/pubmed/28335623.
211
[165] N. Mullins et al. “Polygenic interactions with environmental adversity in
the aetiology of major depressive disorder”. In: Psychol Med 46.4 (2016),
pp. 759–70. issn: 1469-8978 (Electronic) 0033-2917 (Linking). doi: 10.1017/
S0033291715002172. url: https://www.ncbi.nlm.nih.gov/pubmed/
26526099.
[166] J. B. Pingault et al. “Genetic and Environmental Influences on the Develop-
mental Course of Attention-Deficit/Hyperactivity Disorder Symptoms From
Childhood to Adolescence”. In: JAMA Psychiatry 72.7 (2015), pp. 651–8.
issn: 2168-6238 (Electronic) 2168-622X (Linking). doi: 10.1001/jamapsychiatry.
2015.0469. url: https://www.ncbi.nlm.nih.gov/pubmed/25945901.
[167] K. S. Kendler and J. H. Baker. “Genetic influences on measures of the envi-
ronment: a systematic review”. In: Psychol Med 37.5 (2007), pp. 615–26. issn:
0033-2917 (Print) 0033-2917 (Linking). doi: 10.1017/S0033291706009524.
url: https://www.ncbi.nlm.nih.gov/pubmed/17176502.
[168] L. Riglin et al. “Developmental Contributions of Schizophrenia Risk Alleles
and Childhood Peer Victimization to Early-Onset Mental Health Trajecto-
ries”. In: Am J Psychiatry (2018), appiajp201818010075. issn: 1535-7228
(Electronic) 0002-953X (Linking). doi: 10.1176/appi.ajp.2018.18010075.
url: https://www.ncbi.nlm.nih.gov/pubmed/30486671.
[169] L. Murray et al. “Maternal Postnatal Depression and the Development of
Depression in Offspring Up to 16 Years of Age”. In: J Am Acad Child Adolesc
Psychiatry 50.50 (2011), pp. 460–470. doi: https://doi.org/10.1016/j.
jaac.2011.02.001.
[170] C. Quarini et al. “Are female children more vulnerable to the long-term
effects of maternal depression during pregnancy?” In: J Affect Disord 189
(2016), pp. 329–35. issn: 1573-2517 (Electronic) 0165-0327 (Linking). doi:
10.1016/j.jad.2015.09.039. url: https://www.ncbi.nlm.nih.gov/
pubmed/26469300.
[171] L. J. Hannigan et al. “Maternal prenatal depressive symptoms and risk for
early-life psychopathology in offspring: genetic analyses in the Norwegian
Mother and Child Birth Cohort Study”. In: The Lancet Psychiatry 5.10
(2018), pp. 808–815. issn: 22150366. doi: 10.1016/s2215-0366(18)30225-
6.
[172] A. R. Sutin et al. “The trajectory of depressive symptoms across the adult
life span”. In: JAMA Psychiatry 70.8 (2013), pp. 803–11. issn: 2168-6238
(Electronic) 2168-622X (Linking). doi: 10.1001/jamapsychiatry.2013.
193. url: https://www.ncbi.nlm.nih.gov/pubmed/23760442.
212
[173] M. Bartley, D. Blane, and S. Montgomery. “Health and the life course: why
safety nets matter”. In: BMJ 314 (1997), pp. 1194–6.
[174] P. Cuijpers and F. Smit. “Subthreshold depression as a risk indicator for
major depressive disorder: a systematic review of prospective studies”. In:
Acta Psychiatr Scand 109 (2004), pp. 325–331.
[175] S. J. Davies et al. “Symptoms of generalized anxiety disorder but not panic
disorder at age 15 years increase the risk of depression at 18 years in the Avon
Longitudinal Study of Parents and Children (ALSPAC) cohort study”. In:
Psychol Med 46.1 (2016), pp. 73–85. issn: 1469-8978 (Electronic) 0033-2917
(Linking). doi: 10.1017/S003329171500149X. url: https://www.ncbi.
nlm.nih.gov/pubmed/26315278.
[176] C. Joinson et al. “Association between pubertal development and depres-
sive symptoms in girls from a UK cohort”. In: Psychol Med 42.12 (2012),
pp. 2579–89. issn: 1469-8978 (Electronic) 0033-2917 (Linking). doi: 10 .
1017/S003329171200061X. url: https://www.ncbi.nlm.nih.gov/pubmed/
22717026.
[177] M. E. Sequeira et al. “Association of timing of menarche with depressive
symptoms and depression in adolescence: Mendelian randomisation study”.
In: Br J Psychiatry 210.1 (2017), pp. 39–46. issn: 1472-1465 (Electronic)
0007-1250 (Linking). doi: 10.1192/bjp.bp.115.168617. url: https:
//www.ncbi.nlm.nih.gov/pubmed/27491534.
[178] A. Angold, E. J. Costello, and C. M. Worthman. “Puberty and depression: the
roles of age pubertal status and pubertal timing”. In: Psychological Medicine
28 (1998), pp. 51–61.
[179] R. M. Pearson et al. “Impact of dysfunctional maternal personality traits
on risk of offspring depression, anxiety and self-harm at age 18 years: a
population-based longitudinal study”. In: Psychological Medicine (2017), pp. 1–
11. issn: 0033-2917 1469-8978. doi: 10.1017/s0033291717001246.
[180] H. Sallis et al. “Genetics of depressive symptoms in adolescence”. In: BMC
Psychiatry 17.1 (2017), p. 321. issn: 1471-244X (Electronic) 1471-244X (Link-
ing). doi: 10.1186/s12888-017-1484-y. url: https://www.ncbi.nlm.
nih.gov/pubmed/28859627.
[181] W. Mandy et al. “The development of autistic social traits across child-
hood and adolescence in males and females”. In: J Child Psychol Psychiatry
(2018). issn: 1469-7610 (Electronic) 0021-9630 (Linking). doi: 10.1111/
jcpp.12913. url: https://www.ncbi.nlm.nih.gov/pubmed/29672866.
213
[182] W. E. Copeland et al. “Association of Childhood Trauma Exposure With
Adult Psychiatric Disorders and Functional Outcomes”. In: JAMA Netw
Open 1.7 (2018), e184493. issn: 2574-3805 (Electronic) 2574-3805 (Linking).
doi: 10.1001/jamanetworkopen.2018.4493. url: https://www.ncbi.
nlm.nih.gov/pubmed/30646356.
[183] S. J. Lewis et al. “The epidemiology of trauma and post-traumatic stress
disorder in a representative cohort of young people in England and Wales”.
In: The Lancet Psychiatry 6.3 (2019), pp. 247–256. issn: 22150366. doi: 10.
1016/s2215-0366(19)30031-8.
[184] G. Sara and J. Lappin. “Childhood trauma: psychiatry’s greatest public
health challenge?” In: The Lancet Public Health 2.7 (2017), e300–e301. issn:
24682667. doi: 10.1016/s2468-2667(17)30104-4.
[185] M. W. Carlson and A. Oshri. “Depressive Symptom Trajectories Among
Sexually Abused Youth: Examining the Effects of Parental Perpetration and
Age of Abuse Onset”. In: Child Maltreat 23.4 (2018), pp. 387–398. issn: 1552-
6119 (Electronic) 1077-5595 (Linking). doi: 10.1177/1077559518779755.
url: https://www.ncbi.nlm.nih.gov/pubmed/29888624.
[186] C. A. Keane, C. A. Magee, and P. J. Kelly. “Trajectories of Psychological
Distress in Australians Living in Urban Poverty: The Impact of Interpersonal
Trauma”. In: J Trauma Stress 31.3 (2018), pp. 362–372. issn: 1573-6598
(Electronic) 0894-9867 (Linking). doi: 10.1002/jts.22297. url: https:
//www.ncbi.nlm.nih.gov/pubmed/29958335.
[187] G. E. Barboza and S Dominguez. “Longitudinal growth of post-traumatic
stress and depressive symptoms following a child maltreatment allegation:
An examination of violence exposure, family risk and placement type”. In:
Children and Youth Services Review 81 (2017), pp. 368–378. issn: 01907409.
doi: 10.1016/j.childyouth.2017.08.029.
[188] C. B. Dierkhising et al. “Developmental timing of polyvictimization: Con-
tinuity, change, and association with adverse outcomes in adolescence”. In:
Child Abuse Negl 87 (2019), pp. 40–50. issn: 1873-7757 (Electronic) 0145-
2134 (Linking). doi: 10.1016/j.chiabu.2018.07.022. url: https://www.
ncbi.nlm.nih.gov/pubmed/30049476.
[189] J. Croft et al. “Association of Trauma Type, Age of Exposure, and Fre-
quency in Childhood and Adolescence With Psychotic Experiences in Early
Adulthood”. In: JAMA Psychiatry (2018). issn: 2168-6238 (Electronic) 2168-
622X (Linking). doi: 10.1001/jamapsychiatry.2018.3155. url: https:
//www.ncbi.nlm.nih.gov/pubmed/30477014.
214
[190] L. C. Houtepen et al. “Adverse childhood experiences in the children of the
Avon Longitudinal Study of Parents and Children (ALSPAC)”. In: Wellcome
Open Res 3 (2018), p. 106. issn: 2398-502X (Print) 2398-502X (Linking). doi:
10.12688/wellcomeopenres.14716.1. url: https://www.ncbi.nlm.nih.
gov/pubmed/30569020.
[191] E. C. Dunn et al. “The impact of exposure to interpersonal violence on gender
differences in adolescent-onset major depression: results from the National
Comorbidity Survey Replication (NCS-R)”. In: Depress Anxiety 29.5 (2012),
pp. 392–9. issn: 1520-6394 (Electronic) 1091-4269 (Linking). doi: 10.1002/
da.21916. url: https://www.ncbi.nlm.nih.gov/pubmed/22447513.
[192] S. J. Lupien et al. “Effects of stress throughout the lifespan on the brain,
behaviour and cognition”. In: Nat Rev Neurosci 10.6 (2009), pp. 434–45.
issn: 1471-0048 (Electronic) 1471-003X (Linking). doi: 10.1038/nrn2639.
url: https://www.ncbi.nlm.nih.gov/pubmed/19401723.
[193] C. Heim et al. “The link between childhood trauma and depression: in-
sights from HPA axis studies in humans”. In: Psychoneuroendocrinology 33.6
(2008), pp. 693–710. issn: 0306-4530 (Print) 0306-4530 (Linking). doi: 10.
1016/j.psyneuen.2008.03.008. url: https://www.ncbi.nlm.nih.gov/
pubmed/18602762.
[194] S. A. Owens et al. “Interpersonal Stress Severity Longitudinally Predicts
Adolescent Girls’ Depressive Symptoms: the Moderating Role of Subjective
and HPA Axis Stress Responses”. In: J Abnorm Child Psychol (2018). issn:
1573-2835 (Electronic) 0091-0627 (Linking). doi: 10.1007/s10802- 018-
0483-x. url: https://www.ncbi.nlm.nih.gov/pubmed/30298267.
[195] A. D. Smith et al. “A structured approach to hypotheses involving continuous
exposures over the life course”. In: Int J Epidemiol 45.4 (2016), pp. 1271–
1279. issn: 1464-3685 (Electronic) 0300-5771 (Linking). doi: 10.1093/ije/
dyw164. url: https://www.ncbi.nlm.nih.gov/pubmed/27371628.
[196] W. E. Copeland et al. “Adult Functional Outcomes of Common Childhood
Psychiatric Problems: A Prospective, Longitudinal Study”. In: JAMA Psy-
chiatry 72.9 (2015), pp. 892–9. issn: 2168-6238 (Electronic) 2168-622X (Link-
ing). doi: 10.1001/jamapsychiatry.2015.0730. url: https://www.ncbi.
nlm.nih.gov/pubmed/26176785.
[197] C. Otte et al. “Major depressive disorder”. In: Nature Reviews Disease Primers
2 (2016).
215
[198] P. F. Sullivan, M. Neale, and K. S. Kendler. “Genetic epidemiology of major
depression: review and meta-analysis”. In: Am J Psychiatry 157.10 (2000),
pp. 1552–1562.
[199] F. Rice. Genetic Influences on Depression and Anxiety in Childhood and Ado-
lescence. Vol. 2. Behavior Genetics of Psychopathology. Advances in Behavior
Genetics. New York, NY: Springer, 2014. doi: https://doi.org/10.1007/
978-1-4614-9509-3_3.
[200] F. Rice. “The genetics of depression in childhood and adolescence”. In: Curr
Psychiatry Rep 11.2 (2009), pp. 167–173. doi: https://doi.org/10.1007/
s11920-009-0026-9.
[201] S. E. Bergen, C. O. Gardner, and K. S. Kendler. “Age-related changes in
heritability of behavioral phenotypes over adolescence and young adulthood:
a meta-analysis”. In: Twin Res Hum Genet 10.3 (2007), pp. 423–33. issn:
1832-4274 (Print) 1832-4274 (Linking). doi: 10.1375/twin.10.3.423. url:
https://www.ncbi.nlm.nih.gov/pubmed/17564500.
[202] A. J. Ksinan and A. T. Vazsonyi. “Genetic and environmental effects on
the development of depressive symptoms from adolescence to adulthood in a
nationally representative sample”. In: J Affect Disord 245 (2019), pp. 163–
173. issn: 1573-2517 (Electronic) 0165-0327 (Linking). doi: 10.1016/j.jad.
2018.10.085. url: https://www.ncbi.nlm.nih.gov/pubmed/30391772.
[203] M. G. Nivard et al. “Stability in symptoms of anxiety and depression as a
function of genotype and environment: a longitudinal twin study from ages
3 to 63 years”. In: Psychol Med 45.5 (2015), pp. 1039–49. issn: 1469-8978
(Electronic) 0033-2917 (Linking). doi: 10.1017/S003329171400213X. url:
https://www.ncbi.nlm.nih.gov/pubmed/25187475.
[204] A. R. Martin et al. “Predicting Polygenic Risk of Psychiatric Disorders”. In:
Biol Psychiatry (2018). issn: 1873-2402 (Electronic) 0006-3223 (Linking).
doi: 10.1016/j.biopsych.2018.12.015. url: https://www.ncbi.nlm.
nih.gov/pubmed/30737014.
[205] T. Halldorsdottir et al. “Polygenic Risk: Predicting Depression Outcomes
in Clinical and Epidemiological Cohorts of Youths”. In: Am J Psychiatry
(2019), appiajp201918091014. issn: 1535-7228 (Electronic) 0002-953X (Link-
ing). doi: 10.1176/appi.ajp.2019.18091014. url: https://www.ncbi.
nlm.nih.gov/pubmed/30947532.
216
[206] L. Paternoster et al. “Adult height variants affect birth length and growth
rate in children”. In: Hum Mol Genet 20.20 (2011), pp. 4069–75. issn: 1460-
2083 (Electronic) 0964-6906 (Linking). doi: 10.1093/hmg/ddr309. url:
https://www.ncbi.nlm.nih.gov/pubmed/21757498.
[207] A. V. Khera et al. “Polygenic Prediction of Weight and Obesity Trajectories
from Birth to Adulthood”. In: Cell 177.3 (2019), 587–596 e9. issn: 1097-4172
(Electronic) 0092-8674 (Linking). doi: 10.1016/j.cell.2019.03.028. url:
https://www.ncbi.nlm.nih.gov/pubmed/31002795.
[208] N. M. Warrington et al. “Association of a body mass index genetic risk
score with growth throughout childhood and adolescence”. In: PLoS One
8.11 (2013), e79547. issn: 1932-6203 (Electronic) 1932-6203 (Linking). doi:
10.1371/journal.pone.0079547. url: https://www.ncbi.nlm.nih.gov/
pubmed/24244521.
[209] A. S. Hatoum et al. “Etiology of Stability and Growth of Internalizing and
Externalizing Behavior Problems Across Childhood and Adolescence”. In:
Behav Genet 48.4 (2018), pp. 298–314. issn: 1573-3297 (Electronic) 0001-
8244 (Linking). doi: 10.1007/s10519-018-9900-8. url: https://www.
ncbi.nlm.nih.gov/pubmed/29679193.
[210] N. M. Warrington et al. “Modelling BMI trajectories in children for genetic
association studies”. In: PLoS One 8.1 (2013), e53897. issn: 1932-6203 (Elec-
tronic) 1932-6203 (Linking). doi: 10.1371/journal.pone.0053897. url:
https://www.ncbi.nlm.nih.gov/pubmed/23349760.
[211] P. J. Curran and A. M. Hussong. “The use of latent trajectory models in
psychopathology research”. In: J Abnorm Psychol 112.4 (2003), pp. 526–44.
issn: 0021-843X (Print) 0021-843X (Linking). doi: 10.1037/0021-843X.
112.4.526. url: https://www.ncbi.nlm.nih.gov/pubmed/14674867.
[212] T. Paus, M. Keshavan, and J. N. Giedd. “Why do many psychiatric disorders
emerge during adolescence?” In: Nature Reviews Neurosciene 9.12 (2008).
doi: http://dx.doi.org/10.1038/nrn2513.
[213] S. J. Blakemore. “The social brain in adolescence”. In: Nat Rev Neurosci
9.4 (2008), pp. 267–77. issn: 1471-0048 (Electronic) 1471-003X (Linking).
doi: 10.1038/nrn2353. url: https://www.ncbi.nlm.nih.gov/pubmed/
18354399.
[214] M. Nagel et al. “Item-level analyses reveal genetic heterogeneity in neuroti-
cism”. In: Nat Commun 9.1 (2018), p. 905. issn: 2041-1723 (Electronic)
2041-1723 (Linking). doi: 10.1038/s41467-018-03242-8. url: https:
//www.ncbi.nlm.nih.gov/pubmed/29500382.
217
[215] F. Rice et al. “Adolescent and adult differences in major depression symp-
tom profiles”. In: J Affect Disord 243 (2019), pp. 175–181. issn: 1573-2517
(Electronic) 0165-0327 (Linking). doi: 10.1016/j.jad.2018.09.015. url:
https://www.ncbi.nlm.nih.gov/pubmed/30243197.
[216] T. B. Bigdeli et al. “Genetic effects influencing risk for major depressive
disorder in China and Europe”. In: Transl Psychiatry 7.3 (2017), e1074. issn:
2158-3188 (Electronic) 2158-3188 (Linking). doi: 10.1038/tp.2016.292.
url: https://www.ncbi.nlm.nih.gov/pubmed/28350396.
[217] K. L. Musliner et al. “Polygenic risk, stressful life events and depressive
symptoms in older adults: a polygenic score analysis”. In: Psychol Med 45.8
(2015), pp. 1709–20. issn: 1469-8978 (Electronic) 0033-2917 (Linking). doi:
10.1017/S0033291714002839. url: https://www.ncbi.nlm.nih.gov/
pubmed/25488392.
[218] E. Netsi et al. “Association of Persistent and Severe Postnatal Depression
With Child Outcomes”. In: JAMA Psychiatry (2018). issn: 2168-622X. doi:
10.1001/jamapsychiatry.2017.4363.
[219] C. Joinson, D. Kounali, and G. Lewis. “Family socioeconomic position in
early life and onset of depressive symptoms and depression: a prospective co-
hort study”. In: Soc Psychiatry Psychiatr Epidemiol 52.1 (2017), pp. 95–103.
issn: 1433-9285 (Electronic) 0933-7954 (Linking). doi: 10.1007/s00127-
016-1308-2. url: https://www.ncbi.nlm.nih.gov/pubmed/27837235.
[220] E. I. Fried and R. M. Nesse. “Depression sum-scores don’t add up: why an-
alyzing specific depression symptoms is essential”. In: BMC Med 13 (2015),
p. 72. issn: 1741-7015 (Electronic) 1741-7015 (Linking). doi: 10 . 1186 /
s12916-015-0325-4. url: https://www.ncbi.nlm.nih.gov/pubmed/
25879936.
[221] E. I. Fried et al. “Depression is more than the sum score of its parts: indi-
vidual DSM symptoms have different risk factors”. In: Psychol Med 44.10






Appendix 2: A Review on The Nature of Trajectories of Depressive Symptoms from
Childhood to Young Adulthood: Methods, Predictors and Future Considerations
Appendix 4: Identifying Trajectories of Depressive Symptoms Across Adolescence
and Young Adulthood
Appendix 5: Genetic and Environmental Risk Factors Associated with Trajectories
of Depressive Symptoms from Adolescence to Young Adulthood
Appendix 6: Sex Differences and Trajectories of Depressive Symptoms from Child-
hood to Young Adulthood: The Role of Critical Points
Appendix 7: Childhood Trauma and Trajectories of Depressive Symptoms Across
Adolescence





Appendix 2 – A Review on The Nature of Trajectories of Depressive Symptoms from Childhood to Young Adulthood: Methods, 
Predictors and Future Considerations 
Appendix Table 2.1 




Waves Trajectories Main Findings 
Brendgen et al. 
(2005) 
414 11-14 Canadian 
Children 






Brendgen et al. 
(2010) 
201 11-13 Canadian 
Children 
CDI SPGBM 2 3 3 Low stable (75%), 
Increasing (15%), 
High stable (10%). 
Briere et al. 
(2015) 
6910 12-16 Canadian 
Children 





Brook et al. 
(2014) 






22 6 5 5 joint trajectories. 
One group had high 
depressive symptoms 
and high smoking. 
Another group had 
low depressive 
symptoms and low 
smoking. 
Chaiton et al. 
(2013) 
1293 12-16 NDIT 6 DS 
Items 





36% & Females: 
43%), Low (Males: 
50% & Females: 
29%). 
Colman et al. 
(2007) 


















Costello et al. 
(2008) 
11,559 11-18 ADD Health CES-D SPGBM 7 3 4 No depressed mood 
(28.7%), Low 
depressed mood 





Cumsille et al. 
(2015) 
1072 14-17 Chilean 
Adolescents 
CES-D GMM 3 4 4 High persistent 







Dekker et al. 
(2007) 
2076 4-18 Dutch 
Community 
Sample 
CBC SPGBM 14 5 12 Males: Very low 
decreasing (39.6%), 









Very low increasing 








et al. (2011) 
1423 11-18 ZHLS YSR GMM 14 7 6 Males: Low (92%), 
Decreasing (3%), 
Increasing (5%). 






414 11-16 Canadian 
Children 
CDI SPGBM 5 6 4 Moderate stable 
(54.57%), Low stable 
(27.16 %), Moderate 
increasing (11.30 %), 




Duivis et al. 
(2015) 





Ellis et al. 
(2017) 
243 12-18 ADS CES-D LCGA/ 
GMM 
7 4 4 Low stable (65.4%), 
Moderate early 
(20.2%), Severe early 





3902 11-14 German 
Children 





increasing (62.5 %). 
Stratified by sex - 
Males: High-strong 




(69.6 %). Females: 
Very high-stable (1.3 
%), High-slightly 
decreasing (9.7 %), 
Moderate-slightly 
increasing (32.7 %), 
Low-increasing (56.3 
%). 
Ferro et al. 
(2015b) 











4 4 2 2 trajectories, one for 
males and one for 
females and their 





268 Grades 6-8 American 
Children 
CDI ANOVA 3 6 6 Low stable (Males: 
27%; Females: 27%), 
Medium stable 
(Males: 30%; 
Females: 34%), High 
stable (Males: 8%; 
Females: 10%), 
Episodic (Males: 
21%; Females: 9%), 
Decreaser (Males: 
9%; Females: 4%), 
Increaser (Males: 
6%; Females: 16%). 
Kingsbury et al. 
(2016) 






Leadbeater et al. 
(2012) 
662 12-18 HYS BCFPI MGLGC
M 
6 4 6 3 trajectories for 
males and 3 
trajectories for 
females. 
Lee et al. (2017) 537 15-26 FTP SCL-90-
R 
LT-GMM 11 6 6 Adolescence: High 





Low and stable 
(74.9%). Young 




Low and stable 
(86.1%). 










GMM NA 6 > 2 Separate trajectories 
and classes derived 
for males and 
females. 
Mazza et al. 
(2010) 
951 Grades 2-8 RHC SPQ SPGBM 6 6 5 Low depressed 









Mezulis et al. 
(2014) 
382 11-18 WSFW CDI GMM 7 4 3 Stable low (51%), 
Increasing (37%), 
Early high (12%). 
Mumford et al. 
(2013) 
8320 15-27 NLSCY MHI-5 GGMM 
(Joint) 
8 5 5 Stable normal weight, 
stable good mental 
health (82.2%), 
Consistently obese, 












stable good mental 
health (2.1%). 
Olino et al. 
(2010) 
1709 16-30 American 
Adolescents 
K-SADS LCGA 14 4 6 Persistent depression 
(1.3%), Persistent 
anxiety (2.1%), Later 









Otten et al. 
(2010) 
428 13-20 FHS GSE GMM Not 
reported 
5 3 High (25%), Medium 
(50%), low (25%). 
Reinke et al. 
(2012) 
361 10-16 American 
Adolescents 
CDI GMM 6 6 4 Increasing symptoms 
(5.1 %), High levels 
of depressive 
symptoms (5.2 %), 
Decreasing 
depressive symptoms 
(8.9 %), Low levels 
of depressive 
symptoms (80.9 %). 
 
 
















CES-D GGMM 4 4 3 High (23%), 
Moderate (44%), 
Low (33%). 
Sabiston et al. 
(2013) 
860 12-18 NDIT 6 DS 
Items 
SPGBM 6 21 3 Low and declining 
(37.8%), Moderate 
and stable (41.6%), 
High increasing 
(20.6%). 
Sallinen et al. 
(2016) 
112 13-16 Finish 
adolescents 







297 18-25 Finish Young 
Adults 




Stoolmiller et al. 
(2005) 
206 15-24 Oregon 
Youth Study 






Weeks et al. 
(2014) 
6337 4-14 NLSCY OCHD LCGA 10 8 5 Low stable (68%), 
Adolescent onset 
(10%), Moderate 
stable (12%), High 
 
 
childhood (6%), High 
stable (4%). 
Whalen et al. 
(2016) 
348 4-13 PDS PAPA; 
CAPA 
GMM 10 8 6 Males: Low 
(51.88%), Medium 
(31.25%) and High 
(16.87%). Females: 
Low (56%), Medium 
(35.3%) and High 
(8.7%). 
Wickrama et al. 
(2009) 
14,058 11-18 ADD Health CES-D ANOVA; 
SEM 
















985 15-17 MAVS CES-D DTA 2 3 7 Males: Rarely 
depressed (4.5%), 










NLSCY CES-D LCGA 
(Joint) 
4 4 8 Males: Low co-
occurrence (43.8%), 
High co-occurrence 
(10.1%), High dep 
 
 
only (14.5%), High 





High dep only 
(13.5%), Moderate 
alcohol only (37%). 
Yaroslavsky et 
al. (2013) 
719 14-30 OADP CES-D GMM 14 4 3 Low decreasing 
(24%), Moderate-
decreasing (44%), 
High stable (32%). 
Table 2. A summary of group-based trajectory studies examining trajectories of depressive symptoms from childhood to young adulthood. 
ANOVA: Analysis of Variance, ADD Health: National Longitudinal Study of Adolescent Health, ADS: Orygen Adolescent Development 
Study, ALSPAC: Avon Longitudinal Study of Parents and Children, BCFPI: Brief Child and Family Phone Interview, BDI: Beck Depression 
Inventory, BSI: Brief Symptom Inventory, CAPA: Child and Adolescent Psychiatric Assessment, CBC: Child Behavior Checklist, CDI: 
Children's Depression Inventory, CES-D: Centre for Epidemiological Depression Scale, DS: Depressive Symptoms, DTA: Dual Trajectory 
Analysis, FHS: Family and Health Study, FTP: Family Transitions Project, GGMM: General Growth Mixture Modelling, GMM: Growth 
Mixture Modelling, GSE: Global Negative Self-Evaluation Scale, HYS: Victoria Healthy Youth Survey, K-SADS: Schedule for Affective 
Disorders and Schizophrenia for School-Age Children, LCGA: Latent Class Growth Analysis, LCA: Latent Class Analysis, LT-GMM: Latent 
Transition Growth Mixture Model, MAVS:  Middle Adolescent Vulnerability Study, MFQ: Mood and Feelings Questionnaire, MGLGCM: 
Multiple-Group Latent Growth Curve Models, MHI-5: Mental Health Inventory 5-Item, NDIT: Nicotine Dependence in Teens Study, NLSCY: 
National Longitudinal Survey of Children and Youth, OADP: Oregon Adolescent Depression Project, OCHS: Ontario Child Health Study, 
PAPA: Preschool Age Psychiatric Assessment, PDS: Preschool Depression Study, RHC: Raising Healthy Children, SCL-90-R: Symptom-
Checklist-90-Revised, SES: Socio-economic Status, SPGBM: Semiparametric Group Based Models, SPQ: Seattle Personality Questionnaire, 
SMFQ: Short Mood and Feelings Questionnaire, TRAILS: TRacking Adolescents’ Individual Lives’ Survey, WSFW: Wisconsin Study of 
Families and Work, YNTR: Young and Adult Netherlands Twin Register, YSR: Anxious/Depressed scale of Youth Self-Report, ZHLS: Zuis-




Appendix Table 2.2 
Author N Age/Grade 
Range 
Sample Measure Method Years 
Follow 
Up 
Waves Main Findings 
Adkins et al. 
(2009) 
18764 11-18 ADD Health CES-D LCM 7 3 4 trajectories for males and 4 for 
females depending on ethnicity, SES 
and stressful life events. 
Adkins et al. 
(2012) 
1909 11-18 ADD Health CES-D Mixed-
effects 
models 
7 3 4 trajectories for males and 4 for 
females depending on CES-D score. 
Brown et al. 
(2007) 
20126 11-18 ADD Health CES-D LTA 7 3 4 trajectories for males and 4 for 
females depending on ethnicity.  
Chen et al. 
(2011) 
12330 11-18 ADD Health CES-D LCM 7 3 4 trajectories under 15 years old & 4 
trajectories over 15 years old 
(Chinese-American males, Chinese-
American females, White-American 
males, White-American females). 
Edwards et al. 
(2014) 
6182 12-17 ALSPAC SMFQ LGM 5 4 1 trajectory for males and 1 for 
females. 
Ferro et al. 
(2015a) 
2825 10-24 NLSCY CES-D MLM 14 8 2 trajectories, one for chronic illness 
and one for healthy.  
Galambos et 
al. (2006) 
920 18-25 Canadian 
Adolescents 
CES-D MLM 7 5 2 overall trajectories, one for males 
and one females. 3 for conflict with 
parents. 






CDI LFGM 6 6 4 trajectories identified for different 
attributional styles. 
Gaysina et al. 
(2011) 
4559 15-53 1946 British 
Cohort 
Rutter B2 MLM 
(Joint) 
38 6 8 trajectories: 4 each for males and 
females: adolescent-onset repeated, 
adolescent-onset with good adult 
outcome, adult-onset repeated. 
 
 
Ge et al. 
(1994) 
376 9-20 IYFP SCL-90-R LGM 4 4 1 trajectory for males and 1 for 
females. 




IYFP SCL-90-R MLM 6 5 1 trajectory for males and 1 for 
females. 3 trajectories for pubertal 
status. 3 trajectories for pubertal 
transition. 
Ge et al. 
(2006) 
550 12-23 FTP SCL-90-R MLM 10 11 4 trajectories: 2 each for males and 





2286 11-18 ADD Health CES-D MLM 7 3 2 trajectories for DRD2 and DRD4 
genetic variants. 
Hankin (2009) 350 11-17 American 
Adolescents 
CDI MLM 5 4 1 trajectory for males and 1 for 
females. 






CDI MLM 2 6 4 trajectories for males and females 







CDRS-R MLM 6 7 1 population trajectory established. 
Mahedy et al. 
(2017) 
5539 13-18 ALSPAC SMFQ LGM 5 4 2 high and low trajectories for both 
males and females.  
Marmorstein 
(2009) 
20728 11-18 ADD Health CES-D MLM 7 3 4 trajectories identified in relation to 
alcohol problems. 
Marshal et al. 
(2013) 




18924 11-18 ADD Health CES-D LTA 7 3 1 population trajectory established. 
Natsuaki et al. 
(2009) 
> 10,673 12-23 ADD Health CES-D MLM 7 3 2 trajectories for just depressive 
symptoms, 1 for males and 1 for 
females. 4 trajectories for dating. 6 
trajectories for pubertal timing. 
Needham 
(2007) 









4359 12-21 NLSCY CES-D MLM 12 7 2 trajectories for depressive 
symptoms. 2 trajectories for low self-
esteem. 











1; 3 4; 3 4 trajectories, 2 for males and 2 for 
females. 
Stapinski et al. 
(2013) 
2508 12-18 Chilean 
Adolescents 
BDI LGM 1.5 3 6 trajectories identified, 3 for males 
and 3 for females. 
Wickrama et 
al. (2008) 
458 15-25 FTP SCL-90-R LGM 10 7 1 population trajectory established. 
Williams and 
Merten (2014) 
1796 12-24 ADD Health CES-D LGM 12 4 1 population trajectory established. 
Yip (2015) 146 13-16 American 
Adolescents 
CES-D MLM 3 9 4 trajectories identified for high/low 
discrimination and high/low sleep 
quality. 
Table 3. A summary of individual population trajectory approaches studies examining trajectories of depressive symptoms from childhood to 
young adulthood. ADD Health: National Longitudinal Study of Adolescent Health, ALSPAC: Avon Longitudinal Study of Parents and 
Children, BDI: Beck Depression Inventory, CDI: Children's Depression Inventory, CDRS-R: Children’s Depression Rating Scale-Revised,  
CES-D: Centre for Epidemiological Depression Scale, CHAMP: Cambridge Hormones and Moods Project, FTP: Family Transitions Project, 
IYFP: Iowa Youth and Families Project, LCM: Latent Curve Models, LFGM: Latent Factor Growth Model, LGM: Latent Growth Models, 
LTA: Latent Trajectory Analysis, MFQ: Mood and Feelings Questionnaire, MLM: Multilevel Modelling, NLSCY: National Longitudinal 
Survey of Children and Youth, SCL-90-R: Symptom-Checklist-90-Revised, SES: Socio-economic Status, SEM: Structural Equation 




Appendix 4 - Identifying Trajectories of Depressive Symptoms Across Adolescence and Young Adulthood 
Appendix Table 4.1.  
 Fractional Cubic Polynomial Model Fractional Quartic Polynomial Model 
Parameter Estimate Std. Error p-value Estimate Std. Error p-value 
𝛽0 - Intercept 6.123 0.056 <.001 6.312 0.058 <.001 
𝛽1- Age (linear) 2.699 0.072 <.001 -89.581 4.449 <.001 
𝛽2- Age
2 (quadratic) -8.761 0.259 <.001 -96.614 4.474 <.001 
𝛽3- Age
3 (cubic) 11.720 0.560 <.001 -41.152 1.995 <.001 
𝛽4- Age
4 (quartic) - - - 91.280 4.402 <.001 
Intercept var 16.701 0.397 - 16.622 0.405 - 
Intercept/slope cov 11.629 0.403 - -245.720 19.286 - 
Slope var 15.775 0.635 - -708.725 53.201 - 
Intercept/quadratic cov -48.578 1.643 - -289.810 19.756 - 
Slope/quadratic cov -43.476 2.056 - 731.261 46.095 - 
Quadratic var 177.170 8.551 - 2271.649 132.106 - 
Intercept/cubic cov 68.681 3.264 - -104.083 8.591 - 
Slope/cubic cov 28.371 3.401 - -1061.195 126.071 - 
Quadratic/cubic cov -209.179 15.767 - -366.232 114.373 - 
Cubic var 407.060 37.840 - -712.268 111.480 - 
Intercept/quartic cov - - - 256.117 19.178 - 
Slope/quartic cov - - - 356.829 26.318 - 
Quadratic/quartic cov - - - -1098.660 65.067 - 
Cubic/quartic cov - - - 872.115 122.412 - 
Quartic var - - - NIL NIL - 
Residual variance 11.662 0.114 - 11.897 0.122 - 
ICC 0.59 0.58 
Deviance 252728.57 252279.69 
AIC 252758.6 252319.7 
BIC 252889.8 252493.5 
Note: Var: Variance; Cov: Covariance; ICC: Intraclass correlation; AIC: Akaike information criterion; BIC: Bayesian information criterion. 
Model comparisons between the polynomials and fractional polynomials. Age was centered to 16.53. The 3rd order fractional polynomials takes 




Appendix 5 - Genetic and Environmental Risk Factors Associated with Trajectories of 
Depressive Symptoms from Adolescence to Young Adulthood. 
Genotyping Information 
Participants were genotyped using the Illumina HumanHap550 quad chip. Individuals were 
excluded based on gender mismatches, minimal or excessive heterozygosity, disproportionate 
levels of individual missingness (>3%), evidence of cryptic relatedness (>10% of alleles 
identical by descent), insufficient sample replication (IBD < 0.8) and being of non-European 
ancestry (assessed by multidimensional scaling analysis including HapMap 2 individuals). 
Thus, our analysis is only on individuals of European descent. SNPs with a minor allele 
frequency (MAF) of < 1%, Impute2 information quality metric of < 0.8, a call rate of < 95% 
or evidence for violations of Hardy-Weinberg equilibrium (P-value < 5e-7) were removed. 
Imputation performed using Impute v2.2.2 with the 1000 genomes reference panel (Phase 1, 
Version 3), using 2186 reference haplotypes. The maximum number of single nucleotide 
polymorphisms (snps) that were imputed (and passed filtering on MAF of > 1% and info 
score > 80%) was 8282911. In the case of siblings, one individual was dropped from analysis 
















5-Class Model Without Risk Factors or Confounders (n=9,394) 324 (3.5) 1086 (11.6) 880 (9.4) 480 (5.1) 6624 (70.5) 
Unadjusted Univariate 5-Class Model (n=4,092) 106 (2.6) 461 (11.3) 393 (9.6) 241 (5.9) 2891 (70.7) 
Adjusted Univariate 5-Class Model (n=3,525) 98 (2.8) 393 (11.1) 325 (9.2) 203 (5.8) 2506 (71.1) 















 Low x2, p 
Sex (n=9,394)       
Males n (%) 54 (19.8) 232 (34.6) 203 (27.5) 177 (45.5) 3,829 (52.3) x2 = 314.62,  
p = < .001 Females n (%) 219 (80.2) 439 (65.4) 535 (72.5) 212 (54.5) 3,494 (47.7) 
Maternal Education (n=8,449)       
A Level or Higher n (%) 78 (32.0) 259 (42.3) 261 (39.1) 140 (40.4) 2,715 (41.3) 
x2 = 14.09,  
p = .079 
O Level n (%) 89 (36.5) 217 (35.4) 252 (37.7) 124 (35.7) 2,298 (34.9) 
< O Level n (%) 77 (31.5) 137 (22.3) 155 (23.2) 83 (23.9) 1,564 (23.8) 
Maternal Socioeconomic Status (n=7,203)       
Professional/Managerial/Technical n (%) 73 (36.5) 201 (39.3) 227 (40.7) 103 (35.3) 2,336 (40.4) x2 = 6.53,  
p = .163 Skilled non-manual or lower n (%) 127 (63.5) 310 (60.7) 331 (59.3) 189 (64.7) 3,306 (58.6) 
Parity (n=8,528)       
First Born n (%) 95 (38.8) 288 (47.4) 299 (44.7) 166 (47.2) 3,070 (46.2) 
x2 = 12.53,  
p = .129 
Second Born n (%) 91 (37.1) 220 (36.2) 229 (34.2) 124 (35.2) 2,377 (35.7) 
Third Born + n (%) 59 (24.1) 100 (16.4) 141 (21.1) 62 (17.6) 1,207 (18.4) 
Maternal Age At Pregnancy (n=8,872)       
< 25 Years n (%) 54 (21.0) 126 (19.7) 116 (16.7) 79 (21.7) 1,156 (16.7) 
x2 = 18.31,  
p = .107 
25-29 n (%) 67 (26.1) 199 (31.2) 207 (29.9) 94 (25.8) 2,185 (31.6) 
30-34 n (%) 97 (37.7) 218 (34.2) 251 (36.2) 134 (36.8) 2,501 (36.1) 
35+ n (%) 39 (15.1) 95 (14.9) 119 (17.2) 57 (15.7) 1,078 (15.6) 
Pearson’s chi-squared tests (x2) used to highlight differences between participant demographics and the varying trajectories of depression 
symptoms.  















 Low x2, p 
Sex (n=4,092)       
Males n (%) 23 (23.7) 113 (39.8) 87 (26.8) 84 (44.9) 1,729 (54) x2 = 130.74,  
p = < .001 Females n (%) 74 (76.3) 171 (60.2) 237 (73.2) 103 (55.1) 1,471 (46) 
Maternal Education (n=4,041)       
A Level or Higher n (%) 37 (38.5) 144 (50.9) 154 (48) 88 (48.1) 1,477 (46.8) 
x2 = 8.62,  
p = .375 
O Level n (%) 35 (36.5) 94 (33.2) 119 (37.1) 60 (32.8) 1,108 (35.1) 
< O Level n (%) 24 (25.0) 45 (15.9) 48 (14.9) 35 (19.1) 573 (18.1) 
Maternal Socioeconomic Status (n=3,567)       
Professional/Managerial/Technical n (%) 36 (40.9) 113 (45.9) 135 (48.9) 69 (43.7) 1,265 (45.2) x2 = 2.35,  
p = .671 Skilled non-manual or lower n (%) 52 (59.1) 133 (54.1) 141 (51.1) 89 (56.3) 1,534 (54.8) 
Parity (n=4,034)       
First Born n (%) 38 (39.2) 129 (46.2) 139 (43.6) 87 (47.0) 1,476 (46.8) 
x2 = 4.95,  
p = .763 
Second Born n (%) 41 (42.3) 104 (37.3) 115 (36) 65 (35.2) 1,140 (36.1) 
Third Born + n (%) 18 (18.6) 46 (14.5) 65 (20.4) 33 (17.8) 538 (17.1) 
Maternal Age At Pregnancy (n=4,092)       
< 25 Years n (%) 15 (15.5) 33 (11.6) 30 (16.2) 29 (15.5) 380 (11.9) 
x2 = 9.16,  
p = .689 
25-29 n (%) 26 (26.8) 86 (30.3) 100 (30.9) 48 (25.7) 973 (30.4) 
30-34 n (%) 38 (39.2) 120 (42.2) 135 (41.7) 71 (38.0) 1,282 (40.1) 
35+ n (%) 18 (18.6) 45 (15.9) 59 (18.2) 39 (20.9) 565 (17.7) 
Pearson’s chi-squared tests (x2) used to highlight differences between participant demographics and the varying trajectories of depression 
symptoms for individuals with all the risk factors.  
Risk factors included in this analysis were: sex, the polygenic risk score for depressive symptoms (PRS), postnatal depression, cruelty to the 




   





Postnatal Depression Cruelty to Mother Anxiety Bullied 
Sex 1 . . . . . 
Polygenic Risk Score -0.015 (P = 0.36)c 1 . . . . 
Postnatal Depression 0.016 (P = 0.66)b 0.032 (P = 0.06)c 1 . . . 
Cruelty to Mother  -0.018 (P = 0.60)b 0.039 (P = 0.02)c 0.322 (P < 0.001)b 1 . . 
Anxiety  0.017 (P = 0.33)c 0.016 (P = 0.33)a 0.125 (P < 0.001)c 0.067 (P < 0.001)c 1 . 
Bullied at Age 10 -0.147 (P < 0.001)b 0.048 (P = 0.005)c 0.095 (P = 0.02)b 0.142 (P = 0.002)b 0.06 (P = 0.001)c 1 
Correlations presented with P values for correlations in parenthesis. 
Sex was coded as 0 for males and 1 for females. The PRS was standardised to have a mean of 0 and a SD of 1. Postnatal depression, cruelty to 
mother and bullied at age 10 were coded as 0 for no and 1 for yes. Anxiety was coded between 0-12, with greater scores corresponding to worse 
childhood anxiety. 
a Analysis was conducted using Pearson’s correlations. 
b Analysis was conducted using Tetrachoric correlations. 
c Analysis was conducted using Point-Biserial correlations and verified using Pearson’s correlations. 
 
 
 Appendix Table 5.5. Adjusted Univariate Associations Between All Risk Factors and Trajectories of Depressive Symptoms. 
a Analysis was not adjusted for any confounders or risk factors.  
b Analysis included postnatal depression and cruelty to mother and the following confounders: biological sex, maternal age at birth, maternal 
socioeconomic status at birth, maternal educational attainment at birth and parity.  
c Analysis included anxiety and bullying and was adjusted for the following confounders: biological sex, maternal age at birth, maternal 
socioeconomic status at birth, maternal educational attainment at birth and parity.  
Multinomial Odds Ratios (ORs) [Lower, Upper 95% CIs] 
  
Childhood persistent vs. 
Stable low  
Early-adult onset vs. 
Stable low 
Adolescent limited vs. 
Stable low 




Sex (n=9,394)a      
Female 6.13 [3.92, 9.58] 2.49 [1.97, 3.14] 4.5 [3.33, 6.07] 1.28 [0.96, 1.7] <.001 
Genetics (n=6,309)a      
Polygenic Risk Score 1.53 [1.27, 1.84] 1.2 [1.04, 1.38] 1.09 [0.94, 1.27] 1.04 [0.89, 1.23] <.001 
Early Life (n=6,345)b      
Postnatal Depression 2.14 [1.28, 3.57] 1.99 [1.35, 2.94] 1.2 [0.72, 1.99] 1.87 [1.17, 2.99] <.001 
Cruelty to Mother 2-4 Years 1.91 [1.16, 3.16] 1.73 [1.05, 2.85] 1.78 [1.2, 2.63] 1.3 [0.8, 2.12] <.001 
Childhood (n=4,733)c      
Anxiety at 7.6 Years 1.35 [1.22, 1.5] 1.14 [1.04, 1.24] 1.13 [1.03, 1.24] 1.22 [1.08, 1.37] <.001 
Bullied at 10 Years 4.94 [2.84, 8.6] 1.69 [1.15, 2.5] 1.89 [1.22, 2.91] 7.58 [5.0, 11.51] <.001 
 
 
Appendix Table 5.6. Unadjusted Multivariate Associations Between All Risk Factors and Trajectories of Depressive Symptoms (n=4,092). 
a Analysis was not adjusted for any confounders. 
* Indicates a substantive difference from the univariate model. 
Multinomial Odds Ratios (ORs) [Lower, Upper 95% CIs]a 
  
Childhood persistent vs. 
Stable low  
Early-adult onset vs. 
Stable low 
Adolescent limited vs. 
Stable low 





     
Female 6.09 [2.91, 12.74] 2.22 [1.55, 3.19] 5.9 [3.6, 9.66] 1.88 [1.23, 2.89]
* <.001 
Genetics 
     
Polygenic Risk Score 1.54 [1.16, 2.02] 1.28 [1.08, 1.52] 1.12 [0.93, 1.35] 1.05 [0.86, 1.28] .002 
Early Life 
     
Postnatal Depression 2.56 [1.3, 5.02] 1.98 [1.2, 3.28] 1.18 [0.64, 2.2] 1.69 [0.9, 3.18] .008 
Cruelty to Mother 2-4 Years 1.82 [0.82, 4.05]* 2.17 [1.36, 3.46] 2.13 [1.33, 3.42] 1.07 [0.54, 2.12] <.001 
Childhood 
     
Anxiety at 7.6 Years 1.26 [1.12, 1.4] 1.12 [1.02, 1.23] 1.1 [1, 1.21] 1.27 [1.14, 1.41] <.001 
Bullied at 10 Years 4.23 [2.27, 7.89] 1.71 [1.12, 2.6] 1.37 [0.84, 2.25]
* 7.55 [4.86, 11.71] <.001 
 
 
Appendix 6 - Identifying Critical Points of Trajectories of Depressive Symptoms from 




Reconsider equation 1 in the manuscript: 
 
𝑦𝑖𝑗 = 𝛽0 + 𝛽1𝑡𝑖𝑗 + 𝛽2𝑡𝑖𝑗
2 + 𝛽3𝑡𝑖𝑗
3 + 𝛽4𝑥1𝑗 + 𝛽5𝑥1𝑗𝑡𝑖𝑗 + 𝛽6𝑥1𝑗𝑡𝑖𝑗
2 + 𝛽7𝑥1𝑗𝑡𝑖𝑗
3  
+𝑢0𝑗 + 𝑢1𝑗𝑡𝑖𝑗 + 𝑢2𝑗𝑡𝑖𝑗
2 + 𝑢3𝑗𝑡𝑖𝑗
3 + 𝑒𝑖𝑗 
(Appendix equation 1) 
 
where 𝑦𝑖𝑗 is the depressive symptom score and 𝑡𝑖𝑗 is the age (centred around 16 years, the 
approximate sample mean) for individual 𝑗 at occasion 𝑖, 𝑥1𝑗 is a dummy variable for being 
female, and 𝑢0𝑗, 𝑢1𝑗, 𝑢2𝑗, and 𝑢3𝑗 are the random linear, quadratic and cubic effects, 
respectively, and 𝑒𝑖𝑗 is the occasion-specific residual. 
Predicted depressive symptom scores 
The predicted depressive symptom score for individual 𝑗 at occasion 𝑖 is given by 
 
?̂?𝑖𝑗 = 𝛽0 + 𝛽1𝑡𝑖𝑗 + 𝛽2𝑡𝑖𝑗
2 + 𝛽3𝑡𝑖𝑗
3 + 𝛽4𝑥1𝑗 + 𝛽5𝑥1𝑗𝑡𝑖𝑗 + 𝛽6𝑥1𝑗𝑡𝑖𝑗
2 + 𝛽7𝑥1𝑗𝑡𝑖𝑗
3  
+𝑢0𝑗 + 𝑢1𝑗𝑡𝑖𝑗 + 𝑢2𝑗𝑡𝑖𝑗
2 + 𝑢3𝑗𝑡𝑖𝑗
3  
(Appendix equation 2) 
 
The mean male and female predicted depressive symptom score at a given age 𝑡𝑖𝑗 can be 
obtained by setting all random effects to 0 and by setting 𝑥1𝑗 to 0 or 1 accordingly. 
Velocity 





= 𝛽1 + 2𝛽2𝑡𝑖𝑗 + 3𝛽3𝑡𝑖𝑗
2 + 𝛽5𝑥1𝑗 + 2𝛽6𝑥1𝑗𝑡𝑖𝑗 + 3𝛽7𝑥1𝑗𝑡𝑖𝑗
2 + 𝑢1𝑗 + 2𝑢2𝑗𝑡𝑖𝑗 + 3𝑢3𝑗𝑡𝑖𝑗
2  
(Appendix equation 3) 
The mean male and female velocities at a given age 𝑡𝑖𝑗 can be obtained by setting all random 










2 = 2𝛽2 + 6𝛽3𝑡𝑖𝑗 + 2𝛽6𝑥𝑖𝑗 + 6𝛽7𝑥𝑖𝑗𝑡𝑖𝑗 + 2𝑢2𝑗 + 6𝑢3𝑗𝑡𝑖𝑗 
(Appendix equation 4) 
 
The mean male and female accelerations at a given age 𝑡𝑖𝑗 can be obtained by setting all 
random effects to 0 and by setting 𝑥1𝑗 to 0 or 1 accordingly. 
 
Age of peak velocity 




2𝛽2 + 2𝛽6𝑥1𝑗 + 2𝑢2𝑗
6𝛽3 + 6𝛽7𝑥1𝑗 + 6𝑢3𝑗
 
(Appendix equation 5) 
 
The predicted depressive symptom scores evaluated at 𝑡𝑖𝑗,APV can be found by substituting 
𝑡𝑖𝑗,APV into appendix equation 2. 
The mean male and female ages of peak velocity can be obtained by setting all random 
effects to 0 and by setting 𝑥1𝑗 to 0 or 1 accordingly. 
 
Age of maximum depressive symptoms 
Setting appendix equation 3 equal to zero and rearranging using the quadratic formulae gives 





−2(𝛽2 + 𝛽6𝑥1𝑗 + 𝑢2𝑗) ± √4(𝛽2 + 𝛽6𝑥1𝑗 + 𝑢2𝑗)
2
− 12(𝛽1 + 𝛽5𝑥1𝑗 + 𝑢1𝑗)(𝛽3 + 𝛽7𝑥1𝑗 + 𝑢3𝑗)




(Appendix equation 6) 
 
The predicted depressive symptom scores evaluated at the two values of 𝑡𝑖𝑗,AMDS can be 
found by substituting the two values into Appendix equation 2. 
The mean male and female ages of maximum depressive symptoms can be obtained by 




Covariates were included based upon previous evidence from the depressive 
symptoms literature that highlight correlations between depressive symptoms and missing 
data (Kingsbury et al., 2016; Mahedy et al., 2017; Pearson et al., 2017). These covariates 
were completed by the participant’s main carer and assessed during the antenatal period. 
These included: maternal education (coded as ‘A-level or higher’, ‘O-level’ or ‘<O-level’), 
maternal social class (coded as ‘Professional occupations or managerial and technical 
occupations’ or ‘Skilled non-manual occupations, skilled manual occupations, partly-skilled 
occupations and unskilled occupations’, parity (whether the study child was 1st/2nd/3rd born or 
greater), housing tenure (coded as ‘Mortgaged or owned’, ‘Privately rented’ or ‘Subsided 
rented’), financial difficulties (yes/no), maternal smoking in pregnancy (yes/no), maternal 
prenatal depression (yes/no) and maternal postnatal depression (yes/no). A binary indicator of 
the SMFQ source was also included as a covariate (clinic/questionnaire). 
 
Our results were robust to the inclusion of these covariates that are associated with 
missing data (see Appendix tables 3-7 and Appendix figure 4). The total sample that included 






 Quadratic Cubic Quartic 
Parameter Estimate Std. Error p-value Estimate Std. Error p-value Estimate Std. Error p-value 
𝛽0 - Intercept 4.538 0.069 <.001 4.568 0.069 <.001 4.736 0.082 <.001 
𝛽1- Age (slope) 0.135 0.01 <.001 0.357 0.022 <.001 0.361 0.022 <.001 
𝛽2- Age^2 (acceleration) 0.002 0.002 0.308 0.012 0.002 <.001 -0.026 0.009 0.003 
𝛽3- Age^3 (cubic change) - - - -0.007 0.001 <.001 -0.009 0.001 <.001 
𝛽4- Female 2.222 0.095 <.001 2.132 0.095 <.001 2.328 0.112 <.001 
𝛽5- FemalexAge 0.191 0.013 <.001 0.135 0.03 <.001 0.169 0.031 <.001 
𝛽6- FemalexAge^2 -0.053 0.003 <.001 -0.051 0.003 <.001 -0.099 0.012 <.001 
𝛽7- FemalexAge
3 - - - 0.002 0.001 0.036 0.001 0.0002 <.001 
𝛽8- Age
4 (quartic change) - - - - - - 0.001 0.0003 <.001 
𝛽9- FemalexAge
4 - - - - - - -0.001 0.001 0.335 
Intercept variance 12.2 0.294 - 11.9335 0.2918 - 14.431 0.3885 - 
Intercept/Slope covariance 0.773 0.03 - 1.2169 0.0623 - 1.3367 0.0736 - 
Slope variance 0.115 0.005 - 0.4675 0.0275 - 0.5171 0.0281 - 
Intercept/Quadratic covariance -0.149 0.007 - -0.1172 0.0076 - -0.4715 0.033 - 
Slope/Quadratic covariance -0.004 0.001 - -0.0055 0.002 - -0.0243 0.0073 - 
Quadratic variance 0.003 0.0003 - 0.0023 0.0003 - 0.0363 0.0038 - 
Intercept/Cubic covariance - - - -0.0163 0.0017 - -0.0282 0.0023 - 
Slope/Cubic covariance - - - -0.008 0.0007 - -0.0101 0.0008 - 
Quadratic/Cubic covariance - - - 0.0003 0.0001 - 0.0013 0.0003 - 
Cubic variance - - - 0.0001 0.00002 - 0.0002 0.00003 - 
Intercept/Quartic covariance - - - - - - 0.0079 0.0007 - 
Slope/Quartic covariance - - - - - - 0.0005 0.0002 - 
Quadratic/Quartic covariance - - - - - - -0.0006 0.0001 - 
Cubic/Quartic covariance - - - - - - -0.00002 0.00001 - 
Quartic variance - - - - - - 0.00001 0.000002 - 
Female residual variance 14.481 0.173 - 13.69 0.174 - 13.038 0.175 - 
Male residual variance 9.765 0.141 - 9.332 0.149 - 8.899 0.151 - 
Female/Male Variance P Wald-Test <.001 <.001 <.001 
ICC 0.55 0.56 0.62 
Deviance 228583.53 227890.58 227532 
AIC 228611.5 227930.6 227586.5 
BIC 228731.9 228102.5 227818.6 
Appendix Table 1. Model comparisons between the quadratic, cubic and quartic models. 
 
 
Appendix figure 1. The quadratic model for males and females.  
 









 Unadjusted Model (n=9,301) Adjusted Model (n=6,097) 
Parameter Estimate 
Std. 
Error p-value Estimate 
Std. 
Error p-value 
𝛽0 - Intercept 4.568 0.069 <.001 3.997 0.113 <.001 
𝛽1- Age (slope) 0.357 0.022 <.001 0.380 0.027 <.001 
𝛽2- Age^2 (acceleration) 0.012 0.002 <.001 0.013 0.003 <.001 
𝛽3- Age^3 (cubic change) -0.007 0.001 <.001 -0.007 0.001 <.001 
𝛽4- Female 2.132 0.095 <.001 1.99 0.112 <.001 
𝛽5- FemalexAge 0.135 0.03 <.001 0.129 0.036 <.001 
𝛽6- FemalexAge^2 -0.051 0.003 <.001 -0.051 0.004 <.001 
𝛽7- FemalexAge^3 0.002 0.001 0.036 0.001 0.001 0.148 
Measurement - - - 0.252 0.073 0.001 
Mat Edu - O Level - - - -0.019 0.097 0.842 
Mat Edu - <O Level - - - -0.161 0.121 0.181 
Mat Sclass - III-V - - - -0.053 0.091 0.563 
2nd Born - - - 0.012 0.085 0.887 
3rd Born+ - - - 0.355 0.114 0.002 
Housing - Private Rented - - - 0.317 0.184 0.085 
Housing - Subsidised Rented - - - 0.291 0.164 0.076 
Financial Difficulties - - - 0.595 0.101 <.001 
Smoked During Pregnancy - - - 0.829 0.11 <.001 
Depression Pre-Pregnancy - - - 0.641 0.119 <.001 
Depression Post-Pregnancy - - - 0.403 0.131 0.002 
Intercept variance 11.9335 0.2918 - 11.1721 0.3315 - 
Intercept/Slope covariance 1.2169 0.0623 - 1.0772 0.0707 - 
Slope variance 0.4675 0.0275 - 0.4458 0.0314 - 
Intercept/Quadratic covariance -0.1172 0.0076 - -0.1197 0.0088 - 
Slope/Quadratic covariance -0.0055 0.0020 - -0.0044 0.0024 - 
Quadratic variance 0.0023 0.0003 - 0.0026 0.0004 - 
Intercept/Cubic covariance -0.0163 0.0017 - -0.0129 0.0019 - 
Slope/Cubic covariance -0.008 0.0007 - -0.0075 0.0008 - 
Quadratic/Cubic covariance 0.0003 0.0001 - 0.0002 0.0001 - 
Cubic variance 0.0001 0.00002 - 0.0001 0.00002 - 
Female residual variance 13.69 0.174 - 13.175 0.2 - 
Male residual variance 9.332 0.149 - 9.372 0.175 - 
Female/Male Variance P Wald-Test <.001 <.001 
ICC 0.56 0.54 
Deviance 227890.58 158562.55 
AIC 227930.6 158626.5 
BIC 228102.5 158890.2 
Appendix Table 2. Full regression coefficients and variances for the unadjusted and adjusted 
cubic models.  
 
 
 Unadjusted Model (n=5,409) Adjusted Model (n=3,867) 
Parameter Estimate 
Std. 
Error p-value Estimate 
Std. 
Error p-value 
𝛽0 - Intercept 4.471 0.082 <.001 3.955 0.126 <.001 
𝛽1- Age (slope) 0.356 0.024 <.001 0.379 0.029 <.001 
𝛽2- Age^2 (acceleration) 0.012 0.002 <.001 0.013 0.003 <.001 
𝛽3- Age^3 (cubic change) -0.007 0.001 <.001 -0.007 0.001 <.001 
𝛽4- Female 2.090 0.110 <.001 1.977 0.126 <.001 
𝛽5- FemalexAge 0.10 0.032 0.002 0.105 0.038 0.005 
𝛽6- FemalexAge^2 -0.05 0.003 <.001 -0.05 0.004 <.001 
𝛽7- FemalexAge^3 0.002 0.001 0.006 0.002 0.001 0.038 
Measurement - - - 0.25 0.075 0.001 
Mat Edu - O Level - - - -0.127 0.113 0.26 
Mat Edu - <O Level - - - -0.240 0.149 0.107 
Mat Sclass - III-V - - - 0.030 0.106 0.778 
2nd Born - - - 0.004 0.099 0.971 
3rd Born+ - - - 0.379 0.139 0.006 
Housing - Private Rented - - - 0.570 0.2 0.011 
Housing - Subsidised Rented - - - 0.43 0.218 0.049 
Financial Difficulties - - - 0.442 0.124 <.001 
Smoked During Pregnancy - - - 0.758 0.137 <.001 
Depression Pre-Pregnancy - - - 0.745 0.147 <.001 
Depression Post-Pregnancy - - - 0.646 0.160 <.001 
Intercept variance 11.3809 0.3123 - 10.6761 0.3485 - 
Intercept/Slope covariance 1.1070 0.0651 - 0.9934 0.0732 - 
Slope variance 0.4483 0.0277 - 0.4376 0.0316 - 
Intercept/Quadratic covariance -0.1093 0.0079 - -0.1114 0.0091 - 
Slope/Quadratic covariance -0.004 0.002 - -0.003 0.0024 - 
Quadratic variance 0.0020 0.0003 - 0.0023 0.0004 - 
Intercept/Cubic covariance -0.0140 0.0018 - -0.011 0.0020 - 
Slope/Cubic covariance -0.0077 0.0007 - -0.0075 0.0008 - 
Quadratic/Cubic covariance 0.0003 0.0001 - 0.0002 0.0001 - 
Cubic variance 0.0001 0.00002 - 0.0001 0.00002 - 
Female residual variance 13.567 0.183 - 13.083 0.208 - 
Male residual variance 9.41 0.163 - 9.31 0.187 - 
Female/Male Variance P Wald-Test <.001 <.001 
ICC 0.55 0.54 
Deviance 183104.28 132101.03 
AIC 183144.3 132165 
BIC 183311.8 132422.9 
Appendix Table 3. Sensitivity analysis of full regression coefficients and variances for the 





Unadjusted (n=9,301) Adjusted (n=6,097) 
  Males Females Difference p-value Males Females Difference p-value 
Intercept term for 
SMFQ 
4.57 (0.07) 6.7 (0.07) 2.13 (0.09) 
< 0.001 
3.99 (0.11) 5.99 (0.11) 1.99 (0.11) 
< 0.001 
[4.43, 4.7] [6.57, 6.83] [1.95, 2.32] [3.775, 4.218] [5.77, 6.20] [1.77, 2.21] 
Linear term for SMFQ 
0.36 (0.02) 0.49 (0.02) 0.14 (0.03) 
< 0.001 
0.379 (.027) 0.51 (0.03) 0.13 (0.04) 
< 0.001 
[0.31, 0.4] [0.45, 0.53] [0.08, 0.19] [0.326, 0.433] [0.46, 0.56] [0.06, 0.2] 
Quadratic term for 
SMFQ 
0.01 (0.002) -0.04 (0.002) 0.05 (0.003) 
< 0.001 
0.013 (.003) -0.04 (0.003) 0.05 (0.004) 
< 0.001 
[0.008, 0.2] [-0.05, -0.03] [0.05, 0.06] [0.008, 0.018] [-0.04, -0.032] [0.04, 0.06] 
Cubic term for SMFQ 
-0.007 (0.001) -0.01 (.001) 0.002 (0.001) 
0.04 
-0.007 (.001) -0.01 (0.001) 0.001 (0.001) 
0.15 
[-0.01, -0.006] [-0.001, -0.004] [0.0001, 0.003] [-0.01, -0.006] [-0.01, -0.004] [0.0001, 0.003] 
Appendix Table 4. Comparing parameter estimates and trajectories from the unadjusted and adjusted cubic models. The intercept was centered to age 16 for 
interpretability. The differences between each term were calculated as follows: the intercept term for males (𝛽0) minus the intercept term for females (𝛽0 +
𝛽4), the linear term for males (𝛽1) minus the linear term for females (𝛽1 + 𝛽5), the quadratic term for males (𝛽2) minus the quadratic term for females (𝛽2 +




 Unadjusted (n=9,301) Adjusted (n=6,097) 
 Males Females Difference p-value Males Females Difference p-value 
Age of Peak Velocity in 
SMFQ 
16.36 (0.1) 13.51 (0.32) 2.86 (0.34) 
< 0.001 
16.44 (0.12) 13.66 (0.36) 2.78 (0.37) 
< 0.001 
[16.18, 16.55] [12.88, 14.14] [2.2, 3.51] [16.21, 16.67] [12.97, 14.36] [2.05, 3.51] 
Age of Maximum SMFQ 
20.42 (0.14) 19.61 (0.5) 0.80 (0.55) 
0.14 
20.68 (0.18) 19.68 (0.58) .99 (0.65) 
0.13 
[20.14, 20.69] [18.63, 20.6] [-0.27, 1.88] [20.32, 21.03] [18.54, 20.82] [-0.28, 2.27] 
SMFQ at Peak Velocity 
4.76 (0.07) 5.42 (0.06) 0.66 (0.1) 
< 0.001 
4.24 (0.12) 4.77 (0.12) 0.54 (0.12) 
< 0.001 
[4.62, 4.91] [5.30, 5.55] [0.47, 0.85] [4.01, 4.46] [4.54, 5.0] [0.31, 0.77] 
SMFQ at Maximum Point 
5.75 (0.1) 7.7 (0.09) 1.95 (0.14) 
< 0.001 
5.33 (0.13) 7.06 (0.13) 1.73 (0.16) 
< 0.001 
[5.55, 5.95] [7.52, 7.88] [1.69, 2.22] [5.07, 5.59] [6.81, 7.30] [1.41, 2.04] 
Appendix Table 5. Calculated features from the trajectories from the unadjusted and adjusted cubic models. Standard errors are given in (parenthesis), 95% 
confidence intervals are given in [parenthesis]. 
 
 
 Unadjusted (n=5,409) Adjusted (n=3,867) 
 Males Females Difference p-value Males Females Difference p-value 
Age of Peak Velocity in 
SMFQ 
16.358 (.106) 13.09 (.451) 3.267 (.464) < 0.001 16.78 (.124) 13.702 (.473) 3.077 (.489) < 0.001 
[16.15, 16.566] [12.206, 13.975] [2.359, 4.176] [16.536, 17.023] [12.775, 14.63] [2.119, 4.035] 
Age of Maximum SMFQ 20.797 (.146) 20.519 (.684) 0.277 (.701) 0.701 20.979 (.179) 20.528 (.756) .451 (.81) 0.578 
[20.51, 21.083] [19.179, 21.859] [-1.136, 1.691] [20.629, 21.329] [19.047, 22.01] [-1.136, 2.037] 
SMFQ at Peak Velocity 4.527 (.083) 4.9 (.066) 0.369 (.106) 0.001 4.177 (.127) 4.564 (.127) 0.386 (.129) 0.003 
[4.364, 4.69] [4.766, 5.026] [0.161, 0.577] [3.928, 4.427] [4.314, 4.813] [0.133, 0.639] 
SMFQ at Maximum Point 5.644 (.113) 7.407 (.098) 1.764 (.149) < 0.001 5.258 (.146) 6.891 (.135) 1.633 (.171) < 0.001 
[5.423, 5.865] [7.215, 7.6] [1.471, 2.056] [4.973, 5.544] [6.627, 7.155] [1.298, 1.968] 
Appendix Table 6. Calculated features from the trajectories from the unadjusted and adjusted cubic models post sensitivity analysis (minimum of 




Appendix figure 4. Adjusted population trajectories for males and females. SMFQ: Short Mood and Feelings Questionnaire. Features of the trajectories are 
overlaid with the following terms: ● Male age of peak velocity of depressive symptoms. ▲ Male age of maximum depressive symptoms. ♦ Female age of 
peak velocity of depressive symptoms. ■ Female age of maximum depressive symptoms. 
 
 
Appendix 7 - Childhood Trauma and Trajectories of Depressive Symptoms Across Adolescence 
Statistical Methods  
Let 𝑦𝑖𝑗 denote the depressive symptom score for individual 𝑗 at occasion 𝑖. The simplest trajectory model consists of a random intercept and a random quartic 
polynomial comprised of four age terms: age, age2, age3 and age4. The model can then be written as: 
 
𝑦𝑖𝑗 = 𝛽0 + 𝛽1𝑡𝑖𝑗 + 𝛽2𝑡𝑖𝑗
2 + 𝛽3𝑡𝑖𝑗
3 + 𝛽4𝑡𝑖𝑗
4 + 𝑢0𝑗 + 𝑢1𝑗𝑡𝑖𝑗 + 𝑢2𝑗𝑡𝑖𝑗
2 + 𝑢3𝑗𝑡𝑖𝑗
3 + 𝑢4𝑗𝑡𝑖𝑗
4 + 𝑒𝑖𝑗 
(Appendix Equation 7.1) 
where 𝑡𝑖𝑗 denotes the age in years (centred around 16.53 years, the mean age of all assessments) for that individual at that occasion, 𝑡𝑖𝑗
2 , 𝑡𝑖𝑗
3 , and 𝑡𝑖𝑗
4 , denote the 
quadratic, cubic and quartic age terms, and where 𝛽0, 𝛽1, 𝛽2, 𝛽3, 𝛽4 denote the associated regression coefficients. The 𝑢0𝑗, 𝑢1𝑗, 𝑢2𝑗, 𝑢3𝑗 and 𝑢4𝑗 are the 
random intercept, linear, quadratic, cubic and quartic individual-specific effects, and 𝑒𝑖𝑗 is the occasion-specific residual.  




























































(Appendix Equation 7.2) 
The elements of the covariance matrix summarise the degree to which individual-specific trajectories vary around the population-averaged trajectory. The 




(Appendix Equation 7.3)  
 
 
Predicted Depressive Symptom Trajectories 
The model is therefore set up to predict both the population average trajectory 
 




(Appendix Equation 7.4) 
and individual specific trajectories 
 
E(𝑦𝑖𝑗|𝑡𝑖𝑗, 𝑢0𝑗, 𝑢1𝑗, 𝑢2𝑗, 𝑢3𝑗, 𝑢4𝑗) = 𝛽0 + 𝛽1𝑡𝑖𝑗 + 𝛽2𝑡𝑖𝑗
2 + 𝛽3𝑡𝑖𝑗
3 + 𝛽4𝑡𝑖𝑗




(Appendix Equation 7.5) 
Substituting the parameter estimates and the predicted random effect values into the above expression gives the population average and individual specific 





Association Between Any Trauma and Depressive Symptom Trajectories 
We ran a simple model to examine the association between any trauma (between the ages of 5-10) and subsequent trajectories of depressive symptoms. Let 
𝑥1𝑗 denote the presence (𝑥1𝑗 = 1) or absence (𝑥1𝑗 = 0) of trauma. The model can be written as: 
 
𝑦𝑖𝑗 = 𝛽0 + 𝛽1𝑡𝑖𝑗 + 𝛽2𝑡𝑖𝑗
2 + 𝛽3𝑡𝑖𝑗
3 + 𝛽4𝑡𝑖𝑗
4 + 𝛽5𝑥1𝑗 + 𝛽6𝑥1𝑗𝑡𝑖𝑗 + 𝛽7𝑥1𝑗𝑡𝑖𝑗
2 + 𝛽8𝑥1𝑗𝑡𝑖𝑗
3  + 𝛽9𝑥1𝑗𝑡𝑖𝑗
4  
+𝑢0𝑗 + 𝑢1𝑗𝑡𝑖𝑗 + 𝑢2𝑗𝑡𝑖𝑗
2 + 𝑢3𝑗𝑡𝑖𝑗
3  + 𝑢4𝑗𝑡𝑖𝑗
4 + 𝑒𝑖𝑗 
(Appendix Equation 7.6) 
The population average trajectory becomes: 
 
E(𝑦𝑖𝑗|𝑡𝑖𝑗, 𝑥1𝑗) = 𝛽0 + 𝛽1𝑡𝑖𝑗 + 𝛽2𝑡𝑖𝑗
2 + 𝛽3𝑡𝑖𝑗
3 + 𝛽4𝑡𝑖𝑗
4 + 𝛽5𝑥1𝑗 + 𝛽6𝑥1𝑗𝑡𝑖𝑗 + 𝛽7𝑥1𝑗𝑡𝑖𝑗
2 + 𝛽8𝑥1𝑗𝑡𝑖𝑗
3  + 𝛽9𝑥1𝑗𝑡𝑖𝑗
4  
(Appendix Equation 7.7) 
Thus, for individuals with no trauma we have 
 




(Appendix Equation 7.8) 
While for individuals with trauma, and after some rearranging, we have 
 
E(𝑦𝑖𝑗|𝑡𝑖𝑗, 𝑥1𝑗 = 1) =  (𝛽0 + 𝛽5)  + (𝛽1 + 𝛽6)𝑡𝑖𝑗 + (𝛽2 + 𝛽7)𝑡𝑖𝑗
2 + (𝛽3 + 𝛽8)𝑡𝑖𝑗
3 + (𝛽4 + 𝛽9)𝑡𝑖𝑗
4  




Association Between Number of Traumas and Depressive Symptom Trajectories 
We ran a second model to examine the association between the number of traumas (0, 1, 2, 3+) and trajectories of depressive symptoms. We decided to treat 
the number of traumas as a four-category ordinal variable, rather than as a linear variable as the difference in depressive symptoms between successive 
numbers of traumas may not increase linearly. First, we created three dummy variables corresponding to the number of traumas: 1 trauma, 2 traumas and 3 or 
more traumas. The dummy variables were then entered as main effects and as interactions with the four age terms of the quartic polynomial (i.e., number of 
traumas × intercept; number of traumas × age; number of traumas × age2; number of traumas × age3 and number of traumas × age4). The intercept and the 
main effects of the quartic age polynomial therefore describe the no traumas group (i.e., the baseline or reference trajectory). For any give number of traumas, 
the corresponding dummy variable and interactions with the four age terms of the quartic age polynomial then describes how the trajectory for that trauma 
group deviates from that of the bassline no trauma group. 
Let 𝑥𝑗 denote the number of traumas (0, 1, 2, 3+) and 𝑥1𝑗, 𝑥2𝑗, 𝑥3𝑗 the series of three dummy variables derived from this. The following table shows the 
relationship between the dummy variables and the original ordinal variable. 
 
𝑥𝑗 𝑥1𝑗 𝑥2𝑗 𝑥3𝑗 
0 0 0 0 
1 1 0 0 
2 0 1 0 
3 0 0 1 
 
When 𝑥1𝑗 is set to 1 (𝑥2𝑗 and  𝑥3𝑗 are set to 0), the model gives the trajectory with 1 trauma. When 𝑥2𝑗 is set to 1 (𝑥1𝑗 and  𝑥3𝑗 are set to 0), the model gives 
the 2 traumas trajectory and when 𝑥3𝑗 is set to 1 (𝑥1𝑗 and  𝑥3𝑗 are set to 0), the model gives the 3 or more traumas trajectories.   
The depressive symptom score for individual 𝑗 at occasion 𝑖 is therefore given by: 




+ 𝛽5𝑥1𝑗 + 𝛽6𝑥1𝑗𝑡𝑖𝑗 + 𝛽7𝑥1𝑗𝑡𝑖𝑗
2 + 𝛽8𝑥1𝑗𝑡𝑖𝑗
3  + 𝛽9𝑥1𝑗𝑡𝑖𝑗
4   
+ 𝛽10𝑥2𝑗 + 𝛽11𝑥2𝑗𝑡𝑖𝑗 + 𝛽12𝑥2𝑗𝑡𝑖𝑗
2 + 𝛽13𝑥2𝑗𝑡𝑖𝑗
3  + 𝛽14𝑥2𝑗𝑡𝑖𝑗
4   
+ 𝛽15𝑥3𝑗 + 𝛽16𝑥3𝑗𝑡𝑖𝑗 + 𝛽17𝑥3𝑗𝑡𝑖𝑗
2 + 𝛽18𝑥3𝑗𝑡𝑖𝑗
3  + 𝛽19𝑥3𝑗𝑡𝑖𝑗
4  
+𝑢0𝑗 + 𝑢1𝑗𝑡𝑖𝑗 + 𝑢2𝑗𝑡𝑖𝑗
2 + 𝑢3𝑗𝑡𝑖𝑗
3  + 𝑢4𝑗𝑡𝑖𝑗
4 + 𝑒𝑖𝑗 
(Appendix Equation 7.10) 
 
 
The population average depressive symptom score for each trauma group can then be obtained by setting all random effects to 0 and by setting the dummy 
variables to their relevant values as illustrated in the table above. An alternative way to visualise the population-average for each trajectory can be written as 
this: 
 




1 Trauma: 𝐸(𝑦𝑖𝑗|𝑡𝑖𝑗 , 𝑥0𝑗 = 0, 𝑥1𝑗 = 1, 𝑥2𝑗 = 0, 𝑥3𝑗 = 0 ) =  (𝛽0 + 𝛽5)  + (𝛽1 + 𝛽6)𝑡𝑖𝑗 + (𝛽2 + 𝛽7)𝑡𝑖𝑗
2 + (𝛽3 + 𝛽8)𝑡𝑖𝑗
3 + (𝛽4 + 𝛽9)𝑡𝑖𝑗
4  
2 Traumas: 𝐸(𝑦𝑖𝑗|𝑡𝑖𝑗 , 𝑥0𝑗 = 0, 𝑥1𝑗 = 0, 𝑥2𝑗 = 1, 𝑥3𝑗 = 0 ) =  (𝛽0 + 𝛽10)  + (𝛽1 + 𝛽11)𝑡𝑖𝑗 + (𝛽2 + 𝛽12)𝑡𝑖𝑗
2 + (𝛽3 + 𝛽13)𝑡𝑖𝑗
3 + (𝛽4 + 𝛽14)𝑡𝑖𝑗
4  
3+ Traumas: 𝐸(𝑦𝑖𝑗|𝑡𝑖𝑗, 𝑥0𝑗 = 0, 𝑥1𝑗 = 0, 𝑥2𝑗 = 0, 𝑥3𝑗 = 1 ) =  (𝛽0 + 𝛽15)  + (𝛽1 + 𝛽16)𝑡𝑖𝑗 + (𝛽2 + 𝛽17)𝑡𝑖𝑗
2 + (𝛽3 + 𝛽18)𝑡𝑖𝑗
3 + (𝛽4 + 𝛽19)𝑡𝑖𝑗
4  




Calculating Depressive Symptoms Scores at Different Ages 
To calculate and compare the varying depressive symptoms scores for the different trajectories, we first ran the model (i.e., the no trauma vs any trauma) to 
obtain the estimates from the two trajectories. The population averaged relationship conditional on the covariates is then given as follows: 
 
E(𝑦𝑖𝑗|𝑡𝑖𝑗, 𝑥1𝑗) = 𝛽0 + 𝛽1𝑡𝑖𝑗 + 𝛽2𝑡𝑖𝑗
2 + 𝛽3𝑡𝑖𝑗
3 + 𝛽4𝑡𝑖𝑗
4 + 𝛽5𝑥1𝑗 + 𝛽6𝑥1𝑗𝑡𝑖𝑗 + 𝛽7𝑥1𝑗𝑡𝑖𝑗
2 + 𝛽8𝑥1𝑗𝑡𝑖𝑗
3  + 𝛽9𝑥1𝑗𝑡𝑖𝑗
4  
(Appendix Equation 7.12) 
This model can alternatively be written as: 
 





Yes Trauma: 𝐸(𝑦𝑖𝑗|𝑡𝑖𝑗 , 𝑥1𝑗 = 1) =  (𝛽0 + 𝛽5)  + (𝛽1 + 𝛽6)𝑡𝑖𝑗 + (𝛽2 + 𝛽7)𝑡𝑖𝑗
2 + (𝛽3 + 𝛽8)𝑡𝑖𝑗
3 + (𝛽4 + 𝛽9)𝑡𝑖𝑗
4  
(Appendix Equation 7.13) 
As stated above, the intercept score was centred to around age 16.53. The expected outcome at age 16.53 is therefore given by 
 
E(𝑦𝑖𝑗|𝑡𝑖𝑗 = 0, 𝑥1𝑗) = 𝛽0 + 𝛽5𝑥1𝑗 
(Appendix Equation 7.14) 
The any trauma variable was a dummy variable containing the values of 0/1 (with no trauma =0, and yes trauma =1), so the depressive symptoms score at age 
16 for the no trauma trajectory would be the value of 𝛽0 (or the reference category). The depressive symptoms score for the yes trajectory at age 16 would the 
take the value of 𝛽0 + 𝛽5 (the effect of no trauma [the baseline group] + the effect of trauma [the dummy]. 
Or written as follows: 
 
𝑑𝑒𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛𝑎𝑔𝑒16𝑗 = 𝑛𝑜 𝑡𝑟𝑎𝑢𝑚𝑎 𝑖𝑛𝑡𝑒𝑟𝑐𝑒𝑝𝑡 + 𝑦𝑒𝑠 𝑡𝑟𝑎𝑢𝑚𝑎 𝑖𝑛𝑡𝑒𝑟𝑐𝑒𝑝𝑡𝑥1𝑗 
 
 
(Appendix Equation 7.15) 
We can sub in the estimates from the adjusted model in our model formula here where 𝑥1 is 0 or 1: 
 
𝑑𝑒𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛𝑎𝑔𝑒16 = 5.17 + 1.23𝑥1𝑗 
(Appendix Equation 7.16) 
Therefore, if an individual had no trauma, their predicted score would equal just the no trauma intercept (𝛽0, 5.17). However, if an individual had trauma, 
their predicted depressive symptoms score at age 16 would be the no trauma intercept (𝛽0, 5.17) plus the yes trauma intercept (𝛽5, 1.23) = 6.4. We see from 
Table 2 and Table 4 in the manuscript that there is main effect of trauma on predicted depressive symptoms scores at age 16.  
To calculate the depressive symptoms scores at different ages for the no trauma and yes trauma trajectories, we substituted the ages we wanted to investigate 
in for 𝑡𝑖𝑗 and 0/1 for the trauma dummy variable 𝑥1𝑗. In the main analysis in the manuscript, we calculated depressive symptoms scores at seven different 
ages (12, 14, 16, 18, 20, 22 and 24). To calculate the predicted depressive symptoms scores at age 12, we first calculated the mean centred age value to 
substitute for 𝑡𝑖𝑗 in our model (12 - 16.53 = -4.53). We ran the initial model (in supplementary equation 12) to obtain the estimates and then substituted in the 
values for 𝛽, 𝑡𝑖𝑗 and 𝑥1𝑗. For age 12 in the adjusted model, this took the following form where 𝑥1𝑗 is 0 or 1: 
 
𝑑𝑒𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛𝑎𝑔𝑒12𝑗 = 5.17 + (0.32 × −4.53) + (−0.10 × −4.53
2) + (−0.004 × −4.533) + (0.002 × −4.534) 
+1.23 × 𝑥1𝑗 + (0.06 × 𝑥1𝑗 × −4.53) + (−0.001 × 𝑥1𝑗 × −4.53
2) + (−0.001 × 𝑥1𝑗 × −4.53
3)  + (0.0001 × 𝑥1𝑗 × −4.53
4) 
(Appendix Equation 7.17) 
Adding this up, we get the following results for the two different trajectories: 
 




No Trauma Score at Age 12 = 2.9 
Yes Trauma at Age 12 = (𝛽0 + 𝛽5)  + (𝛽1 + 𝛽6)𝑡𝑖𝑗 + (𝛽2 + 𝛽7)𝑡𝑖𝑗
2 + (𝛽3 + 𝛽8)𝑡𝑖𝑗
3 + (𝛽4 + 𝛽9)𝑡𝑖𝑗
4  
Yes Trauma at Age 12 = 4.03 
 
 
(Appendix Equation 7.18) 
Finally, we used ‘nlcom’ in Stata to compare these scores to determine if there is a statistical difference in predicted depressive symptoms between these two 
trauma groups at age 12. ‘nlcom’ is a postestimation command that carries over additional information such as standard errors and confidence intervals when 
calculating postestimations, making it a useful tool for assessing multiple comparisons with levels of certainty.  
 
We used the same format for the remaining ages as well as for the more complex model involving the number of traumas (0, 1, 2, 3+). For instance, to 
calculate the differences at age 22, we just substitute in the difference between 22 and 16.53 (5.47) in place of 𝑡𝑖𝑗. The same format can easily be extended for 




Appendix Table 7.1. Unadjusted Associations Between Any Trauma (between 5-10 Years) and SMFQ Trajectories (n=8,738) 
  Direct Model Output Alternative Parametrisation 
Parameter Estimate Std. Error p-value Estimate Std. Error p-value 
𝛽0 No Trauma Intercept 5.75 [5.61, 5.90] 0.07 <.001 5.75 [5.61, 5.90] 0.07 <.001 
𝛽1 No Trauma x Age 0.33 [0.30, 0.37] 0.02 <.001 0.33 [0.30, 0.37] 0.02 <.001 
𝛽2 No Trauma x Age
2 -0.10 [-0.11, -0.09] 0.01 <.001 -0.1 [-0.11, -0.09] 0.01 <.001 
𝛽3 No Trauma x Age
3 -0.005 [-0.01, -0.004] 0.0005 <.001 -0.005 [-0.01, -0.004] 0.0005 <.001 
𝛽4 No Trauma x Age
4 0.002 [0.002, 0.002] 0.0001 <.001 0.002 [0.002, 0.002] 0.0001 <.001 
𝛽5 Yes Trauma Intercept 1.36 [1.12, 1.60] 0.12 <.001 7.11 [6.92, 7.3] 0.12 <.001 
𝛽6 Yes Trauma x Age 0.09 [0.03, 0.15] 0.03 0.003 0.42 [0.38, 0.47] 0.03 0.003 
𝛽7 Yes Trauma x Age
2 -0.01 [-0.02, 0.01] 0.01 0.59 -0.1 [-0.12, 0.09] 0.01 0.59 
𝛽8 Yes Trauma x Age
3 -0.002 [-0.003, -0.0004] 0.001 0.01 -0.007 [-0.008, -0.006] 0.001 0.01 
𝛽9 Yes Trauma x Age
4 0.0002 [-0.0002, 0.001] 0.0002 0.33 0.002 [0.002, 0.002] 0.0002 0.33 
Deviance 238151.27 
The no trauma variable should be viewed as the reference category as trauma was coded as a dummy variable (0/1). Thus, the intercept score (and subsequent 




Appendix Table 7.2. Unadjusted Associations Between Number of Traumas (5-10 Years) and SMFQ Trajectories (n=8,872) 
The no traumas variable should be viewed as the reference category as the number of traumas were coded as dummy variable (0/1/2/3). Thus, the intercept 
score (and subsequent age terms) for an individual with 3+ traumas is the no trauma intercept + 3+ traumas intercept (i.e., 𝛽0 + 𝛽15). The same applies for all 
age terms. The standard error and p-value correspond to the differences between the trauma estimates and the no trauma differences.  
 
  Direct Model Output Alternative Parametrisation 
Parameter Estimate Std. Error p-value Estimate Std. Error p-value 
𝛽0 No Traumas Intercept  5.78 [5.64, 5.93] 0.07 <.001 5.78 [5.64, 5.93] 0.07 <.001 
𝛽1 No Traumas x Age  0.33 [0.30, 0.37] 0.02 <.001 0.33 [0.30, 0.37] 0.02 <.001 
𝛽2 No Traumas x Age
2  -0.10 [-0.11, -0.09] 0.01 <.001 -0.1 [-0.11, -0.09] 0.01 <.001 
𝛽3 No Traumas x Age
3  -0.005 [-0.01, -0.004] 0.0005 <.001 -0.005 [-0.01, -0.004] 0.0005 <.001 
𝛽4 No Traumas x Age
4  0.002 [0.002, 0.002] 0.0001 <.001 0.002 [0.002, 0.002] 0.0001 <.001 
𝛽5 1 Trauma Intercept 0.81 [0.54, 1.08] 0.14 <.001 6.59 [6.36, 6.82] 0.12 <.001 
𝛽6 1 Trauma x Age 0.05 [-0.02, 0.12] 0.03 0.15 0.38 [0.32, 0.44] 0.03 0.15 
𝛽7 1 Trauma x Age
2 0.01 [-0.01, 0.03] 0.01 0.24 -0.08 [-0.1, -0.07] 0.01 0.24 
𝛽8 1 Trauma x Age
3 -0.001 [-0.003, 0.0003] 0.001 0.11 -0.006 [-0.008, -0.005] 0.001 0.11 
𝛽9 1 Trauma x Age
4 -0.0002 [-0.001, 0.0003] 0.0002 0.45 0.002 [0.001, 0.002] 0.0002 0.45 
𝛽10 2 Traumas Intercept 1.9 [1.48, 2.32] 0.21 <.001 7.69 [7.29, 8.08] 0.21 <.001 
𝛽11 2 Traumas x Age 0.15 [0.04, 0.25] 0.05 0.005 0.48 [0.38, 0.58] 0.05 0.005 
𝛽12 2 Traumas x Age
2 -0.02 [-0.05, 0.01] 0.02 0.27 -0.12 [-0.14, -0.09] 0.02 0.27 
𝛽13 2 Traumas x Age
3 -0.003 [-.0.01, -0.00005] 0.001 0.05 -0.007 [-.0.01, -0.005] 0.001 0.05 
𝛽14 2 Traumas x Age
4 0.001 [-0.0001, 0.001] 0.0003 0.09 0.002 [0.002, 0.003] 0.0003 0.09 
𝛽15 3+ Traumas Intercept 3.63 [3.01, 4.26] 0.32 <.001 9.42 [8.81, 10.03] 0.32 <.001 
𝛽16 3+ Traumas x Age 0.23 [0.08, 0.39] 0.08 0.003 0.57 [0.42, 0.71] 0.08 0.003 
𝛽17 3+ Traumas x Age
2 -0.09 [-0.14, -0.05] 0.02 <.001 -0.19 [-0.24, -0.14] 0.02 <.001 
𝛽18 3+ Traumas x Age
3 -0.005 [-0.01, -0.001] 0.002 0.03 -0.009 [-0.01, -0.005] 0.002 0.03 
𝛽19 3+ Traumas x Age








1. Genotyping Information 
Participants were genotyped using the Illumina HumanHap550 quad chip. Individuals were 
excluded based on gender mismatches, minimal or excessive heterozygosity, disproportionate 
levels of individual missingness (>3%), evidence of cryptic relatedness (>10% of alleles 
identical by descent), insufficient sample replication (IBD < 0.8) and being of non-European 
ancestry (assessed by multidimensional scaling analysis including HapMap 2 individuals). 
Thus, our analysis is only on individuals of European descent. SNPs with a minor allele 
frequency (MAF) of < 1%, Impute2 information quality metric of < 0.8, a call rate of < 95% 
or evidence for violations of Hardy-Weinberg equilibrium (P-value < 5e-7) were removed. 
Imputation performed using Impute v2.2.2 with the 1000 genomes reference panel (Phase 1, 
Version 3), using 2186 reference haplotypes. The maximum number of single nucleotide 
polymorphisms (snps) that were imputed (and passed filtering on MAF of > 1% and info 
score > 80%) was 8282911. In the case of siblings, one individual was dropped from analysis 
in order not to inflate the genetic effect, thus all results are based upon singletons. 
2. Negative Control Variables 
Height in centimetres (cm) was measured at research clinics on eight occasions between ages 
7 and 18. The methods for creating the PRS for height were identical to those listed above, 
except summary statistics for the height GWAS were based on 253,288 individuals (Wood et 
al., 2014), and the PRS was weighted on the effect sizes of 93,588 SNPs.   
Statistical Methods 
1. Negative Control Analysis 
We ran negative control analysis between the height PRS and trajectories of depressive 
symptoms. Negative control exposures are used to examine whether observed associations 
are likely due to a bias that is expected to affect both the exposure and the control exposure, 
but where the control exposure should not affect the outcome. In this context, this was to 
ensure that the association between the depressive symptoms PRS and change in depressive 
symptoms was not due to analysing additional measures in a trajectories framework (i.e., 
change over time being a statistical artefact as a result of more power). We then ran 
additional analysis examining the association between the depressive symptoms PRS and 
height trajectories. Height trajectories were modelled using quadratic polynomial growth 




2. Model Fit 
Model fit for the trajectories were assessed using deviance, Akaike information criterion 
(AIC) and Bayesian information criterion (BIC), as recommended by (Singer & Willett, 
2003). Briefly, lower deviance, AIC and BIC indicate better model fit. We examined model 
fit twice: on the first occasion we examined model fit for just those with at least one 
assessment of the SMFQ (Table S1). Next, we examined model fit for individuals with at 
least one SMFQ assessment and data on sex, principal components and genetic information 
(PRS) (Table S2). Both analyses indicted that a quartic polynomial model fitted the data the 
best. As a final check, we plotted all four models (linear, quadratic, cubic and quartic) over 
the descriptive data to visually compare the models. This once again indicated that that the 
quartic model was preferred (Figure S1). 
Table S1. Comparisons between polynomial models with SMFQ data (n=9,399). 
Model  Deviance AIC BIC 
Linear Model 254892.8 254904.8 254957 
Quadratic Polynomial  252509.6 253529.6 253616.5 
Cubic Polynomial 253115 253145.5 253275.8 
Quartic Polynomial 252257.2 252299.2 252481.7 
Model fit by the four polynomial models. SMFQ: short mood and feelings questionnaire; 
AIC: Akaike information criterion; BIC: Bayesian information criterion 
Table S2. Comparisons between polynomial models with both SMFQ, sex, 
principal component and PRS data (n=6,305). 
Model  Deviance AIC BIC 
Linear Model 182364.65 182402.6 182561.5 
Quadratic Polynomial  181419.9 181467.9 181668.6 
Cubic Polynomial 181131.22 181191.2 181442.1 
Quartic Polynomial 180512.11 180586.1 180895.6 
Model fit by the four polynomial models. SMFQ: short mood and feelings questionnaire; 








3. Model Equations 
The quartic polynomial model that we chose to use can be denoted by the following equation: 
𝑦𝑖𝑗 = 𝛽0 + 𝛽1𝑡𝑖𝑗 + 𝛽2𝑡𝑖𝑗
2 + 𝛽3𝑡𝑖𝑗
3 + 𝛽4𝑡𝑖𝑗




+𝑢0𝑗 + 𝑢1𝑗𝑡𝑖𝑗 + 𝑢2𝑗𝑡𝑖𝑗
2 + 𝑢3𝑗𝑡𝑖𝑗
3 + 𝑢3𝑗𝑡𝑖𝑗
4 + 𝑒𝑖𝑗 
(Appendix equation 8.1) 
where 𝑦𝑖𝑗 is the depressive symptom score and 𝑡𝑖𝑗 is the age (centred to 16.53 years, the approximate sample mean) for individual 𝑗 at occasion 
𝑖. Here 𝛽0, 𝛽1, 𝛽2, 𝛽3 and 𝛽4 represent the intercept, linear, quadratic, cubic and quartic fixed effects respectively. 𝑥1𝑗 is the standardised PRS, 
which in this equation represents a main effect of the PRS 𝛽5𝑥1𝑗 followed by the interactions between the PRS and the linear (𝛽6𝑥1𝑗), quadratic 
(𝛽7𝑥1𝑗), cubic (𝛽8𝑥1𝑗) and quartic terms (𝛽9𝑥1𝑗). Also, 𝑢0𝑗, 𝑢1𝑗, 𝑢2𝑗, 𝑢3𝑗 and 𝑢4𝑗 are the random linear, quadratic, cubic and quartic effects that 
allow each individual to have their own unique trajectory that deviates from the population average. Finally, 𝑒𝑖𝑗 is the occasion-specific residual. 



























































(Appendix equation 8.2) 
The elements of the covariance matrix summarise the degree to which individual-specific trajectories vary around the population-averaged 
trajectory. The residuals are assumed normally distributed with zero mean and constant variance:  
𝑒𝑖𝑗~𝑁(0, 𝜎𝑒
2) 




Predicted trajectories of depressive symptoms with the quartic polynomial growth curve model can therefore be defined in two ways: 
To predict both the population average trajectory: 




(Appendix equation 8.4) 
and individual specific trajectories: 
E(𝑦𝑖𝑗|𝑡𝑖𝑗 , 𝑢0𝑗 , 𝑢1𝑗 , 𝑢2𝑗 , 𝑢3𝑗 , 𝑢4𝑗) = 𝛽0 + 𝛽1𝑡𝑖𝑗 + 𝛽2𝑡𝑖𝑗
2 + 𝛽3𝑡𝑖𝑗
3 + 𝛽4𝑡𝑖𝑗




(Appendix equation 8.5) 
Substituting the parameter estimates and the predicted random effect values into the above expression gives the population average and 




Likewise, to examine the association between the PRS and predicted trajectories of depressive symptoms with the quartic polynomial growth 
curve model, one overall model can be specified where 𝑥1𝑗 is the standardised PRS and can be subbed into the equation: 
E(𝑦𝑖𝑗|𝑡𝑖𝑗 , 𝑥1𝑗) = 𝛽0 + 𝛽1𝑡𝑖𝑗 + 𝛽2𝑡𝑖𝑗
2 + 𝛽3𝑡𝑖𝑗
3 + 𝛽4𝑡𝑖𝑗
4 + 𝛽5𝑥1𝑗 + 𝛽6𝑥1𝑗𝑡𝑖𝑗 + 𝛽7𝑥1𝑗𝑡𝑖𝑗
2 + 𝛽8𝑥1𝑗𝑡𝑖𝑗
3  + 𝛽9𝑥1𝑗𝑡𝑖𝑗
4  
(Appendix equation 8.6) 
To examine differences between individuals with greater or less genetic liability, we ran a simple model to examine the association between a 
higher PRS (+1 SD) and a lower PRS (-1 SD) and subsequent trajectories of depressive symptoms. Let 𝑥1𝑗 denote the higher PRS and can be 
multiplied by either 1 (+ SD) or -1 (-1 SD). The model can be written as: 
High PRS: 𝐸(𝑦𝑖𝑗|𝑡𝑖𝑗 , 𝑥1𝑗) =  (𝛽0 + 𝛽5)*1 + (𝛽1 + 𝛽6)𝑡𝑖𝑗*1 + (𝛽2 + 𝛽7)𝑡𝑖𝑗
2 *1 + (𝛽3 + 𝛽8)𝑡𝑖𝑗
3 *1 + (𝛽4 + 𝛽9)𝑡𝑖𝑗
4 *1 
Low PRS: 𝐸(𝑦𝑖𝑗|𝑡𝑖𝑗, 𝑥1𝑗) =  (𝛽0 + 𝛽5)*-1 + (𝛽1 + 𝛽6)𝑡𝑖𝑗*-1 + (𝛽2 + 𝛽7)𝑡𝑖𝑗
2 *-1 + (𝛽3 + 𝛽8)𝑡𝑖𝑗
3 *-1 + (𝛽4 + 𝛽9)𝑡𝑖𝑗
4 *-1 







3.5. Negative Control Analysis 
Negative control analysis using a PRS for height found no association between the height 
PRSand depressive symptoms at the intercept age (P = 0.753), or an association with change 
over time (Ps ≥ 0.250). Similar results were observed for the other negative control of the 
depressive symptoms PRS and trajectories of height (Ps ≥ 0.330), all of which implying that 




Table S3 Association Between Depressive Symptoms PRS and Depressive Symptoms at Age 10.60 (N=5320) 







FDR Adjusted P with 0.05 Level ΔR2  
5.00x10-08 0.056 -0.037 0.151 0.237 0.348 0.02% 
5.00 x10-07 0.007 -0.100 0.086 0.887 0.939 0.00% 
5.00 x10-06 0.013 -0.080 0.106 0.777 0.848 0.00% 
5.00 x10-05 0.106 0.012 0.201 0.028 0.067 0.09% 
5.00 x10-04 0.101 0.007 0.195 0.035 0.081 0.08% 
5.00 x10-03 0.091 -0.003 0.185 0.057 0.121 0.06% 
5.00 x10-02 0.088 -0.007 0.183 0.124 0.223 0.06% 
5.00 x10-01 0.129 0.034 0.223 0.008 0.026 0.13% 
PRS: Polygenic risk score; FDR: False Discovery rate. Incremental R2 (ΔR2) or the percentage of variance explained by the polygenic risk score 
was calculated by first regressing depressive symptoms on age, sex and first ten principal components of ancestry, then including the PRS and 
comparing the variance explained in the two models. 
Table S4 Association Between Depressive Symptoms PRS and Depressive Symptoms at Age 12.80 (N=4928) 







FDR Adjusted P with 0.05 Level ΔR2  
5.00x10-08 0.044 -0.151 0.063 0.416 0.565 0.01% 
5.00 x10-07 0.038 -0.067 0.143 0.478 0.604 0.01% 
5.00 x10-06 0.029 -0.136 0.077 0.593 0.689 0.00% 
5.00 x10-05 0.023 -0.086 0.131 0.68 0.765 0.00% 
5.00 x10-04 0.043 -0.064 0.150 0.434 0.568 0.01% 
5.00 x10-03 0.145 0.038 0.252 0.008 0.024 0.14% 
5.00 x10-02 0.146 0.039 0.254 0.008 0.025 0.14% 
5.00 x10-01 0.210 0.102 0.317 0.0001 0.0008 0.29% 
PRS: Polygenic risk score; FDR: False Discovery rate. Incremental R2 (ΔR2) or the percentage of variance explained by the polygenic risk score 
was calculated by first regressing depressive symptoms on age, sex and first ten principal components of ancestry, then including the PRS and 




Table S5 Association Between Depressive Symptoms PRS and Depressive Symptoms at Age 13.80 (N=4495) 







FDR Adjusted P with 0.05 Level ΔR2  
5.00x10-08 0.051 -0.181 0.079 0.44 0.566 0.01% 
5.00 x10-07 0.045 -0.081 0.172 0.482 0.598 0.01% 
5.00 x10-06 0.063 -0.192 0.065 0.333 0.470 0.02% 
5.00 x10-05 0.004 -0.128 0.137 0.948 0.975 0.00% 
5.00 x10-04 0.189 0.059 0.319 0.004 0.016 0.18% 
5.00 x10-03 0.163 0.034 0.292 0.013 0.035 0.13% 
5.00 x10-02 0.093 -0.036 0.222 0.158 0.265 0.04% 
5.00 x10-01 0.170 0.041 0.299 0.01 0.028 0.14% 
PRS: Polygenic risk score; FDR: False Discovery rate. Incremental R2 (ΔR2) or the percentage of variance explained by the polygenic risk score 
was calculated by first regressing depressive symptoms on age, sex and first ten principal components of ancestry, then including the PRS and 
comparing the variance explained in the two models. 
Table S6 Association Between Depressive Symptoms PRS and Depressive Symptoms at Age 16.70 (N=3524) 







FDR Adjusted P with 0.05 Level ΔR2  
5.00x10-08 0.033 -0.147 0.214 0.716 0.793 0.00% 
5.00 x10-07 0.064 -0.115 0.243 0.483 0.589 0.01% 
5.00 x10-06 0.140 -0.041 0.320 0.129 0.227 0.06% 
5.00 x10-05 0.112 -0.072 0.296 0.234 0.351 0.04% 
5.00 x10-04 0.254 0.074 0.434 0.006 0.022 0.20% 
5.00 x10-03 0.349 0.170 0.528 0.0001 0.0009 0.39% 
5.00 x10-02 0.344 0.164 0.524 0.0002 0.001 0.37% 
5.00 x10-01 0.304 0.125 0.483 0.001 0.005 0.29% 
PRS: Polygenic risk score; FDR: False Discovery rate. Incremental R2 (ΔR2) or the percentage of variance explained by the polygenic risk score 
was calculated by first regressing depressive symptoms on age, sex and first ten principal components of ancestry, then including the PRS and 




Table S7 Association Between Depressive Symptoms PRS and Depressive Symptoms at Age 17.80 (N=3212) 





P value FDR Adjusted P with 0.05 Level ΔR2  
5.00x10-08 0.022 -0.201 0.157 0.809 0.869 0.01% 
5.00 x10-07 0.001 -0.185 0.168 0.924 0.964 0.00% 
5.00 x10-06 0.002 -0.177 0.181 0.985 0.985 0.00% 
5.00 x10-05 0.135 -0.047 0.317 0.147 0.252 0.07% 
5.00 x10-04 0.242 0.062 0.422 0.009 0.026 0.21% 
5.00 x10-03 0.364 0.186 0.543 0.00007 0.0008 0.49% 
5.00 x10-02 0.371 0.192 0.550 0.00005 0.0007 0.50% 
5.00 x10-01 0.413 0.236 0.591 5.00x10-06 9.00E-05 0.64% 
PRS: Polygenic risk score; FDR: False Discovery rate. Incremental R2 (ΔR2) or the percentage of variance explained by the polygenic risk score 
was calculated by first regressing depressive symptoms on age, sex and first ten principal components of ancestry, then including the PRS and 
comparing the variance explained in the two models. 
Table S8 Association Between Depressive Symptoms PRS and Depressive Symptoms at Age 18.70 (N=2389) 







FDR Adjusted P with 0.05 Level ΔR2  
5.00x10-08 0.190 -0.038 0.417 0.102 0.198 0.11% 
5.00 x10-07 0.245 0.015 0.474 0.036 0.081 0.18% 
5.00 x10-06 0.156 -0.073 0.384 0.181 0.290 0.07% 
5.00 x10-05 0.054 -0.179 0.288 0.648 0.741 0.01% 
5.00 x10-04 0.138 -0.089 0.365 0.233 0.357 0.06% 
5.00 x10-03 0.453 0.225 0.681 0.0001 0.0007 0.61% 
5.00 x10-02 0.311 0.083 0.539 0.007 0.024 0.29% 
5.00 x10-01 0.339 0.109 0.568 0.004 0.015 0.34% 
PRS: Polygenic risk score; FDR: False Discovery rate. Incremental R2 (ΔR2) or the percentage of variance explained by the polygenic risk score 
was calculated by first regressing depressive symptoms on age, sex and first ten principal components of ancestry, then including the PRS and 




Table S9 Association Between Depressive Symptoms PRS and Depressive Symptoms at Age 21.90 (n=2380) 







FDR Adjusted P with 0.05 Level ΔR2  
5.00x10-08 0.192 -0.024 0.408 0.082 0.164 0.12% 
5.00 x10-07 0.003 -0.220 0.215 0.98 0.994 0.00% 
5.00 x10-06 0.088 -0.129 0.305 0.428 0.571 0.02% 
5.00 x10-05 0.144 -0.077 0.364 0.202 0.316 0.06% 
5.00 x10-04 0.176 -0.041 0.393 0.112 0.207 0.10% 
5.00 x10-03 0.371 0.153 0.590 0.0010 0.005 0.46% 
5.00 x10-02 0.328 0.109 0.546 0.003 0.013 0.35% 
5.00 x10-01 0.352 0.135 0.569 0.001 0.005 0.41% 
PRS: Polygenic risk score; FDR: False Discovery rate. Incremental R2 (ΔR2) or the percentage of variance explained by the polygenic risk score 
was calculated by first regressing depressive symptoms on age, sex and first ten principal components of ancestry, then including the PRS and 
comparing the variance explained in the two models. 
Table S10 Association Between Depressive Symptoms PRS and Depressive Symptoms at Age 22.90 (N=2707) 







FDR Adjusted P with 0.05 Level ΔR2  
5.00x10-08 0.067 -0.134 0.268 0.515 0.608 0.01% 
5.00 x10-07 0.103 -0.101 0.306 0.321 0.462 0.03% 
5.00 x10-06 0.165 -0.039 0.370 0.112 0.212 0.09% 
5.00 x10-05 0.150 -0.058 0.358 0.159 0.260 0.07% 
5.00 x10-04 0.206 0.003 0.408 0.047 0.103 0.14% 
5.00 x10-03 0.427 0.224 0.630 0.0004 0.002 0.61% 
5.00 x10-02 0.429 0.227 0.632 0.0003 0.002 0.62% 
5.00 x10-01 0.456 0.253 0.658 0.0001 0.001 0.70% 
PRS: Polygenic risk score; FDR: False Discovery rate. Incremental R2 (ΔR2) or the percentage of variance explained by the polygenic risk score 
was calculated by first regressing depressive symptoms on age, sex and first ten principal components of ancestry, then including the PRS and 




Table S11 Association Between Depressive Symptoms PRS and Depressive Symptoms at Age 23.90 (N=2715) 





P value FDR Adjusted P with 0.05 Level ΔR2  
5.00x10-08 0.078 -0.144 0.301 0.49 0.588 0.02% 
5.00 x10-07 0.095 -0.125 0.315 0.396 0.548 0.03% 
5.00 x10-06 0.206 -0.017 0.428 0.071 0.146 0.12% 
5.00 x10-05 0.282 0.056 0.508 0.015 0.037 0.22% 
5.00 x10-04 0.276 0.054 0.498 0.015 0.039 0.22% 
5.00 x10-03 0.608 0.389 0.828 5.89x10-08 2.12x10-06 1.07% 
5.00 x10-02 0.610 0.392 0.828 4.64x10-08 3.34x10-06 1.09% 
5.00 x10-01 0.517 0.298 0.737 4.08x10-06 9.79x10-05 0.77% 
PRS: Polygenic risk score; FDR: False Discovery rate. Incremental R2 (ΔR2) or the percentage of variance explained by the polygenic risk score 
was calculated by first regressing depressive symptoms on age, sex and first ten principal components of ancestry, then including the PRS and 




Figure S2. Cross-sectional analysis between varying depressive Symptoms PRS (at three thresholds) and depressive symptoms across 
adolescence  
PT: PRS P value threshold. SMFQ: Short Mood and Feelings Questionnaire (depressive symptoms). Analysis were adjusted for sex, age and the 




Table S12. Association Between Depressive Symptoms PRS and Varying Occasions of Depressive Symptoms 
 PRS Threshold 




































































































































































Average 0.330 - 0.44% 0.302 - 0.38% 0.321 - 0.41% 
PRS: Polygenic Risk Score. Upper and lower 95% confidence intervals for the beta are given in (parenthesis). Incremental R2 (ΔR2) or the 
percentage of variance explained by the polygenic risk score was calculated by first regressing depressive symptoms on age, sex and first ten 
principal components of ancestry, then including the PRS and comparing the variance explained in the two models. The confidence intervals for 





Table S13. Association Between Depressive Symptoms PRS (threshold = 0.005) and Trajectories of Depressive Symptoms (N=6,305) 
Parameter Beta 95% Low CIs 95% High CIs Std. Err. P Value b 
Intercept a 5.872 5.693 6.051 0.091 < .0001 
Age 0.345 0.313 0.377 0.016 < .0001 
Age2 -0.097 -0.107 -0.087 0.005 < .0001 
Age3 -0.005 -0.006 -0.004 0.0004 < .0001 
Age4 0.002 0.002 0.002 0.0001 < .0001 
DS PRS c 0.319 0.186 0.452 0.068 2.47x10-06 
DS PRS x Age 0.044 0.012 0.076 0.016 0.007 
DS PRS x Age2 -0.008 -0.018 0.002 0.005 0.108 
DS PRS x Age3 -0.001 -0.001 0.0003 0.0004 0.208 
DS PRS x Age4 0.0002 0.0000 0.0004 0.0001 0.066 
PRS: Polygenic Risk Score. DS: Depressive Symptoms. Upper and lower 95% confidence intervals for the beta are given in (parenthesis). 
Analysis were adjusted for sex and the first ten principal components of ancestry. 
a The intercept was centered to age 16.53, the mean age of all the assessments. 
b The P values of <.001 represents how that parameter differs from 0.  





Table S14. Association Between Depressive Symptoms PRS (threshold = 0.05) and Trajectories of Depressive Symptoms (N=6,305) 
Parameter Beta 95% Low CIs 95% High CIs Std. Err. P Value b 
Intercept a 5.866 5.687 6.045 0.091 < .0001 
Age 0.344 0.312 0.376 0.016 < .0001 
Age2 -0.097 -0.107 -0.087 0.005 < .0001 
Age3 -0.005 -0.006 -0.004 0.0004 < .0001 
Age4 0.002 0.002 0.002 0.0001 < .0001 
DS PRS c 0.363 0.230 0.496 0.068 8.56x10-08 
DS PRS x Age 0.048 0.016 0.080 0.016 0.003 
DS PRS x Age2 -0.008 -0.018 0.003 0.005 0.143 
DS PRS x Age3 -0.001 -0.001 0.0002 0.0004 0.170 
DS PRS x Age4 0.0001 -0.0001 0.0003 0.0001 0.178 
PRS: Polygenic Risk Score. DS: Depressive Symptoms. Upper and lower 95% confidence intervals for the beta are given in (parenthesis). 
Analysis were adjusted for sex and the first ten principal components of ancestry. 
a The intercept was centered to age 16.53, the mean age of all the assessments. 
b The P values of <.001 represents how that parameter differs from 0.  




Table S15. Association Between Depressive Symptoms PRS (threshold = 0.5) and Trajectories of Depressive Symptoms (N=6,305) 
Parameter Beta 95% Low CIs 95% High CIs Std. Err. P Value b 
Intercept a 5.871 5.692 6.050 0.091 < .0001 
Age 0.345 0.313 0.377 0.016 < .0001 
Age2 -0.097 -0.107 -0.087 0.005 < .0001 
Age3 -0.005 -0.006 -0.004 0.0004 < .0001 
Age4 0.002 0.002 0.002 0.0001 < .0001 
DS PRS c 0.332 0.200 0.465 0.068 8.52x10-07 
DS PRS x Age 0.036 0.004 0.068 0.016 0.028 
DS PRS x Age2 -0.003 -0.013 0.007 0.005 0.563 
DS PRS x Age3 -0.0003 -0.001 0.001 0.0004 0.481 
DS PRS x Age4 0.0001 -0.0001 0.0003 0.0001 0.520 
PRS: Polygenic Risk Score. DS: Depressive Symptoms. Upper and lower 95% confidence intervals for the beta are given in (parenthesis). 
Analysis were adjusted for sex and the first ten principal components of ancestry. 
a The intercept was centered to age 16.53, the mean age of all the assessments. 
b The P values of <.001 represents how that parameter differs from 0.  




Table S16. Association between the height PRS and trajectories of depressive symptoms (N=6,305) 
  Beta 95% Low CIs 95% High CIs Std. Err. P-value 
Intercept 5.863 5.683 6.043 0.092 < .0001 
Age 0.343 0.311 0.375 0.016 < .0001 
Age2 -0.097 -0.107 -0.087 0.005 < .0001 
Age3 -0.005 -0.006 -0.004 0.0004 < .0001 
Age4 0.002 0.002 0.002 0.0001 < .0001 
HEI PRS -0.021 -0.154 0.111 0.068 0.753 
HEI PRS x Age 0.019 -0.013 0.050 0.016 0.250 
HEI PRS x Age2 0.003 -0.007 0.013 0.005 0.535 
HEI PRS x Age3 -0.0003 -0.001 0.001 0.0004 0.501 
HEI PRS x Age4 -0.0001 -0.0003 0.0001 0.0001 0.400 
PRS: Polygenic Risk Score. HEI: Height. Upper and lower 95% confidence intervals for the beta are given in (parenthesis). Analysis were 
adjusted for sex and the first ten principal components of ancestry. 
a The intercept was centered to age 16.53, the mean age of all the assessments. 
b The P values of <.001 represents how that parameter differs from 0.  








Table S17. Association between the depressive symptoms PRS and trajectories of height (N=6,754) 
  Beta 95% Low CIs 95% High CIs Std. Err. P-value 
Intercept 154.031 153.773 154.289 0.132 < .0001 
Age 5.209 5.188 5.230 0.011 < .0001 
Age2 -0.237 -0.242 -0.231 0.003 < .0001 
DS PRS -0.085 -0.255 0.086 0.087 0.330 
DS PRS x Age 0.007 -0.014 0.028 0.011 0.519 
DS PRS x Age2 -0.001 -0.007 0.004 0.003 0.650 
PRS: Polygenic Risk Score. DS: Depressive Symptoms. Upper and lower 95% confidence intervals for the beta are given in (parenthesis). 
Analysis were adjusted for sex and the first ten principal components of ancestry. 
a The intercept was centered to age 12.02, the mean age of all the assessments. 
b The P values of <.001 represents how that parameter differs from 0.  
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